{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "gpuType": "T4",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    },
    "accelerator": "GPU",
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "e5e18bc3c3c342c9ac8a526877b4cb1e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a7cade8268d64542a94de9792905ddc8",
              "IPY_MODEL_281bc1a8b7484e3592a2ac97ce7bdf7e",
              "IPY_MODEL_ca6c6f66dfb24b66923f40c4f39c7108"
            ],
            "layout": "IPY_MODEL_7fd4d002083342fd9382ec0df9035b43"
          }
        },
        "a7cade8268d64542a94de9792905ddc8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_361053b11a9a4325b14a66b80bf73b05",
            "placeholder": "​",
            "style": "IPY_MODEL_138af7168445426aa0bdb435e2af4412",
            "value": "modules.json: 100%"
          }
        },
        "281bc1a8b7484e3592a2ac97ce7bdf7e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_59f932776e174d8f8c86d5fdc6f40ff9",
            "max": 387,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_7a33e2a643344b9d854100b5afd7184e",
            "value": 387
          }
        },
        "ca6c6f66dfb24b66923f40c4f39c7108": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b65a8d002e324579a368b7f68fe63118",
            "placeholder": "​",
            "style": "IPY_MODEL_9b9153a71c4e4322a8d7953a7b8700d8",
            "value": " 387/387 [00:00&lt;00:00, 39.7kB/s]"
          }
        },
        "7fd4d002083342fd9382ec0df9035b43": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "361053b11a9a4325b14a66b80bf73b05": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "138af7168445426aa0bdb435e2af4412": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "59f932776e174d8f8c86d5fdc6f40ff9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7a33e2a643344b9d854100b5afd7184e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "b65a8d002e324579a368b7f68fe63118": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9b9153a71c4e4322a8d7953a7b8700d8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "d62b1428700d44549f63aeee7c469106": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_8c133b2ebc604b8ea7a5c3847242e322",
              "IPY_MODEL_6daeb6dd3ca64b8085e8567c5c397ec5",
              "IPY_MODEL_db7ba887252d49099dfb0bc0d16745ae"
            ],
            "layout": "IPY_MODEL_3f4091ce899c429a8c53d61bf21cb4f8"
          }
        },
        "8c133b2ebc604b8ea7a5c3847242e322": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2a81c7960ee046dfa0676c6da2c8357c",
            "placeholder": "​",
            "style": "IPY_MODEL_3ce42a028ce6468fb5cf73a5c9a6f2bb",
            "value": "README.md: "
          }
        },
        "6daeb6dd3ca64b8085e8567c5c397ec5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_111ea3c615af477c8094acc3f55db7fc",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_08f2d0a62982492ab522c48a00055856",
            "value": 1
          }
        },
        "db7ba887252d49099dfb0bc0d16745ae": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_82fb7ff841c045f0aaf0f753d0114ba4",
            "placeholder": "​",
            "style": "IPY_MODEL_00f1622f2c384c2d9c28346483878517",
            "value": " 160k/? [00:00&lt;00:00, 9.60MB/s]"
          }
        },
        "3f4091ce899c429a8c53d61bf21cb4f8": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2a81c7960ee046dfa0676c6da2c8357c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3ce42a028ce6468fb5cf73a5c9a6f2bb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "111ea3c615af477c8094acc3f55db7fc": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "08f2d0a62982492ab522c48a00055856": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "82fb7ff841c045f0aaf0f753d0114ba4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "00f1622f2c384c2d9c28346483878517": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "d9e2f639c1504a30ace4c0e84a96e1d0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_c8dfc30aa446481a91284b1c12d6da12",
              "IPY_MODEL_4eb812fb9f424ec690ac1563427e9920",
              "IPY_MODEL_afddec816feb4a1d9ac22d041ccde51e"
            ],
            "layout": "IPY_MODEL_f063908caecf481c9cc3b9766cdeec36"
          }
        },
        "c8dfc30aa446481a91284b1c12d6da12": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8b0f8aed0022447593c4e59cc83f8ca7",
            "placeholder": "​",
            "style": "IPY_MODEL_cb4e713b5990447795571c636dd7b233",
            "value": "sentence_bert_config.json: 100%"
          }
        },
        "4eb812fb9f424ec690ac1563427e9920": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_eab001fb2b0c4d3c90c0b17ff4d49b8b",
            "max": 57,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_288500fc3c084b01ae37d2b408d9185e",
            "value": 57
          }
        },
        "afddec816feb4a1d9ac22d041ccde51e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0c3769ad37064d5880776a8192613b26",
            "placeholder": "​",
            "style": "IPY_MODEL_def3e4acfbe54552a42feafd0120f205",
            "value": " 57.0/57.0 [00:00&lt;00:00, 6.25kB/s]"
          }
        },
        "f063908caecf481c9cc3b9766cdeec36": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8b0f8aed0022447593c4e59cc83f8ca7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "cb4e713b5990447795571c636dd7b233": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "eab001fb2b0c4d3c90c0b17ff4d49b8b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "288500fc3c084b01ae37d2b408d9185e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "0c3769ad37064d5880776a8192613b26": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "def3e4acfbe54552a42feafd0120f205": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "4ac3682ec65d4d88b16e533c3179e224": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_953331cd82994165917122dd2d02a1fa",
              "IPY_MODEL_2a86bf38c07c431092e33e83febeb90c",
              "IPY_MODEL_94ac5f53dbd94841abec19682c82572d"
            ],
            "layout": "IPY_MODEL_e901b4086d1c4aa1ba2b24bec32ef5b8"
          }
        },
        "953331cd82994165917122dd2d02a1fa": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_be22d9039e2842a0b4f185a41b0921d7",
            "placeholder": "​",
            "style": "IPY_MODEL_1813879d6a824e2fb52a33115a1d9ccb",
            "value": "config.json: 100%"
          }
        },
        "2a86bf38c07c431092e33e83febeb90c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f01687b60f534708bfc385613205b6ce",
            "max": 690,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_a71d436b8f014da09e2bf3dab900d93d",
            "value": 690
          }
        },
        "94ac5f53dbd94841abec19682c82572d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_22eae06327254c81ae0c2ab666e5fe2e",
            "placeholder": "​",
            "style": "IPY_MODEL_75c1e26c267a4c82af27a2d0f5e1b09b",
            "value": " 690/690 [00:00&lt;00:00, 50.7kB/s]"
          }
        },
        "e901b4086d1c4aa1ba2b24bec32ef5b8": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "be22d9039e2842a0b4f185a41b0921d7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1813879d6a824e2fb52a33115a1d9ccb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f01687b60f534708bfc385613205b6ce": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a71d436b8f014da09e2bf3dab900d93d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "22eae06327254c81ae0c2ab666e5fe2e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "75c1e26c267a4c82af27a2d0f5e1b09b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "d1132cc70a3646bcb24daeaf7775d58f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a28450a8c3064563a389b2420f290734",
              "IPY_MODEL_9447ec42ea124fd0833527926c8e70b7",
              "IPY_MODEL_8e3b7c92d542455f81a8241620a004e1"
            ],
            "layout": "IPY_MODEL_7da065cef452466abc0e83e5b928bb07"
          }
        },
        "a28450a8c3064563a389b2420f290734": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8472001b54934d6c957e413235641d99",
            "placeholder": "​",
            "style": "IPY_MODEL_7327144ecc764a718011a44f1f2c7876",
            "value": "model.safetensors: 100%"
          }
        },
        "9447ec42ea124fd0833527926c8e70b7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1ae015a8247a486ba807ef12356202e0",
            "max": 2239611368,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_287118b1b93f4f41b6643eca640c9b92",
            "value": 2239611368
          }
        },
        "8e3b7c92d542455f81a8241620a004e1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_17b72cf6fb2b49eda0c0891a29afdc88",
            "placeholder": "​",
            "style": "IPY_MODEL_06ec303a55be4842b2677eb0ada48100",
            "value": " 2.24G/2.24G [00:40&lt;00:00, 58.1MB/s]"
          }
        },
        "7da065cef452466abc0e83e5b928bb07": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8472001b54934d6c957e413235641d99": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7327144ecc764a718011a44f1f2c7876": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "1ae015a8247a486ba807ef12356202e0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "287118b1b93f4f41b6643eca640c9b92": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "17b72cf6fb2b49eda0c0891a29afdc88": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "06ec303a55be4842b2677eb0ada48100": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "dac87753fe914aaa828acc15bc364488": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a51d6b10bd4f4474b3c05f26a3509d83",
              "IPY_MODEL_f543a12a7211442694d3018d9840bee7",
              "IPY_MODEL_5531b87614844432932c791100b9255d"
            ],
            "layout": "IPY_MODEL_2884a5d1915e4a18afd894ab44a4f959"
          }
        },
        "a51d6b10bd4f4474b3c05f26a3509d83": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0db8ed74a3434ff9ae5a512fe056fc18",
            "placeholder": "​",
            "style": "IPY_MODEL_2b7c0a9cb34f4540b91cec3c70259898",
            "value": "tokenizer_config.json: 100%"
          }
        },
        "f543a12a7211442694d3018d9840bee7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b60e227205f442bbbafb6d9750aba76f",
            "max": 418,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_21a862f67c524ad2b10abfb13db8cd95",
            "value": 418
          }
        },
        "5531b87614844432932c791100b9255d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3057d156645f4d3a979ab007db8b19c2",
            "placeholder": "​",
            "style": "IPY_MODEL_40dec4b166fb430ab15f0d6f76d0569b",
            "value": " 418/418 [00:00&lt;00:00, 45.9kB/s]"
          }
        },
        "2884a5d1915e4a18afd894ab44a4f959": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0db8ed74a3434ff9ae5a512fe056fc18": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2b7c0a9cb34f4540b91cec3c70259898": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b60e227205f442bbbafb6d9750aba76f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "21a862f67c524ad2b10abfb13db8cd95": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "3057d156645f4d3a979ab007db8b19c2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "40dec4b166fb430ab15f0d6f76d0569b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "37c79270654d4488b8c236a00684650c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_d4ea104c47d94346801c093c4c1e1ea4",
              "IPY_MODEL_8bd4df566cc2438d938bcede86d0687c",
              "IPY_MODEL_7996f15a9cd043de8c17ffe02f472d1b"
            ],
            "layout": "IPY_MODEL_b78f5a9b5b684937b7f09dfc0ec8e906"
          }
        },
        "d4ea104c47d94346801c093c4c1e1ea4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_af6f38a8fe4e4a15b8f91d19e2f33a2f",
            "placeholder": "​",
            "style": "IPY_MODEL_b23d752510124d0d8ed484a001590c3b",
            "value": "sentencepiece.bpe.model: 100%"
          }
        },
        "8bd4df566cc2438d938bcede86d0687c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_67a447e8e1d049a6b8968e6205e0f564",
            "max": 5069051,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_fb8313f5c91947748736569daff407bb",
            "value": 5069051
          }
        },
        "7996f15a9cd043de8c17ffe02f472d1b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b850cd17e56441348a0066b6dd6ec690",
            "placeholder": "​",
            "style": "IPY_MODEL_9b4da66e9da44b4b982ea84fa1230cb7",
            "value": " 5.07M/5.07M [00:00&lt;00:00, 8.53MB/s]"
          }
        },
        "b78f5a9b5b684937b7f09dfc0ec8e906": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "af6f38a8fe4e4a15b8f91d19e2f33a2f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b23d752510124d0d8ed484a001590c3b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "67a447e8e1d049a6b8968e6205e0f564": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "fb8313f5c91947748736569daff407bb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "b850cd17e56441348a0066b6dd6ec690": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9b4da66e9da44b4b982ea84fa1230cb7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2357f1d3a3d34e62a19935b39e9d809f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_87e332bb8df14003a9cad342f54e7c8b",
              "IPY_MODEL_644eaf75f5cd45a5b67ced0d6fcc981b",
              "IPY_MODEL_60bc9d2d983c4a74bfa9f377b93c08fe"
            ],
            "layout": "IPY_MODEL_93aaaf002a55440e83902584d0a04ba1"
          }
        },
        "87e332bb8df14003a9cad342f54e7c8b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6080604458874e708b6740a0cd6d7304",
            "placeholder": "​",
            "style": "IPY_MODEL_dcefc9162874485c8d671b3b576b43a3",
            "value": "tokenizer.json: 100%"
          }
        },
        "644eaf75f5cd45a5b67ced0d6fcc981b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ed3284d9f10946759a022544c2526f26",
            "max": 17082660,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_b46fa33afb424b3889c0e18cfea87989",
            "value": 17082660
          }
        },
        "60bc9d2d983c4a74bfa9f377b93c08fe": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1634cd9114fb41a6b9cfbcb4d72f7de9",
            "placeholder": "​",
            "style": "IPY_MODEL_6e3be71b15084b78ae74b30f9cd2527b",
            "value": " 17.1M/17.1M [00:00&lt;00:00, 34.2MB/s]"
          }
        },
        "93aaaf002a55440e83902584d0a04ba1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6080604458874e708b6740a0cd6d7304": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "dcefc9162874485c8d671b3b576b43a3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ed3284d9f10946759a022544c2526f26": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b46fa33afb424b3889c0e18cfea87989": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "1634cd9114fb41a6b9cfbcb4d72f7de9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6e3be71b15084b78ae74b30f9cd2527b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "29efe5b446514c36b8807978f2754df8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_5bbc37fa54d947768c8f7b5bfa438121",
              "IPY_MODEL_2d1479239a5748c89268a122bce23377",
              "IPY_MODEL_5d17de7b3a794587a964ac674cff0740"
            ],
            "layout": "IPY_MODEL_41da561fe83f426991b48af3cd79e464"
          }
        },
        "5bbc37fa54d947768c8f7b5bfa438121": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c0cb300f8d0f4702956762185b7874c7",
            "placeholder": "​",
            "style": "IPY_MODEL_6b70e3ebe64d482a9399a57dca01a9b9",
            "value": "special_tokens_map.json: 100%"
          }
        },
        "2d1479239a5748c89268a122bce23377": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c51d690ac08f4c05885ae115391128f2",
            "max": 280,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_b54a4c64366b4bcfadb4887a68d52674",
            "value": 280
          }
        },
        "5d17de7b3a794587a964ac674cff0740": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_be06da1080444ce88ba941c885012f83",
            "placeholder": "​",
            "style": "IPY_MODEL_19a69851e2f74a3a94c877cde1a03962",
            "value": " 280/280 [00:00&lt;00:00, 33.6kB/s]"
          }
        },
        "41da561fe83f426991b48af3cd79e464": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c0cb300f8d0f4702956762185b7874c7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6b70e3ebe64d482a9399a57dca01a9b9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "c51d690ac08f4c05885ae115391128f2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b54a4c64366b4bcfadb4887a68d52674": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "be06da1080444ce88ba941c885012f83": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "19a69851e2f74a3a94c877cde1a03962": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "a513b0301e964553a535b3c089c386cb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_370b23730d6c43ac80830a85a9317db9",
              "IPY_MODEL_1d83c9e8262f4adfb04c2e7dc34ab788",
              "IPY_MODEL_3bd3802355f0455eba3009d46f877697"
            ],
            "layout": "IPY_MODEL_95749b352d60458d8d206e3ca682913f"
          }
        },
        "370b23730d6c43ac80830a85a9317db9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_eaeedd1cb8904539a1c8edc61a93d5af",
            "placeholder": "​",
            "style": "IPY_MODEL_75a146adda24480e8dbdd2cd47c26326",
            "value": "config.json: 100%"
          }
        },
        "1d83c9e8262f4adfb04c2e7dc34ab788": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_58f738534fb74bfebdf999151cfd9cb2",
            "max": 201,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_f73816581b074b5bae1c552501df851c",
            "value": 201
          }
        },
        "3bd3802355f0455eba3009d46f877697": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c8fb111764be4e3187d8b794d117402e",
            "placeholder": "​",
            "style": "IPY_MODEL_5f9d65071876428ab508e0069db07c79",
            "value": " 201/201 [00:00&lt;00:00, 2.28kB/s]"
          }
        },
        "95749b352d60458d8d206e3ca682913f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "eaeedd1cb8904539a1c8edc61a93d5af": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "75a146adda24480e8dbdd2cd47c26326": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "58f738534fb74bfebdf999151cfd9cb2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f73816581b074b5bae1c552501df851c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "c8fb111764be4e3187d8b794d117402e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5f9d65071876428ab508e0069db07c79": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3a85d8e5fdc542b5806a6bd3e42673ff": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_140a9f69445144f1aa42f6d8edceaa3b",
              "IPY_MODEL_c0d347d4845142ec9cd2062eb024b3dc",
              "IPY_MODEL_0ef6d67809fa45bb8b2436bc730ac77d"
            ],
            "layout": "IPY_MODEL_8a1730e7909243a9b6482064c0c7298b"
          }
        },
        "140a9f69445144f1aa42f6d8edceaa3b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d33a78d43c944cd6bc8a92a1b6866d95",
            "placeholder": "​",
            "style": "IPY_MODEL_84c041404d5249608d44787e8d6c9262",
            "value": "tokenizer_config.json: 100%"
          }
        },
        "c0d347d4845142ec9cd2062eb024b3dc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2d66f952b7044fabab57881ff2348fe4",
            "max": 26,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_f03fe4e8eddc48beb5fe92d214280796",
            "value": 26
          }
        },
        "0ef6d67809fa45bb8b2436bc730ac77d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_03f5897da53e461ab0d360ef2ed57cb9",
            "placeholder": "​",
            "style": "IPY_MODEL_5c2cddd38a864a88bcecaf3652babf4b",
            "value": " 26.0/26.0 [00:00&lt;00:00, 2.75kB/s]"
          }
        },
        "8a1730e7909243a9b6482064c0c7298b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d33a78d43c944cd6bc8a92a1b6866d95": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "84c041404d5249608d44787e8d6c9262": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2d66f952b7044fabab57881ff2348fe4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f03fe4e8eddc48beb5fe92d214280796": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "03f5897da53e461ab0d360ef2ed57cb9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5c2cddd38a864a88bcecaf3652babf4b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b8d265c0257740dea15aac3604482a49": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a35fbeec89ca4b24be0590fa5c6eb775",
              "IPY_MODEL_0f50f84a32054e9c8fcad17b68ff3632",
              "IPY_MODEL_15cb6fc965824d0aa415deb6307c87e3"
            ],
            "layout": "IPY_MODEL_a4952b408bdf46868eb354ced86fadb3"
          }
        },
        "a35fbeec89ca4b24be0590fa5c6eb775": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ec9795c97bc0424b94492b250089ca4b",
            "placeholder": "​",
            "style": "IPY_MODEL_64a902ab1def44ca8ebbecd48a3bf076",
            "value": "vocab.json: 100%"
          }
        },
        "0f50f84a32054e9c8fcad17b68ff3632": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e1927cdc5b3f40d790897129657af3a3",
            "max": 1042301,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_78f01eb3b57240fe852d88217a859bb1",
            "value": 1042301
          }
        },
        "15cb6fc965824d0aa415deb6307c87e3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_62e35e60685e47ecaaf3765a3590216d",
            "placeholder": "​",
            "style": "IPY_MODEL_87d6cf7ee6ef4d978c7d30d72708d07f",
            "value": " 1.04M/1.04M [00:00&lt;00:00, 2.36MB/s]"
          }
        },
        "a4952b408bdf46868eb354ced86fadb3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ec9795c97bc0424b94492b250089ca4b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "64a902ab1def44ca8ebbecd48a3bf076": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e1927cdc5b3f40d790897129657af3a3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "78f01eb3b57240fe852d88217a859bb1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "62e35e60685e47ecaaf3765a3590216d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "87d6cf7ee6ef4d978c7d30d72708d07f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "db7d238611324b77bc513c1a272b4aa5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_63b0d43847da48608fed65c4c81793fe",
              "IPY_MODEL_737f6fa768334399a19742e74d199886",
              "IPY_MODEL_b22d708fa0054715bb7753795835e6c4"
            ],
            "layout": "IPY_MODEL_fd0092ce70384e5b80a128a836cb55d5"
          }
        },
        "63b0d43847da48608fed65c4c81793fe": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1583d626b3be4d299706dfdc3db843a0",
            "placeholder": "​",
            "style": "IPY_MODEL_940d4d47b6474b699159173e463ab981",
            "value": "merges.txt: 100%"
          }
        },
        "737f6fa768334399a19742e74d199886": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_181bbe09ffaf436ba5da797f0aad9cb0",
            "max": 456318,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_d0fa2d1fe49c4fe5ae4a6aa308767517",
            "value": 456318
          }
        },
        "b22d708fa0054715bb7753795835e6c4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f5da3252ddd24c2797e3d1069165df16",
            "placeholder": "​",
            "style": "IPY_MODEL_74fb56bf6c1049c4aeb8cf832fc0aaa4",
            "value": " 456k/456k [00:00&lt;00:00, 2.05MB/s]"
          }
        },
        "fd0092ce70384e5b80a128a836cb55d5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1583d626b3be4d299706dfdc3db843a0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "940d4d47b6474b699159173e463ab981": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "181bbe09ffaf436ba5da797f0aad9cb0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d0fa2d1fe49c4fe5ae4a6aa308767517": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "f5da3252ddd24c2797e3d1069165df16": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "74fb56bf6c1049c4aeb8cf832fc0aaa4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ea09c9e86b5540ef96922b2c1f99b3e5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_237ddf96de6143b797e41b106d748b64",
              "IPY_MODEL_251121e47cf1476985510a284de27caa",
              "IPY_MODEL_6b98c9c771c74dad970e692c47bcbd0f"
            ],
            "layout": "IPY_MODEL_d58761d9d1a34620979de45d8acfb9e3"
          }
        },
        "237ddf96de6143b797e41b106d748b64": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ab61c374546d4dc3a0b534ae708978b1",
            "placeholder": "​",
            "style": "IPY_MODEL_da724e546d824aceb7d720ab5e2e4522",
            "value": "tokenizer.json: 100%"
          }
        },
        "251121e47cf1476985510a284de27caa": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_aed0fd62700544f587c83e487ce32a59",
            "max": 1355256,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_4f3e186082c14f7287d2226c46f9bd3f",
            "value": 1355256
          }
        },
        "6b98c9c771c74dad970e692c47bcbd0f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_4d9637eb035f4154a5c1b9eb239a0e87",
            "placeholder": "​",
            "style": "IPY_MODEL_994d09fd19f043b09de3a875979691ce",
            "value": " 1.36M/1.36M [00:00&lt;00:00, 2.83MB/s]"
          }
        },
        "d58761d9d1a34620979de45d8acfb9e3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ab61c374546d4dc3a0b534ae708978b1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "da724e546d824aceb7d720ab5e2e4522": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "aed0fd62700544f587c83e487ce32a59": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4f3e186082c14f7287d2226c46f9bd3f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "4d9637eb035f4154a5c1b9eb239a0e87": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "994d09fd19f043b09de3a875979691ce": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "72624c3c40184374ba0d6a00c4c1de62": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_f9626bd94c294ca3b345e28d82431a05",
              "IPY_MODEL_4040bf1216a54d269f0ab1e130e35f8a",
              "IPY_MODEL_a4e4f401cb0244da84a99b70a0f53809"
            ],
            "layout": "IPY_MODEL_348f078088de410d92b4104990e40cad"
          }
        },
        "f9626bd94c294ca3b345e28d82431a05": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_06c09dde66d04e2db00b760e2267f491",
            "placeholder": "​",
            "style": "IPY_MODEL_6f30b76c710b4572a19b876bbe7fad29",
            "value": "config.json: 100%"
          }
        },
        "4040bf1216a54d269f0ab1e130e35f8a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7c387791a7024a398845ad3ebc20365f",
            "max": 665,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_12611016611f413e851893d0cec5993a",
            "value": 665
          }
        },
        "a4e4f401cb0244da84a99b70a0f53809": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5ad47d875eac4c189508fc1e923a844c",
            "placeholder": "​",
            "style": "IPY_MODEL_8546a84bfefb41ada2a82ee8a1a3e6a6",
            "value": " 665/665 [00:00&lt;00:00, 77.5kB/s]"
          }
        },
        "348f078088de410d92b4104990e40cad": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "06c09dde66d04e2db00b760e2267f491": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6f30b76c710b4572a19b876bbe7fad29": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "7c387791a7024a398845ad3ebc20365f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "12611016611f413e851893d0cec5993a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "5ad47d875eac4c189508fc1e923a844c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8546a84bfefb41ada2a82ee8a1a3e6a6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/gabrielfraga17/IA-Generativa/blob/main/AKCIT_ANAIAGT_GenAI_M9_Colab_Unidade_3.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "![Horizontal Preta.png](data:image/png;base64,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)\n",
        "\n",
        "\n",
        "# Identificação\n",
        "\n",
        "**Microcurso:** Arquiteturas neurais avançadas para IA generativa para texto\n",
        "\n",
        "**Docente:** Dr. Sávio Salvarino Teles de Oliveira e co-autores David O’Neil Campos Ferreira e Daniel Fazzioni"
      ],
      "metadata": {
        "id": "a_bguvWHyu4U"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Objetivos de Aprendizagem\n",
        "\n",
        "*   Aprofundamento no conceito de Retrieval-Augmented Generation (RAG) em Processamento de Linguagem Natural (NLP).\n"
      ],
      "metadata": {
        "id": "gfevqw7Eyf76"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Este colab sobre *Retrieval-Augmented Generation* (RAG) em NLP é dividido em três tópicos principais. O primeiro introduz os fundamentos de RAG, explorando seus componentes básicos e proporcionando a configuração de um sistema simples. O segundo foca na implementação e integração técnica, com estudos de caso e práticas de construção de um sistema RAG. O terceiro tópico aborda aplicações avançadas e projetos, com um foco prático na criação de um projeto que integre RAG a outros conceitos de NLP, desde a definição do escopo até os testes e iterações. O texto segue uma estrutura progressiva para facilitar o aprendizado prático."
      ],
      "metadata": {
        "id": "eBYRUh7IZcQI"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "\n",
        "---\n",
        "\n",
        "\n",
        "\n",
        "---\n",
        "\n"
      ],
      "metadata": {
        "id": "eF9N4iktqmfB"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Boa! Fico muito feliz que já avançamos suficiente em NLP para podermos discutirmos um pouco sobre **RAG**."
      ],
      "metadata": {
        "id": "MoZMa7-5qnAF"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "O conceito de *Retrieval-Augmented Generation* (RAG) representa uma evolução importante nas técnicas de Processamento de Linguagem Natural (NLP), ao combinar os pontos fortes de grandes modelos de linguagem (LLMs) com sistemas de recuperação de informações. Nessa abordagem híbrida, o modelo de geração não se limita ao que foi aprendido durante seu treinamento: ele é capaz de acessar informações externas em tempo real para produzir respostas mais relevantes, completas e atualizadas.\n",
        "\n",
        "Tradicionalmente, modelos de linguagem respondem com base apenas nos dados usados em seu treinamento, o que pode limitar o acesso a fatos recentes ou conhecimentos específicos que não estavam presentes nesse conjunto de dados. O RAG supera essa limitação ao incorporar um mecanismo de recuperação: quando recebe uma solicitação, o modelo consulta uma base de dados externa ou um repositório de documentos, seleciona as informações mais relevantes e utiliza esses dados como suporte na geração da resposta.\n",
        "\n",
        "Essa integração amplia significativamente o potencial dos modelos de linguagem, tornando-os úteis em situações onde o conhecimento mais recente ou específico é necessário. Exemplos práticos incluem assistentes virtuais, sistemas de suporte ao cliente, busca de informações técnicas e recomendações personalizadas.\n",
        "\n",
        "Enquanto outras técnicas, como o *Fine-tuning*, ajustam o modelo com base em novos dados para especializá-lo em determinados temas, o RAG permite que o modelo mantenha sua capacidade geral e ainda se beneficie de informações atualizadas e especializadas durante o próprio proces\n"
      ],
      "metadata": {
        "id": "eNT5wo7TqvuY"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "![Imagem 3 _ C_ fundo branco.png](data:image/png;base64,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)"
      ],
      "metadata": {
        "id": "PVWiQrAIZAw-"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "[Fonte](https://medium.com/@drjulija/what-is-retrieval-augmented-generation-rag-938e4f6e03d1)"
      ],
      "metadata": {
        "id": "A3viuhQW1HXO"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "<h4>\n",
        "Exploração dos Componentes Principais: Mecanismos de Busca e Modelos de Geração</h4>\n",
        "\n",
        "A eficácia do *Retrieval-Augmented Generation* (RAG) reside na sinergia entre dois componentes cruciais: os mecanismos de busca e os modelos de geração. Esses elementos trabalham em conjunto para extrair e incorporar informações relevantes do mundo externo nas respostas geradas pelos modelos de linguagem, permitindo uma interação mais rica e informada. Vamos explorar cada um desses componentes em detalhes.\n",
        "\n",
        "<h4>Mecanismos de Busca</h4>\n",
        "\n",
        "O mecanismo de busca no contexto do RAG não é meramente uma ferramenta para encontrar informações; ele é um componente estratégico que determina a qualidade e a relevância dos dados que serão utilizados pelo modelo de geração. Esse mecanismo pode variar desde uma simples busca de palavras-chave até sistemas mais complexos baseados em inteligência artificial que compreendem o contexto da consulta e a relevância do conteúdo relacionado.\n",
        "\n",
        "A funcionalidade principal do mecanismo de busca em um sistema RAG é indexar e recuperar informações de um corpus documental extenso, que pode incluir livros, artigos, bases de dados acadêmicas, ou mesmo a internet inteira. O objetivo é encontrar e fornecer trechos de texto que sejam mais pertinentes à pergunta ou ao contexto fornecido pelo usuário. A eficiência deste mecanismo é crucial, pois uma recuperação inadequada pode levar a respostas imprecisas ou irrelevantes.\n",
        "\n",
        "<h4>Modelos de Geração</h4>\n",
        "\n",
        "Uma vez que os dados relevantes são recuperados pelo mecanismo de busca, o modelo de geração entra em ação. Este componente é responsável por interpretar as informações recuperadas e integrá-las de maneira coerente e contextualizada na resposta final. Os modelos de geração em sistemas RAG geralmente são baseados em arquiteturas de transformadores, que são capazes de entender e manipular linguagem natural de forma eficaz.\n",
        "\n",
        "A integração das informações recuperadas ocorre através de técnicas de fusão, onde o modelo de geração considera tanto a entrada (*input*) original do usuário quanto as informações adicionais recuperadas para construir uma resposta que seja informativa e fluente. O desafio aqui é garantir que a incorporação desses dados externos seja natural e útil, evitando respostas que pareçam deslocadas ou artificialmente construídas.\n",
        "\n",
        "<h4>Sinergia entre os Componentes</h4>\n",
        "\n",
        "A interação entre o mecanismo de busca e o modelo de geração deve ser fluida e bem coordenada. A precisão na busca determina a qualidade das informações que o modelo de geração tem à disposição para criar respostas. Da mesma forma, a habilidade do modelo de geração de interpretar e utilizar essas informações afeta diretamente a utilidade e a aceitabilidade das respostas geradas. Juntos, esses componentes formam o coração de qualquer sistema RAG, determinando seu sucesso em aplicar conhecimento externo para enriquecer as capacidades de geração de texto de um modelo de NLP."
      ],
      "metadata": {
        "id": "W5ahAVHQ8Qj_"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "\n",
        "---\n",
        "\n",
        "\n",
        "\n",
        "---\n",
        "\n"
      ],
      "metadata": {
        "id": "N8taIHHyVWRs"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### A Importância da Indexação e Recuperação de Dados Eficiente\n",
        "\n",
        "A indexação e a recuperação de dados desempenham um papel fundamental para maximizar o potencial dos sistemas de NLP, especialmente quando precisão e velocidade são essenciais para a performance do sistema. Entender como esses processos funcionam é crucial para construir soluções de NLP robustas e eficientes.\n",
        "\n",
        "#### Fundamento da Indexação e Recupereração\n",
        "\n",
        "**Indexação e recuperação de dados** são processos que organizam grandes volumes de informação para que possam ser acessados rapidamente pelos sistemas de NLP. A indexação transforma dados brutos em estruturas otimizadas para busca, enquanto a recuperação utiliza essas estruturas para trazer informações relevantes em resposta a consultas específicas.\n",
        "\n",
        "#### Integração com Sistemas de NLP\n",
        "\n",
        "A eficiência desses processos impacta diretamente a forma como modelos de linguagem operam em sistemas modernos de NLP:\n",
        "- **Contextualização de Prompts:** A recuperação eficiente permite fornecer contextos ricos e relevantes, o que é fundamental para melhorar a interpretação e a geração de respostas pelos modelos.\n",
        "- **Treinamento e Aprimoramento:** A qualidade dos dados recuperados influencia o aprendizado e a adaptação dos modelos, tornando-os mais precisos e úteis para tarefas específicas.\n",
        "\n",
        "#### Desafios e Impactos na Performance\n",
        "\n",
        "Alguns dos principais desafios encontrados nesses processos incluem:\n",
        "- **Velocidade vs. Precisão:** É essencial encontrar o equilíbrio entre a rapidez na recuperação e a precisão das informações. Respostas lentas ou imprecisas podem comprometer toda a experiência do usuário.\n",
        "- **Atualização Contínua:** Em ambientes dinâmicos, manter a indexação sempre atualizada sem prejudicar o tempo de resposta é um desafio recorrente.\n",
        "\n",
        "#### Tecnologias e Ferramentas Envolvidas\n",
        "\n",
        "Diversas tecnologias são utilizadas para otimizar a indexação e a recuperação de dados:\n",
        "- **Elasticsearch:** Ferramenta amplamente utilizada para buscas complexas e indexação em tempo real.\n",
        "- **FAISS:** Biblioteca desenvolvida pelo Facebook AI para recuperação eficiente de grandes volumes de vetores, ideal para indexação semântica.\n",
        "\n",
        "A eficiência desses componentes é o que possibilita que sistemas de NLP modernos forneçam respostas rápidas, precisas e relevantes, mesmo quando operando em grande escala.\n"
      ],
      "metadata": {
        "id": "Fs_wQNj6VXU4"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# ATIVE A GPU - T4 NA HORA DE SE CONECTAR.\n",
        "\n",
        "Iremos usar GPU neste notebook e você pode seguir o tutorial abaixo para se conectar com GPU. A GPU vai ser utilizada para criar os embeddings a partir dos documentos textuais.\n",
        "\n",
        "Clique no canto superior direito na seta ao lado de \"CONECTAR\"\n",
        "\n",
        "![image.png](data:image/png;base64,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)\n",
        "\n",
        "Clique em \"ALTERAR O TIPO DE AMBIENTE DE EXECUÇÃO\"\n",
        "\n",
        "![image.png](data:image/png;base64,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)\n",
        "\n",
        "\n",
        "Clique em \"T4 - GPU\" e depois em \"SALVAR\"\n",
        "\n",
        "\n",
        "![image.png](data:image/png;base64,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)\n"
      ],
      "metadata": {
        "id": "vQnLCAquezyt"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Instalação das bibliotecas\n",
        "\n",
        "A célula abaixo instala várias bibliotecas Python usando o gerenciador de pacotes `pip`, todas com versões específicas para garantir compatibilidade e reprodutibilidade no seu ambiente:\n",
        "\n",
        "**`langchain==0.3.25`**  \n",
        "Instala a biblioteca `langchain` na versão 0.3.25. `langchain` é um framework para desenvolvimento de aplicações que utilizam Large Language Models (LLMs), facilitando a criação de fluxos de trabalho com IA generativa.\n",
        "\n",
        "**`langchain_groq==0.3.2`**  \n",
        "Instala a biblioteca `langchain_groq` na versão 0.3.2, que integra o `langchain` a serviços da Groq, permitindo utilizar LLMs e recursos avançados da plataforma Groq em seus projetos.\n",
        "\n",
        "**`langchain_community==0.3.9`**  \n",
        "Instala a biblioteca `langchain_community` na versão 0.3.9. Ela oferece uma coleção de integrações, módulos extras e conectores desenvolvidos pela comunidade para expandir as funcionalidades do `langchain`.\n",
        "\n",
        "**`pypdf==5.3.1`**  \n",
        "Instala a biblioteca `pypdf` na versão 5.3.1. `pypdf` é uma biblioteca para leitura, manipulação e extração de conteúdo de arquivos PDF em Python.\n",
        "\n",
        "**`sentence-transformers==3.2.1`**  \n",
        "Instala a biblioteca `sentence-transformers` na versão 3.2.1. Essa biblioteca disponibiliza modelos pré-treinados para gerar embeddings semânticos de frases e textos, essenciais para tarefas de busca, comparação e clustering em NLP.\n",
        "\n",
        "**`faiss-cpu==1.11.0`**  \n",
        "Instala a biblioteca `faiss-cpu` na versão 1.11.0. `faiss` (Facebook AI Similarity Search) é uma biblioteca eficiente para busca por similaridade em grandes volumes de vetores de alta dimensão. A variante `cpu` garante funcionamento otimizado em CPUs.\n",
        "\n",
        "> ⚠️ **Atenção:**  \n",
        "> O `faiss-cpu` depende do `numpy` em uma versão **menor que 2.0**, enquanto o Colab, por padrão, utiliza o `numpy` 2.0 ou superior.  \n",
        "> Por isso, ao instalar o `faiss-cpu`, **você verá um aviso pedindo para reiniciar a sessão**.\n",
        ">\n",
        "> **É obrigatório reiniciar o ambiente do Colab após instalar o `faiss-cpu`!**\n",
        ">\n",
        "> Só assim as versões corretas das bibliotecas serão carregadas na memória e o notebook funcionará normalmente.  \n",
        "> Depois de reiniciar, execute novamente a célula de instalação e siga com as próximas células do notebook.\n",
        "\n",
        "\n",
        "> **Observação:**  \n",
        "> É importante notar que as versões específicas das bibliotecas são especificadas na linha de código. Isso garante que a aplicação seja executada com as versões testadas e compatíveis entre si."
      ],
      "metadata": {
        "id": "nWAdIQ7IZ0zs"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install langchain==0.3.25 langchain_groq==0.3.2 langchain_community==0.3.9 pypdf==5.3.1 faiss-cpu==1.11.0 sentence-transformers==3.2.1"
      ],
      "metadata": {
        "collapsed": true,
        "id": "rCGxrHBYPRgD",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "792f4c13-408d-4085-a491-3ead94262386"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: langchain==0.3.25 in /usr/local/lib/python3.12/dist-packages (0.3.25)\n",
            "Requirement already satisfied: langchain_groq==0.3.2 in /usr/local/lib/python3.12/dist-packages (0.3.2)\n",
            "Requirement already satisfied: langchain_community==0.3.9 in /usr/local/lib/python3.12/dist-packages (0.3.9)\n",
            "Requirement already satisfied: pypdf==5.3.1 in /usr/local/lib/python3.12/dist-packages (5.3.1)\n",
            "Requirement already satisfied: faiss-cpu==1.11.0 in /usr/local/lib/python3.12/dist-packages (1.11.0)\n",
            "Requirement already satisfied: sentence-transformers==3.2.1 in /usr/local/lib/python3.12/dist-packages (3.2.1)\n",
            "Requirement already satisfied: langchain-core<1.0.0,>=0.3.58 in /usr/local/lib/python3.12/dist-packages (from langchain==0.3.25) (0.3.63)\n",
            "Requirement already satisfied: langchain-text-splitters<1.0.0,>=0.3.8 in /usr/local/lib/python3.12/dist-packages (from langchain==0.3.25) (0.3.8)\n",
            "Requirement already satisfied: langsmith<0.4,>=0.1.17 in /usr/local/lib/python3.12/dist-packages (from langchain==0.3.25) (0.1.147)\n",
            "Requirement already satisfied: pydantic<3.0.0,>=2.7.4 in /usr/local/lib/python3.12/dist-packages (from langchain==0.3.25) (2.11.7)\n",
            "Requirement already satisfied: SQLAlchemy<3,>=1.4 in /usr/local/lib/python3.12/dist-packages (from langchain==0.3.25) (2.0.43)\n",
            "Requirement already satisfied: requests<3,>=2 in /usr/local/lib/python3.12/dist-packages (from langchain==0.3.25) (2.32.4)\n",
            "Requirement already satisfied: PyYAML>=5.3 in /usr/local/lib/python3.12/dist-packages (from langchain==0.3.25) (6.0.2)\n",
            "Requirement already satisfied: groq<1,>=0.4.1 in /usr/local/lib/python3.12/dist-packages (from langchain_groq==0.3.2) (0.31.1)\n",
            "Requirement already satisfied: aiohttp<4.0.0,>=3.8.3 in /usr/local/lib/python3.12/dist-packages (from langchain_community==0.3.9) (3.12.15)\n",
            "Requirement already satisfied: dataclasses-json<0.7,>=0.5.7 in /usr/local/lib/python3.12/dist-packages (from langchain_community==0.3.9) (0.6.7)\n",
            "Requirement already satisfied: httpx-sse<0.5.0,>=0.4.0 in /usr/local/lib/python3.12/dist-packages (from langchain_community==0.3.9) (0.4.1)\n",
            "Requirement already satisfied: numpy<3,>=1.26.2 in /usr/local/lib/python3.12/dist-packages (from langchain_community==0.3.9) (2.0.2)\n",
            "Requirement already satisfied: pydantic-settings<3.0.0,>=2.4.0 in /usr/local/lib/python3.12/dist-packages (from langchain_community==0.3.9) (2.10.1)\n",
            "Requirement already satisfied: tenacity!=8.4.0,<10,>=8.1.0 in /usr/local/lib/python3.12/dist-packages (from langchain_community==0.3.9) (8.5.0)\n",
            "Requirement already satisfied: packaging in /usr/local/lib/python3.12/dist-packages (from faiss-cpu==1.11.0) (24.2)\n",
            "Requirement already satisfied: transformers<5.0.0,>=4.41.0 in /usr/local/lib/python3.12/dist-packages (from sentence-transformers==3.2.1) (4.56.1)\n",
            "Requirement already satisfied: tqdm in /usr/local/lib/python3.12/dist-packages (from sentence-transformers==3.2.1) (4.67.1)\n",
            "Requirement already satisfied: torch>=1.11.0 in /usr/local/lib/python3.12/dist-packages (from sentence-transformers==3.2.1) (2.8.0+cu126)\n",
            "Requirement already satisfied: scikit-learn in /usr/local/lib/python3.12/dist-packages (from sentence-transformers==3.2.1) (1.6.1)\n",
            "Requirement already satisfied: scipy in /usr/local/lib/python3.12/dist-packages (from sentence-transformers==3.2.1) (1.16.1)\n",
            "Requirement already satisfied: huggingface-hub>=0.20.0 in /usr/local/lib/python3.12/dist-packages (from sentence-transformers==3.2.1) (0.34.4)\n",
            "Requirement already satisfied: Pillow in /usr/local/lib/python3.12/dist-packages (from sentence-transformers==3.2.1) (11.3.0)\n",
            "Requirement already satisfied: aiohappyeyeballs>=2.5.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community==0.3.9) (2.6.1)\n",
            "Requirement already satisfied: aiosignal>=1.4.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community==0.3.9) (1.4.0)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community==0.3.9) (25.3.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.12/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community==0.3.9) (1.7.0)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.12/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community==0.3.9) (6.6.4)\n",
            "Requirement already satisfied: propcache>=0.2.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community==0.3.9) (0.3.2)\n",
            "Requirement already satisfied: yarl<2.0,>=1.17.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community==0.3.9) (1.20.1)\n",
            "Requirement already satisfied: marshmallow<4.0.0,>=3.18.0 in /usr/local/lib/python3.12/dist-packages (from dataclasses-json<0.7,>=0.5.7->langchain_community==0.3.9) (3.26.1)\n",
            "Requirement already satisfied: typing-inspect<1,>=0.4.0 in /usr/local/lib/python3.12/dist-packages (from dataclasses-json<0.7,>=0.5.7->langchain_community==0.3.9) (0.9.0)\n",
            "Requirement already satisfied: anyio<5,>=3.5.0 in /usr/local/lib/python3.12/dist-packages (from groq<1,>=0.4.1->langchain_groq==0.3.2) (4.10.0)\n",
            "Requirement already satisfied: distro<2,>=1.7.0 in /usr/local/lib/python3.12/dist-packages (from groq<1,>=0.4.1->langchain_groq==0.3.2) (1.9.0)\n",
            "Requirement already satisfied: httpx<1,>=0.23.0 in /usr/local/lib/python3.12/dist-packages (from groq<1,>=0.4.1->langchain_groq==0.3.2) (0.28.1)\n",
            "Requirement already satisfied: sniffio in /usr/local/lib/python3.12/dist-packages (from groq<1,>=0.4.1->langchain_groq==0.3.2) (1.3.1)\n",
            "Requirement already satisfied: typing-extensions<5,>=4.10 in /usr/local/lib/python3.12/dist-packages (from groq<1,>=0.4.1->langchain_groq==0.3.2) (4.15.0)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.12/dist-packages (from huggingface-hub>=0.20.0->sentence-transformers==3.2.1) (3.19.1)\n",
            "Requirement already satisfied: fsspec>=2023.5.0 in /usr/local/lib/python3.12/dist-packages (from huggingface-hub>=0.20.0->sentence-transformers==3.2.1) (2025.3.0)\n",
            "Requirement already satisfied: hf-xet<2.0.0,>=1.1.3 in /usr/local/lib/python3.12/dist-packages (from huggingface-hub>=0.20.0->sentence-transformers==3.2.1) (1.1.9)\n",
            "Requirement already satisfied: jsonpatch<2.0,>=1.33 in /usr/local/lib/python3.12/dist-packages (from langchain-core<1.0.0,>=0.3.58->langchain==0.3.25) (1.33)\n",
            "Requirement already satisfied: orjson<4.0.0,>=3.9.14 in /usr/local/lib/python3.12/dist-packages (from langsmith<0.4,>=0.1.17->langchain==0.3.25) (3.11.3)\n",
            "Requirement already satisfied: requests-toolbelt<2.0.0,>=1.0.0 in /usr/local/lib/python3.12/dist-packages (from langsmith<0.4,>=0.1.17->langchain==0.3.25) (1.0.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.12/dist-packages (from pydantic<3.0.0,>=2.7.4->langchain==0.3.25) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.33.2 in /usr/local/lib/python3.12/dist-packages (from pydantic<3.0.0,>=2.7.4->langchain==0.3.25) (2.33.2)\n",
            "Requirement already satisfied: typing-inspection>=0.4.0 in /usr/local/lib/python3.12/dist-packages (from pydantic<3.0.0,>=2.7.4->langchain==0.3.25) (0.4.1)\n",
            "Requirement already satisfied: python-dotenv>=0.21.0 in /usr/local/lib/python3.12/dist-packages (from pydantic-settings<3.0.0,>=2.4.0->langchain_community==0.3.9) (1.1.1)\n",
            "Requirement already satisfied: charset_normalizer<4,>=2 in /usr/local/lib/python3.12/dist-packages (from requests<3,>=2->langchain==0.3.25) (3.4.3)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.12/dist-packages (from requests<3,>=2->langchain==0.3.25) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.12/dist-packages (from requests<3,>=2->langchain==0.3.25) (2.5.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.12/dist-packages (from requests<3,>=2->langchain==0.3.25) (2025.8.3)\n",
            "Requirement already satisfied: greenlet>=1 in /usr/local/lib/python3.12/dist-packages (from SQLAlchemy<3,>=1.4->langchain==0.3.25) (3.2.4)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (75.2.0)\n",
            "Requirement already satisfied: sympy>=1.13.3 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (1.13.3)\n",
            "Requirement already satisfied: networkx in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (3.5)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (3.1.6)\n",
            "Requirement already satisfied: nvidia-cuda-nvrtc-cu12==12.6.77 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (12.6.77)\n",
            "Requirement already satisfied: nvidia-cuda-runtime-cu12==12.6.77 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (12.6.77)\n",
            "Requirement already satisfied: nvidia-cuda-cupti-cu12==12.6.80 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (12.6.80)\n",
            "Requirement already satisfied: nvidia-cudnn-cu12==9.10.2.21 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (9.10.2.21)\n",
            "Requirement already satisfied: nvidia-cublas-cu12==12.6.4.1 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (12.6.4.1)\n",
            "Requirement already satisfied: nvidia-cufft-cu12==11.3.0.4 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (11.3.0.4)\n",
            "Requirement already satisfied: nvidia-curand-cu12==10.3.7.77 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (10.3.7.77)\n",
            "Requirement already satisfied: nvidia-cusolver-cu12==11.7.1.2 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (11.7.1.2)\n",
            "Requirement already satisfied: nvidia-cusparse-cu12==12.5.4.2 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (12.5.4.2)\n",
            "Requirement already satisfied: nvidia-cusparselt-cu12==0.7.1 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (0.7.1)\n",
            "Requirement already satisfied: nvidia-nccl-cu12==2.27.3 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (2.27.3)\n",
            "Requirement already satisfied: nvidia-nvtx-cu12==12.6.77 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (12.6.77)\n",
            "Requirement already satisfied: nvidia-nvjitlink-cu12==12.6.85 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (12.6.85)\n",
            "Requirement already satisfied: nvidia-cufile-cu12==1.11.1.6 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (1.11.1.6)\n",
            "Requirement already satisfied: triton==3.4.0 in /usr/local/lib/python3.12/dist-packages (from torch>=1.11.0->sentence-transformers==3.2.1) (3.4.0)\n",
            "Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.12/dist-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers==3.2.1) (2024.11.6)\n",
            "Requirement already satisfied: tokenizers<=0.23.0,>=0.22.0 in /usr/local/lib/python3.12/dist-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers==3.2.1) (0.22.0)\n",
            "Requirement already satisfied: safetensors>=0.4.3 in /usr/local/lib/python3.12/dist-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers==3.2.1) (0.6.2)\n",
            "Requirement already satisfied: joblib>=1.2.0 in /usr/local/lib/python3.12/dist-packages (from scikit-learn->sentence-transformers==3.2.1) (1.5.2)\n",
            "Requirement already satisfied: threadpoolctl>=3.1.0 in /usr/local/lib/python3.12/dist-packages (from scikit-learn->sentence-transformers==3.2.1) (3.6.0)\n",
            "Requirement already satisfied: httpcore==1.* in /usr/local/lib/python3.12/dist-packages (from httpx<1,>=0.23.0->groq<1,>=0.4.1->langchain_groq==0.3.2) (1.0.9)\n",
            "Requirement already satisfied: h11>=0.16 in /usr/local/lib/python3.12/dist-packages (from httpcore==1.*->httpx<1,>=0.23.0->groq<1,>=0.4.1->langchain_groq==0.3.2) (0.16.0)\n",
            "Requirement already satisfied: jsonpointer>=1.9 in /usr/local/lib/python3.12/dist-packages (from jsonpatch<2.0,>=1.33->langchain-core<1.0.0,>=0.3.58->langchain==0.3.25) (3.0.0)\n",
            "Requirement already satisfied: mpmath<1.4,>=1.1.0 in /usr/local/lib/python3.12/dist-packages (from sympy>=1.13.3->torch>=1.11.0->sentence-transformers==3.2.1) (1.3.0)\n",
            "Requirement already satisfied: mypy-extensions>=0.3.0 in /usr/local/lib/python3.12/dist-packages (from typing-inspect<1,>=0.4.0->dataclasses-json<0.7,>=0.5.7->langchain_community==0.3.9) (1.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.12/dist-packages (from jinja2->torch>=1.11.0->sentence-transformers==3.2.1) (3.0.2)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### ⚠️ Recebeu um aviso pedindo para reiniciar o runtime?\n",
        "\n",
        "Caso apareça um aviso na tela pedindo para reiniciar a sessão, prossiga da seguinte forma:\n",
        "\n",
        "**O que fazer:**\n",
        "1. Clique em “Reiniciar ambiente de execução” no menu do Colab.\n",
        "2. Rode novamente a célula de instalação das dependências.\n",
        "3. Siga normalmente com as próximas células.\n",
        "\n",
        "Esse aviso é normal quando versões diferentes das bibliotecas já carregadas são instaladas. Reiniciar resolve e o notebook funcionará normalmente!"
      ],
      "metadata": {
        "id": "VfvUMe4ctkis"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_groq import ChatGroq  # Importa a classe ChatGroq da biblioteca langchain_groq, usada para interagir com modelos Groq.\n",
        "import time  # Importa a biblioteca time, que pode ser usada para funções relacionadas a manipulação de tempo.\n",
        "from langchain_core.prompts import ChatPromptTemplate  # Importa ChatPromptTemplate para criação de prompts customizados em chat.\n",
        "from langchain.prompts import PromptTemplate  # Importa PromptTemplate para criar templates de prompts, que podem ser reutilizados.\n",
        "from langchain_core.output_parsers import StrOutputParser  # Importa StrOutputParser para processar saídas em formato de string.\n",
        "from langchain_core.output_parsers import JsonOutputParser  # Importa JsonOutputParser para processar saídas no formato JSON.\n",
        "import getpass\n",
        "\n",
        "import os  # Importa o módulo os, que permite interagir com o sistema operacional.\n",
        "from google.colab import userdata  # Importa userdata do Google Colab para manipular dados do usuário no ambiente Colab.\n",
        "os.environ[\"GROQ_API_KEY\"] = getpass.getpass(\"Digite sua GROQ API Key: \")  # Define a variável de ambiente GROQ_API_KEY com a chave de API do Groq, recuperada do Colab.\n",
        "\n",
        "GROQ_LLM = ChatGroq(  # Instancia o modelo de linguagem Groq.\n",
        "            model=\"llama-3.1-8b-instant\",  # Especifica o modelo a ser utilizado, no caso, o \"llama-3.1-8b-instant\".\n",
        "        )\n"
      ],
      "metadata": {
        "id": "h01FUKqwStNz",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "a671a614-2906-453c-8594-f8209857928a"
      },
      "execution_count": null,
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Digite sua GROQ API Key: ··········\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Download do arquivo\n",
        "No código a seguir utilizaremos o texto disponível em um arquivo `.pdf`. Para tal é necessário realizar o download do [livro](https://ampllaeditora.com.br/books/2023/03/CardiologianaEmergencia.pdf) \"Cardiologia na emergência: guia para o pronto-Socorro\". É um arquivo com abordagem prática das emergências cardiológicas elaborado pela Liga Médico-Acadêmica de Cardiologia de Sobral (LIMACS).\n",
        "\n"
      ],
      "metadata": {
        "id": "bJFF7TTDdVja"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "O livro está disponível no Google Drive também e o código abaixo faz o download do livro:"
      ],
      "metadata": {
        "id": "C1wucfFKamhS"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!gdown https://drive.google.com/uc?id=1mnp4Og7gTl96hul0233j3zDRtT4qTPna"
      ],
      "metadata": {
        "id": "7LT-4AtFZB_q",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "866bcfd4-9d5f-44c2-e407-7d6f3acfb570"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Downloading...\n",
            "From: https://drive.google.com/uc?id=1mnp4Og7gTl96hul0233j3zDRtT4qTPna\n",
            "To: /content/CardiologianaEmergencia.pdf\n",
            "100% 12.3M/12.3M [00:00<00:00, 24.4MB/s]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Após a realização do download certifique de que o arquivo esteja dentro da pasta que você baixou."
      ],
      "metadata": {
        "id": "SZl61myQmb8F"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Carregando o arquivo PDF\n",
        "\n",
        "Este código em Python demonstra os passos iniciais para carregar e preparar um arquivo PDF para ser utilizado em sistemas de RAG (Retrieval-Augmented Generation).\n",
        "\n",
        "Antes que um arquivo PDF possa ser processado e compreendido por um modelo de linguagem, seu conteúdo precisa ser convertido em texto estruturado. Esse passo é fundamental, pois modelos de IA só conseguem “ler” e interpretar texto, e não arquivos binários ou imagens diretamente. A extração e o fracionamento do texto em partes menores (como páginas) tornam o processamento muito mais eficiente e facilitam a recuperação de informações relevantes.\n",
        "\n",
        "**Passo a Passo:**\n",
        "\n",
        "1. **Importar a Ferramenta:**\n",
        "   - A primeira linha importa a função `PyPDFLoader` da biblioteca `langchain_community`. Essa função é especializada em carregar e processar arquivos PDF.\n",
        "\n",
        "2. **Definir o Caminho do Arquivo:**\n",
        "   - A variável `file_path` armazena o caminho para o arquivo PDF que você deseja analisar.\n",
        "\n",
        "3. **Criar o \"Loader\":**\n",
        "   - Um objeto `PyPDFLoader` é criado e armazenado na variável `loader`. Este objeto recebe o caminho do arquivo como argumento e será responsável por interagir com o PDF.\n",
        "\n",
        "4. **Carregar e Dividir o PDF:**\n",
        "   - A função `load_and_split()` do objeto `loader` é chamada. Esta função realiza duas tarefas importantes:\n",
        "     - **loader:** extrai e converte o conteúdo do PDF em texto.\n",
        "     - **split:** separa o documento em páginas individuais, retornando uma lista onde cada elemento representa o conteúdo textual de uma página. Isso facilita o processamento posterior, permitindo que você trabalhe com cada página separadamente e recupere informações de maneira eficiente para o seu pipeline de RAG.\n"
      ],
      "metadata": {
        "id": "gYmKysGpYFGS"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_community.document_loaders import PyPDFLoader\n",
        "\n",
        "# 1. Aqui estamos importando uma ferramenta (PyPDFLoader) que permite carregar arquivos PDF.\n",
        "# Essa ferramenta faz parte de uma biblioteca chamada \"langchain_community\" usada em processamento de linguagem.\n",
        "\n",
        "file_path = (\n",
        "    \"CardiologianaEmergencia.pdf\" #caso você mude o nome do arquivo, adicione o novo nome depois de \"/content/...NOVO NOME.pdf\"\n",
        ")\n",
        "# 2. Nesta linha, estamos definindo o caminho do arquivo PDF que queremos carregar.\n",
        "# O caminho do arquivo PDF é onde ele está armazenado no computador ou na nuvem (neste caso, \"/content/cardiologia.pdf\").\n",
        "\n",
        "loader = PyPDFLoader(file_path)\n",
        "# 3. Agora estamos criando uma \"ferramenta\" chamada 'loader' que vai utilizar o caminho do PDF para ler o arquivo.\n",
        "# O PyPDFLoader será o responsável por abrir e preparar o PDF para ser trabalhado.\n",
        "\n",
        "pages = loader.load_and_split()\n",
        "# 4. Finalmente, estamos usando a ferramenta 'loader' para carregar o PDF e dividir o documento em várias partes (páginas).\n",
        "# O 'load_and_split()' lê o PDF e separa o conteúdo em páginas, facilitando o processamento de cada uma."
      ],
      "metadata": {
        "id": "FSr7HNbjX0Eh"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "O código abaixo imprime as páginas do documento:"
      ],
      "metadata": {
        "id": "ejyca8YabJjp"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Conferindo como estão as páginas.\n",
        "print(pages)"
      ],
      "metadata": {
        "id": "Fw_Xn8XtZ_kB",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "005d1549-a414-4163-8045-2bf8d3ff6e97"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 0}, page_content='CARDIOLOGIA NA EMERGÊNCIA: GUIA PARA O \\nPRONTO-SOCORRO \\nOrganizadores: \\nPedro José Leite de Almeida Mendonça \\nMateus de Sousa Cavalcante \\nFelipe Salim Habib Buhamara Alves Nasser Gurjão \\nDara Medeiros Mendes \\nBenedito Mesley Lima Portela \\nEditora Amplla \\nCampina Grande, janeiro de 2023'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 2}, page_content='2023 - Editora Amplla \\nCopyright da Edição © Editora Amplla \\nCopyright do Texto © Os autores \\nEditor Chefe: Leonardo Pereira Tavares \\nDesign da Capa: Editora Amplla \\nDiagramação: Higor Brito \\nRevisão: Os autores \\n \\n \\n \\n \\nCardiologia na Emergência: Guia para o Pronto-Socorro está licenciado sob CC BY 4.0. \\nEsta licença exige que as reutilizações deem crédito aos criadores. Ele permite que \\nos reutilizadores distribuam, remixem, adaptem e construam o material em \\nqualquer meio ou formato, mesmo para fins comerciais. \\nO conteúdo da obra e seus dados em sua forma,  correção e confiabilidade são de responsabilidade \\nexclusiva dos autores, não representando a posição oficial da Editora Amplla. É permitido o \\ndownload da obra e o compartilhamento desde que sejam atribuídos créditos aos autores. Todos os \\ndireitos para esta edição foram cedidos à Editora Amplla. \\n \\n \\n \\n \\n \\n \\nISBN: 978-65-5381-116-4 \\nDOI: 10.51859/amplla.ceg164.1123-0 \\n \\n \\n \\n \\n \\nEditora Amplla \\nCampina Grande – PB – Brasil \\ncontato@ampllaeditora.com.br \\nwww.ampllaeditora.com.br \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n2023'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 3}, page_content='CONSELHO EDITORIAL  \\n \\nAndréa Cátia Leal Badaró – Universidade \\nTecnológica Federal do Paraná \\nAndréia Monique Lermen – Universidade \\nFederal do Rio Grande do Sul \\nAntoniele Silvana de Melo Souza – Universidade \\nEstadual do Ceará \\nAryane de Azevedo Pinheiro – Universidade \\nFederal do Ceará \\nBergson Rodrigo Siqueira de Melo – \\nUniversidade Estadual do Ceará \\nBruna Beatriz da Rocha – Instituto Federal do \\nSudeste de Minas Gerais \\nBruno Ferreira – Universidade Federal da Bahia \\nCaio Augusto Martins Aires – Universidade \\nFederal Rural do Semi-Árido \\nCaio César Costa Santos – Universidade Federal \\nde Sergipe \\nCarina Alexandra Rondini – Universidade \\nEstadual Paulista \\nCarla Caroline Alves Carvalho – Universidade \\nFederal de Campina Grande \\nCarlos Augusto Trojaner – Prefeitura de \\nVenâncio Aires \\nCarolina Carbonell Demori – Universidade \\nFederal de Pelotas \\nCícero Batista do Nascimento Filho – \\nUniversidade Federal do Ceará \\nClécio Danilo Dias da Silva – Universidade \\nFederal do Rio Grande do Norte \\nDandara Scarlet Sousa Gomes Bacelar – \\nUniversidade Federal do Piauí \\nDaniela de Freitas Lima – Universidade Federal \\nde Campina Grande \\nDarlei Gutierrez Dantas Bernardo Oliveira – \\nUniversidade Estadual da Paraíba \\nDenilson Paulo Souza dos Santos – Universidade \\nEstadual Paulista \\nDenise Barguil Nepomuceno – Universidade \\nFederal de Minas Gerais \\nDinara das Graças Carvalho Costa – \\nUniversidade Estadual da Paraíba \\nDiogo Lopes de Oliveira – Universidade Federal \\nde Campina Grande \\nDylan Ávila Alves – Instituto Federal Goiano \\nEdson Lourenço da Silva – Instituto Federal de \\nEducação, Ciência e Tecnologia do Piauí \\nElane da Silva Barbosa – Universidade Estadual \\ndo Ceará \\nÉrica Rios de Carvalho – Universidade Católica \\ndo Salvador \\nFernanda Beatriz Pereira Cavalcanti – \\nUniversidade Estadual Paulista “Júlio de \\nMesquita Filho” \\nFredson Pereira da Silva – Universidade \\nEstadual do Ceará \\nGabriel Gomes de Oliveira – Universidade \\nEstadual de Campinas \\nGilberto de Melo Junior – Instituto Federal do \\nPará \\nGivanildo de Oliveira Santos – Instituto \\nBrasileiro de Educação e Cultura \\nHigor Costa de Brito – Universidade Federal de \\nCampina Grande \\nHugo José Coelho Corrêa de Azevedo – Fundação \\nOswaldo Cruz \\nIsabel Fontgalland – Universidade Federal de \\nCampina Grande \\nIsane Vera Karsburg – Universidade do Estado \\nde Mato Grosso \\nIsrael Gondres Torné – Universidade do Es tado \\ndo Amazonas \\nIvo Batista Conde – Universidade Estadual do \\nCeará \\nJaqueline Rocha Borges dos Santos – \\nUniversidade Federal Rural do Rio de Janeiro \\nJessica Wanderley Souza do Nascimento – \\nInstituto de Especialização do Amazonas \\nJoão Henriques de Sousa Jún ior – Universidade \\nFederal de Santa Catarina \\nJoão Manoel Da Silva – Universidade Federal de \\nAlagoas \\nJoão Vitor Andrade – Universidade de São Paulo \\nJoilson Silva de Sousa – Instituto Federal do Rio \\nGrande do Norte \\nJosé Cândido Rodrigues Neto – Universidade \\nEstadual da Paraíba \\nJose Henrique de Lacerda Furtado – Instituto \\nFederal do Rio de Janeiro \\nJosenita Luiz da Silva – Faculdade Frassinetti do \\nRecife \\nJosiney Farias de Araújo – Universidade Federal \\ndo Pará'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 4}, page_content='Karina de Araújo Dias – SME/Prefeitura \\nMunicipal de Florianópolis \\nKatia Fernanda Alves Moreira – Universidade \\nFederal de Rondônia \\nLaís Portugal Rios da Costa Pereira – \\nUniversidade Federal de São Carlos \\nLaíze Lantyer Luz – Universidade Católica do \\nSalvador \\nLindon Johnson Pontes Portela – Universidade \\nFederal do Oeste do Pará \\nLuana Maria Rosário Martins – Universidade \\nFederal da Bahia \\nLucas Araújo Ferreira – Universidade Federal do \\nPará \\nLucas Capita Quarto – Universidade Federal do \\nOeste do Pará \\nLúcia Magnólia Albuquerque Soares de Camargo \\n– Unifacisa Centro Universitário \\nLuciana de Jesus Botelho Sodré dos Santos – \\nUniversidade Estadual do Maranhão \\nLuís Paulo Souza e Souza – Universidade Federal \\ndo Amazonas \\nLuiza Catarina Sobreira de Souza – Faculdade de \\nCiências Humanas do Sertão Central \\nManoel M ariano Neto da Silva – Universidade \\nFederal de Campina Grande \\nMarcelo Alves Pereira Eufrasio – Centro \\nUniversitário Unifacisa \\nMarcelo Williams Oliveira de Souza – \\nUniversidade Federal do Pará \\nMarcos Pereira dos Santos – Faculdade Rachel \\nde Queiroz \\nMarcus V inicius Peralva Santos – Universidade \\nFederal da Bahia \\nMaria Carolina da Silva Costa – Universidade \\nFederal do Piauí \\nMaria José de Holanda Leite – Universidade \\nFederal de Alagoas \\nMarina Magalhães de Morais – Universidade \\nFederal do Amazonas \\nMário Cézar de Oliveira – Universidade Federal \\nde Uberlândia \\nMichele Antunes – Universidade Feevale \\nMichele Aparecida Cerqueira Rodrigues – Logos \\nUniversity International \\nMilena Roberta Freire da Silva – Universidade \\nFederal de Pernambuco \\nNadja Maria Mourão – Universidade do Estado \\nde Minas Gerais \\nNatan Galves Santana – Universidade \\nParanaense \\nNathalia Bezerra da Silva Ferreira – \\nUniversidade do Estado do Rio Grande do Norte \\nNeide Kazue Sakugawa  Shinohara – \\nUniversidade Federal Rural de Pernambuco \\nNeudson Johnson Martinho – Faculdade de \\nMedicina da Universidade Federal de Mato \\nGrosso \\nPatrícia Appelt – Universidade Tecnológica \\nFederal do Paraná \\nPaula Milena Melo Casais – Universidade Federal \\nda Bahia \\nPaulo Henrique Matos de Jesus – Universidade \\nFederal do Maranhão \\nRafael Rodrigues Gomides – Faculdade de \\nQuatro Marcos \\nReângela Cíntia Rodrigues de Oliveira Lima – \\nUniversidade Federal do Ceará \\nRebeca Freitas Ivanicska – Universidade Federal \\nde Lavras \\nRenan Gustavo Pacheco Soares – Autarquia do \\nEnsino Superior de Garanhuns \\nRenan Monteiro do Nascimento – Universidade \\nde Brasília \\nRicardo Leoni Gonçalves Bastos – Universidade \\nFederal do Ceará \\nRodrigo da Rosa Pereira – Universidade Federal \\ndo Rio Grande \\nRubia Katia Azevedo Montenegro – \\nUniversidade Estadual Vale do Acaraú  \\nSabrynna Brito Oliveira – Universidade Federal \\nde Minas Gerais \\nSamuel Miranda Mattos – Universidade Estadual \\ndo Ceará \\nShirley Santos Nascimento – Universidade \\nEstadual Do Sudoeste Da Bahia \\nSilvana Carloto Andres – Universidade Federal \\nde Santa Maria \\nSilvio de Almeida Junior – Universidade de \\nFranca \\nTatiana Paschoalette R. Bachur – Universidade \\nEstadual do Ceará | Centro Universitário \\nChristus \\nTelma Regina Stroparo – Universidade Estadual \\ndo Centro-Oeste \\nThayla Amorim Santino – Universidade Federal \\ndo Rio Grande do Norte \\nThiago Sebastião Reis Contarato – Universidade \\nFederal do Rio de Janeiro \\nTiago Silveira Machado – Universidade de \\nPernambuco \\nVirgínia Maia de Araújo Oliveira – Instituto \\nFederal da Paraíba'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 5}, page_content='Virginia Tomaz Machado – Faculdade Santa \\nMaria de Cajazeiras \\nWalmir Fernandes Pereira – Miami University of \\nScience and Technology \\nWanessa Dunga de Assis – Universidade Federal \\nde Campina Grande \\nWellington Alves Silva – Universidade Estadual \\nde Roraima \\nWilliam Roslindo Paranhos – Universidade \\nFederal de Santa Catarina \\nYáscara Maia Araújo de Brito – Universidade \\nFederal de Campina Grande \\nYasmin da Silva Santos – Fundação Oswaldo \\nCruz \\nYuciara Bar bosa Costa Ferreira – Universidade \\nFederal de Campina Grande'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 6}, page_content='2023 - Editora Amplla \\nCopyright da Edição © Editora Amplla \\nCopyright do Texto © Os autores \\nEditor Chefe: Leonardo Pereira Tavares \\nDesign da Capa: Editora Amplla \\nDiagramação: Higor Brito \\nRevisão: Os autores \\nEditora Amplla \\nCampina Grande – PB – Brasil \\ncontato@ampllaeditora.com.br \\nwww.ampllaeditora.com.br \\n2023\\n  Dados Internacionais de Catalogação na Publicação (CIP) \\nCardiologia na emergência [livro eletrônico]: guia para o \\n   pronto-Socorro / organização Pedro José Leite de Almeida \\n Mendonça...[et al]. –– Campina Grande : Editora Amplla, 2023. \\n   267 p.  \\n   Formato: PDF  \\n   ISBN: 978-65-5381-105-8 \\n1. Medicina. 2. Cardiologia. 3. Emergência. I. Mendonça,\\nPedro José Leite de Almeida. II. Título. \\nCDD-612.17\\nSueli Costa - Bibliotecária - CRB-8/5213 \\n(SC Assessoria Editorial, SP, Brasil) \\nÍndices para catálogo sistemático: \\n1. Medicina  :  Cardiologia  612.17'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 7}, page_content='PRÉFACI O \\n \\nCaro leitor, \\nEste é o livro de Abordagem Prática das Emergências Cardiológicas \\nelaborado pela Liga Médico -Acadêmica de Cardiologia de Sobral (LIMACS). Nosso \\nlivro surgiu da necessidade de ter um material que pudesse auxiliar na revisão do \\nraciocínio clínico de médicos e acadêmi cos em formação na área das emergências \\ncardiológicas. \\nNosso livro é composto por 12 capítulos, nos quais seguimos um padrão com \\nfoco na parte prática. Para isso, cada capítulo conta com um caso clínico sobre o tema \\npara poder ilustrar ao leitor um exemplo  de condução daquela emergência. O caso \\nclínico é separado em boxes e são colocados em pontos estratégicos do capítulo para \\ncorrelacionar o texto teórico ao conteúdo prático. \\nAlém disso, todos os capítulos contam, no início, com perguntas norteadoras \\nque c onsideramos serem as mais pertinentes sobre cada tema. A ideia com estas \\nperguntas é que o leitor seja capaz de respondê -las ao concluir a leitura. Já ao final \\ndos capítulos, há fluxogramas que visam facilitar a compreensão e o raciocínio \\nclínico diante das emergências. \\nEste livro não possui o intuito de substituir a leitura de livros -texto \\nconsagrados ou mesmo de ditar condutas, mas sim de ajudar na revisão de temas \\npertinentes à prática médica.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 8}, page_content='SUMÁRIO  \\n \\n \\nCAPÍTULO I - RESSUSCITAÇÃO CARDIOPULMONAR (RCP) ........................................................................................... 9 \\nCAPÍTULO II - DOR TORÁCICA ............................................................................................................................. 25 \\nCAPÍTULO III - SÍNCOPE .................................................................................................................................... 43 \\nCAPÍTULO IV - TAQUIARRITMIAS ......................................................................................................................... 66 \\nCAPÍTULO V - BRADIARRITMIAS ......................................................................................................................... 109 \\nCAPÍTULO VI - SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) .................................................................... 125 \\nCAPÍTULO VII - SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) .................................................................. 142 \\nCAPÍTULO VIII - EMERGÊNCIAS HIPERTENSIVAS .................................................................................................... 172 \\nCAPÍTULO IX - TROMBOEMBOLISMO VENOSO (TEV) ............................................................................................... 197 \\nCAPÍTULO X - SÍNDROMES AÓRTICAS AGUDAS (SAA) .............................................................................................. 220 \\nCAPÍTULO XI - INSUFICIÊNCIA CARDÍACA AGUDA (ICA) ........................................................................................... 232 \\nCAPÍTULO XII - PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO ......................................................................... 251'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 9}, page_content='9 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nCAPÍTULO I  \\nRESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nJosé Igor de Carvalho Freitas 1 \\nLuís Eduardo Rodrigues Reis 1 \\nMatheus Uchoa 1  \\nFelipe Salim Habib Buhamara Alves Nasser Gurjão 1 \\nGabriel Luan Batista de Ávila 2 \\nDOI: 10.51859/amplla.ceg164.1123-1 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médico. Hospital Santa Casa de Misericórdia de Sobral. Sobral, Ceará, Brasil.  \\nCASO CLÍNICO  \\nHomem, 60 anos, vendedor, com antecedentes de hipertensão arterial. Estava em uma \\nestação de ônibus São Paulo quando sentiu forte dor precordial em aperto, em seguida surgiu \\nquadro de  tontura com evolução para perda de consciência. Usuários acionaram os \\nfuncionários do local (que possuem treinamento básico em RCP), os quais constataram PCR e \\niniciaram o atendimento. Após a abordagem inicial e passagem pelo ABCDE do trauma \\nsolicitaram o DEA e começaram a aplicar CTC de imediato. Em três minutos, o DEA estava no \\nlocal, com as pás aplicadas no tórax da vítima; foi feita a análise do ritmo (fibrilação ventricular) \\ne indicou -se choque em menos de 30s segundos. As compressões torácicas foram \\nimediatamente retomadas, e o DEA indicou 3 choques ao longo de 10 minutos, todos seguidos \\nde CTC. Após o quarto choque, a vítima voltou a respirar ainda que inconsciente, não \\napresentando mais indicação de desfibrilação devido à retomada do ritmo sin usal. Com a \\nchegada do Serviço de Atendimento Móvel de Urgência (SAMU), foram realizadas intubação \\norotraqueal, pois paciente se encontrava em Glasgow 7, medicações e cuidados necessários \\ncondizentes com o suporte de vida avançado (SAV). A vítima foi encaminhada para um hospital \\nsecundário, dando entrada inconsciente, em ritmo sinusal, com frequência cardíaca de 50 bpm, \\npressão arterial de 90 x 60 mmHg, frequência respiratória de 12 rpm, pupilas isocóricas e \\nreativas, murmúrio vesicular presente, abdome flácido à palpação e escala de rass -3. O infarto \\nagudo do miocárdio foi confirmado pela elevação do segmento ST nas derivações anteriores e \\npela elevação de enzimas (troponina e CKMB). O paciente foi submetido a cateterismo com \\nimplante de stent na artéria d escendente anterior. Recebeu alta hospitalar após 19 dias, sem \\nsequelas.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 10}, page_content='10 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nPERGUNTAS NORTEADORAS \\n1. Mediante o quadro de perda da consciência, o que deve ser feito? \\n2. Quais as medidas iniciais para o caso? \\n3. Após a chegada de equipe médica, que medidas de suporte mais avançadas podem ser \\ntomadas? \\n4. Qual a conduta do caso após atendimento primário? \\n \\nBOX 1. DEVIDO A PERDA DE CONSCIÊNCIA, O QUE DEVE SER FEITO? \\nUsuários acionaram os funcionários do local (que possuem treinamento básico em RCP), os \\nquais constataram PCR e iniciaram o atendimento. \\n1. INTRODUÇÃO \\nA ressuscitação cardiopulmonar (RCP) consiste em uma série de manobras realizadas \\npor profissionais de saúde, ou por leigos, para reverter a parada cardiorrespiratória (PCR) e \\nmanter a oxigenação e perfusão tecidual a dequadas 2, devido a causas intrínsecas ou \\nextrínsecas.  \\nO tempo entre o início de uma paragem cardiorrespiratória (PCR) e a prestação de \\ncuidados é fundamental; encurtar esse tempo aumenta a probabilidade de sobrevivência da \\nvítima 3. \\nO principal motivo q ue leva a uma pessoa, leiga ou profissional de saúde, a necessitar \\nperforma uma RCP é a parada cardiorrespiratória (PCR), que ocorre quando o coração do \\npaciente deixa de bater ou começa a bater de forma insuficiente, reduzindo o aporte do O2 para \\no corpo. Dessa forma levando a parada ou redução drástica da pressão arterial e consequente \\nqueda dos níveis de oxigênio que chega a todo corpo. Se não resolvida logo, essa redução do O2 \\ncirculante, hipóxia, leva a lesão de órgãos e, posteriormente, à sua falência  4. Logo, a RCP é \\nimprescindível em uma emergência para a preservação da vida de um paciente. \\nApesar de ter suma importância na manutenção da vida de um paciente a RCP é um \\nprocedimento complicado e que exige treinamento técnico para que seja feito de mane ira \\nefetiva. Já que, dentro de seu protocolo de realização exigem diversos passos a serem seguidos \\ne critérios a serem atendidos, ambos serão abordados durante esse capítulo 5. \\nDentre as causas que levam a PCR a principal é a síndrome coronariana aguda. A parada \\ncardiorrespiratória (PCR) pode ser causada por quatro ritmos: fibrilação ventricular (FV),'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 11}, page_content='11 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\ntaquicardia ventricular sem pulso (TVSP), atividade elétrica sem pulso (AESP) e assistolia 6. Em \\n2016, no brasil, ocorreram cerca de 30 casos de morte súbita para cada 10.000 pessoas 7. A \\nparada PCR permanece como uma das emergências cardiovasculares de grande prevalência e \\ncom morbidade e mortalidade elevadas. \\nBOX 2. QUAIS AS MEDIDAS INICIAIS PARA O CASO? \\nApós a abordagem inicial e passagem pelo ABCDE do trauma solicitaram o DEA e \\ncomeçaram a aplicar CTC de imediato. Em três minutos, o DEA estava no local, com as pás \\naplicadas no tórax da vítima; foi feita a análise do ritmo (fibrilação ventricular) e indicou-\\nse choque em menos de 30s segundos. As compressões torácicas foram imediatamente \\nretomadas, e o DEA indicou 3 choques ao longo de 10 minutos, todos seguidos de CTC. \\nApós o quarto choque, a vítima voltou a respirar ainda que inconsciente, não apresentando \\nmais indicação de desfibrilação devido à retomada do ritmo sinusal. \\n2. SUPORTE BÁSICO DE VIDA (SBV) \\nO Suporte Básico de Vida (SBV) é o protocolo de atendimento inicial às vítimas de parada \\ncardiorrespiratória (PCR), que pode ser iniciado no ambiente extra -hospitalar, no qual se \\nestabelece o reconhecimento e a realização de manobras. O grande objetivo do SBV é manter o \\npaciente viável e com o Sistema Nervoso Central (SNC) o mais intacto possível. Com a chegada \\nda equipe médica equipada e treinada, terá início o Suporte Avançado de Vida (SAV)⁵,⁸. \\nO atendimento inicial é feito pela pessoa mais próxima e inicia com uma vítima suspeita \\nde PCR. De início, após identificação de vítima suspeita de PCR, é preciso verificar se o local do \\natendimento é s eguro para o socorrista e para a vítima. Feito isso, deve -se checar a \\nresponsividade do paciente, realizando estímulo auditivo (chamar pelo paciente) e manual \\n(realizar toques na clavícula, por exemplo), e a respiração da vítima. A associação de \\nirresponsividade com respiração anormal (apneia ou agônica) configura o quadro de PCR. A \\nchecagem de pulso em grandes artérias é opcional para socorristas leigos, se profissional de \\nsaúde, a checagem não pode ultrapassar 10 segundos. Constatada a PCR, o próximo pass o é \\nacionar o serviço de emergência e pedir que tragam o desfibrilador. A desfibrilação pode ser \\nrealizada por pessoas leigas minimamente treinadas para tal, com auxílio dos Desfibriladores \\nExternos Automáticos (DEA)⁵,⁸. \\nA partir disso, podem ser iniciadas  as manobras de SBV, que consistem em quatro \\npilares, sendo representadas por meio de letras: C (ciculation), A (airway), B (Breathing) e D'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 12}, page_content='12 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\n(Desfibrilation). A sequência de realização das manobras mais preconizadas é C -A-B. A \\nmanobra correspondente a letra  D (Desfibrilation), que corresponde à desfibrilação, deve ser \\nrealizada, quando bem indicada, assim que possível⁵,⁸. \\n2.1. C (CIRCULATION – CIRCULAÇÃO) \\nApós a identificação da PCR, é imprescindível o início imediato das compressões \\ntorácicas. Alguns pilares importantes desta manobra são: \\n• A vítima deve estar sobre superfície rígida \\n• Deve ser realizada sobre o esterno, aplicando força sobre o tórax, com braços \\nestendidos. \\n• A compressão deve gerar uma profundidade no tórax de 5-6 cm \\n• Permitir o retorno completo do tórax \\n• A frequência deve ser de 100/120 por minuto \\n• Minimizar as interrupções nas compressões (“no hands-off”) \\n• Trocar rapidamente o reanimador a cada 2 minutos \\n• Se possível, alternar as compressões com as ventilações, na relação de 30:2 (30 \\ncompressões seguidas por duas ventilações) \\n• Socorristas leigos podem realizar apenas as compressões torácicas, sem \\nnecessidade de associar as ventilações (\"hands-only\"). \\n• Um ciclo de RCP corresponde a 5 séries de 30 compressões, associada à 2 \\nventilações, isto é, cerca de 2min de RCP \\n2.2. A (AIRWAY – VIA AÉREA) \\nEsta manobra objetiva abrir a via aérea da vítima, por meio da realização das manobras \\nde extensão cervical (Head tilt) e elevação do queixo (Chin lift). Além disso, é fundamental \\ninspecionar a cavidade oral do paciente e retirar prótese dentária ou qualquer corpo estranho \\nda via aérea⁵,⁸. \\n2.3. B (BREATHING – VENTILAÇÃO) \\nApós as compressões iniciais e abertas as vias aéreas, são realizadas duas ventilações \\napós as primeiras 30 compressões torácicas, mantendo a relação compressão/vent ilação de \\n30:2. Socorristas leigos podem realizar apenas compressões torácicas. A ventilação pode ser'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 13}, page_content='13 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nfeita sem proteção (boca a boca ou boca nariz) ou com proteção (uso de dispositivos e válvulas, \\ntais como dispositivos com válvula unidirecional, máscaras ou bolsa-máscara)⁵,⁸. \\n2.4. D (DEFIBRILLATION – DESFIBRILAÇÃO) \\nEste procedimento pode ser realizado assim que possível, quando corretamente \\nindicado, ou seja, na presença de ritmos de parada “chocáveis” (Taquicardia Ventricular s/ \\npulso e Fibrilação Ventricular). Existe o cardiodesfibrilador manual, utilizado em ambie nte \\nintra-hospitalar, e o Desfibrilador Externo Automático (DEA), que pode ser utilizado por leigos \\nem ambiente extra -hospitalar, já que identifica se o ritmo é “chocável” ou “não -chocável” de \\nforma automática, indicando ou não a desfibrilação, contribuindo para aumento das chances de \\nsobrevivência da vítima. A posição tradicional recomendada dos eletrodos é um na região apical \\ne outro na região infraclavicular direita. A carga recomendada depende do cardiodesfibrilador, \\nsendo indicado 360J no monofásico. Já no bifásico, a preferência é pela carga preconizada pelo \\nfabricante do aparelho, geralmente entre 120 -200 J, mas se dúvida, utilize 200J. Logo após a \\nrealização do choque, é recomendado recomeçar novo ciclo de RCP, para posteriormente ser \\nchecado o ritmo⁵,⁸. \\nBOX 3. APÓS A CHEGADA DA EQUIPE MÉDICA, QUE MEDIDAS DE SUPORTE MAIS \\nAVANÇADAS PODEM SER TOMADAS? \\nCom a chegada do Serviço de Atendimento Móvel de Urgência (SAMU), foram \\nrealizadas intubação orotraqueal, medicações e cuidados necessários condizentes com o \\nsuporte de vida avançado (SAV). \\nA vítima foi encaminhada para um hospital secundário, dando entrada inconsciente, \\nem ritmo sinusal, com frequência cardíaca de 150 bpm, pressão arterial de 180 x 100 mmHg, \\nfrequência respiratória de 16 rpm, pupilas isocóricas e  reativas, murmúrio vesicular \\npresente, abdome flácido à palpação e Glasgow de 7. \\n3. SUPORTE AVANÇADO DE VIDA (SAV) \\nO Suporte Avançado de Vida (SAV) é a segunda etapa da abordagem paciente com parada \\ncardiorrespiratória (PCR) e deve ser realizada por equipe médica treinada e equipada. Agora, \\nestão presentes medidas de suporte avançado, que englobam, além das compressões torácicas \\ne desfibrilação, obtenção de via aérea definitiva, acesso venoso, administração de drogas e uma \\nsérie de medidas que podem ser utilizadas em casos específicos de PCR. (Livro: ACLS)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 14}, page_content='14 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nNa abordagem do ACLS, as medidas do ABCD não são sequenciais, mas sim simultâneas⁹. \\nDe forma geral, temos alguns conceitos básicos: \\n3.1. A – (AIRWAY) \\nÉ de suma importância a obtenção de via aérea (VA) avançada, sendo fundamental a não \\ninterrupção das compressões torácicas durante esta tentativa. A intubação orotraqueal (IOT) \\ngeralmente é a via mais utilizada. Se IOT, deve -se checar, sem interromper compressões \\ntorácicas, se a posição do tubo orotraqueal (TOT) est á correta, por meio da ausculta da região \\nepigástrica e dos pulmões, além de inspecionar se há expansão pulmonar bilateral. Outra forma \\nde avaliar a correta posição do TOT é a capnografia. Entre as alternativas à IOT, temos o tubo \\nesofágico-traqueal (Combitube) e a máscara laríngea⁹.  \\n3.2. B - (BREATHING) \\nA ventilação no paciente com VA avançada ocorre com ambu, não mais na proporção \\n30:2, e sim na frequência de 10 ventilações por minuto (1 ventilação a cada 6 segundos), com \\nambu ligado ao oxigênio 10L/min. As v entilações ocorrem independentemente das \\ncompressões torácicas⁹.  \\n3.3. C (CIRCULATION) \\nA obtenção de acesso venoso periférico é necessária para infusão de drogas, \\npreferencialmente uma veia antecubital calibrosa. Se não for possível, tentar a veia jugular \\nexterna, de preferência. Se o acesso periférico não for possível, as drogas poderão ser \\nadministradas pelo tubo endotraqueal enquanto se prepara o kit de acesso venoso intraósseo, \\nse disponível. Apenas naloxona, adrenalina e lidocaína podem ser feitas pela via endotraqueal \\nna PCR. Neste caso, a adrenalina deve ser realizada na dose 2-3x superior a dose IV⁹. \\n3.4. D (DIFFERENTIAL DIAGNOSIS) \\nPensar em causas de PCR que exigem medidas específicas para resolução do quadro do \\npaciente. Dentre as prováveis etiologias, podemos pensar nos 5H´s e 5 T´s⁸,⁹.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 15}, page_content='15 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nTabela 1 - Etiologias de PCR \\n5 H´s 5 T´s \\nHidrogênio (acidose) Trombose Pulmonar \\nHipo/hipercalemia Trombose Coronariana \\nHipóxia Tamponamento Cardíaco \\nHipovolemia Tenso Pneumotórax \\nHipotermia Toxicidade \\n \\nNas figuras a seguir estão alguns exemplos de achados que podem ser reconhecidos no \\ntraçado eletrocardiográfico que nos faz lembrar de condições clínicas que podem ocasionar \\numa PCR. \\n \\nFigura 1 - HIPERCALEMIA MODERADA \\n \\nOcorre achatamento da onda P, alargamento do intervalo PR e do complexo QRS, além \\ndo apiculamento de onda T'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 16}, page_content='16 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nFigura 2 - PADRÃO S1Q3T3\\n \\nPadrão sugestivo de TEP \\nA conduta específica depende do ritmo de parada cardíaca, que pode ser de quatro \\nformas⁹, conforme a tabela 2: \\n \\nTabela 2 - Ritmos de parada cardíaca \\nRitmo de PCR Choque Desfibrilatório \\nFibrilação Ventricular (FV)  \\nIndicado \\nTaquicardia Ventricular Sem Pulso (TV s/ \\npulso) \\nAtividade Elétrica Sem Pulso (AESP)  \\nNão indicado \\nAssistolia \\n \\nFigura 3 - Fibrilação Ventricular'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 17}, page_content='17 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nFigura 4 - Taquicardia Ventricular \\n \\n \\nFigura 5 - AESP \\n \\n \\nFigura 6 - Assistolia \\n \\nBOX 4. O QUE LEVOU A PESSOA DO CASO CLÍNICO A TER UMA PCR?  \\nO paciente teve uma PCR devido a infarto agudo do miocárdio. \\n \\n3.5. CONDUTA NA PCR DE ACORDO COM O RITMO \\n3.5.1. Fv e Tv s/ pulso \\nSão situações em que o choque desfibrilatório é imprescindível na tentativa ao Retorno \\nda Circulação Espontânea (RCE). Ao se identificar FV ou TV s/ pulso no monitor, imediatamente \\ndeve ser feita a desfibrilação. A carga empregada varia de acordo com o cardiodesfibrilador, \\nsendo indicado o uso de 360J (se monofásico) ou 120-200J (se bisáfico). Após o choque, retorna-\\nse de imediato as compressões torácicas na frequência de 100 -120 por minuto, durante 2 \\nminutos. Após os 2 minutos, verifica -se o ritmo. Se o ritmo persiste “chocável”, aplica -se o \\nchoque e inicia-se novamente compressões torácicas. Assim que for obtido acesso venoso, é \\nrecomendada a infusão de adrenalina (epinefrina) na dose de 1mg (uma ampola), sendo \\nrepetida a cada 3-5 minutos, preferencialmente por acesso venoso periférico, seguido de fl ush'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 18}, page_content='18 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nde 20 mL de SF ou água destilando e elevando o braço do paciente. Após os 2 minutos de RCP, \\né feita a checagem do ritmo, se persistir como “ritmo chocável”, aplica -se o choque e logo em \\nseguida são iniciadas novamente as compressões torácicas. Durante este ciclo, é feita a infusão \\nda primeira dose do antiarrítmico, sendo a amiodarona a droga de escolha, na dose de 300mg \\nIV em bolus (duas ampolas). A outra opção é a lidocaína 1-1,5 mg/kg IV em bolus. A amiodarona \\npode ser repetida, posteriormente, na dos e de 150mg (uma ampola). Já a lidocaína, pode ser \\nrepetida na dose de 0,5-0,75 mg/kg a cada 5-10 minutos, até atingir a dose total de 3 mg/kg. O \\ndiagnóstico e o tratamento das causas reversíveis de PCR são fundamentais na abordagem dos \\nritmos de PCR. No ca so de FV ou TV s/ pulso refratária, considerar como causa potencial a \\nsíndrome coronariana aguda (SCA). Se em qualquer momento o ritmo identificado alterar, ou \\nseja, tornar-se “não chocável” (AESP ou Assistolia), devemos adotar abordar como tal. Caso haja \\nRetorno da Circulação Espontânea (RCE), iniciar Cuidados Pós-PCR⁸,⁹. \\n3.5.2. AESP e assistolia \\nSão situações em que o choque desfibrilatório e os antiarrítmicos não estão indicados. \\nDeve-se, então, promover RCP de boa qualidade, aplicar as drogas indicadas e procu rar \\nidentificar e tratar as causas reversíveis. A obtenção de VA avançada é a primeira medida após \\ndetectada AESP ou Assistolia. O ritmo comumente encontrado na AESP é um ritmo \\nidioventricular,  contudo, ele pode ser diverso, incluindo ritmo sinusal. Sempr e que for \\nobservada Assistolia, é preciso lembrar do protocolo da linha reta, que consiste em verificar o \\ncabeamento da monitorização eletrocardiográfica e as pás, aumentar o ganho das derivações, \\npara que sejam detectadas as pequenas ondulações no traçado  eletrocardiográfico, e, por fim, \\nalterar as derivações do monitor. Identificada AESP/Assistolia, fazer tão logo seja possível a \\ninfusão de adrenalina na dose 1 mg (uma ampola) e repetir a cada 3 -5 minutos. Após isso, \\nretorna-se de imediato as compressões torácicas na frequência de 100-120 por minuto, durante \\n2 minutos. Após os 2 minutos, verifica -se o ritmo. Se o ritmo persiste não “chocável”, inicia -se \\nnovamente compressões torácicas, iniciando novo ciclo de RCP. Se em qualquer momento, o \\nritmo identificado alterar, ou seja, tornar -se “chocável” (FV ou TV s/ pulso), devemos abordar \\ncomo tal. O diagnóstico e o tratamento das causas reversíveis de PCR são fundamentais na \\nabordagem dos ritmos de PCR. Caso haja Retorno da Circulação Espontânea (RCE), iniciar \\nCuidados Pós-PCR⁸,⁹.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 19}, page_content='19 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nBOX 5. QUAL A CONDUTA NO CASO APÓS O ATENDIMENTO PRIMÁRIO? \\nO infarto agudo do miocárdio foi confirmado pela elevação do segmento ST nas derivações \\nanteriores e pela elevação de enzimas (troponina e CKMB). O paciente foi submetido a \\ncateterismo com implante de stent na artéria descendente anterior. Recebeu alta \\nhospitalar após 19 dias, sem sequelas. \\n \\n4. CUIDADOS PÓS-PCR \\nApós uma parada cardiorrespiratória, pacientes que conseguem retorno à circulação \\nespontânea são considerados de altíssimo risco, com taxas de mortalidade hospitalar em torno \\nde 63 a 90%. O manejo do atendimento pós-parada tem como principal objetivo, minimizar as \\nlesões nos órgãos-alvo, otimizar a função cardiopulmonar e garantir normalização da perfusão \\nde órgãos vitais a fim de evitar a síndrome da falência orgânica múltipla. Esse manejo é de \\nextrema importância visto que a maioria das mortes após o retorno da circulação espontânea \\n(RCE) ocorrem nas primeiras 24h posteriores ao evento. De forma geral, durante a parada, \\ntodos os órgãos sofrem algum tipo de lesão, e após o retorno é comum que o dano se \\nintensifique, devido a chamada injúria de isquemia -reperfusão. Esse processo acomete \\nprincipalmente a microcirculação, causando vasodilatação generalizada, aumento da \\npermeabilidade vascular e consequentemente levando a instabilidade hemodinâmica (má \\nperfusão tecidual), podendo levar a um desfecho desfavorável8,11,12 .  \\nDiante disso, inicialmente devemos alocar o paciente em uma unidade de terapia \\nintensiva, monitorando sinais vitais continuamente, além disso é fundamental a identificação \\ne o tratamento da causa da PCR, normalmente esse reconhecimento e início do tratamento é \\nrealizado durante a RCP, no entanto após a RCE o médico deve tentar obter mais informações \\nsobre o paciente (através de amigos, familiares ou equipe de emergência) e deve -se realizar \\nnovamente o exame físico, com coleta de exames laboratoriais gerais e realização de \\neletrocardiograma (ECG) de urgência8,10,11,12.  \\nDeve-se garantir o suporte ventilatório adequado, sendo indicado a obtenção de uma \\nvia aérea avançada para garantir uma ventilação adequada e proteção contra broncoaspiração. \\nInicialmente 100% de oxigénio é aceitável para a intervenção precoce mas não para períodos \\nprolongados, a FiO2 deve ser titulada para manter SaO2≥ 94%, procurando evitar níveis \\nexcessivos de oxigênio, devido ao risco de lesões por hiperóxia. Também é recomendado evitar'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 20}, page_content='20 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\na hiperventilação (volume corrente 6-8 ml/kg) pois reduz o débito cardíaco e promove redução \\nda perfusão cerebral devendo se manter a pCO2 entre 40-45 mmHg8,10,11,12. \\nAlém disso, é necessário g arantir o suporte hemodinâmico,  sendo indicado a \\nobtenção/verificação de um acesso venoso em todos os pacientes.  A hipovolemia deve ser \\ncorrigida, principalmente nos casos de labilidade hemodinâmica, a reposição volêmica deve ser \\nconsiderada para otimizar perfusão orgânica devendo se manter a PA sistólica ≥ 90 mmHg e a \\nPAM ≥ 65 mmHg.  A reposição volêmica deve ser de 1 -2 L de SF 0,9% ou Ringer e naqueles \\npacientes em choque refratários à reposição, pode -se utilizar algum vasopressor, não há \\nevidências que mostram benefício de um vasopressor em relação aos demais, podem ser \\nutilizadas noradrenalina (0,1 a 0,5 mcg/kg/minuto), dopamina (5 a 10 mcg/kg/minuto), ou \\nepinefrina (0,1 a 0,5 mcg/kg/minuto)8,10,11,12.  \\nEm casos específicos pode se requerer estimulação elétrica artificial com marca -passo \\ntranscutâneo ou transvenoso. Em pacientes com choque cardiogênico refratário, pode ser \\nnecessário o emprego de balão intra -aórtico ou dispositivos de assistência circulatória. \\nAntiarrítmicos podem ser considerados, no ca so de fibrilação ventricular (FV) ou taquicardia \\nventricular sem pulso (TVSP) que evoluem para restauração da circulação espontânea (RCE) \\n(apesar de fracas evidências suportivas), com uso de amiodarona 360 mg, EV, nas primeiras 6 \\nhoras, e 540 mg, EV, nas p róximas 18 horas, ou, caso tenha sido utilizada durante a PCR, \\nlidocaína 1 a 4 mg/min, a associação de antiarrítmicos deve ser evitada8,10,11,12.  \\nAlém disso, a nova versão do ACLS considera que a angiografia coronariana  é um \\nprocedimento de emergência que  deve ser feito tão logo seja possível em todas as vítimas de \\nPCR de origem cardíaca após retorno da circulação espontânea. Isso justifica -se pela alta \\nprevalência de doenças coronarianas, associada a baixo valor preditivo negativo da ausência de \\nalterações isquêmicas agudas no ECG8,11,12.  \\nAdemais, também  é fundamental o suporte neurológico , as lesões neurológicas \\nconstituem a maior causa de mortalidade em pacientes com RCE, logo a Hipotermia terapêutica \\n(ou Controle Direcionado de Temperatura) deve ser re alizada para todos os pacientes em \\nestado comatoso, constituindo a única medida eficiente para tentar evitar lesão neurológica de \\nreperfusão. A temperatura central deve ser mantida entre 32 -36ºC por pelo menos 24h, \\nExistem diversas metodologias para indução de hipotermia, como infusão de solução isotônica \\na 4 °C associada a sacos de gelo ou bolsas geladas sobre o pescoço, axilas e virilhas do paciente, \\naté dispositivos endovenosos com cateter de feedback intravascular. Não existem diferenças \\nnos resultados entre as diferentes metodologias até o presente momento, e a metodologia deve'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 21}, page_content='21 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nser escolhida de acordo com a disponibilidade de equipamento e a experiência da \\nequipe8,10,11,12.  \\nTambém deve ser realizado o controle da glicemia com alvo de 144-180 mg/dl, evitando \\na hipoglicemia, dosagem de lactato de maneira seriada para avaliar a perfusão sistêmica e o \\ncontrole do potássio sérico a fim de evitar arritmias8,10,11,12.   \\n5. CONSIDERAÇÕES IMPORTANTES \\n• A PCR é uma das maiores emergências da medicina com taxas de mortalidade e \\nmorbidade elevadas em todo o mundo.  \\n• A principal etiologia da PCR é a Síndrome Coronariana Aguda.  \\n• A parada cardiorrespiratória pode ser causada por quatro ritmos: Fibrilação \\nVentricular (FV), Taquicardia Ventricular sem Pulso (TVSP), Atividade Elétrica sem \\nPulso (AESP) e Assistolia. \\n• O Suporte Básico de Vida (SBV) é o protocolo de atendimento inicial às vítimas de \\nparada cardiorrespiratória (PCR), que pode ser iniciado no ambiente ex tra-\\nhospitalar. \\n• Diante da suspeita de uma PCR inicialmente deve-se checar a responsividade do \\npaciente. \\n• Se não houver resposta e o paciente não estiver respirando ou apresentar respiração \\nagônica, deve-se solicitar ajuda com desfibrilador. \\n• A checagem do pu lso é opcional: Se realizada deve -se checar pulso carotídeo ou \\nfemoral por 5 a 10 segundos. \\n• Após a identificação da PCR, é imprescindível o início imediato das compressões \\ntorácicas.  \\n• As compressões ideais devem gerar uma profundidade no tórax de 5-6 cm, permitir \\no retorno completo do tórax, a frequência deve ser de 100/120 por minuto e deve -\\nse  minimizar interrupções nas compressões. \\n• Deve-se realizar a abertura das vias aéreas e a ventilação. \\n• A ventilação ideal pode ser realizada boca a boca ou com di spositivos de proteção, \\nmantendo a relação compressão/ventilação de 30:2. \\n• A desfibrilação deve ser realizada assim que possível  na presença de ritmos de \\nparada “chocáveis” (Taquicardia Ventricular s/ pulso e Fibrilação Ventricular).'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 22}, page_content='22 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\n• O Suporte Avançado de V ida (SAV) é a segunda etapa da abordagem paciente com \\nPCR e deve ser realizada por equipe médica treinada e equipada.  \\n• No SAV deve-se obter via aérea definitiva e acesso venoso para administração de \\ndrogas. \\n• A ventilação no paciente com VA avançada deve oco rrer na frequência de 1 \\nventilação a cada 6 segundos. \\n• Nessa fase deve -se pensar em causas de PCR que exigem medidas específicas para \\nresolução do quadro do paciente. Lembrar dos 5H´s e 5 T´s. \\n• Para pacientes em FV ou TV s/ pulso o choque desfibrilatório é i mprescindível e as \\ndrogas que podem ser utilizadas incluem adrenalina, amiodarona e lidocaína. \\n• Para pacientes em AESP e Assistolia o choque desfibrilatório e os antiarrítmicos não \\nestão indicados. Deve-se, então, promover RCP de boa qualidade e fazer tão logo seja \\npossível a infusão de adrenalina na dose 1 mg repetindo a cada 3-5 minutos. \\n• Caso haja Retorno da Circulação Espontânea (RCE) deve -se iniciar os cuidados Pós-\\nPCR.  \\n• O manejo do atendimento pós -parada tem como principal objetivo, minimizar as \\nlesões nos órgãos-alvo, otimizar a função cardiopulmonar e garantir normalização \\nda perfusão de órgãos vitais. \\n• Os cuidados Pós-PCR se baseiam em alocar o paciente em uma unidade de terapia \\nintensiva, garantir o suporte ventilatório, hemodinâmico e neurológico  \\nadequado. \\n• O ACLS considera que a angiografia coronariana  deve ser feita tão logo seja \\npossível em todas as vítimas de PCR de origem cardíaca após RCE. \\n• Deve-se titular a fração inspirada de oxigênio (FiO2 ) para manter Sat > 94%, evitar \\nhipovolemia mantendo a PA sistólica ≥ 90 mmHg e a PAM ≥ 65 mmHg e em pacientes \\nem choque refratários à reposição volêmica pode-se utilizar  vasopressores. \\n• O suporte neurológico deve ser implementado através da Hipotermia Terapêutica \\npara pacientes em estado comatoso, a temperat ura central deve ser mantida entre \\n32-36ºC por pelo menos 24h. \\n• Também deve ser realizado o controle da glicemia com alvo de 144 -180 mg/dl, a \\ndosagem de lactato sérico para avaliar a perfusão sistêmica e o controle do potássio \\nsérico.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 23}, page_content='23 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nFLUXOGRAMA'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 24}, page_content='24 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nREFERÊNCIAS \\n1- Gianotto-Oliveira [maio, 2014]. Disponivel em \\n<https://www.scielo.br/j/abc/a/WdHzDMXKCxZyFZjWmcykwjF/?lang=pt#:~:text=Apresent\\namos%20um%20caso%20de%20PCR,Desfibrilador%20Externo%20Autom%C3%A1tico%20\\n(DEA).>. \\n2- Sabará Hopital Infantil [https://www.hospitalinfantilsabara.org.br/sinto mas-doencas-\\ntratamentos/ressuscitacao-cardiopulmonar/] . Ressuscitação cardiopulmonar [acesso em 19 \\nfev 2022]. \\n3- Ribeiro Ana Rafaela Marques, Sá Juliana Marília Pereira de, Tjeng Ricardo. Desenho e \\nAvaliação do Impacto de uma Ação de Formação em Suporte B ásico de Vida nas Escolas. Gaz \\nMed  [Internet]. 2020  Mar [citado  2022  Mar  28] ;  7( 1 ): 7 -12. Disponível em: \\nhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282020000100007&lng=pt.  \\nEpub 02-Jun-2021.  https://doi.org/10.29315/gm.v7i1.253. \\n4- LONG DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscaizo  J. Medicina Interna de \\nHarrison. 18th ed. Porto Alegre: AMGH; 2013. \\n5-Mateus BA, laranjeira LN, corrêa DCT, Oliveira, Souza SF. SBV para Profissionais de Saúde \\n(manual do aluno). ed. PT. São Paulo: Sesil; 2011. \\n6- Takeda LK, Oliveira LAT, Figueiredo ET. P arada cardiorrespiratória e RCP.  Figueiredo ET. \\nManual de Clínica Médica. Salvador: Sanar; 2019. 125-129. \\n7 - Berg RA, Hemphill R, Abella BS, Aufderheide TP, Cave DM, Hazinski MF, et al. Part 5: Adult \\nBasic Life Support. 2010 American Heart Association gu idelines for cardiopulmonary \\nressuscitation and emergency cardiovascular care \\n8- Santos EC, Figuinha FC, Lima AG, Henares BB, Mastrocola F. Manual de Cardiologia \\nCardiopapers. 1st ed. São Paulo: Atheneu; 2015. 698 p. 1 vol. \\n9 - AHA. Adult Basic Life Suppor t. 2020 International Consensus on Cardiopulmonary \\nResuscitation and Emergency Cardiovascular Care Science With Treatment. Recommendations. \\nCirculation. 2020;142 (suppl 1):S41 –S91. DOI: 10.1161/CIR.0000000000000892. Disponível \\nem: https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines \\n10- American Heart Association. Destaques das diretrizes de RCP e ACE de 2020 da America n \\nHeart Association. Disponível em: https://cpr.heart.org/en/resuscitation-science/cpr-and-\\necc-guidelines \\n11- Gonzalez MM, Timerman S,  Gianotto-Oliveira R, et al. I Diretriz de Ressuscitação \\nCardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de \\nCardiologia. 2013; v.101, n.2. \\n12-  International Liaison Committee on Resuscitation. 2005 International Consensus on \\nCardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment \\nRecommendations. Part 1: introduction. Resuscitation. 2005;67:181.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 25}, page_content='25 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nCAPÍTULO II  \\nDOR TORÁCICA \\nBenedito Mesley Lima Portela 1 \\nJosé Igor de Carvalho Freitas 1 \\nMarconni Alves Ferreira 1 \\nPedro José Leite de Almeida Mendonça 1 \\nJoaquim David Carneiro Neto 2 \\nDOI: 10.51859/amplla.ceg164.1123-2 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médico cardiologista hemodinamicista. Hospital do Coração de Sobral. Sobral, Ceará, Brasil. \\nCASO CLÍNICO \\nHomem com 62 anos, antecedentes de diabetes mellitus (DM) e hipertensão arterial \\nsistêmica (HAS), comparece ao Pronto -Atendimento com queixa de dois episódios de dor \\nretroesternal em queimação com duração de 15 minutos nas últimas 24 horas. Ao exame físico, \\nfrequência cardíaca de 80 bpm, pressão arterial 135/85 mmHg em todos os membros, pulsos \\nsimétricos, temperatura axilar de 37,5°C, ausência de edema nos membros inferiores, ausculta \\ncardíaca e pulmonar normais. \\nPERGUNTAS NORTEADORAS \\n1. Quais as principais hipóteses diagnósticas? \\n2. Como estratificar o risco do paciente? \\n3. Quais os exames complementares a serem realizados? \\n4. Qual a conduta a ser realizada? \\n1. INTRODUÇÃO E EPIDEMIOLOGIA \\nA dor torácica constitui um  dos maiores desafios diagnósticos no departamento de \\nemergência, sendo importante e prevalente motivo de busca por atendimento médico devido \\nàs mais diversas etiologias e associações com risco de mortalidade, a depender da causa base. \\nSem dúvida, uma das situações mais significativas desse contexto se refere à dor torácica de \\norigem cardíaca, a qual requer rápido diagnóstico com vistas à intervenção precoce. Nos \\nEstados Unidos, a dor torácica chega a ser queixa de 5,8 milhões de pessoas que buscam'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 26}, page_content='26 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\natendimento nos pronto -atendimentos, ao passo que no Brasil, anualmente, pelo menos 4 \\nmilhões de pessoas buscam atendimento por dor torácica.¹ \\nO panorama da dor torácica demonstra sua grande importância quando se trata de \\nnúmeros. Dados de 2011 mostram que pelo me nos 20 milhões de pessoas foram acometidas \\npor doença cardiovascular (DCV), destes, 12 milhões foram a óbito, sendo esta uma importante \\netiologia de dor torácica a ser buscada ou descartada na avaliação médica nos serviços de \\nemergência.² A discussão deste  tema também é fundamental para que se evitem iatrogenias, \\ncomo pacientes submetidos desnecessariamente a protocolos de síndrome coronariana aguda \\n(SCA), quando a dor seria na verdade de origem não isquêmica. Isso gera momentos de \\nansiedade para o paciente e onera o sistema de saúde com gastos que poderiam ser evitados.³ \\n Na maioria das vezes, a dor torácica está associada a condições de baixo risco. \\nEstatísticas americanas falam de falhas diagnósticas de até 4% considerando a SCA, com \\nmortalidade precoce de até 25% desta coorte. Além da SCA, outras causas potencialmente fatais \\nde dor torácica incluem as síndrome aórticas, a embolia pulmonar, o pneumotórax \\nhipertensivo, o tamponamento pericárdico e a rotura esofágica. Por isso, a importância de um \\ndiagnóstico precoce e correto. DCVs têm importância cada vez maior no Brasil, com \\nlevantamentos do DATASUS de 2016 a 2018 mostrando essas doenças como responsáveis por \\n27% dos óbitos na faixa de 40 a 49 anos de idade, representando nesta faixa etária a segunda \\ncausa de morte, com 18.774 mortes por ano, perdendo apenas para causas externas. Acima \\ndesta faixa etária, são a principal causa de morte isoladamente, sendo a terceira causa de \\ninternamentos no SUS, estando atrás de causas externas e internações obstétricas. N o Brasil, a \\ndor torácica como atendimento nos serviços de emergência, constitui de 4,7 a 6,2% dos \\natendimentos.4 \\n2. FISIOPATOLOGIA E ETIOLOGIA \\nA fisiopatologia da dor torácica, envolve a estimulação simpática e ativação dos centros \\nnervosos superiores de dor, com particularidades de mecanismos e apresentações clínicas que \\nvariam conforme a etiologia. Dada esta variedade, a dor pode ter origem visceral e uma \\nlocalização e reconhecimento causal um tanto inespecífica. Coração, pulmões, esôfago e \\ngrandes vasos est imulam os mesmos gânglios autônomos torácicos, o que permite que o \\nindivíduo sinta a dor como proveniente do tórax, mas como as fibras confluem para o mesmo \\nlocal, a localização precisa (dor parietal) nem sempre é identificada no primeiro momento (dor \\nvisceral), tornando-se um desafio para o médico no diagnóstico, e requerendo dele uma coleta'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 27}, page_content='27 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nadequada da história clínica, como localização, fatores de piora e de melhora e estratificação de \\nrisco, além de outros, para poder determinar a etiologia e a solicita ção adequada de exames \\ncomplementares, bem como a terapêutica correta frente a esses casos.5 \\nA caracterização da dor auxilia no estabelecimento diagnóstico, permitindo ao médico \\ninferir quais exames necessitará e como proceder o tratamento. Diagnósticos ma is graves de \\ndor torácica incluem: SCA (dor retroesternal em aperto ou queimação com irradiação para \\nmembros superiores e mento e frequentemente alterações no eletrocardiograma, com ou sem \\nalterações de marcadores de necrose miocárdica), dissecção aórtica (dor súbita interescapular \\ncom sensação de “rasgando”, sopro sistólico em foco aórtico e assimetria de pulsos), embolia \\npulmonar (dor pleurítica com dispneia súbita), pneumotórax hipertensivo (abolição dos \\nmurmúrios vesiculares no hemitórax e hipertimpanis mo), tamponamento cardíaco (dor que \\npiora à inspiração com presença da tríade de Beck, pulso paradoxal e alterações de voltagem \\nno eletrocardiograma), dentre outros que serão abordados mais adiante neste capítulo.6 \\nOutras etiologias, de aspecto crônico par a dor torácica incluem angina estável, \\ncardiomiopatia hipertrófica, estenose aórtica, espasmo esofagiano, hipertensão pulmonar, \\nfibromialgia e tumor de Pancoast 7. Cabe também destacar que, alguns pacientes podem \\napresentar dor torácica cardiovascular de fo rma atípica, mas sem toda exuberância clínica de \\numa dor tipicamente anginosa, como é o caso de mulheres, idosos, diabéticos, pacientes com \\ndoença renal crônica ou com quadro demencial, sendo mais um desafio diagnóstico para o \\nmédico.8 \\n3. QUADRO CLÍNICO \\nDevido às diversas etiologias da dor torácica, é essencial a sua classificação. Visto que a \\ndoença cardíaca isquêmica tem relevância considerável tanto pela sua prevalência quanto pela \\nsua morbimortalidade, é importante enquadrar a queixa de dor torácica do paciente em um dos \\ngrupos a seguir, objetivando  caracterizá -la como de causa cardíaca isquêmica ou não \\nisquêmica.9,10 \\n3.1. Classificação da dor torácica \\n3.1.1. Tipo A – Dor definitivamente anginosa \\nDor ou desconforto retroesternal ou precordial precipitada pelo esforço físico, com \\nirradiação típica para o ombro, mandíbula ou face interna do braço esquerdo, aliviada pelo'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 28}, page_content='28 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nrepouso ou uso de nitrato. As características dão certeza do diagnóstico de Doenç a Arterial \\nCoronariana (DAC), independentemente dos resultados de exames complementares.9,10 \\n3.1.2. Tipo B – Provavelmente anginosa \\nTem a maioria das características da dor definitivamente anginosa, mas não todas. A \\nDAC ainda é a principal hipótese diagnóstica, m as há necessidade de exames complementares \\npara confirmação do diagnóstico.9,10 \\n3.1.3. Tipo C – Provavelmente não anginosa \\nApresenta pouca característica da dor definitivamente anginosa, pode ser definida como \\num padrão atípico de dor torácica. A DAC não é a prin cipal hipótese diagnóstica, porém existe \\na necessidade da realização de exames complementares para a sua exclusão.9,10 \\n3.1.4. Tipo D – Definitivamente não anginosa \\nNão apresenta nenhuma característica da dor anginosa. A DAC não pode ser incluída \\ncomo hipótese diagnóstica.9,10 \\n3.2. Causas de dor torácica potencialmente fatais \\nComo visto anteriormente, a caracterização da dor torácica pode indicar a sua provável \\netiologia, permitindo que se adote a conduta mais adequada. Pelo fato de existir patologias \\npotencialmente fatais que podem apresentar a dor torácica como queixa principal, é importante \\npensar e excluir essas causas: \\n3.2.1. Pneumotórax \\nO paciente apresenta dor torácica súbita, unilateral, do lado do hemitórax acometido. \\nAssociado à isso, pode ter dispneia. No exame físic o, é possível identificar hipertimpanismo à \\npercussão do hemitórax (HT) acometido, além do murmúrio vesicular estar abolido do mesmo \\nlado do pneumotórax. O eletrocardiograma (ECG) é normal.9,10 \\n3.2.2. Tromboembolismo Pulmonar (TEP) \\nO paciente com TEP chega no Pro nto Socorro (PS) com dor torácica súbita do tipo \\npleurítica (ventilatório-dependente). Além disso, dispneia e hemoptise podem estar associadas. \\nNa anamnese, é preciso buscar ativamente a presença de fatores de risco para \\ntromboembolismo: pós -operatório, câ ncer, imobilização prolongada, sinais de Trombose \\nVenosa Profunda (TVP), TVP ou TEP prévios. No ECG, inversões de onda T contíguas em \\nderivações anteriores e inferiores, segundo estudo de Ferrari et al, é o sinal com melhor'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 29}, page_content='29 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nsensibilidade, valor preditivo positivo e negativo no diagnóstico de TEP. O padrão S1, Q3 e T3 \\npode ser visto em alguns casos, além de distúrbios da condução de ramo direito.9,10 \\n3.2.3. Dissecção de aorta \\nO paciente se apresenta com dor torácica súbita, lancinante, com irradiação para dorso, \\nde grande intensidade. No exame físico, pode haver pulsos e/ou PA assimétricos, à ausculta \\npode ser percebido sopro de insuficiência aórtica, além de sintomas neurológicos (síncope, \\nAVEi). A sintomatologia depende do grau de acometimento da aorta e de qual p orção foi \\nlesionada. No ECG, pode estar normal ou com alterações isquêmicas do segmento ST -T, se \\nacometimento de coronárias, principalmente que irrigam a parede inferior.9,10  \\n3.2.4. Síndromes Coronarianas Agudas \\nA dor é relatada em região precordial, retroesternal e/ou epigástrica, de início gradual e \\nintensidade progressiva. Descrita como do tipo em aperto, peso ou pressão retroesternal (às \\nvezes relatada como queimação ou pontada) e difusa, que pode durar > 10-20min. A irradiação \\npode, ou não,  ocorrer. Quando p resente, comumente, direciona-se para membros superiores, \\nmandíbula ou ombros. Geralmente desencadeada por esforço físico, emoções ou refeições \\ncopiosas. Tem como fatores de alívio, o repouso ou uso de nitratos, 1 -5 min após ingesta. \\nSintomas associados como sudorese, náuseas e vômitos, além do mal estar geral podem compor \\no quadro clínico. Conforme os dados colhidos na anamnese, devemos classificá-la em Tipo A, B, \\nC ou D. A presença de fatores de risco para aterosclerose, tais como idade (homens ≥ 45 anos;  \\nmulheres ≥ 55 anos), hipertensão, diabetes, dislipidemia, obesidade, sedentarismo, tabagism o \\ne história familiar de Doença Cardiovascular precoce corroboram para a suspeita clínica de \\nDAC. No exame físico, os achados são variáveis: sinais de insuficiência  cardíaca aguda, \\nhipotensão arterial, presença de B3, insuficiência mitral nova  e congestão pulmonar. O ECG \\npode apresentar supra ou infradesnivelamento do segmento ST; BRE novo; Onda Q; alteração \\ndinâmica; fibrilação ventricular ou taquicardia ventricular.9,10,11 \\n3.2.5. Rotura de esôfago \\nOs sinais e sintomas desta patologia são inespecíficos e, por vezes, pode mimetizar \\nquadros clínicos de doenças mais comuns, como infarto agudo do miocárdio, pneumotórax \\nespontâneo, pneumonia, TEP. O paciente chega ao PS relatand o dor torácica retroesternal \\nintensa, associada à quadro de vômitos, após ingestão excessiva de álcool ou refeição copiosa. \\nA dor pode ser unilateral, do tipo pleurítica, com irradiação para membro superior esquerdo \\n(MSE) ou ombro. Na história do paciente,  foi identificada associação com etilismo e doença'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 30}, page_content='30 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nulcerosa péptica (DUP). No exame físico, o enfisema subcutâneo é um achado um pouco mais \\nespecífico. Ademais,  o paciente pode se apresentar com mal estar geral, taquicárdico, \\ntaquipneico, febril e até mesmo em choque séptico.12,13 \\n3.3. Outras causas de dor torácica \\n3.3.1. Pericardite aguda \\nO paciente apresenta -se no PS com dor torácica de localização precordial ou \\nretroesternal, contínua, do tipo pleurítica (ventilatório -dependente), com irradiação para \\ntrapézio, que m elhora com a posição genupeitoral e “agarrado ao travesseiro” (posição de \\nBlechman), e piora ao decúbito. Em alguns casos, pode mimetizar a dor torácica anginosa, \\napresentando-se com caráter constritivo e com irradiação para MSE. Associado ao quadro \\nálgico, pode ser visualizada dificuldade respiratória. No exame físico, à ausculta pode ser \\nidentificado atrito pericárdico na grande maioria dos casos, mais intenso na borda esternal \\nesquerda, em um paciente dispneico e taquicárdico. Na história clínica, os dad os podem variar \\ndependendo da etiologia da pericardite, sendo relatado um quadro viral inespecífico associado \\nà etiologia mais comum de pericardite (viral/idiopática). O ECG pode evidenciar \\nsupradesnivelamento difuso do segmento ST, associado ou não ao inf ra de PR (achado mais \\nespecífico), além do sinal de Spodick. 9,10,14 \\n3.3.2. Dor esofágica \\nNo espasmo esofagiano difuso, o paciente pode apresentar um desconforto retroesternal \\nem aperto muito semelhante a angina, contudo, geralmente não apresenta relação com esforço \\nfísico e sim com a alimentação. A Doença do Refluxo Gastroesofágico (DRGE), por sua vez, \\ncostuma cursar com dor epigástrica e/ou retroesternal em “queimação”, sem possuir relação \\ndireta com esforço físico, e sim com as refeições e com o decúbito. Pode ser relatada melhora \\ncom antiácidos e inibidores da bomba de prótons.9,10,14 \\n3.3.3. Dor Musculoesquelética \\nA dor de origem musculoesquelética é frequentemente associada à DAC pela população \\nem geral. Contudo, a história e o exame físico são suficientes para descartar causa isquêmica. O \\npaciente chega no PS relatando dor ou desconforto torácico, geralmente sem irradiação, bem \\nlocalizada, reproduzida à digitopressão local e ao movimento. Melhora com analgésicos e anti -\\ninflamatórios não hormonais. Dependendo da etiol ogia, podem estar presentes sinais \\nflogísticos no tórax do paciente.9,10,14'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 31}, page_content='31 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\n3.3.4. Distúrbios psiquiátricos \\nGeralmente é identificável pelo contexto clínico, principalmente quando há diagnóstico \\nprévio de doença psiquiátrica e ausência de fatores de risco para doença arterial coronariana. \\nNeste caso, ocorre a somatização de queixas cardíacas devido a distúrbios psíquicos. O grau de \\nsemelhança com a dor de origem orgânica depende do conhecimento do paciente acerca do \\ntema. É um diagnóstico de exclusão.14 \\n4. ESTRATIFICAÇÃO DE RISCO \\nPara auxílio do diagnóstico na sala de emergência foram desenvolvidos alguns métodos \\npara classificação de risco, hipótese diagnóstica e na terapêutica, entre eles, o escore HEART.  \\nEsse escore é bastante empregado na triagem dos pacientes, uma vez que mostra as chances de \\neventos cardiológicos graves, baseado em cinco variáveis: história, eletrocardiograma, idade, \\nfatores de risco e troponinas15, como mostra a tabela 1. \\n \\nTabela 1 - Escore HEART \\nFator Características Pontos \\nHistória Altamente suspeita de SCA 2 \\nModeradamente suspeita de SCA 1 \\nBaixa suspeita de SCA 0 \\nECG Depressão do segmento ST 2 \\nAlteração de repolarização inespecífica 1 \\nNormal 0 \\nIdade ≥ 65 anos 2 \\n45-64 anos 1 \\n< 45 anos 0 \\nFatores de risco ≥ 3 fatores de risco ou história aterosclerótica 2 \\n1 ou 2 fatores de risco 1 \\nNenhum fator de risco  0 \\nTroponina ≥ 3x o limite da normalidade 2 \\n1-3x o limite da normalidade 1 \\ndentro do limite da normalidade 0 \\nFonte: Manual de Emergências Cardiovasculares, Cardiopapers.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 32}, page_content='32 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nOs pacientes com escore de HEART até 3 pontos têm baixa taxa de eventos adversos, a \\nevolução é favorável e na ausência de outros diagnósticos diferenciais podem ser liberados para \\ncasa. Nos pacientes com escore de 4 pontos ou mais, está indicada a investigação por testes não \\ninvasivos.15  \\nO escore HEART é utilizado principalmente nos casos em que há um cenário duvidoso \\nem relação à origem da dor torácica e que apresentam ECG e troponinas não diagnosticadas.15 \\n5. DIAGNÓSTICO DIFERENCIAL E EXAMES COMPLEMENTARES \\nEm decorrência de suas peculiaridades e das diversas possibilidades diagnósticas, a dor \\ntorácica deve ser tratada como prioridade na sala de emergência e a Síndrome Coronariana \\nAguda (SCA) sempre deve estar entre as principais possibilidades diagnósticas, sem esquecer \\ndas causas potencialmente fatais: embolia pulmonar, dissecção de aorta, pneumotórax \\nhipertensivo e ruptura de esôfago.16 \\n5.1. Eletrocardiograma \\nO eletrocardiograma é o primeiro exame a ser realizado no paciente com dor ou \\ndesconforto torácico . D eve ser feito e interpretado em até 10 minutos após a chegada do \\npaciente ao hospital. Em casos não diagnosticados, o ECG deve ser repetido pelo menos uma \\nvez em até 6 horas e, em  casos de recorrência dos sintomas, o ECG também deve ser \\nrepetido.11,17 \\nNa maioria das vezes, o ECG encontra -se normal nos pacientes com dor torácica e , \\ndesses, 5% terão síndrome coronariana aguda. Em pacientes com Infarto Agudo do Miocárdio \\n(IAM) a sensibilidade do ECG varia entre 45-60%, dessa forma metade dos pacientes com IAM \\nnão são diagnosticados com apenas o ECG realizado na admissão, necessitando da realização \\nde ECG’s seriados para comparação e monitor ização. Em outra perspectiva, o ECG apresenta \\nbaixa sensibilidade diagnóstica para os casos de insuficiência coronariana aguda e não deve ser \\no único exame a ser solicitado para diagnosticar ou afastar essa condição.17 \\nAlgumas condições dificultam a avaliação do ECG e  o resultado pode ser um falso \\npositivo em casos de repolarização precoce, bloqueio de ramo esquerdo, sobrecarga de \\nventrículo esquerdo, síndrome de pré -excitação, síndrome de Brugada, cardiomiopatia \\nhipertrófica, miocardite, pericardite, embolia pulmonar, hemorragia subaracnóide, \\nhipercalemia, colecistite e erro na localização do ponto J. Além disso, o resultado pode ser falso'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 33}, page_content='33 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nnegativo em bloqueio de ramo esquerdo, ritmo de marca -passo, IAM prévio com onda Q  e \\npersistente elevação do segmento ST.17 \\nNa avaliação inicial do ECG, observa -se o segmento eletrocardiográfico ST em busca de  \\nIAM com supradesnivelamento do segmento ST (IAMCSSST) ou IAM sem supradesnivelamento \\ndo segmento ST (IAMSSSST).  \\n5.1.1. IAMCSST \\nPara o diagnóstico utiliza-se os critérios da quarta definição universal de infarto16: \\n• Nova elevação do segmento ST, medida no ponto J (ponto entre o fim do QRS e \\ninício do segmento ST), ≥ 1mm em pelo menos duas derivações contíguas, com \\nexceção de V2 e V3. \\n• Nas derivações V2 e V3, o critério de elevação do segmento ST muda de acordo \\ncom a idade e com o gênero do paciente: \\n▪ se mulher, independentemente da idade: ≥ 1,5 mm; \\n▪ se homem, menor que 40 anos: ≥ 2,5 mm; \\n▪ se homem, maior ou igual a 40 anos: ≥ 2 mm. \\n• Nas derivações V3R, V4R, V7 e V8, considerar elevação do segmento ST ≥ 0,5 mm. \\n \\nFigura 1 - ECG de um IAM com supradesnivelamento do segmento ST em D2, D3 e aVF (parede \\ninferior).'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 34}, page_content='34 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\n5.1.2. IAMSSST \\nNo ECG não é observado elevação do segmento ST maior ou igual a 1 mm.  As principais \\nalterações eletrocardiográficas vistas são: infra de ST persistente ou tran sitória e inversão da \\nonda T. Vale lembrar que em alguns casos o ECG pode ser normal, mas mesmo com ECG normal \\nnão pode-se descartar doença coronariana.16 \\nDiante disso, se o paciente apresentar quadro clínico compatível, deve -se solicitar os \\nmarcadores de necrose miocárdica17:  \\n• se os valores estiverem normais: trata-se de uma Angina Instável; \\n• se os valores estiverem aumentados: trata-se de IAMSSSST. \\n    \\nFigura 2 - IAM com infradesnivelamento do segmento ST em V3-V6 \\n \\nBOX 6.  \\nFoi realizado um eletrocardiograma que mostrou ritmo sinusal e ausência sinais de \\nisquemia miocárdica. Como o paciente era suspeito para SCA, solicitou-se a dosagem de \\ntroponina cardíaca.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 35}, page_content='35 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\n5.2. Marcadores de necrose miocárdica \\nOs marcadores bioquímicos são de fundamental impo rtância tanto para o diagnóstico \\nquanto para o prognóstico da síndrome coronariana aguda, por isso devem ser solicitados na \\nadmissão e repetidos entre 6 e 12 horas após a admissão. Durante o processo de lesão, a \\nmembrana das células cardíacas perde sua integridade e há liberação de proteínas e de enzimas \\nestruturais dos miócitos para o sangue, que podem ser quantificados por exames. Os resultados \\ndos marcadores de necrose miocárdica devem estar disponíveis em até 1 horas após a coleta.11  \\nAs  troponinas pos suem cinética diferentes em relação a início, pico e duração da \\nelevação, como mostrado na Tabela 2. \\n \\nTabela 2 - Cinética dos marcadores miocárdicos após infarto agudo do miocárdio.  \\nMarcador Início Pico Duração \\nMioglobina 1-3 horas 6-7 horas 24 horas \\nCKMB 3-12 horas 20-24 horas 48-72 horas \\nTroponina I 3-12 horas 24-48 horas 5-10 dias \\nTroponina T 3-12 horas 24-48 horas 5-14 dias \\nFonte: Livro de emergências clínicas - Abordagem prática, USP. \\n \\n5.2.1. Troponinas cardíacas T e I \\nSão os marcadores de necrose miocárdica mais sensíveis e específicos e por isso são os \\nbiomarcadores de primeira escolha na suspeita de IAM. A troponina T possui sensibilidade de \\n96,9% e especificidade de 94,5% para casos de IAM.18  \\n5.2.2. Mioglobina \\nEntre os marcadores de lesão mioc árdica, a mioglobina é o que se eleva mais \\nprecocemente nas primeiras 2 -3 horas após o infarto, porém não é muito utilizado por ter \\npouca especificidade.17 \\n5.2.3. CK-MB \\nAs dosagens de creatinoquinase MB podem ser utilizadas quando as dosagens das \\ntroponinas não e stiverem disponíveis ou para diagnosticar reinfarto, uma vez que as \\ntroponinas podem permanecer alteradas por até 14 dias após o infarto.11'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 36}, page_content='36 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nBOX 7.  \\nAs dosagens das troponinas cardíacas estavam aumentadas, indicando necrose miocárdica. \\n5.3. Radiografia do tórax \\nA radiografia de tórax deve ser solicitada nos diagnósticos diferenciais, quando a dor \\ntorácica é de origem não isquêmica, como em casos de pneumonia, pneumotórax, derrame \\npleural, entre outros. Além disso, a radiografia de tórax ainda pode sugerir hipertens ão \\npulmonar, embolia pulmonar, entre outros.17 \\n5.4. Tomografia do tórax e angiotomografia das coronárias \\nA tomografia do tórax possui maior especificidade e sensibilidade do que a radiografia \\nde tórax e é bastante utilizada para definir causas pulmonares, como doenças do parênquima, \\npleural e de vasculatura pulmonar. Importante ferramenta diagnóstica na dissecção de aorta, \\nno  Tromboembolismo Pulmonar (TEP) e no pneumotórax.18  \\n A angiotomografia das coronárias é importante para avaliar a anatomia das coronárias  \\nde uma forma menos invasiva, indicando a presença de estenose por placas de aterosclerose \\npor meio da análise do lúmen das coronárias.18 \\n5.5. Teste de esforço \\nRecomendado para pacientes com dor torácica de baixo risco, com biomarcadores \\nnormais e que possam se r submetidos a exercícios, para descartar doença coronariana. É um \\nexame simples, apresenta baixo custo e possui alto valor preditivo negativo, uma vez que com \\no resultado negativo, o paciente possui menos de 2% de chance de apresentar eventos \\ncardiovasculares em 6 meses.11,17 \\nEste exame possui algumas contraindicações absolutas, como SCA de moderado a alto \\nrisco, dissecção de aorta, TEP, quadros de inflamação do miocárdio e pericárdio. Dessa forma, \\nestas condições devem ser descartadas antes da realização do teste de esforço.18 \\n5.6. Cintilografia miocárdica de repouso \\nPossui alto custo e , quando normal, há baixa probabilidade de eventos cardíacos \\nadversos nos próximos meses, podendo o paciente ser liberado de imediato do pronto \\natendimento, o que contribui para a redução de custos hospitalares. Geralmente utilizado  \\nquando o paciente não pode ser submetido ao teste de esforço.17,18'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 37}, page_content='37 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\n5.7. Ecocardiograma \\nO ecocardiograma é de grande utilidade em pacientes com dor torácica, uma vez que a \\nausência de anormalidades na contra tilidade segmentar ventricular praticamente descarta a \\nisquemia como causa da dor precordial aguda. Além disso, o ecocardiograma também avalia \\ndiversas outras etiologias da dor torácica, como dissecção de aorta, estenose da aorta, \\nmiocardiopatia hipertrófica e pericardite.11 \\n Este exame também avalia defeitos valvares, extensão da lesão miocárdica e a fração de \\nejeção do ventrículo esquerdo.11  \\nAlterações nos exames complementares podem variar de acordo com a etiologia da dor \\ntorácica como mostra a tabela 3. \\n \\nTabela 3 - Principais alterações nos exames complementares e principais diagnóstico diferencial da \\ndor torácica. \\nDiagnósticos \\ndiferenciais  Achados nos exames complementares \\nDispepsia ECG: normal \\nTromboembolismo \\nPulmonar \\nECG: padrão S1, Q3 e T3, pode ter onda P pulmonale, distúrbios de condução \\nde ramo e fibrilação. \\nRadiografia de Tórax: ausência de sinais de congestão, zonas de \\nhipertransparência com áreas de hipoperfusão. \\nEcocardiograma: indicando hipertensão pulmonar \\nPneumotórax ECG: normal. \\nRadiografia de tórax: presença das linhas indicativas de pneumotórax. \\nDissecção de aorta \\nECG: normal ou com alterações isquêmicas e dinâmicas do segmento ST-T \\nem parede inferior. \\nRadiografia de Tórax: aumento do mediastino, velamento do hemitórax \\nesquerdo e duplo contorno no arco aórtico. \\nEcocardiograma: insuficiência aórtica e derrame pericárdico. \\nPericardite \\nECG: pode apresentar supradesnivelamento do segmento ST-T difuso, onda T \\nachatadas ou negativas. \\nRadiografia de Tórax: inespecífica. \\nMarcadores bioquímicos: normais. \\nEcocardiograma: pode ou não apresentar derrame pericárdico ou sinais de \\nespessamento do pericárdio. \\nDor musculoesquelética ECG: normal. \\nRadiografia de tórax: normal. \\nFonte: Adaptado do protocolo de conduta no atendimento da dor torácica.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 38}, page_content='38 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\n6. TRATAMENTO \\nNos pacientes que chegam ao PS com dor torácica, mesmo na presença de ECG e \\ntroponinas normais, não se pode descartar doença cardíaca de origem isquêmica e, por isso, \\nmuitas vezes são internados para monitorização e investigação, gerando um alto custo para o \\nsistema de saúde. Com o objetivo de reduzir esses custos, foram desenvolvidas muitas \\npesquisas para elaborar estratégias para garantir a segurança do paciente e o custo-efetividade \\nda internação.17 \\nNessa perspectiva, foram criadas as Unidades de Dor Torácica (UDT) , que possuem \\nprotocolos elaborados para o manejo do paciente, levando em conta a abordagem diagnóstica \\ne a estratificação de risco de cada paciente, para ver quais pacientes irão se beneficiar de  \\nperíodos mais longos de internação e quais irão receber alta hospitalar, sem oferecer nenhum \\nrisco ao paciente, reduzindo os custos do sistema de saúde.17 \\nA UDT tem o fito de diagnosticar de forma rápida os casos de infarto agudo do miocárdio \\ne iniciar de imediato a terapia de reperfusão, bem como afastar das possibilidades diagnósticas \\nas causas de dor torácica que são potencialmente fatais, como pneumotórax, TEP, dissecção de \\naorta, ruptura de esôfago, entre outros. Nesse sentido, a UDT necessita de leit os com monitor \\ncardíaco, material para RCP, equipamentos para realização de eletrocardiograma e laboratório \\nde análises clínicas para dosar os marcadores de necrose miocárdica.17 \\nDessa forma , há diversas possibilidades na conduta do paciente com dor toráci ca à \\ndepender do quadro clínico e dos resultados dos exames inicialmente solicitados, como \\nmostrado abaixo. Vale salientar que no paciente com dor torácica é necessário realizar a \\nmonitorização cardíaca, avaliar a necessidade de oxigênio suplementar e fazer acesso venoso.17 \\n6.1. Pacientes com ECG evidenciando IAMCSST \\nIndicação de trombólise ou angioplastia primária e transferir o paciente para unidade \\ncoronariana.17 \\n6.2. Paciente com ECG sem isquemia e com provável insuficiência coronariana \\nSolicitar as troponinas cardíacas seriadas e ECG seriado (3,6 e 9 horas).17  \\n6.2.1. Aumento das troponinas e/ou alterações isquêmicas \\nEncaminhar o paciente para a unidade coronariana.17'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 39}, page_content='39 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\n6.2.2. ECG seriado normal e troponinas seriadas normais \\nSubmeter o paciente ao teste de esforço.17 \\n6.2.2.1. Teste de esforço apresentando isquemia \\nManter o paciente internado e continuar a investigação.17 \\n6.2.2.2. Teste de esforço não apresenta isquemia \\nPaciente apto para alta hospitalar.17 \\nAdemais, pacientes com dor torácica potencialmente fatal, devem ser submetidos ao \\ntratamento inicial e encaminhados conforme sua causa: \\n6.3. Dissecção de aorta \\nIniciar betabloqueador e nitroprussiato.17 \\n6.4. TEP \\nIniciar anticoagulação.17 \\n6.5. Pneumotórax \\nObservação ou drenagem.17 \\n6.6. Pericardite \\nIniciar Anti-inflamatórios não esteroides (AINE) ou corticóide.17 \\n6.7. Ruptura de esôfago \\nCirurgia o mais rápido possível.17 \\n \\nBOX 8.  \\nO paciente foi diagnosticado com SCA sem supradesnivelamento do segmento ST e foi \\nencaminhado para unidade coronariana..'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 40}, page_content='40 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nFLUXOGRAMA'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 41}, page_content='41 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\nREFERÊNCIAS BIBLIOGRÁFICAS \\n1. Rampelllotti, LF, Miranda, AVS. Incidência da queixa de dor torácica como sintoma de \\ninfarto agudo do miocárdio em uma unidade de pronto -atendimento. BrJP, São Paulo, \\n2019 jan -mar; 2(1): 44 -8. Disponível em: \\nhttps://www.scielo.br/j/brjp/a/YN33Ck6kcjXDJLG4rfwk7Ww/?lang=pt&format=pdf  \\n2. Huguenin, FM, Pinheiro, RS, Almeida, RMVR, Infantosi, AFC. Caracterização dos padrões de \\nvariação dos cuidados de saúde a partir dos gastos com internações por infarto agudo do \\nmiocárdio no Sistema Único de Saúde . Rev Bras Epidemiol, abr -jun 2016, 19 (2): 229 -242. \\nDisponível em: \\nhttps://www.scielo.br/j/rbepid/a/XyDjX4y6tXLWcXTZzdKvD3j/?format=pdf&lang=pt  \\n3. Barbosa, AC, Silva, AS, Cordeiro, AA, Ribeiro BN, Pedra, FR, Borges, IN, Rievrs, KB, Serufo JC. \\nDiagnóstico diferencial da dor torácica: ênfase em causas não coronarianas.  Rev Med \\nMinas Gerais 2010; 20 (2 supl 1): S24 -S29. Disponível em: \\nhttp://www.rmmg.org/artigo/detalhes/1046  \\n4. Marchini, JFM, Brandão Neto, RA. Cap 24 Dor torácica. In: Medicina de emergência: \\nabordagem prática, 15ªed, Barueri (SP): Manole, 2021, pp. 307-324. \\n5. Thompson, AD, SHEA, MJ. Dor torácica, Manual MSD versão para profissionais de saúde, \\nsetembro de 2020.  Disponível em: https://www.msdmanuals.com/pt-\\nbr/profissional/doen%C3%A7as-cardiovasculares/sintomas-de-doen%C3%A7as-\\ncardiovasculares/dor-tor%C3%A1cica  \\n6. Oliveira, GFF, Marcellos, DC. Cap 19 - Dissecção aórtica. Manual de pronto -socorro. Liu, \\nDJJ, Leal, R, Vendrame LS. 2ed. Rio de Janeiro: Guanabara Koogan, 2018, pp 175-182 \\n7. Valadares, E, Queiroz, C, Lobo, P. Cap 6 - Dor torácica, Yellowbook: como fazer todos os \\ndiagnósticos. org: Clistenes Queiroz Oliveira. Salvador: Editora Sanar, 2020, pp153-172. \\n8.Braga, IC, Santos, ECL, Holanda, RF, Pereira, CAC. Cap 1 - Investigação de dor torácica na \\nemergência. Manual de emergências cardiovasculares: cardiopapers. 1ed. Rio de Janeiro: \\nAtheneu, 2021, pp 1-12. \\n9. SANTOS, E. C. L. et al. Manual de Cardiologia: Cardiopapers. 1 ed. São Paulo: Atheneu, v. 1, \\n2015. 698 p. \\n10. COSTA, Gabriel Dalla. Protocolo de Cuidados Clínicos : Protocolo de Conduta no \\nAtendimento da Dor Torácica . São Paulo. 2021. E-book (24p.) color. \\n11. Nicolau JC, Feitosa Filho GS, Petriz JL, Furtado RHM, Précoma DB, Lemke W, Lopes RD, et al. \\nDiretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo \\ndo Miocárdio sem Supradesnível do Segmento ST – 2021. Arq. Bras. Cardiol. \\n2021;117(1):181-264. \\n12. Blencowe NS ET AL. Spontaneous oesophageal rupture. BMJ 2013; 346:i3095. \\n13. Herbella FA, Matone J, Del Grande JC.  Eponyms in esophageal surgery, part 2 . Dis \\nEsophagus 2005; 18:4.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 42}, page_content='42 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO II | DOR TORÁCICA \\n14. Semiologia Médica - Celmo Celeno Porto - 7ª Edição. 2013. Editora Guanabara Koogan. \\n15. SANTOS, E. C. L. et al. Manual de Emergências Cardiológicas: Cardiopapers. 1 ed. São \\nPaulo: Atheneu, v. 1, 2020. 464 p. \\n16. SANTOS , E. e. L.; MASTROCOLA, F.; FIGUINHA, F. e. R; LIMA, A. G. S. Cardiologia \\nCardioPapers - 2ª edição: São Paulo, Rio de Janeiro: Atheneu, v.2, 2019.  \\n17. Martins, H. S. et al.  Emergências clínicas : abordagem prática . 10. ed. rev. e atual. -- \\nBarueri, SP : Manole, 2015. \\n18. SANTOS, E. S. dos; TIMERMAN, A.. DOR TORÁCICA NA SALA DE EMERGÊNCIA: QUEM FICA \\nE QUEM PODE SER LIBERADO?. SOCESP, São Paulo: SOCESP, ed. 28, ano 2018, n. 4, p. 394-402, \\n29 ago. 2018. Anual.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 43}, page_content='43 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nCAPÍTULO III  \\nSÍNCOPE \\nPedro José Leite de Almeida Mendonça 1 \\nGabriel Magalhães Torquato 1 \\nIgor Menezes Bambeko 1 \\nMateus de Sousa Cavalcante 1 \\nLeandro Cordeiro Portela 2 \\nDOI: 10.51859/amplla.ceg164.1123-3 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médico cardiologista eletrofisiologista. Hospital do Coração de Sobral. Sobral, Ceará, Brasil.  \\nCASO CLÍNICO \\nHomem, 39 anos, dá entrada na emergência  após um episódio de perda transitória da \\nconsciência enquanto jogava basquete. O paciente relata que poucos segundos antes sentiu um \\nformigamento na testa e tontura. Seus amigos referem que ele não tentou se proteger ou evitar \\na queda, além de não haver l iberação esfincteriana ou movimentos convulsivos ou espásticos. \\nRecobrou a consciência rapidamente, conseguindo se levantar e andar, sentindo apenas dor \\nfacial. Paciente diz que esta é a primeira vez que isso ocorre, não tendo história de dispneia, \\npalpitações, dor torácica, trauma ou ansiedade. \\nEm sua história patológica pregressa, nega doenças ou medicamentos de uso diário, bem \\ncomo cirurgias prévias e alergias. Na sua história familiar, não há casos de morte súbita cardíaca \\nou convulsão, e diz não ter do enças na família. Já em sua história pessoal e social nega \\ntabagismo, etilismo ou drogas ilícitas. \\nNo exame físico apresenta sinais vitais: \\n• Na posição supina: PA = 120x70 mmHg e FC = 70 bpm; \\n• Na posição ortostática: PA = 115x65 mmHg e FC = 65 bpm; \\n• FR = 15 irpm; \\n• T = 36,4 °C; \\n• SatO2 98% em ar ambiente. \\nAparelho cardiovascular: ritmo cardíaco regular em 2 tempos, bulhas normofonéticas e \\nsem sopros. \\nDemais aparelhos sem alterações.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 44}, page_content='44 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nPERGUNTAS NORTEADORAS \\n1. Qual a definição de síncope? \\n2. Toda perda de consciência é síncope? \\n3. Quais são os principais tipos de síncope? \\n4. Como estratificar o risco do paciente? \\n5. Qual deve ser a conduta do médico na emergência de acordo com o risco do paciente? \\n1. INTRODUÇÃO \\nPode-se dizer que síncope é uma síndrome clínica caracterizada por uma perd a \\nmomentânea da consciência devido a um estado de baixa perfusão cerebral global ou \\nhipoperfusão focal do sistema reticular do tronco cerebral. É um fenômeno de curta duração, \\ngeralmente de 8 a 10 segundos, e de rápida recuperação, sem sequelas neurológica s, bastante \\nprevalente na população em geral, principalmente em adultos jovens 1. A duração do episódio \\nde síncope raramente é maior que 1 a 2 minutos. Em especial, períodos maiores de 5 minutos \\nsão mais sugestivos de outros acometimentos patológicos que nã o síncope ou síncope \\nassociado a outra injúria, como um traumatismo craniano pela queda logo após2. \\nLogo, o reconhecimento desse fenômeno patológico é de elevada importância no que se \\nrefere à alta prevalência dele, à possibilidade de existência de doenças de base \\nsubdiagnosticadas em pessoas com primeiro episódio de síncope e à possibilidade de \\ntraumatismos, principalmente em síncopes recorrentes pela perda do tônus postural1. \\nAo longo do capítulo, iremos abordar síncope de maneira objetiva, mediant e o descarte \\nde diagnósticos diferenciais, o reconhecimento de fatores de risco e, por fim, o manejo de \\nacometimentos mais comuns que marcam as principais etiologias de síncope.  \\n2. EPIDEMIOLOGIA \\nA síncope é uma condição frequente no departamento de emergência, sendo responsável \\npor 1% a 3% das consultas e, aproximadamente, 1% das taxas de internação hospitalar. Cerca \\nde 35% dos pacientes atendidos por síncope necessitam de admissão na unidade de \\natendimento, com o escopo de avaliar o risco, definir sua etiolo gia e corrigir as possíveis \\nconsequências traumáticas decorrentes do episódio de perda transitória da consciência3. \\nSão encontradas muitas divergências estatísticas a respeito da síncope, sobretudo, pelas \\ndiferenças das populações estudadas, pelo conceito de síncope utilizado nos diferentes estudos'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 45}, page_content='45 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\ne pelos métodos e critérios diagnósticos abordados. No entanto, em uma análise macroscópica, \\nsíncope se apresenta de maneira mais frequente em mulheres, com os homens possuindo uma \\nprevalência maior de síncope ca rdíaca, o que pode ser explicado pela ocorrência maior de \\ndoenças cardiovasculares no sexo masculino3. \\nA etiologia da síncope, embora muitas vezes não seja fácil diagnosticar, é fundamental \\npara dar prosseguimento na conduta terapêutica, principalmente, quando o paciente abordado \\né classificado como alto risco pelos critérios atualmente validados. Em linhas gerais, as síncopes \\nvasovagais são as mais comuns, seguidas pelas síncopes por hipotensão ortostática e arritmias \\ncardíacas. Até recentemente, aproximadamente 1/5 a 1/3 dos casos de síncope a etiologia era \\ndesconhecida, porém esse número começou a decair com o aumento das clínicas e profissionais \\nespecialistas em síncope, sendo por volta de 10% os diagnósticos de síncope por causa \\ndesconhecida na atualidade. É válido destacar, ainda, que as síncopes sem etiologia conhecida, \\nnormalmente, cursam com bom prognóstico3. \\nEstima-se que 20% da população, em algum momento da vida, sofrerá com algum \\nepisódio de síncope. O estudo, que seguiu por 17 anos um total de 7814 pacientes, relatou uma \\ntaxa de  10,5% de síncope nos participantes. Além disso, os pacientes que sofreram um episódio \\nde síncope no ano anterior, possuem um risco mais elevado de ter novos episódios4. \\nA incidência da síncope se apresenta de maneira bimodal, sendo comum no período que \\nse estende do final da adolescência até o início da vida adulta, sobretudo as etiologias \\nvasovagais, e na terceira idade, se tornando ainda mais frequente a partir dos 70 anos. A \\nocorrência acentuada nas idades mais avançad as, pode ser explicada pela lentidão fisiológica \\ndos mecanismos compensatórios e pelas doenças de base que acometem a população mais \\nenvelhecida5. \\n3. ETIOLOGIAS \\nNa suspeita de um paciente com síncope, inicialmente, deve-se fazer a distinção entre as \\npossíveis causas de perda transitória da consciência, incluindo distúrbios do sono, condições \\npsiquiátricas, convulsões e quedas acidentais para, então, investigar a causa da síncope. A \\nseguir, estão listadas as 4 classes de síncope e suas etiologias mais comuns, c om breves \\nexplicações sobre algumas patologias prevalentes no departamento de emergência. Os quadros \\nque não se enquadram em nenhuma etiologia são considerados como síncope de origem \\ndesconhecida3.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 46}, page_content='46 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\n3.1. SÍNCOPE REFLEXA \\nEssa condição possui como causa principal a síncope vasovagal, conhecida como \\ndesmaio comum. Outras causas incluem a síncope do seio carotídeo e as síncopes situacionais \\nresultantes de acessos de tosse, esforço defecatório, esforço miccional e deglutição3. \\n3.2. SÍNCOPE POR HIPOTENSÃO ORTOSTÁTICA \\nÉ definida como uma diminuição de pelo menos 20 mmHg da pressão arterial sistólica \\ne/ou de pelo menos 10 mmHg da pressão arterial diastólica quando o paciente passa da posição \\nsentada ou deitada para em pé. Podendo ser ocasionada por diferentes etiologias. \\nVolume intravascular reduzido  - Consequente ao uso de diuréticos, consumo \\ninsuficiente de líquidos e alguns problemas gastrointestinais que diminuem a absorção \\nhídrica3. \\nUso de determinados medicamentos  - Anti Hipertensivos (bloqueadores da enzima \\nconversora de angiotensina, bloqueadores ganglionares, hidralazina e bloqueadores alfa e beta \\nadrenérgicos), antidepressivos tricíclicos, fenotiazina, bloqueadores dos canais de cálcio, \\nnitratos (sobretudo em pacientes idosos), bromocriptina e opiáceos3. \\nDeficiência primária do sistema nervoso autônomo  - Ocasionado na doença de \\nParkinson e na atrofia de múltiplos sistemas3. \\nDeficiência secundária do sistema nervoso autônomo  - encontrando como causas \\nimportantes a Diabetes mellitus e a amiloidose3. \\nO envelhecimento e o consumo de álcool  também são causas frequentes de síncope \\npor hipotensão postural3. \\n3.3. SÍNCOPE POR ARRITMIAS CARDÍACAS \\nTaquiarritmias ventriculares - A síncope, nesses casos, ocorre principalmente em \\npacientes que possuem alguma cardiopatia prévia3. \\nTaquiarritmias supraventriculares - Quase nunca estão associadas a episódios \\nsincopais, exceto nos casos em que ocorre uma resposta vascular retardada3. \\nParada cardíaca - Ocorre com maior prevalência nos pacientes com doença do nó \\nsinusal e durante a fase de recuperação do flutter atrial e da fibrilação atrial3. \\nBigeminia ventricular  - Embora resulte em uma diminuição do débito cardíaco, \\nnormalmente, os pacientes sentem apenas um fenômeno de quase síncope. No entanto, na'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 47}, page_content='47 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nvigência de outras condições de base, como  bradicardia sinusal e disfunção ventricular \\nesquerda grave, é comum o episódio de síncope3. \\nBloqueio atrioventricular (BAV) - Ocorre, preferencialmente, nos pacientes com BAV \\nde segundo grau Mobitz tipo 2 ou bloqueio atrioventricular total (BAVT)3. \\n3.4. SÍNCOPE POR DOENÇA CARDÍACA ESTRUTURAL \\nCardiomiopatia hipertrófica (CMH)  - A causa da síncope nesses pacientes é a \\nobstrução da via de saída do ventrículo esquerdo (VSVE). Hipovolemia, medicamentos e \\nalterações da postura podem potencializar a obstrução da VSVE3. \\nEstenose aórtica - A síncope nesses pacientes ocorre, principalmente, associada com o \\nesforço, dado que a obstrução limita o débito cardíaco nas situações em que o corpo eleva sua \\ntaxa metabólica. É possível, também, a ocorrência de síncope durante o rep ouso, sendo essa \\ncondição resultado de uma estenose significativa da valva aórtica3. \\nCausas menos comuns  - Estenose pulmonar grave, hipertensão arterial pulmonar \\nidiopática, embolia pulmonar e mixomas atriais3. \\n4. FISIOPATOLOGIA \\nA síncope possui diversas causas e todas resultam, em última instância, em uma \\ninatividade do córtex cerebral dos dois hemisférios ou do tronco cerebral, sendo essa disfunção \\ntransitória e totalmente reversível, exceto nos casos de lesões traumáticas ocasionadas durante \\no episódio sincopal3,4. \\nEssas regiões anatômicas podem ter seu fluxo sanguíneo diminuído como consequência \\nde uma vasoconstrição ou hipotensão, sendo, respectivamente, fenômenos locais e sistêmicos, \\nocorrendo síncope na vigência de uma parada completa da circulação por, aproximadamente, \\n10 segundos ou, ainda, por uma perfusão de 35% a 50% do ideal. Estudos baseados no uso do \\ntilt-test relataram a presença de episódio sincopal em pacientes com redução de 60 mmHg na \\npressão arterial sistólica3,4. \\nNo caso da síncope reflexa (neuromediada), ocorre ativação de arcos reflexos e \\nmodificação da frequência cardíaca e da pressão arte rial. Já na síncope por hipotensão \\nortostática (postural) o mecanismo é alguma condição de base que prejudica a atividade \\nsimpática, a exemplo da idade e do uso de certos medicamentos, como diuréticos.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 48}, page_content='48 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nEm relação à síncope arritmogênica, causa frequente de  síncope, tanto taquiarritmias \\nquanto bradiarritmias podem resultar em um quadro sincopal, ocorrendo diminuição do débito \\ncardíaco e, consequentemente, perda temporária do fluxo sanguíneo cerebral.  \\nPor fim, os episódios sincopais por doença estrutural car diopulmonar ocorrem por \\nimpedir a condução sanguínea adequada, resultando em perda transitória da consciência. \\nCondições como estenose aórtica e cardiomiopatia hipertrófica limitam o débito cardíaco, \\ninduzindo síncope, por exemplo, em situações de esforço,  em que o organismo não consegue \\ncompensar as demandas fisiológicas por meio do aumento do débito cardíaco3. \\n5. EXAMES COMPLEMENTARES \\nAlém do próprio exame clínico, de suma importância para suspeita e diagnóstico, a \\nequipe médica pode -se dispor de exames auxi liares no diagnóstico e descarte de hipóteses \\ndiagnósticas diferenciais. Embora os mais utilizados em departamentos de emergência sejam o \\neletrocardiograma e o ecocardiograma, é importante conhecer o arsenal de exames \\ncomplementares para o correto manejo e boa condução do paciente.   \\n5.1. ELETROCARDIOGRAFIA \\nO principal deles é o eletrocardiograma (ECG) de 12 derivações, exame rápido e de alta \\ndisponibilidade, que deve ser feito em todos os pacientes com diagnóstico suspeito de síncope, \\napesar de raramente identi ficar alguma arritmia causa do episódio sincopal no momento do \\nexame. A justificativa para tal exame ser de suma importância são achados específicos que \\nditam o diagnóstico, como certas arritmias flagradas durante o episódio de síncope, além de ser \\num exam e simples e um importante fator na estratificação de risco 4,6. Entretanto, a \\nmonitorização eletrocardiográfica contínua invasiva ou não invasiva somente deve ser feita em \\npacientes considerados de alto risco, como veremos a seguir7. Essa monitorização pode ser feita \\npor Holter, monitor de eventos implantado (ILR), entre outros. \\n5.2. ECOCARDIOGRAMA \\nEsse exame é indicado quando há suspeita de acometimentos estruturais cardíacos ou \\nefusão pericárdica, embora, no geral, não provenha uma caus a específica da síncope. Em \\npacientes com síncope sem etiologia definida, alteração não especificada no ECG e com histórico \\nde doença cardíaca pode definir etiologia e, portanto, abordagem específica 4,6. É importante'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 49}, page_content='49 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nrelatar, entretanto, que não há evidênc ias que comprovem o benefício da realização de \\necocardiografia à beira do leito, de rotina, para pacientes sem fatores de risco2. \\n5.3. TILT TEST \\nO tilt-test ou teste da inclinação é um exame adicional que pode ser feito em pacientes \\ncom suspeita de síncope neur omediada. É feito após 4 horas de jejum, com o paciente \\ninicialmente em posição supina, por pelo menos 5 minutos, depois inclina -se a mesa de teste \\npara uma angulação entre 60 e 80° por 30 a 45 minutos, sempre sob rigorosa avaliação de \\npressão arterial, saturação de oxigênio, frequência cardíaca e monitoração eletrocardiográfica. \\nPara a sensibilização do teste, pode ser usado isoproterenol ou nitroglicerina sublingual – no \\nBrasil, é possível a utilização sublingual de dinitrato de isossorbida 1,25mg, devido  à ausência \\nde nitroglicerina sublingual no mercado, com mais 20 minutos de monitoração dos sinais vitais \\ne do ECG1. O teste é considerado positivo se o paciente desenvolver sintomas compatíveis com \\nsíncope neuromediada, como queda da pressão arterial ou taquicardia postural, decorrente do \\ncomprometimento do sistema nervoso simpático e hiperatividade da resposta vagal8. \\n5.4. OUTROS EXAMES \\nO método da massagem do seio carotídeo  é recomendado em casos suspeitos de \\nsíncope reflexa e na hipersensibilidade do seio carotídeo, em pacientes acima de 40 anos. É feita \\ncom pressão leve localizada em região sob o ângulo da mandíbula, por 5 a 10 segundos, \\nprimeiro de um lado e depois do outro. A reprodução dos sintomas do paciente após a \\nmassagem corrobora para o diagnóstico de hipersensibilidade do seio carotídeo1,4. \\nO teste de esforço faz parte do arsenal diagnóstico em pacientes com queixa de síncope \\nou pré-síncope em momentos de esforço físico ou imediatamente depois. O teste simula um \\nevento de estresse físico ocasional pelo paciente. Síncope durante o exercício fala mais a favor \\nde um acometimento cardíaco como causa de base7. \\nTestes eletrofisiológicos também são opção para investigação de síncope, entretanto \\nsão mais indicados para pacientes com arritmias documentadas ou síndromes de pré-excitação, \\nsendo raro sua utilização em um contexto de abordagem prática em emergências4. \\nEm situações de trauma ou suspeita de causas neurológicas para a síncope, tomografia \\ncomputadorizada de crânio  pode ser solicitada, mas a indicação é restrita a esse perfil de \\npaciente. Semelhante a isso, há o eletroencefalograma, o qual promove uma avaliação \\nespecífica de pacientes para o diagnóstico diferencial de episódio convulsivo4.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 50}, page_content='50 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nAlém desses, exames laboratoriais são de suma importância a depender do diagnóstico \\ndiferencial pensado: glicemia em caso de anormalidades metabólicas, saturação e gasometria \\nem suspeita de hipoxemia e distúrbio ácido-base, troponinas cardícas quando um infarto agudo \\ndo miocárdio for cogitado, D -dímero nos casos em que  tromboembolismo foi uma hipótese \\ntambém, entre outros1,4. \\n \\nTabela 1 - Outros exames complementares que podem ser solicitados em casos duvidosos de acordo \\ncom a etiologia suspeita7. \\nEXAME INDICAÇÕES \\nMassagem do seio carotídeo Causa desconhecida, história compatível com síncope \\nreflexa e > 40 anos; \\nTilt test Pacientes com suspeita de: \\nSíncope reflexa; \\nHipotensão ortostática; \\nSíndrome taquicárdica ortostática postural; \\nPseudo-síncope psicogênica; \\nMAPA Hipertensão noturna em pacientes com disautonomia; \\nHipotensão ortostática em pacientes com disautonomia; \\nTestes de função autonômica \\n(manobra de Valsalva, respiração \\nprofunda e outros) \\nSuspeita de hipotensão ortostática neurogênica \\nMonitorização eletrocardiográfica Intra-hospitalar \\nPacientes de alto risco; \\nHolter \\nEpisódios frequentes de síncope ou pré -síncope (pelo \\nmenos 1x/semana); \\nMonitor de eventos implantado (ILR) \\nSíncope recorrente sem fatores de alto risco e de \\netiologia incerta; \\nPacientes de alto risco sem etiologia definida e sem \\nindicação primária para marcapasso e CDI; \\nSíncope reflexa frequente ou episódios graves; \\nGravação em vídeo do episódio Em casa, pelos parentes ou pelo próprio paciente; \\nDurante o tilt test , para aume ntar confiabilidade do \\nexame; \\nEstudo eletrofisiológico Quando diagnóstico é incerto após avaliação não \\ninvasiva em casos de: \\nHistória de IAM com cicatriz no ECO; \\nBloqueio bifascicular; \\nBradicardia sinusal; \\nPalpitações súbitas e curtas pré-síncope; \\nEcocardiograma Suspeita de doença cardíaca estrutural'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 51}, page_content='51 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nEXAME INDICAÇÕES \\nTeste de estresse por exercício físico Episódio de síncope relacionado a esforço \\nAngiografia coronariana Mesmas indicações em pacientes com suspeita de IAM \\nsem episódio de síncope (olhar capítulos de SCA) \\nCDI = cardiodesfibrilador implantável; ECO = ecocardiograma; IAM = infarto agudo do miocárdio; ILR = \\nImplantable loop recorders; MAPA = monitorização ambulatorial da pressão arterial; SCA = síndrome \\ncoronariana aguda. \\n \\n6. DIAGNÓSTICOS DIFERENCIAIS \\nDeve-se ter sempre em mente que a síncope é um tipo de perda de consciência \\nmomentânea, mas nem todo episódio de perda de consciência é definido como síncope. A perda \\ntransitória de consciência que não se encaixe nas quatro características principais já citadas em \\ncasos de síncope deve ser pensada e investigada mediante a anamnese, o exame físico e os \\nexames complementares específicos já citados. \\nPacientes que perdem a consciência e mantêm déficits neurológicos persistentes ou \\nestado mental alterado não são classificados como possuindo síncope propriamente dita, mas \\nsim algum estado neurológico de base, como enxaquecas, convuls ões, ataques isquêmicos \\ntransitórios. O principal diagnóstico diferencial nesses casos é a convulsão, embora \\ncaracterísticas específicas auxiliam na diferenciação diagnóstica, como início súbito ou áurea \\nbreve, mordedura de língua, face cianótica durante o evento, desvio ocular horizontal, liberação \\nesfincteriana, sintomas residuais – mialgia, cefaleia e fadiga, por exemplo – com estado pós-ictal \\npresente1,7,9. \\nAcometimentos psicogênicos também são importantes diferenciais de síncope. Em sua \\nmaioria, agrupam características marcantes, embora seu diagnóstico seja sempre de exclusão4. \\nNo geral, não há sintomas premonitórios, não há diaforese, não há liberação esfincteriana, além \\nde ser um evento de duração prolongada, os olhos permanecem fechados durante o eve nto, a \\npressão arterial e a frequência cardíaca permanecem normais, com ausência de sintomas \\nresiduais1,7. Os diagnósticos psiquiátricos mais comuns que podem desencadear episódios de \\nperda transitória de consciência são transtorno de ansiedade generalizad a e transtorno \\ndepressivo maior4.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 52}, page_content='52 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\n7. DIAGNÓSTICO \\nPrimeiramente é necessário ter certeza que o paciente teve um episódio de perda \\ntransitória de consciência (TLOC – transient loss of consciousness , em inglês). Há 4 \\ncaracterísticas específicas para esse episódio: controle motor anormal, irresponsividade, curta \\nduração e amnésia em relação à perda de consciência (paciente não lembra bem do episódio)7. \\nDefinidas as demais causas de perda transitória de consciência, fica mais fácil realizar o \\ndiagnóstico dos casos que realmente são síncopes. Como dito previamente neste capítulo, a \\nsíncope é definida como a perda completa, abrupta e transitória da consciência, sem a \\ncapacidade de manter o tônus postural e com recuperação espontânea, rápida e sem sequelas \\nneurológicas, sendo seu provável mecanismo a hipoperfusão cerebral10. \\nDeve-se, portanto, realizar uma avaliação inicial para todos os casos suspeitos de \\nsíncope, a qual consiste na tríade: história clínica, exame físico e ECG, visto que diferentes \\nestudos apontam que esse conjunto identifica o diagnóstico etiológico em cerca de metade dos \\ncasos de síncope2. O objetivo é a confirmação do episódio sincopal e sua provável etiologia, que \\né dividida em: síncope neuromediada (reflexa), síncope por hipotensão ortostática e sí ncope \\ncardíaca7. \\n7.1. SÍNCOPE NEUROMEDIADA (REFLEXA) \\nNormalmente o paciente tem menos de 40 anos, história de outros episódios \\nsemelhantes, bem como relata a presença de pródromos, como: sudorese, tontura, palidez e \\nsensação de calor ou frio6. Além disso, a síncope é desencadeada por algum gatilho que dispara \\nresposta parassimpática, sendo os principais7: \\n• Vasovagal – pode ser de caráter emocional, como dor e medo, ou ortostático \\n(longos períodos em pé), ou mesmo por situações de desidratação e calor; \\n• Situacional – o gatilho tem origem em alguma ação, como urinar, evacuar, pós -\\nexercício, tosse ou espirro, dentre outros. \\n• Síndrome ou hipersensibilidade do seio carotídeo  – ocorre em pacientes \\nsuscetíveis em situações que realizem pressão no seio carotídeo, como: após  \\nrotação da cabeça, tumores, uso de gravata e ao fazer a barba. Ao exame físico, \\npode-se reproduzir os sintomas ao realizar a massagem do seio carotídeo de \\nforma cuidadosa. Essa manobra é realizada da seguinte forma: massageia -se \\nseparadamente por 5 a 10 segundos cada corpo carotídeo. A positividade do teste \\nocorre quando há assistolia por > 3 s ou queda da pressão arterial sistólica (PAS)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 53}, page_content='53 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\n> 50 mmHg. Essa massagem não deve ser feita em pacientes com história de AVC \\nhá menos de 3 meses, taquicardia ventricular, fibrilação ou estenose carotídea4. \\n7.2. SÍNCOPE POR HIPOTENSÃO ORTOSTÁTICA \\nNeste caso o corpo “demora a entender” uma mudança brusca de posição. Na história do \\npaciente, ele irá relatar, geralmente, que o episódio ocorreu após estar deitado e levantar -se, \\npodendo ser também durante exercício físico ou mesmo uma hipotensão pós -prandial. Além \\ndisso, deve-se investigar a causa principal desta hipotensão postural, a qual pode ocorrer por7: \\n• Medicamentos – principal causa de hipotensão ortostática, sendo na maioria das \\nvezes relacionada a vasodilatadores, diuréticos e antidepressivos. Procurar \\nestabelecer o uso das medicações com o início dos episódios de hipotensão. \\n• Depleção de volume – história de diarreia, vômitos, hemorragia e outras causas \\nque deixem o paciente hipovolêmico. \\n• Disautonomia primária – é uma falha própria do sistema autonômico, a qual \\npode ocorrer na doença de Parkinson e demência por corpúsculos de Lewy, por \\nexemplo. \\n• Disautonomia secundária – doenças que lesam o sistema autonômico, dentre \\nelas: diabetes, amiloidose, lesões da medula espinal, insuficiência renal e outras. \\nUm dos principais métodos diagnósticos é realizar a aferição da pressão arterial (PA) e \\nfrequência cardíaca (FC), nas posições supina (por 5 minutos), sentada, imediatamente em pé \\ne após 3 minutos na postura ereta. Em pacientes com hipotensão ortostática, haverá, após 3 \\nminutos em pé, uma queda da PAS > 20 mmHg e/ou queda da pressão arterial diastólica (PAD) \\n≥ 10 mmHg, ou uma PAS < 90 mmHg, associada a sintomas ou história de sintomas em outros \\nepisódios7,10. \\nCaso não haja essa alteração da PA, mas o paciente apresente, ao ficar em ortostase, uma \\nelevação da FC > 30 bpm ou atinja uma FC > 120 bpm após 10 minutos em ortostase, associada \\na sintomas, pode -se considerá-lo com síndrome taquicárdica ortostática postural  (POTS – \\npostural orthostatic tachycardia syndrome , em inglês), mas com a ressalva de que est a é uma \\ncausa infrequente e com pouca evidência de que tenha relação direta com a síncope7,10. \\n7.3. SÍNCOPE CARDÍACA \\nEsse grupo inclui as causas de maior gravidade, pois o próximo episódio do paciente \\npode ser fatal. Na história clínica os paciente podem relata r que o episódio sincopal ocorreu'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 54}, page_content='54 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\ndurante algum esforço físico ou ainda na posição supina. A depender da causa, pode haver \\npalpitações imediatamente antes da síncope ou história familiar de morte súbita inexplicada \\nem < 50 anos 7,10. As duas principais etio logias são as arritmias e as doenças cardíacas \\nestruturais. \\n• Arritmias – podem ser bradi  ou taquiarritmias, as quais pioram o volume \\nsistólico e débito cardíaco. O ECG tem papel primordial neste caso, onde \\ndiferentes achados são altamente sugestivos de síncope de origem arritmogênica \\n(tabela 2)6,7. \\n \\nTabela 2 – Achados altamente sugestivos de síncope de origem arritmogênica6,7. \\nExemplos de Achados no ECG \\nBradicardia sinusal persistente < 40 bpm ou pausas sinusais > 3 s no estado de vigília e na ausência \\nde treinamento físico; \\nBloqueio AV de 3º grau e de 2º grau Mobitz II \\nAlternância entre bloqueios de ramo esquerdo e direito; \\nTaquicardia ventricular (TV) ou taquicardia supraventricular (TSV) paroxística rápida; \\nEpisódios não sustentados de TV polimórfica e intervalo QT longo ou curto; \\nMau funcionamento do marcapasso ou do cardiodesfibrilador implantável (CDI) com pausas \\ncardíacas \\n \\n• Doenças cardíacas estruturais  – há importantes causas cardíacas estruturais \\nde síncope, merecendo destaque: a estenose aórtica, principalmente em idosos, \\ncom sopro sistólico rude em foco aórtico, também podendo haver angina e \\ndispneia; infarto agudo do miocárdio (IAM), onde o paciente  pode manifestar \\nprecordialgia antes da síncope; cardiomiopatia hipertrófica (CMH), normalmente \\njovens atletas com histórico familiar de morte súbita de causa desconhecida; \\nsíndrome de Wolff-Parkinson-White (WPW); dentre outras. Novamente o ECG é \\nde suma i mportância para sugerir a possível causa e necessidade de outros \\nexames. A tabela a seguir (tabela 3) mostra alguns exemplos de alterações no ECG \\nsugestivas de doenças cardíacas6,7.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 55}, page_content='55 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nTabela 3 - Exemplos de possíveis achados sugestivos de doenças cardíacas estruturais6,7 \\nExemplos de Achados no ECG \\nComplexos QRS pré-excitados, sugestivos de síndrome de Wolff-Parkinson-White \\nHipertrofia ventricular esquerda, podendo indicar cardiomiopatia hipertrófica \\nOnda épsilon e onda T negativa em V1 e V2, sugere cardiomiopatia arritmogênica do ventrículo direito \\nAchados sugestivos de IAM (olhar capítulos de SCA) \\n \\nÉ importante salientar que nos casos de síncope em pacientes jovens, sem  história de \\ndoença cardíaca, sem história familiar, sem fatores desencadeantes ou pródromos incomuns e \\ncom ECG normal, a chance de síncope de origem cardíaca é muito baixa7. \\nExames adicionais podem ser solicitados em casos ainda duvidosos após uma boa \\navaliação inicial, a fim de se confirmar ou excluir o diagnóstico da etiologia pensada, podendo \\nserem vistos no tópico de exames complementares.  \\n8. ESTRATIFICAÇÃO DE RISCO \\nNa emergência, em um paciente que aparece com um episódio de síncope é de extrema \\nimportância realizar sua estratificação de risco, pois irá auxiliar na conduta adequada para seu \\ncaso. Isso também é válido para os casos de pré -síncope, já que este possui o mesmo \\nprognóstico de um episódio de síncope. O objetivo principal é definir os pacientes com síncope \\nde alto risco, isto é, aquela na qual o próximo episódio do paciente pode trazer sérios danos ou \\nmesmo ser fatal 7,11. É importante destacar que, como dito previamente, cerca de metade dos \\npacientes têm seu diagnóstico estabelecido apenas com a avaliação inicial (história clínica + \\nexame físico + ECG)2, os quais possuem risco e conduta melhor estabelecidos. \\nEntretanto, os outros 50% podem ser divididos em: diagnóstico suspeito  (30%), \\nquando o paciente possui características em sua avaliação que apontam para uma etiologia, \\nporém esta não pode ser confirmada; e diagnóstico inexplicado  (20%), no qual nada na \\navaliação inicial indica uma etiologia11. Esses 2 grupos de pacientes, principalmente, são os que \\nmais necessitam da estratificação de risco, p ara que a melhor conduta seja adotada em cada \\ncaso7,11.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 56}, page_content='56 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nBOX 9.  \\nO ECG solicitado apresentou -se com ritmo sinusal, sem alterações de repolarização, \\ncondução ou isquemia. \\n \\nCom base na avaliação inicial, o paciente foi estratificado como risco intermediário, \\npor possuir algumas características de baixo risco, como exame físico e ECG normais, mas \\ntambém características de alto risco, como o fato de o episódio sincopal ter ocorrido durante \\natividade física e pródromos aparentemente curtos (< 10 s), os quais podem indicar causa \\narritmogênica. Foi optado, então, por interná -lo para investigar mais detalhadamente sua \\npossível etiologia. \\n \\nNas figuras a seguir estão descritos os fat ores de baixo risco (figura 1), fatores de alto \\nrisco (figura 2) e achados no ECG que são de alto risco quando associados a uma história \\ncompatível com síncope de causa arritmogênica (figura 3)7.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 57}, page_content='57 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nFigura 1 – Fatores de baixo risco que sugerem etiologia benigna7. \\n \\nFigura 2 – Fatores de alto risco que sugerem etiologia grave7. \\n \\nFA = fibrilação atrial; FC = frequência cardíaca; CDI = cardiodesfibrilador implantável; DAC = doença arterial \\ncoronariana; TGI = trato gastrointestinal.  AAlto risco apenas se associado à doença cardíaca estrutural ou \\nalterações no ECG. BCom o paciente acordado e sem estar realizando esforço físico.  CAlto risco apenas se história \\ncompatível com síncope de causa arritmogênica. \\nFATORES DE BAIXO RISCO \\nHistória Clínica \\n Exame Físico \\n ECG \\nPródromos típicos de síncope \\nreflexa; \\nApós longo tempo em pé, em \\nmultidão ou locais quentes; \\nDurante refeição ou pós -\\nprandial; \\nApós estímulo desagradável \\n(dor, medo); \\nApós micção, evacuação, tosse, \\noutros; \\nCompressão do seio carotídeo; \\nMudança da posição supina para \\nortostática; \\nHistória prévia de episódios de \\nbaixo risco; \\nAusência de doença cardíaca \\nestrutural. \\nSem alterações. \\n Sem alterações. \\nFATORES DE ALTO RISCO \\nHistória Clínica \\n Exame Físico \\n ECG \\nNovo início de dor torácica, \\nfalta de ar, dor abdominal ou \\ndor de cabeça; \\nSíncope na posição supina ou \\ndurante esforço; \\nInício súbito de palpitação \\nseguido de síncope; \\nHistória de doença cardíaca \\nsevera ou DAC; \\nSem pródromos ou \\npródromos curtos (< 10 s)A; \\nHistória familiar de morte \\nsúbita < 50 anosA; \\nSíncope sentadoA. \\nPAS < 90 mmHg inexplicada; \\nExame retal sugestivo de \\nsangramento do TGI; \\nFC < 40 bpm persistenteB; \\nSopro sistólico sem \\ndiagnóstico. \\nAlterações compatíveis à \\nisquemia aguda; \\nFA com FC < 40 bpm; \\nFC < 40 bpm ou bloqueio \\nsinoatrial ou pausa sinusal > 3 \\nsB; \\nAchados de cardiomiopatia ou \\nDAC; \\nDisfunção de marca -passo ou \\nCDI; \\nPadrão de Brugada tipo I em \\nV1-V3; \\nSíndrome do QT longo. \\nOutras alterações no ECG que \\ndependem da história do \\npacienteC (Figura 3)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 58}, page_content='58 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\n \\nFigura 3 – Achados no ECG que são de alto risco quando o paciente possui história compatível com \\nsíncope de origem arritmogênica7. \\n \\nBAV = bloqueio atrioventricular; FA = fibrilação atrial; FC = frequência cardíaca; TSV = taquicardia \\nsupraventricular. \\n \\nBOX 10.  \\nDurante sua internação foi feito um ecocardiograma, o qual revelou função e estrutura \\nnormais do miocárdio e das valvas. Também se realizou uma monitorização \\neletrocardiográfica que não mostrou alterações, com ritmo sinusal normal contínuo. Com \\nbase nesses resultados, optou-se por realizar um teste de estresse por exercício físico, já \\nque o episódio do paciente ocorreu durante esforço. \\n \\nÉ importante destacar que os escores clínicos atuais não devem ser utilizados de \\nforma isolada para a estratificação de r isco do paciente, pois não possuem um \\ndesempenho melhor do que um bom julgamento clínico7. Dentre os mais conhecidos, pode-\\nse citar: OESIL ( Osservatorio Epidemiologico sulla Sincope nel Lazio ), SFSR ( Saint Francis \\nSyncope Rule ) e EGSYS ( Evaluation of Guide lines in Syncope Study ). Suas principais \\ncaracterísticas são resumidas na tabela 4. \\n \\n \\nHISTÓRIA COMPATÍVEL COM \\nSÍNCOPE ARRITMOGÊNICA \\nPossíveis achados \\nde Alto risco no \\nECG \\nBAV 2º grau Mobitz I e BAV 1º grau com \\nprolongamento do intervalo PR; \\nFA com FC 40-50 bpm; \\nFC 40-50 bpm; \\nPresença de TSV paroxística ou FA; \\nComplexo QRS pré-excitado; \\nPadrão de Brugada atípico; \\nAlterações sugestivas de cardiomiopatia \\narritmogênica ventricular direita (ondas T \\nnegativas em derivações precordiais \\ndireitas + ondas épsilon);'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 59}, page_content='59 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nTabela 4 – Exemplos de escores clínicos para síncope e suas características12,13,14. \\nESCORE CRITÉRIOS CARACTERÍSTICAS \\nOESIL 1.      Idade > 65 anos \\n2.      história de DCV \\n3.      ECG alterado \\n4.      Síncope sem pródromos \\nPacientes são de \\nmoderado a alto risco \\nquando presença > 2 \\nSFSR 1.      História de IC; \\n2.      Hematócrito < 30%; \\n3.      ECG alterado; \\n4.      História de dispneia; \\n5.      PAS < 90 mmHg na triagem. \\nA presença de qualquer um \\ndos critérios indica maior \\nrisco para complicação \\ngrave em 7 dias \\nEGSYS 1.      Palpitações antes da síncope (+4 pontos); \\n2.      ECG alterado ou história de DCV (+3 \\npontos); \\n3.      Síncope precipitada por esforço (+3 \\npontos); \\n4.      Síncope em posição deitada (supina) (+2 \\npontos); \\n5.      Pródromos autonômicos (-1 ponto); \\n6.      Existência de fatores precipitantes ( -1 \\nponto) \\nSão considerados alto risco \\nos pacientes com \\npontuação > 3 \\nDCV = doença cardiovascular; EGSYS = Evaluation of Guidelines in Syncope Study; IC = insuficiência cardíaca; OESIL \\n= Osservatorio Epidemiologico sulla Sincope nel Lazio; PAS = pressão arterial sistólica; SFSR = Saint Francis Syncope \\nRule. \\n9. CONDUTA \\nNo contexto da emergência, foco deste livro, o objetivo principal do médico é definir, \\ncom base na avaliação inicial, estratificação de risco e provável diagnóstico, quais os paciente \\nque podem ser dispensados e quais devem ter uma investigação mais detalhada , com \\nsolicitação de outros exames, por exemplo7. \\nApesar das diretrizes americana e europeia apresentarem diferenças, um ponto em \\ncomum entre ambas é de que pacientes de alto risco devem ser internados , os de baixo \\nrisco podem ser dispensados da emergência e os de risco intermediário (sem características \\nde alto ou baixo risco, os casos duvidosos) devem ficar em observação na emergência ou ter \\nencaminhamento imediato para especialista15. \\nO tratamento baseia-se, de forma geral, em 3 princípios: a eficácia do tratamento é mais \\nligada ao mecanismo da síncope do que a etiologia, por exemplo, o tratamento com estimulação \\ncardíaca é mais eficaz nos pacientes com bradicardia do que naqueles com hipotensão; muitas \\nvezes a terapia para prevenir outros episódios de síncope é diferente da terapia para a etiologia'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 60}, page_content='60 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nde base; e que a recorrência dos episódios decai espontaneamente após avaliação médica, \\nmesmo que sem terapia específica7. \\nA seguir são detalhados os principais tratamentos para os tipos de síncope, porém \\nsempre reforçando que o principal objetivo do médico na emergência já foi concluído  \\n(avaliação inicial + estratificação de risco). \\nBOX 11.  \\nDurante o teste ergométrico, paciente apresentou leve dispneia, mas sem palpitações, dor \\ntorácica ou síncope. Foi constatado o seguinte traçado no ECG: \\n \\n \\n9.1. TRATAMENTO DA SÍNCOPE REFLEXA \\nMesmo sendo considerada uma etiologia benigna, quando imprevisível e recorrente, ela \\npode ser incapacitante. O p onto principal do tratamento inicial é não -farmacológico, \\nincluindo: educação, explicando para o paciente o caráter benigno de sua condição e alertando \\npara riscos de lesão quando houver o episódio; e mudança de estilo de vida, evitando potenciais \\ngatilhos e situações, como desidratação, locais quentes ou grandes multidões, bem como ser \\norientado a identificar os pródromos e, sempre que possível, deitar e elevar os membros \\ninferiores quando os sintomas ficam mais intensos7. \\nAlém dessas medidas, devem -se avaliar as medicações utilizadas  pelo paciente, \\nretirando ou reduzindo, quando possível, as doses de drogas hipotensoras  que possam ter \\ndesencadeado o episódio de síncope. Nos casos dos pacientes com síncope vasovagal e \\npródromos, são recomendadas manobras  físicas de contrapressão isométrica , como o \\nhandgrip ou cruzar as pernas e realizar tensão7,16.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 61}, page_content='61 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nNos casos em que o paciente continua tendo episódios recorrentes mesmo com as \\nmedidas anteriores, pode-se realizar tratamento farmacológico, com o uso da fludrocortisona \\n(0,05-0,2 mg 1x/dia), mas em pacientes jovens, com pressão normal e sem contraindicações \\npara o medicamento, sendo outra opção a midodrina (2,5-10 mg 3x/dia), um agonista alfa -\\nadrenérgico7. \\nQuando há pausa sinusal documentada (espontânea ou induzid a) > 3 s correlacionada \\naos episódios de síncope em pacientes > 40 anos, há benefício do uso de marca-passo com \\nestimulação de dupla câmara7. \\n9.2. TRATAMENTO DA HIPOTENSÃO ORTOSTÁTICA \\nO tratamento inicial dessa etiologia é semelhante ao anterior com medidas não  \\nfarmacológicas envolvendo educação e mudança de estilo de vida, evitando mudanças bruscas \\nde posição, além de hidratação adequada (2-3 litros/dia) e ingestão correta de sal (10 g/dia)7. \\nTambém deve-se avaliar medicações vasoativas utilizadas e se há relação dessas com \\nos episódios sincopais, a fim de suspender ou reduzir a dose, quando possível. Lembrando que \\nos pacientes com riscos de queda devem ter o controle da PAS entre 140 -150 mmHg. Outras \\nmedidas são as manobras físicas de contrapressão isométrica7. \\nEm casos persistentes, pode ser usado o tratamento farmacológico , no qual a \\nmidodrina (2,5-10 mg 3x/dia) desempenha ótimo papel sintomático, porém deixando claro \\npara o paciente que não irá curá -lo. Neste caso a 2ª opção é a fludrocortisona (0,05-0,2 mg \\n1x/dia)7. \\n9.3. TRATAMENTO DA SÍNCOPE ARRITMOGÊNICA \\n9.3.1. BRADICARDIAS \\nQuando há relação entre a sintomatologia e a síncope do paciente com sua alteração no \\nECG, o marca-passo é útil e efetivo para alívio sintomático. Dentre as alterações há: disfunção \\ndo nodo sinusal e BAV intrínseco. Nos casos de não ter comprovação da relação, há benefício \\ndesta terapia para casos de bloqueio de ramo bifascicular, quando o estudo eletrofisiológico ou \\no monitor de eventos implantado for positivo. Os BAV de 2º e 3º grau n ão necessitam da \\ncomprovação para o tratamento com marca-passo. É importante destacar que o marca-passo é \\ncontraindicado quando a causa da bradicardia é reversível7.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 62}, page_content='62 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\n9.3.2. TAQUIARRITMIAS \\nNos casos de taquiarritmias supraventriculares a 1ª escolha é a ablação cardíaca. \\nQuando há falha na ablação ou enquanto o paciente aguarda a realização do procedimento, as \\ndrogas antiarrítmicas podem ser utilizadas7. \\nJá nas taquiarritmias ventriculares, quando devido a medicamentos que prolongam o \\nQT (azitromicina e cloroquina, por exemplo), deve-se suspendê-los. O tratamento de escolha é \\na ablação cardíaca  a fim evitar episódios recorrentes, e a 2ª opção são as drogas \\nantiarrítmicas, assim como nas supraventriculares. A grande diferença é que também há a \\nalternativa de cardiodesfibrilador implantável (CDI)  para casos selecionados, sendo \\nindicado para: fração de ejeção < 35% e história prévia de IAM com taquiarritmia ventricular \\ninduzida durante estudo eletrofisiológico. Também pode ser considerado nos  pacientes com \\nfração de ejeção > 35% e que ou não podem realizar ou foram refratários às outras duas opções \\nde tratamento7. \\nBOX 12.  \\nCom base no resultado do ECG de TV monomórfica e por não haver cardiopatia estrutural \\naparente, paciente foi diagnosticado com taquicardia ventricular idiopática. Foi \\nsubmetido à ablação cardíaca e sem necessidade de CDI, pois teve melhora do seu quadro \\napós terapêutica e sem recidivas. \\n \\n9.4. TRATAMENTO DA SÍNCOPE POR DOENÇA CARDÍACA ESTRUTURAL \\nÉ consenso que o objetivo principal nestes pacientes não é só prevenir outros episódios \\nsincopais, mas também tratar a doença de base. Diversas são as causas e cada uma tem um \\ntratamento específico, como é o caso de: cardiomiopatia hipertrófica, estenose aórtica, \\ndissecção aguda de aorta, embolia p ulmonar, tumor, hipertensão pulmonar, tamponamento \\ncardíaco, dentre outros7.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 63}, page_content='63 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nFLUXOGRAMA\\n \\nECG = eletrocardiograma; EF = exame físico; HO = hipotensão ortostática; MEV = mudança de estilo de \\nvida; TLOC = perda transitória de consciência, em inglês. \\nPACIENTE COM TLOC NA EMERGÊNCIA \\nAvaliação Inicial \\n(história clínica + EF + ECG) \\nÉ síncope? \\nNão \\nSim \\nPerda completa, abrupta e \\ntransitória da consciência + \\nSem controle do tônus postural + \\nRecuperação espontânea, rápida e \\nsem sequelas neurológicas \\n \\nConvulsão \\nPsicogênica \\nOutros \\nEtiologia \\ndefinida? \\nNão \\nSim \\nConduta de \\nacordo com \\netiologia e \\nrisco \\n \\nEstratificação de \\nrisco \\nCaracterísticas de \\nsíncope reflexa ou de \\nHO \\n \\n Características de \\nsíncope cardíaca \\n \\nRisco \\nintermediário \\nAlta da emergência \\nEducação + MEV \\nAvaliar medicações \\nutilizadas \\nCasos refratários = tratamento \\nfarmacológico \\n \\nInternação \\nExames adicionais para \\ndiagnóstico \\nTratamento de acordo com a \\netiologia \\nEncaminhamento \\npara especialista \\nBaixo risco \\n Alto risco'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 64}, page_content='64 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\nREFERÊNCIAS \\n1. Mann DL et al. Braunwald: tratado de doenças cardiovasculares. 10. ed. Rio de Janeiro: \\nElsevier, 2018. \\n2. McDermott D, Quinn JV. Approach to the adult patient with syncope in the emergency \\ndepartment. UpToDate (2020). Disponível em: \\n<https://www.uptodate.com/contents/approach-to-the-adult-patient-with-syncope-in-\\nthe-emergency-department#H1>. Acesso em: 05 mar. 2022. \\n3. Benditt D. Syncope in adults: Epidemiology, pathogenesis, and etiologies . UpToDate \\n(2020). Disponível em: <https://www.uptodate.com/contents/syncope -in-adults-\\nepidemiology-pathogenesis-and-etiologies>. Acesso em: 05 mar. 2022. \\n4. Velasco IT. Manual de Emergência: Abordagem Prática. 14. ed. São Paulo: Manole, 2020. \\n5. Araújo JS. Manual Prático Para Urgências e Emergências Clínicas. 2. ed. Salvador: Sanar, \\n2020. \\n6. Benditt D. Syncope in adults: Clinical manifestations and initial diagnostic evaluation. \\nUpToDate (2020). Disponível em: <https://www.uptodate.com/contents/syncope -in-\\nadults-clinical-manifestations-and-diagnostic-\\nevaluation?source=history_widget#H14005354>. Acesso em: 05 mar. 2022. \\n7. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and \\nmanagement of syncope. European Heart Journal (2018), 39, 1883–1948. \\n8. White L, Jones HT, Davies A. What is a tilt table test and why is it performed during the \\ninvestigation of syncope?. Br J Hosp Med (Lond). 2021 Oct 2;82(10):1-7. \\n9. Runser LA, Gauer RL, Houser A. Syncope: Evaluation and Differential Diagnosis. Am Fam \\nPhysician. 2017 Mar 1;95(5):303-312. PMID: 28290647. \\n10. Shen W -K, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the \\nevaluation and management of patients with syncope: a report of the American \\nCollege of Cardiology/American Heart Association Task Force on Clin ical Practice \\nGuidelines and the Heart Rhythm Society. J Am Coll Cardiol (2017), 70, e60–e122. \\n11. Benditt D. Syncope in adults: Risk assessment and additional diagnostic evaluation . \\nUpToDate (2020). Disponível em: <https://www.uptodate.com/contents/syncope -in-\\nadults-risk-assessment-and-additional-diagnostic-evaluation>. Acesso em: 05 mar. 2022. \\n12. Colivicchi F, Ammirati F, Melina D, et al. Development and prospective validation of a \\nrisk stratification system for patients with syncope in the emergency department: the \\nOESIL risk score. European Heart Journal (2003), 24, 811–819. \\n13. Quinn JV, Stiell IG, McDermott DA, et al. Derivation of the San Francisco Syncope Rule to \\npredict patients with short -term serious outcomes . Ann Emerg Med. (2004), 43, 224 -\\n232.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 65}, page_content='65 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO III | SÍNCOPE \\n14. Bispo JS, Az evedo P, Mota T, et al. Score EGSYS para predição de etiologia cardíaca na \\nsíncope: tem utilidade no contexto de consulta? . Rev Port Cardiol. (2020) 39(5), 255 -\\n261. \\n15. Goldberger ZD, Petek BJ, Brignole M, et al. ACC/AHA/HRS Versus ESC Guidelines for the \\nDiagnosis and Management of Syncope: JACC Guideline Comparison . J Am Coll Cardiol \\n(2019), 74, 2410–2423. \\n16. Benditt D. Reflex syncope in adults and adolescents: Treatment . UpToDate (2020). \\nDisponível em: <https://www.uptodate.com/contents/reflex -syncope-in-adults-and-\\nadolescents-treatment>. Acesso em: 05 mar. 2022.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 66}, page_content='66 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nCAPÍTULO IV  \\nTAQUIARRITMIAS \\nLuís Eduardo Oliveira Matos 1 \\nGiovanna Lídia Gondim Oliveira Dias 1 \\nDaniel Salmito Chaves 1 \\nMateus de Sousa Cavalcante 1 \\nLeandro Cordeiro Portela 2 \\nDOI: 10.51859/amplla.ceg164.1123-4 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médico cardiologista eletrofisiologista. Hospital do Coração de Sobral. Sobral, Ceará, Brasil.  \\nCASO CLÍNICO \\nMulher, 37 anos de idade, vendedora, bra nca, deu entrada no pronto atendimento do \\nsetor de Emergência devido a um quadro de dispneia súbita, palpitações, sudorese e vertigens \\niniciados há cerca de uma hora, quando a paciente estava em repouso. O marido, que \\nacompanhava a consulta, relata que, no caminho para o hospital, a paciente desmaiou no carro, \\napenas acordando cerca de 4 minutos depois, fato que ela não lembra. Nega precordialgia, \\nporém relata que apresentou três episódios semelhantes nos últimos seis meses, que \\nregrediram espontaneamente e m cerca de meia hora. Relata hipertensão, diabetes mellitus e \\nhistória familiar positiva para tireoidopatia. Faz uso de metformina para controle da diabetes, \\ne losartana e hidroclorotiazida para controle da hipertensão. Nega internações, cirurgias e \\ndoenças prévias. Quando questionada sobre outros sintomas no Interrogatório de Órgãos e \\nAparelhos, relatou apresentar queda de cabelo, diarreia e sudorese excessiva (“não suporta o \\ncalor de Sobral”).  \\nAo exame físico, a paciente estava em estado geral ruim, hidratada, acianótica, anictérica \\ne afebril, com os sinais vitais: Pressão Arterial: 155 x 75 mmHg; Frequência Cardíaca: 145 bpm; \\nFrequência Respiratória: 31 irpm; Saturação de Oxigênio: 89%. A ausculta cardíaca mostrava \\nritmo irregular, em dois tempos, com no rmofonese de B1 e B2, sem sopros; pulsos palpáveis \\ncom amplitude diminuída. Ausculta respiratória sem alterações. À inspeção do pescoço, notou-\\nse a tireoide aumentada de tamanho, o que motivou a sua palpação, onde esta se mostrava de \\nconsistência elástica e aumento difuso, sem nodularidade.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 67}, page_content='67 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nQUESTÕES \\na. Qual a afecção aguda que acometeu esta paciente? Ela apresenta sinais de gravidade? Se sim, \\nquais? (BOX 13) \\nb. Que exames complementares você solicitaria diante da sua suspeita diagnóstica para esta \\npaciente? (BOX 14) \\nc. Qual a doença subjacente, possivelmente apresentada por essa paciente, que é considerada \\nfator de risco para esta afecção aguda? (BOX 15) \\nd. Como você conduziria esta paciente no departamento de Emergência? E a longo prazo? \\n(BOX 16) \\nOBJETIVOS DE APRENDIZAGEM DO CAPÍTULO \\na. Quais são os principais mecanismos fisiopatológicos pelos quais acontece uma \\ntaquiarritmia? \\nb. Quais os sinais e sintomas esperados em um paciente com taquiarritmia estável? E instável? \\nc. Como diferenciar as principais taquiarritmias supraventri culares e ventriculares pelo \\neletrocardiograma? \\nd. Qual a conduta a se tomar diante das principais taquiarritmias estáveis? E se o paciente \\nestiver instável? \\n1. INTRODUÇÃO \\nAs taquiarritmias são, fundamentalmente, definidas por alterações da frequência, \\nformação ou condução do impulso elétrico através do miocárdio cuja origem pode ser \\nsupraventricular, quando o ritmo é originado acima da junção entre o nó AV e o feixe de His, ou \\nventricular, quando a origem é abaixo da bifurcação do feixe de H is, habitualmente expressa \\npor QRS alargado. Além disso, apresentam como principal característica a frequência cardíaca \\nacima de 100 batimentos por minuto (bpm)1. \\n2. FISIOPATOLOGIA \\nCompreender a formação desses distúrbios possibilita a identificação do tratam ento \\nmais eficaz da disfunção geradora do ritmo alterado 2. As arritmias cardíacas são produzidas \\npor anormalidades na geração ou na condução do impulso, ou em ambas. Taquiarritmias podem \\nser classificadas de acordo com o mecanismo envolvido na sua formação . A classificação dos'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 68}, page_content='68 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nmecanismos inclui automaticidade aumentada, arritmias com mecanismo de gatilho e \\nreentrada3. \\n- Automaticidade aumentada: um conjunto de células do miocárdio despolariza com \\nlimiar menor em relação às demais. A despolarização ocorre em  frequência aumentada, de \\nforma a assumir o controle do ritmo cardíaco. Alterações estruturais do tecido miocárdico, \\ndistúrbios hidroeletrolíticos e medicamentos podem facilitar esse mecanismo. Essas arritmias \\nsão frequentemente precipitadas por estimulaçã o adrenérgica, tendem a acelerar até a \\nfrequência cardíaca máxima e não são precipitadas por contrações prematuras. Exemplos: \\ntaquicardia atrial focal e taquicardia juncional2. \\n- Automaticidade por gatilho (pós -potenciais precoces ou tardios): ocorre quand o o \\npotencial de ação pode deflagrar despolarizações anormais adicionais. Pode ser pós -\\ndespolarização precoce quando ocorre antes da repolarização ou pós -despolarização tardia \\nquando ocorre depois da repolarização. Exemplo: arritmias ventriculares associad as a QT \\nlongo, como torsades de pointes2. \\n- Reentrada: Distúrbio na propagação do estímulo elétrico em que um mesmo impulso \\nretorna e produz uma série de despolarizações, geralmente, desencadeadas por uma \\nextrassístole, em áreas denominadas reentradas anat ômicas, as quais envolvem regiões de \\nfibrose, ou isquemia, em que os períodos refratários dos átrios estão encurtados. Nesse caso, \\nexistem duas vias de condução próximas, com velocidades de propagação do estímulo elétrico \\ndiferentes: uma rápida, porém com período refratário lento, e outra via lenta, com período \\nrefratário rápido. Desse modo, a ativação do impulso elétrico pode persistir em uma região do \\ncoração pelo tempo suficiente para que o tecido adjacente recupere a excitabilidade. Assim, o \\nmesmo impul so volta a excitar o coração. O mecanismo gerador pode ser localizado no nó \\natrioventricular (AV), no átrio, ou através de uma via acessória atrioventricular (como na \\nsíndrome de Wolff –Parkinson-White). Esse mecanismo é caracteristicamente paroxístico, \\nporém, pode ser sustentado com necessidade de tratamento farmacológico.4 \\n3. QUADRO CLÍNICO E AVALIAÇÃO INICIAL \\nAs manifestações clínicas das taquiarritmias são variadas, e muitos pacientes também \\npodem apresentar -se de forma assintomática. 5 Os sinais e sintomas mais comuns incluem \\ndispneia, palpitações, sudorese, turgência jugular, alterações do nível de consciência, dor ou \\ndesconforto torácico, hipotensão, síncope e pré -sincope.2,5 Durante a anamnese, é importante \\ncaracterizar como iniciara m as palpitações, se foi súbito ou gradual, a duração do episódio e'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 69}, page_content='69 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\ncomo a percepção dos batimentos cardíacos cessou. Se essa sensação ocorreu após esforço \\nfísico e estresse, normalmente é relacionada a automatismo sensível a catecolaminas, enquanto \\npalpitações que iniciaram espontaneamente durante o repouso podem ser desencadeadas por \\nestímulo vagal, como na FA.5 \\nNa avaliação inicial, é fundamental identificar condições clínicas de instabilidade , \\ncomo sinais de baixo débito cardíaco, de baixa perfusão cerebral, de isquemia miocárdica aguda \\ne de falência ventricular esquerda, a fim de priorizar a avaliação desses pacientes na sala de \\nemergência, monitorá -los e iniciar a terapêutica adequada. 6 De forma simplificada, deve -se \\ninvestigar os “D’s” da instabilidad e: dispnéia; diminuição do nível de consciência; desmaio; \\ndiminuição da pressão arterial e dor torácica. \\nNo entanto, é válido ressaltar que é necessário descartar outras causas de instabilidade \\nhemodinâmica, que podem estar associadas ao quadro de taquicar dia, como sepse e choque \\nséptico, anemia grave, distúrbios metabólicos, tromboembolismo pulmonar, entre outros.2 \\nAlém disso, ao interrogar sobre a história patológica pregressa, deve -se investigar \\nepisódios prévios de arritmias, hipertireoidismo, cardiopat ias (IAM, IC), condições que \\nfavoreçam distúrbios hidroeletrolíticos (ex: doença renal crônica, desidratação), uso de drogas \\nde abuso e uso de medicamentos, como diuréticos, antiarrítmicos, antidepressivos, e drogas \\nque prolongam intervalo QT. A história f amiliar de distúrbios do ritmo cardíaco também deve \\nser questionada, como síndrome do QT longo, FA, cardiomiopatia hipertrófica e distrofia \\nmuscular.2,5 \\nNo exame físico, é importante palpar os pulsos do paciente e identificar se o ritmo é \\nregular ou irregular, definir a frequência cardíaca, medir a pressão arterial nos dois membros \\nsuperiores, determinar o tempo de enchimento capilar, realizar a ausculta cardíaca em busca \\nde B3 ou B4 e hipofonese de bulhas, avaliar sinais de congestão pulmonar e sistêmica, como \\ncrepitações em ausculta pulmonar e edema de membros inferiores, além de sinais de \\nhipertireoidismo, como tremores de extremidades e protrusão ocular. 2,5 Se a manobra de \\nValsalva ou a compressão do seio carotídeo forem realizadas, taquiarritmias que dependem do \\nnó AV podem ser cessadas ou tornar -se mais lentas. Ao determinar a frequência cardíaca do \\npaciente, esse valor pode ser comparado com a frequência máxima esperada pela idade, \\nutilizando a equação de Karvonen, que define esse resultado como: 220 – idade.2'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 70}, page_content='70 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nBOX 13. CLÍNICA \\nQual a afecção aguda que acometeu esta paciente? Ela apresenta sinais de \\ngravidade? Se sim, quais? \\nEssa paciente está sendo acometida por uma taquiarritmia instável. Entre os sintomas que \\nreforçam essa hipótese diagnóstica, tem-se: dispneia súbita, palpitações, sudorese e \\nvertigens, além da síncope relatada pelo acompanhante. A história pregressa de três crises \\nsemelhantes contribui para a suspeita. Entre os sinais que reforçam a hipótese, tem-se o \\nritmo cardíaco irregular à ausculta. Diante de um paciente com dispneia súbita, deve-se \\natentar a outros diagnósticos diferenciais, principalmente, para este caso, insuficiência \\ncardíaca aguda, pneumonia aguda e tromboembolismo pulmonar. Essa paciente apresenta \\nsinais de gravidade, sendo eles: dispneia súbita e desmaio. \\n4. EXAMES COMPLEMENTARES / ALGORITMO DIAGNÓSTICO \\nO exame complementar essencial para o diagnóstico e classificação das taquiarritmias é \\no eletrocardiograma. Um ECG de 12 derivações deve ser realizado no momento em que se \\nidentificam as manifestações clínicas do paciente, com a finalidade de registrar a alteração da \\natividade elétrica do coração.21 Outros exames também podem ser solicitados posteriormente, \\na depender da suspeita clínica do paciente, como eletrólitos (ex: po tássio e magnésio), para a \\ninvestigação de distúrbios hidroeletrolíticos, marcadores bioquímicos de lesão cardíaca, ureia \\ne creatinina para a avaliação da função renal e dosagem de substâncias (digoxina, quinidina, \\nprocainamida), além de testes adicionais como Holter 24h, teste de esforço, Tilt -Test, loop \\nrecorder implantável e estudo eletrofisiológico invasivo.2,5 \\nDiante da variabilidade dos tipos de taquiarritmia, sua identificação por meio do \\neletrocardiograma pode ser complexa. Para facilitar esse proce sso, pode -se realizar a \\nabordagem inicial sistematizando a identificação de quatro fatores:2,9 \\n1.      O intervalo QRS é estreito ou largo? \\n2.      O ritmo é regular ou irregular? \\n3.      Há onda P visível? \\n4.      Se presente, qual a relação da onda P com o QRS?'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 71}, page_content='71 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n \\n4.1. QRS ESTREITO \\nUma taquicardia de QRS estreito define -se como frequência cardíaca maior do que 100 \\nbatimentos por minuto com o intervalo QRS de duração inferior a 120 milissegundos. 5 Isso \\nreflete a ativação rápida dos ventrículos pelo sistema normal His-Purkinje e que a arritmia tem \\norigem acima ou dentro do feixe, logo, todas as taquicardias de QRS estreito são taquicardias \\nsupraventriculares.7 Uma vez identificadas, o segundo passo é classificá-las entre ritmo regular \\nou irregular: \\n4.1.1. RR irregular \\nQuando o intervalo RR é irregular, o terceiro ponto será identificar a presença de ondas \\nP (melhor visualizadas em derivações DII e V1)2: \\n- Se ausentes, o paciente possui Fibrilação Atrial; Nesse caso, a massagem carotídea pode \\nreduzir a frequência ventricular.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 72}, page_content='72 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n- Se forem identificadas, outras possibilidades são a Taquicardia Atrial Multifocal (TAM), \\ncom presença de pelo menos 3 ondas P morfologicamente distintas, ou o flutter atrial de \\ncondução AV variável. \\n4.1.2. RR regular \\nCaso o intervalo RR seja regular, novamente devemos prosseguir com a observação de \\nondas P: \\n4.1.2.1. Ondas P não visíveis: \\nSe não forem identificadas, pode-se fazer um teste com adenosina ou massagem de seio \\ncarotídeo para bloquear o nó AV . Essas medidas permitem a reversão da arritmia ou a \\nvisualização de ondas P, auxiliando no diagnóstico 5. Os diagnósticos diferenciais dessa classe \\nincluem: \\n- Taquicardia por Reentrada Nodal: FC entre 150 -250 bpm; pode haver presença de \\n“ondas P retrógrada s” (ver adiante). A massagem carotídea pode reduzir a frequência ou \\nreverter a arritmia9. \\n- Taquicardia Atrial: Eixo da onda P anormal (causado por automatismo de um foco atrial \\nectópico)9. \\n- Taquicardia Juncional: Pode haver “ondas P retrógradas” dissociadas aparecendo após \\no complexo QRS ou escondidas no QRS7. \\n4.1.2.2. Relação de 1:1 de Ondas P e complexo QRS \\nSe a relação entre as ondas P e os complexos QRS correspondem 1:1, devemos identificar \\na distância da onda P com início do complexo QRS que a precede, que normalmente é longa.2 \\n \\n- RP Curto \\nCaso essa distância permaneça curta, as possibilidades diagnósticas são: taquicardia por \\nreentrada nodal típica, taquicardia por reentrada atrioventricular ortodrômica, taquicardia \\natrial com RP longo.2'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 73}, page_content='73 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n-  RP Longo \\nQuando a distância entre RP permanece longa, o paciente pode estar apresentando uma \\ntaquicardia sinusal. Porém, existem outros eventos que se encaixam nesse perfil, como \\ntaquicardia juncional reciprocante, taquicardia atrial e taquicardia por reentrada nodal atípica \\ne taquicardia atrioventricular tipo Coumel.2 \\n4.1.2.3. Número de ondas P superior aos de complexo QRS \\nNesses casos, dois tipos de taquicardia se manifestam dessa forma: \\n- Flutter atrial: “Ondas F” numa frequência de 250 -350 bpm, em “dente de serra”; \\nbloqueio 2:1, 3:1, etc; frequência ventricular: metade, um terço, etc. da frequência atrial; \\nmassagem carotídea: aumenta o bloqueio.9 \\n- Outros: taquicardia atrial. \\n4.2. QRS LARGO \\nSe um paci ente com FC > 100 bpm realizar um ECG evidenciando complexo QRS que \\nultrapassa os 120 milissegundos, ele apresenta uma taquicardia de QRS largo. 6 A maior parte \\ndessas taquicardias correspondem a ritmos ventriculares, que normalmente estão relacionados \\na quadros mais graves. No entanto, se houver bloqueio de ramo anterior, condução aberrante, \\nefeito de fármacos ou eletrólitos, algumas taquicardias supraventriculares podem se apresentar \\ndessa forma.2.8 \\nUma vez diagnosticado uma taquicardia de QRS largo, podem os prosseguir com a \\nclassificação quanto ao ritmo: \\n4.2.1. RR Regular: \\nGeralmente são representados pela Taquicardia Ventricular Monomórfica e a maioria \\ndas Taquicardias Supraventriculares (TSV), embora uma pequena variação do intervalo RR \\npossa ser vista na TV. C aso o indivíduo esteja instável hemodinamicamente, a abordagem \\nterapêutica baseia-se considerando como uma taquicardia ventricular, devido ao seu potencial \\nde gravidade.2 \\nComo uma forma de identificar o tipo de arritmia, podemos utilizar os seguintes critérios \\nde diferenciação:8,10'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 74}, page_content='74 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n1. Critérios de Brugada \\n \\n \\n*Critérios morfológicos para TV \\nTV: Taquicardia Ventricular; TSV-A: Taquicardia Supraventricular com Aberrância; BRD: Bloqueio de Ramo \\nDireito; BRE: Bloqueio de Ramo Esquerdo. \\n \\n \\n \\n \\n \\n \\nNão \\nNão \\nNão \\nNão \\nSim \\nTV \\nSim \\nTV \\nSim \\nTV \\nSim \\nTV \\n1 – Ausência de complexo RS em todas as derivações precordiais? \\n2 – Início do R ao nadir da onda S > 100 ms, em uma derivação precordial? \\n3 – Dissociação AV? \\n4 – Critérios morfológicos para TV nas derivações V1-2 e V6*?'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 75}, page_content='75 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n2. Critérios de Vereckei  \\n \\n3. Critérios de Santos (12-16) \\n \\n \\n \\n                   \\n• Imagem 2:  2. Critérios de Vereckei: \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nOnda R ou Q inicial > 40 ms TV \\nSIM NÃO \\nSIM \\nOnda R inicial presente \\nNÃO \\nEntalhe na fase \\ndescendente do QRS? \\nTV \\nSIM NÃO \\nTV \\nVVVf < 1 \\nSIM NÃO \\nTSV com aberrância \\nTV'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 76}, page_content='76 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n4.2.2. RR Irregular \\n• TV Polimórfica: Complexos QRS com duração, amplitude eixos e morfologias \\ndiferentes. Dividida entre QT longo e QT curto. Quando associa -se ao QT longo, \\ndenomina-se torsades de pointes.2 \\n• Outros: FA pré -excitada: FA com Wolff-Parkinson-White (WPW) 2; FA com \\naberrância: FA com complexo QRS de morfologia constante com BRD ou BRE.2 \\nBOX 14. DIAGNÓSTICO + EXAMES COMPLEMENTARES \\nQue exames complementares você solicitaria diante da sua suspeita diagnóstica para \\nesta paciente? \\nForam solicitados, para essa paciente, hemograma completo, glicemia de jejum, função \\nrenal, função hepática, marcadores de necrose miocárdica, TSH, T4 livre, eletrocardiograma, \\nradiografia de tórax e ecocardiograma transtorácico. Seguem os resultados: \\nLaboratório Valores obtidos Valores de referência \\nHEMOGRAMA \\nHemácias 11,4 g/dL 12-15,5 g/dL \\nHematócrito 32,6% 34-45% \\nLeucócitos 6.600 cel/mm3 4.000-10.000/mm3 \\nNeutrófilos 3.900/mm3 1600-7700/mm3 \\nLinfócitos 2.250/mm3 1100-4400/mm3 \\nBIOQUÍMICA \\nGlicemia e função renal sem alterações \\nTGO/AST 120 U/L < 40 U/L \\nTGP/ALT 92/L > 40 U/L \\nMARCADORES DE NECROSE MIOCÁRDICA \\nTroponina e CK-MB sem alterações \\nHORMÔNIOS \\nTSH <0,05 mU/L 0,45-4,5 mU/L \\nT4 livre 4,6 ng/dL 0,9-1,7 ng/dL'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 77}, page_content='77 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n \\nEletrocardiograma: ritmo de FA. \\nRadiografia de tórax: sem alterações. \\nEcocardiograma transtorácico: ritmo cardíaco irregular taquicárdico, sem aumento \\ncameral, função sistólica ventricular esquerda preservada (FE = 67%). \\nDiante destes exames, confirmou-se que a paciente apresentava uma fibrilação atrial. \\n5. PRINCIPAIS TAQUIARRITMIAS \\nEstudar as taquiarritmias é sempre um desafio complexo, afinal, trata -se de um \\nconteúdo bastante extenso e por vezes de explicação rebuscada demais ao entendimento rápido \\ndo estudante. A seguir, abordaremos as principais taquiarritmias de maneira sintética e \\ndidática, discorrendo a respeito de suas respectivas epidemiologia, fisiopatologia, etiologia, \\ndiagnóstico e tratamento. \\n5.1. FIBRILAÇÃO ATRIAL  \\n5.1.1. Epidemiologia \\nA fibrilação atrial (FA) é a taquiarri tmia crônica mais comum, com uma prevalência de \\n1-2% na população, aumentando progressivamente com a idade. Mais de 95% dos pacientes \\ncom FA têm mais de 60 anos de idade. O risco de desenvolver FA em toda a vida para homens \\nde 40 anos de idade é de aproximadamente 25%. A FA é um pouco mais comum em homens do \\nque em mulheres e mais comum em brancos do que em negros11.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 78}, page_content=\"78 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nEntre os fatores de risco para FA, além da idade e de doença cardíaca subjacente, estão \\na hipertensão arterial (HA), diabetes mellitus, cardio patia, obesidade e apneia do sono. A FA \\nestá associada com um aumento de 1,5 a 1,9x no risco de mortalidade após o controle da doença \\ncardíaca subjacente. A FA também está associada com o risco de desenvolver insuficiência \\ncardíaca (IC), assim como quem te m IC também têm mais risco de desenvolver FA. A FA \\naumenta em cinco vezes o risco de acidente vascular cerebral (AVC) e estima-se que seja a causa \\nde 25% desses casos11. \\nPor vezes, a FA é associada a um fator desencadeante agudo, como o hipertireoidismo \\nou a intoxicação alcoólica aguda, ou a uma enfermidade aguda, como o infarto agudo do \\nmiocárdio (IAM) ou a embolia pulmonar. A FA ocorre em até 30% dos pacientes em \\nrecuperação de cirurgia cardíaca, associada à pericardite inflamatória11. \\nA classificação mais utilizada na prática clínica refere-se à forma de apresentação da FA. \\nDefine-se “FA paroxística” aquela que é revertida espontaneamente em até 7 dias do seu início. \\nEpisódios com duração superior a 7 dias têm o nome de “FA persistente' '. Alguns estudos \\nutilizam a terminologia de “FA persistente de longa duração'' para designar os casos com \\nduração superior a um ano. Finalmente, o termo “fibrilação atrial permanente'' é utilizado nos \\ncasos onde as tentativas de reversão ao ritmo sinusal não serão mais instituídas. FA não valvar \\né definida por FA na ausência de estenose mitral reumática, válvula mecânica ou biológica ou \\nplastia mitral prévia12. \\n5.1.2. Fisiopatologia \\nQuando os miócitos atriais estão danificados, importantes alterações de suas \\npropriedades eletrofisiológicas podem ocorrer, predispondo à formação de novos “trajetos \\nelétricos” através do miocárdio atrial. Dessa forma, um estímulo proveniente de uma \\nextrassístole atrial pode se fragmentar, fazendo surgir múltiplos pequenos circuitos de  \\nreentrada (movimentos circulares). Estes circuitos aparecem e desaparecem em momentos \\ndiferentes e em diversas partes do miocárdio atrial, que perde, portanto, a sua atividade rítmica. \\nVisualmente o átrio apresenta movimentos fibrilatórios completamente desorganizados, a uma \\nfrequência de 400-600 por minuto12.  \\nSe todos os estímulos elétricos atriais passassem para os ventrículos, a frequência \\ncardíaca seria 400 -600 bpm, degenerando -se para uma fibrilação ventricular, acontecimento \\nque é impedido pela exis tência do nó atrioventricular, que atrasa a condução elétrica entre os \\nátrios e os ventrículos e mantém a FC entre 90-170 bpm12.\"), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 79}, page_content='79 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nEmbora os mecanismos precisos que contribuem para o desenvolvimento da FA não \\nsejam claros, vários fatores são prováveis, inclu indo ativação do sistema renina -angiotensina-\\naldosterona, a carga hemodinâmica e mudanças estruturais nos átrios, gatilhos focais iniciando \\nfibrilação atrial paroxística e fibrose atrial por reentrada \\natrial persistente. O distúrbio também pode ser desencadeado pela ativação atrial rápida \\nassociada a outras taquicardias supraventriculares, como taquicardia atrial ou flutter atrial, \\ntaquicardia de reentrada nodal atrioventricular ou síndrome de Wolff -Parkinson-White. A \\nmanutenção da FA tende a perpetuar esse ritmo2. \\n5.1.3. Etiologias \\nEm nosso meio, dois grupos de cardiopatia predominam como causa de FA: 1) \\nhipertensiva e 2) reumática. Os idosos com HA formam o grupo etiológico mais comum. O IAM \\npode cursar com FA em 6 -10% dos casos. Presumivelmente, a isquemia atria l e o estiramento \\natrial, decorrentes da disfunção de VE, são os fatores patogênicos. A doença coronariana crônica \\nsem disfunção de VE, IAM ou HA não é propriamente uma causa de FA11. \\nA cardiomiopatia dilatada cursa com FA em 15 -20% dos casos, enquanto a \\ncardiomiopatia hipertrófica, em 10 -30%. Outras cardiopatias associada à FA é a comunicação \\ninteratrial. Pacientes com miocardite, pericardite, tromboembolismo pulmonar (TEP), doença \\npulmonar obstrutiva crônica (DPOC) grave e apneia obstrutiva do sono (AOS) também têm \\nincidência aumentada de FA. Estudos recentes demonstraram a grande relação entre AOS e FA, \\nsendo que pacientes com essa condição, sem terapia otimizada, possuem taxas \\nsignificativamente mais altas de falência da reversão para ritmo sinusal11. \\nA libação alcoólica pode levar a surtos autolimitados de FA paroxística em pacientes \\nhígidos (“Holiday Heart Syndrome”), bem como o uso de drogas como cocaína e anfetaminas. \\nOutras drogas que podem cursar com FA são a teofilina e os digitálicos (intoxicação digitálica). \\nDistúrbios hidroeletrolíticos e gasométricos também podem precipitar FA, principalmente nos \\ncardiopatas prévios.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 80}, page_content='80 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nBOX 15. ETIOLOGIAS DA FA \\nQual a doença subjacente, possivelmente apresentada por essa paciente, que é \\nconsiderada fator de risco para esta afecção aguda? \\nComo essa paciente apresentava, além do quadro clínico já explanado de taquiarritmia \\ninstável, o relato de queda de cabelo, diarreia e intolerância ao calor, história familiar para \\ntireoideopatias, e um aumento da glândula tireóide ao exame físico, suspeita-se fortemente de \\numa condição de hipertireoidismo. Essa suspeita foi confirmada pelos exames laboratoriais, \\nque mostraram aumento de T4 livre e diminuição do TSH. \\n5.1.4. Diagnóstico \\nPara o diagnóstico de FA é absolutamente necessário o ECG. Existem dois critérios para \\ndefinição de um ritmo de FA: \\n• Complexos QRS espaçados de forma irregular (intervalos aleatórios); \\n• Ausência de onda P. \\nA figura 1 mostra um exemplo de FA. A linha de base da FA pode apresentar ondas f, que \\nsão pequenos potenciais elétricos gerados aleatoriamente pelos átrios. Essas ondas f podem ser \\nmuito finas e indistinguíveis de uma linha reta, ou podem ser grosseiras, simulando ondas de \\nflutter atrial ou de taquicardia paroxística atrial. A diferença é que na FA as ondas são de  \\nformato aleatório sem enlace entre a onda f e o disparo do complexo QRS. No flutter e na \\ntaquicardia paroxística atrial, a atividade elétrica atrial é regular e existe uma relação AV fixa \\nque pode conduzir 2:1, ou 3:2, ou 3:1 etc. ou ainda de forma variável, mas não aleatória2. \\n \\nFigura 1 - Eletrocardiograma de Fibrilação Atrial.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 81}, page_content='81 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nNa FA persistente, a manifestação da doença é normalmente evidente em um ECG de 12 \\nderivações. O Holter pode ser utilizado naqueles com FA paroxística, mas um gravador de ciclo \\nde eventos automático pode ser necessário em pacientes com paroxismos infrequentes. Hoje, \\ntemos à disposição o Holter de 7 dias, que aumenta a sensibilidade e especificidade para o \\ndiagnóstico de Fibrilação Atrial Paroxística. Um ECG de 12 derivações també m pode indicar a \\npresença de pré -excitação na síndrome de Wolff -Parkinson-White (um intervalo PR curto ou \\nonda delta)10. \\nA FA comumente é associada com outras comorbidades. Por isso, a exclusão de outros \\nfatores relevantes e dependentes de história clínica  e procura de doenças associadas, como \\ndoenças da tireoide (TSH, T4 livre), doença cardíaca estrutural (por exemplo, com a \\necocardiografia) e patologia intratorácica (por exemplo, por radiografia) é importante. Assim, \\nna avaliação inicial, além do exame clínico e do ECG, exames como ecocardiograma, radiografia \\nde tórax, hemograma, função tireoidiana, troponinas, BNP, eletrólitos, função renal e \\ncoagulograma (caso seja indicada anticoagulação) também são de suma relevância2. \\n5.1.5. Tratamento \\nO tratamento depende d as circunstâncias do paciente. Em pacientes com quadro \\ncaracterizado na história como agudo, a estratégia usualmente privilegia o controle de ritmo. \\nEm outros casos, pode -se considerar uma estratégia de controle de ritmo ou de frequência \\ncardíaca (FC) associado ou não à anticoagulação. Nos casos em que a FA é secundária, deve -se \\nsempre tratar a causa primária. \\nEm pacientes com FA recém -diagnosticada, o objetivo do tratamento de curto prazo \\ndeve ser o controle de seus sintomas com diminuição da frequência ca rdíaca ou o controle do \\nritmo. Estudos randomizados não mostraram diferenças entre essas duas terapias na taxa de \\nmortalidade cardiovascular, entretanto, a estratégia de controle do ritmo pode ser mais \\nadequada para pacientes nos quais a manutenção do ritm o sinusal tem boas expectativas de \\napresentar sucesso. A tabela 1  traz condições com baixa probabilidade de sucesso de \\ncardioversão. \\nA cardioversão de emergência é indicada na presença de instabilidade definida por \\npresença de descompensação de insuficiência cardíaca com edema agudo de pulmão; isquemia \\ncoronariana secundária a FA ou hipoperfusão tecidual.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 82}, page_content='82 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nTabela 1 - Situações de baixa probabilidade de sucesso de cardioversão ou de manutenção do ritmo \\nsinusal após cardioversão. Adaptado de Marchini et al., 2018 \\nFibrilação atrial há mais de um ano \\nAumento importante de átrio esquerdo (diâmetro > 6 cm ou volume indexado > 48 \\nRecorrência de FA apesar de doses adequadas de antiarrítmico e cardioversão \\nrecente \\nCondições subjacentes não resolvidas (tireotoxicose, pericardite, pneumonia ou \\ndoença valvar mitral) \\n \\n5.1.5.1. Controle de frequência cardíaca (FC) \\nExiste pouca evidência sobre o melhor medicamento para controle de FC. As \\nconsiderações para a escolha de longo prazo de agentes bloqueadores do nó atrioventricular \\npara controle da frequência ventricular devem incluir estilo de vida e comorbidades do \\npaciente. Particularmente importante é saber se o paciente apresenta disfunção ventricular \\nesquerda associada quando se indica a terapia com contr ole de frequência ventricular. Em \\npacientes com FE >= 40%, tanto os beta -bloqueadores como os bloqueadores dos canais de \\ncálcio são escolhas adequadas. O esmolol é opção interessante, pois tem meia-vida muito curta, \\ne se a hemodinâmica do paciente responder adversamente, basta suspender a infusão.  \\nEm pacientes com FE < 40%, a droga inicial recomendada é usualmente a amiodarona, \\nassim como também os beta -bloqueadores, embora exista o risco de conversão para o ritmo \\nsinusal (risco pequeno), sendo outra opção  a digoxina, que pode ser adicionada em caso de \\ncontrole de FC inadequado com a amiodarona. \\nNa FA com pré -excitação (síndrome de Wolff -Parkinson-White), nunca se deve usar \\ndigoxina, betabloqueadores e bloqueadores de canal de cálcio. A Figura 2 mostra um exemplo \\nda FA pré-excitada. Essas medicações bloqueiam mais a condução pelo nó AV do que pelo feixe \\nacessório, trazendo o risco de condução de frequência muito alta pelo feixe acessório e evolução \\npara fibrilação ventricular. Nesses casos deve -se proceder c om cardioversão elétrica de \\nurgência. A  tabela 2  traz os principais medicamentos utilizados para controle da FC e suas \\nrespectivas posologias. \\n \\nTabela 2 - Principais medicamentos utilizados para controle da FC na FA e suas posologias.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 83}, page_content='83 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nMedicamento Posologia \\nEsmolol Dose de ataque (opcional): 0,5 mg/kg em 1 minuto. Dose de manutenção: 50 \\nμg/kg/min até um máximo de 200 μg/kg/min. A meia -vida média em \\nadultos é de 9 minutos. \\nMetoprolol Dose de ataque: 2,5 a 10 mg EV em bolus, repetir conforme necessi dade. \\nDose oral é de 100 a 200 mg ao dia. \\nVerapamil Bolus EV 0,075-0,15 mg/kg (por volta de 5 a 10 mg) em 2 minutos e dose de \\nmanutenção de 5 mg/h. \\nDiltiazem Bolus EV 0,25 mg/kg em 2 minutos e dose de manutenção de 5-15 mg/hora. \\nDose oral de manutenção de 120 a 360 mg ao dia. \\nAmiodarona Dose de ataque 150 mg EV em 10 minutos. Dose de manutenção: 0,5 a 1 \\nmg/min. A dose necessária chega a 1,2 a 1,8 g nas primeiras 24 horas. \\n \\nDigoxina Bolus EV 0,25-0,5 mg até um máximo de 1 mg (dose máxima por peso: 8-12 \\nμg/kg). \\n \\nFigura 2 - Eletrocardiograma de Taquicardia Atrioventricular com Circuito Antidrômico e Fibrilação \\nAtrial (Síndrome de Wolff-Parkinson-White). \\n \\nEm pacientes com IC estável e FE diminuída, os betabloqueadores devem ser a terapia \\nde primeira linha. Em pacientes sintomáticos, uma abordagem mais rigorosa guiada por 24h de \\nHolter e teste ergométrico é utilizada ambulatorialmente. A figura 3 mostra a ab ordagem de \\ncontrole de frequência cardíaca sumarizada.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 84}, page_content='84 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nFigura 3 - Controle agudo da FC na FA. Adaptado de Marchini et al., 2018. \\n \\n5.1.5.2. Controle de ritmo \\nEm pacientes com primeiro episódio de FA, deve -se considerar pelo menos uma vez a \\nconversão para ritmo sinusal. Em pacientes com indicação de controle agudo de ritmo, é preciso \\nprimeiro saber se estes apresentam ou não instabilidade hemodinâmica. Caso sim,  existe \\nindicação urgente de cardioversão usualmente elétrica. Em pacientes sem instabilidade, pode -\\nse optar tanto por uma estratégia de controle de ritmo como uma estratégia de controle de \\nresposta ventricular. \\nEm pacientes com disfunção cardíaca signific ativa, a amiodarona é a medicação de \\nescolha em doses similares às utilizadas para controle da FC. Em pacientes com disfunção \\ncardíaca moderada a leve, uma opção é o Vernakalant, fármaco antiarrítmico recentemente \\naprovado com propriedades seletivas atriai s por bloqueio de corrente de potássio que é \\nexpressa principalmente nos átrios. O Vernakalant é contraindicado em pacientes com \\nhipotensão, insuficiência cardíaca moderada a grave, valvopatias significativas, prolongamento \\ndo intervalo QT e bradicardia. \\nEm pacientes sem doença cardíaca estrutural, a estratégia “pill in the pocket” com \\nmedicações orais é uma boa opção, utilizando propafenona e flecainida (não disponível no \\nBrasil). A posologia da propafenona encontra -se na tabela 3. Pode ser decidida em pac ientes \\nBetabloqueador ou \\nBloqueador do canal de \\ncálcio \\nTentar dose baixa de \\nbetabloqueador  \\nFE < 40% \\n FE ≥ 40% \\nControle agudo da FC \\nSe instabilidade \\nhemodinâmica, preferir \\namiodarona \\n \\nConsiderar digoxina (reservada \\ngeralmente quando FE < 40 %) \\nEvitar bradicardia'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 85}, page_content='85 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nsem doença cardíaca estrutural, embora não seja uma conduta muito comum, a cardioversão \\nquímica endovenosa; nesses casos, são opções propafenona, flecainida, ibutilide, e Vernakalant, \\nesses três últimos não disponíveis no Brasil. A figura 4 resume o protocolo de reversão de ritmo \\nna fibrilação atrial (FA). \\n \\nTabela 3 - Medicações orais na estratégia “pill in the pocket” para pacientes com FA de início recente \\nsem doença cardíaca estrutural. \\nMedicamento Posologia \\nPropafenona Dose para cardioversão: 450 mg (< 70 kg) e \\n600 mg (> ou igual a 70 kg). Não repetir por \\npelo menos 24 horas. Por causa dos efeitos \\npró-arrítmicos, no primeiro uso manter sob \\nmonitorização por pelo menos 6 horas. Pode \\nprovocar taquicardia ventricular, fibrilação \\nventricular, assistolia e torsades de pointes. \\n \\n \\n \\nFigura 4 - Protocolo de reversão de ritmo na FA. Adaptado de Marchini et al., 2018. \\n \\n5.1.5.3. Cardioversão elétrica \\nA cardioversão elétrica sincronizada direta é um modo rápido e efetivo de converter o \\nritmo de FA para ritmo sinusal. O procedimento pode ser realizado com segurança com sedação \\nCom doença \\ncardíaca \\nestrutural \\nCom instabilidade \\nhemodinâmica  \\nAmiodarona EV \\nFA de início recente \\nCardioversão \\nelétrica \\nsincronizada \\nSem instabilidade \\nhemodinâmica  \\nSem doença \\ncardíaca \\nestrutural \\nCardioversão oral \"pill in the \\npocket\"  \\nou cardioversão química \\n(opções: amiodarona, \\nflecainida, propafenona)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 86}, page_content='86 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nusualmente com midazolam ou propofol. O uso de cardioversores bifásicos é um pou co mais \\neficaz que o dos cardioversores monofásicos. O uso prévio de outros antiarrítmicos antes da \\ncardioversão elétrica aumenta a chance de sucesso da cardioversão elétrica. Detalhes sobre a \\ncardioversão elétrica nas taquiarritmias serão explanados ainda neste capítulo. \\n5.1.5.4. Anticoagulação na FA \\nUma complicação importante da FA é o tromboembolismo cerebral, por isso, deve -se \\ndecidir sobre a necessidade de anticoagular o paciente. É importante separar as duas \\npopulações que foram estudadas com FA. No primeiro grupo, temos os pacientes com estenose \\nmitral moderada ou grave ou aqueles com prótese valvar mecânica. Esses pacientes têm \\nindicação de anticoagulação com varfarina. No segundo grupo, temos os demais pacientes, que \\ndevem ser estratificados com o escore CHA 2DS2-VASc. A figura 5 resume o protocolo de \\ndecisão sobre anticoagulação na FA, ao passo que a tabela 4 traz o escore CHA2DS2 -VASc \\ncompleto. \\nUm escore CHA2DS2 -VASc maior ou igual a 2 em homens ou maior ou igual a 3 em \\nmulheres indica anticoagulação por pe lo menos 4 semanas após a cardioversão. CHA2DS2 -\\nVASc de 0 indica anticoagulação com heparina (durante a conversão), sem necessidade de \\nanticoagulação subsequente. CHA2DS2 -VASc de 1: usar o julgamento clínico e considerar um \\nantiagregante (aspirina). \\n \\nTabela 4 - Escore CHA2DS2-VASc. \\nLETRA DESCRIÇÃO PONTUAÇÃO \\nC Insuficiência cardíaca 1 ponto \\nH Hipertensão 1 ponto \\nA2 Idade >=75 anos 2 pontos \\nD Diabetes mellitus 1 ponto \\nS2 AVC ou AIT prévio 2 pontos \\nV Doença vascular coronariana ou periférica 1 ponto \\nA Idade entre 65-74 anos 1 ponto \\nSc Sexo feminino 1 ponto'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 87}, page_content='87 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nFigura 5 - Protocolo de anticoagulação na FA. Adaptado de Marchini et al., 2020. \\n \\n \\nAs drogas anticoagulantes orais devem ser preferidas para prevenção do \\ntromboembolismo na maioria dos pacientes. Essas drogas podem ser divididas em duas \\ngrandes categorias, que são os inibidores diretos da trombina orais e inibidores de fator Xa via \\noral. Os principais anticoagulantes usados são: varfarina, dabigatrana, rivaroxabana, apixabana \\ne edoxabana. A tabela 5 traz a posologia dessas medicações.  \\n \\nTabela 5 - Principais anticoagulantes orais utilizados e sua posologia. \\nVarfarina Iniciar 5 mg/d ou 2,5 mg/d se paciente idoso ou < 60 kg. Dosar o INR a partir \\ndo terceiro dia. O efeito pleno da varfarina necessita de pelo menos 7 dias de \\nuso (meia-vida do fator II). \\nDabigatrana 150 mg 2x/d. Para pacientes com risco de sangramento, podem ser usados \\n110 mg 2x/d. \\nRivaroxabana 20 mg 1x/d ou 15 mg 1x/d. \\nCHA2D₂-VASc? \\nEM moderada/grave ou prótese valvar metálica \\nVarfarina \\nDecisão de CVS? \\nUrgente? (CVS < 8 \\nhoras) \\n0 em homens \\n1 em \\nmulheres \\n1 em \\nhomens \\n2 em \\n>= 2 em homens \\n>= 3 em mulheres \\nEnoxaparina ou heparina \\nEV \\n> 48 h de \\nFA? \\nACO (DOACs ou varfarina) por 3 \\nsemanas ou ETE excluindo trombo \\nCVS \\nNão \\nanticoagular \\nConsiderar \\nACO \\nACO (DOACs ou \\nvarfarina) \\nCVS'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 88}, page_content='88 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nApixaban 5 mg 2x/d. Para pacientes com risco de sangramento, 2,5 mg 2x/d. \\nEdoxaban 30 ou 60 mg/d. \\n \\nDeve-se verificar a função renal e hepática do paciente antes de iniciar tratamento com \\nos novos anticoag ulantes. Durante o tratamento, deve -se monitorar a função renal \\nregularmente e a função hepática ocasionalmente para as medicações inibidoras de fator Xa. \\nNo final das contas, a regra de que os novos anticoagulantes não necessitam de controle não é \\ncompletamente verdadeira, pois apesar de não ser necessário monitorar a anticoagulação em \\nsi, é fundamental monitorar a função renal regularmente. \\nUma outra consideração importante no paciente anticoagulado  é seu risco de \\nsangramento. Para essa avaliação, pode -se usar o escore HAS -BLED, onde um escore > 3 \\nrepresenta alto risco de sangramento. Entretanto, isso não necessariamente significa uma \\ncontraindicação à anticoagulação, pela sobreposição entre o HAS-BLED e O CHA2DS2-VASc. Os \\npacientes com maior risco de sangramento têm também maior risco de eventos embólicos. A \\ntabela 8 traz o escore HAS-BLED completo. \\n \\nTabela 6 - Escore HAS-BLED. \\nLETRA DESCRIÇÃO PONTUAÇÃO \\nH Hipertensão descontrolada ou PAS >= 160 mmHg 1 ponto \\nA Alteração hepática ou renal 1 ponto \\nS AVC prévio 1 ponto \\nB Antecedentes ou predisposição a sangramento 1 ponto \\nL Labilidade no INR 1 ponto \\nE Idade >=75 anos 1 ponto \\nD Idade entre 65-74 anos 1 ponto \\n \\n5.1.5.5. Internação, terapia intensiva e seguimento \\nSão consideradas indicações de internação hospitalar em pacientes com FA: episódio de \\nFA instável ou muito sintomático; bradicardia grave após cardioversão; indicação de internação \\npara tratamento de gatilho para FA como hipertensão grave, isquemia, TEP e DPOC; \\ninsuficiência cardíaca descompensada. \\nOs pacientes com IC grave ou outras comorbidades sérias podem necessitar de \\ninternação em terapia intensiva para monitorização. O paciente deve ser referenciado para'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 89}, page_content='89 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nacompanhamento com card iologista ou médico generalista para avaliação de manutenção de \\nestratégia de controle de ritmo ou frequência, ajuste de medicações e terapia anticoagulante. \\nAmbulatorialmente, várias medicações podem ser utilizadas para controle de FC ou \\nritmo. Para manut enção do ritmo sinusal, flecainida, propafenona e sotalol são agentes de \\nprimeira linha em pacientes com FA paroxística ou doença cardíaca estrutural mínima. A \\namiodarona é reservada para pacientes com IC congestiva ou hipertrofia ventricular esquerda \\nimportante, ou como agente de segunda linha, após falha de outros fármacos antiarrítmicos, em \\nrazão de seus graves efeitos colaterais extracardíacos.  \\nEm pacientes com FA irresponsiva ou que são intolerantes a drogas bloqueadoras do nó \\nAV para controle da freq uência ventricular, a ablação nodal atrioventricular com implante de \\nmarca-passo definitivo melhora os sintomas e a qualidade de vida.2  \\n \\nBOX 16. TRATAMENTO DA FA \\nComo você conduziria esta paciente no departamento de Emergência? E a longo \\nprazo? \\nComo a paciente apresenta uma FA de início há uma hora, secundária ao seu quadro de \\nhipertireoidismo, classifica-se essa arritmia como sendo uma FA de início recente secundária. \\nComo ela apresentava dois sinais de instabilidade hemodinâmica (dispneia persistente súbita \\ne síncope), optou-se pela internação da paciente, com monitorização cardíaca, oximetria de \\npulso, administração de oxigênio por cateter nasal (satO2 estava 89%), resolução do quadro \\nde hipertireoidismo e cardioversão elétrica de urgência se necessário. \\nDiante da condição de hipertireoidismo, optou-se pelo uso de propiltiouracil 1,5 g/dia \\nVO associado a hidrocortisona 100 mg EV, buscando inibir a produção de hormônios \\ntireoidianos e reduzir sua concentração, respectivamente. Para controle da FC durante esse \\nmanejo inicial com fármacos antitireoidianos, optou -se pelo uso de esmolol 0,5 mg/kg em \\ndose de ataque e 100 mcg/kg em dose de manutenção, obtendo sucesso clínico (redução da \\nFC e melhora dos sintomas de palpitação na paciente). Uma hora após o início dessa te rapia, \\na paciente teve outra síncope e piora da dispneia, o que reforçou a necessidade de realização \\nde uma cardioversão elétrica emergencial. \\nProcedeu-se, então, à cardioversão elétrica da paciente, iniciando com 120 J usando \\ncardioversores monofásicos. P ara a realização desse procedimento, a paciente foi sedada \\nutilizando propofol 2,5 mg/kg. Após a cardioversão de emergência, realizou -se'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 90}, page_content='90 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nmonitoramento cardíaco contínuo por 2 horas, observando -se reversão imediata para ritmo \\nsinusal, que se manteve. A paci ente também teve melhora clínica ao longo deste período, \\nmantendo-se eupneica e com satO2 de 98%. \\nComo a paciente apresentava pontuação de 3 pelo escore CHA2DS2-VASc (1 ponto para \\nhipertensão, 1 ponto para diabetes e 1 ponto para sexo feminino), configuran do alto risco \\ntromboembólico, decidiu-se por anticoagular esta paciente cronicamente após a cardioversão, \\nfazendo uso de varfarina 5mg VO 1x/dia. Para manutenção do ritmo sinusal cronicamente, \\ntambém se optou pela prescrição de propafenona 500 mg/dia VO. Como o quadro de FA dessa \\npaciente foi ocasionado pela sua condição de hipertireoidismo, ela foi encaminhada para o \\nambulatório de Endocrinologia, além do acompanhamento no ambulatório de Cardiologia \\npara monitorar possíveis recidivas da FA. \\n \\n5.2. FLUTTER ATRIAL \\n5.2.1. Epidemiologia \\nNa população geral, o desenvolvimento de flutter atrial “nova” é incomum e ocorre \\nsignificativamente em menor frequência que a fibrilação atrial 13. Em um estudo de base \\npopulacional, o aparecimento de flutter atrial isolado, sem identificação de fatores \\npredisponentes recentes ou comorbidades crônicas, ocorreu em apenas 3 dos 181 pacientes14. \\nNesse mesmo estudo, 16% dos casos foram atribuídos à IC e 12% à doença pulmonar obstrutiva \\ncrônica (DPOC). \\n5.2.2. Fisiopatologia \\nO flutter atrial, antigamente, era classificado em tipo I ou tipo II conforme sua \\nfisiopatologia, entretanto, tal terminação não é mais usada, sendo o flutter dividido em “típico” \\ne “atípico”. \\nA designação de flutter atrial \"típico\" envolve um circuito macroreentrante \\natravessando o istmo cavo-tricúspide (ICT). Esse istmo é a região do átrio direito tecido entre \\no orifício da veia cava inferior e o anel da valva tricúspide. Se esse istmo está envolvido, é \\nchamado de flutter atrial \"típico\" ou flutter atrial dependente de ICT. O circuito geralmente é \\numa rotação no sentido anti-horário em torno da valva tricúspide, exibindo um aspecto “dente \\nde serra\\'\\' nas derivações inferiores do ECG. Se o circ uito é no sentido horário, é chamado de'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 91}, page_content='91 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nvibração típica \"reversa\" ou \"horária\", exibindo ondas positivas nas derivações inferiores do \\nECG13. \\nSe o ICT não estiver envolvido no mecanismo subjacente, então ele é chamado de flutter \\natrial \"atípico\". Esse tipo de vibração pode envolver qualquer região dos átrios direito ou \\nesquerdo, em torno de áreas de tecido cicatricial devido a doença cardíaca intrínseca ou tecido \\ncicatricial cirúrgico/ablado13. \\n5.2.3. Etiologia \\nEm geral, as etiologias do flutter são bastante simila res às da FA, destacando -se as \\ndoenças que sobrecarregam os átrios (especialmente o direito), como a IC e a Doença Pulmonar \\nObstrutiva Crônica (DPOC). Outras causas clássicas incluem doença valvar mitral, pós -\\noperatório de cirurgia cardíaca, doença do nó sinusal, miocardite e pericardite13.  \\nUma vez tendo uma condição precipitante, o flutter pode surgir espontaneamente ou ser \\nprecipitado por fatores do tipo distúrbios eletro -gasométricos ou pela insuficiência cardíaca \\naguda. O flutter “isolado” é raro. A associação de flutter com FA é muito comum, às vezes até no \\nmesmo traçado de ECG (fibrilo-flutter), muito em razão das etiologias semelhantes.  \\n5.2.4. Diagnóstico \\nO ECG é essencial para o diagnóstico. Para os pacientes com flutter no momento da \\nrealização do ECG, este geralmente mostra uma frequência atrial de aproximadamente 300 \\nbpm (varia entre 240-340). Ondas P estão ausentes, e a atividade atrial é vista como um padrão \\n“em dente de serra”, especialmente nas derivações II, III e aVF. A condução atrioventricular é \\ntipicamente 2:1 (o ventrículo usualmente bate na metade da frequência atrial, em flutt ers sem \\ndisfunção do nó AV). A figura 6 mostra um eletrocardiograma de um flutter atrial típico, com \\ncondução 2:113. \\nUm ecocardiograma transtorácico deve ser feito em todos os pacientes com flutter, \\nprincipalmente para avaliar o tamanho e a função atrial e ventricular bilateralmente. Testes de \\nexercício podem ajudar a reproduzir flutters atriais induzidos por esforço. Monitorização com \\nHolter pode ser útil para identificar a arritmia quando os sintomas são não específicos ou não \\npresentes no momento da consulta. Exames laboratoriais como dosagem de eletrólitos, função \\nrenal e hepática podem ser pedidos para avaliar causas secundárias13.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 92}, page_content='92 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nFigura 6 - Eletrocardiograma de flutter atrial típico, com condução 3:1.  \\n \\n5.2.5. Tratamento \\nO tratamento, em geral, é bastant e semelhante ao da FA, já previamente debatido, com \\nalgumas diferenças a serem elucidadas. Diante de um paciente com flutter, deve -se primeiro \\nverificar se há instabilidade. Caso sim, deve -se realizar a cardioversão elétrica emergencial. O \\nflutter é uma arritmia facilmente revertida com cardioversão elétrica (um choque sincronizado \\nde 50 J é bem sucedido em 90% dos casos). Caso não seja revertido, um segundo choque de 100 \\nJ deve ser aplicado13. \\nNos pacientes estáveis, mas sintomáticos, pode -se iniciar o tra tamento com inibidores \\ndo nó AV, de preferência via EV, em uma dose um pouco maior do que a usada na FA. Em alguns \\npacientes, a arritmia pode reverter espontaneamente, após a melhora da função cardíaca e do \\ncontrole eletrolítico13.  \\nNos demais pacientes, d eve-se tentar a cardioversão farmacológica ou elétrica eletiva. \\nTodas as drogas antiarrítmicas utilizadas na cardioversão da FA também podem atuar no \\nflutter, porém com menor eficácia, exceto a ibutilida e a dofetilida. As doses são as mesmas da \\nFA. A pref erência, entretanto, costuma ser para a cardioversão elétrica eletiva, sempre \\ncomeçando com 50J13. \\nCom relação a anticoagulação no flutter, as recomendações são para adotar os mesmos \\nesquemas de anticoagulação da FA nos casos de: história de FA; flutter cr ônico (por mais de 6 \\nmeses); e grupo de risco para tromboembolismo (aplicar CHA2DS2-VASc)13.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 93}, page_content='93 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nA chance de recidiva do flutter é alta, assim como a da FA. Os mesmos antiarrítmicos \\ncitados na FA podem ser usados para prevenir o retorno da arritmia, porém, não  há um \\nconsiderado de escolha. Ainda há chance de recidiva da arritmia usando o antiarrítmico. Por \\nisso, muitos autores recomendam a terapia intervencionista para os casos recorrentes \\nsintomáticos, sendo o principal método utilizado a ablação por radiofreq uência do circuito do \\nflutter13. \\n5.3. TAQUICARDIA SINUSAL \\n5.3.1. Epidemiologia \\nA taquicardia sinusal é um ritmo em que a frequência de impulsos provenientes do nó \\nsinoatrial está elevada. Esta taquicardia é, mais frequentemente, um fenômeno normal e \\nfisiológico, observado em resposta, por exemplo, ao exercício. Entretanto, em algumas \\ninstâncias, esta taquicardia pode ser inapropriada ou patológica. É a arritmia cardíaca mais \\ncomum e pode resultar em prognóstico adverso, particularmente em pacientes co m doença \\ncardiovascular15. \\n5.3.2. Fisiopatologia \\nNa maioria dos pacientes, a taquicardia sinusal é uma resposta fisiológica a uma \\ndemanda de maior débito cardíaco, estado simpatomimético aumentado ou inibição \\nvagal/parassimpática, sendo um importante mecanismo de  aumento do débito cardíaco em \\nvigência de infecções, hipovolemia ou outros estressores. É causada por um hiperautomatismo \\ndo nó sinusal, sem necessariamente indicar doença 2. A maioria dos pacientes não apresenta \\nsintomas diretamente atribuíveis à taquicardia, mas sim às condições associadas a ela15. \\n5.3.3. Etiologia \\nComo já dito, a taquicardia sinusal é, mais comumente, uma resposta fisiológica. \\nEntretanto, pode também estar presente em situações de aumento patológico da liberação de \\ncatecolaminas, tais como: hip ovolemia, sepse, anemia, hipóxia, embolia pulmonar, \\nfeocromocitoma, hipertireoidismo, DPOC, síndromes coronarianas agudas e abuso de \\nestimulantes (cafeína, nicotina, anfetaminas)15. \\n5.3.4. Diagnóstico \\nO ECG é essencial para o diagnóstico. A taquicardia sinusal é basicamente um ritmo \\nsinusal com a FC aumentada, sendo características do seu ECG: 1) frequência cardíaca > 100 \\nbpm; 2) onda P presente e com orientação normal (eixo da onda P entre 0 e 90); 3) intervalo'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 94}, page_content='94 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nPR normal (< 200 ms); 4) QRS em geral estreito; 5) RR regular; 6) RP longo2. A figura 7 traz um \\nexemplo de taquicardia sinusal. \\n \\nFigura 7 - Eletrocardiograma de taquicardia sinusal.  \\n \\n5.3.5. Tratamento \\nNa maioria das vezes, a taquicardia é apropriada para a condição clínica do paciente e \\nnão necessita de tratamento específico. Deve-se procurar e tratar a causa de base. \\n5.4. TAQUICARDIA ATRIAL (focal e multifocal) \\n5.4.1. Epidemiologia \\nA taquicardia atrial é uma incomum, mas não rara taquiarritmia. Foi estimado que a \\nunifocal ocorre em 5 -15% das arritmias em adultos com  taquicardia supraventricular \\nparoxística16, e que a multifocal ocorre em 0,05 até 0,32% dos eletrocardiogramas em hospitais \\ne em 0,37% dos pacientes hospitalizados. A idade de acometimento é de aproximadamente 70 \\nanos. Esses pacientes idosos são geralment e acometidos por várias comorbidades, com uma \\ntaxa de mortalidade de 40-60% por causas cardiovasculares, pulmonares e outras doenças17. \\n5.4.2. Fisiopatologia \\nA taquicardia atrial focal (TAF) é causada por um hiperautomatismo de um foco atrial. \\nNão há mecanismo de  reentrada. Por outro lado, a taquicardia atrial multifocal é causada por \\nmúltiplos focos ectópicos de automatismo atrial2. \\n5.4.3. Etiologias \\nA taquicardia atrial multifocal (TAM) é encontrada associada a doença pulmonar em 60 \\na 85% dos casos, geralmente quadros de exacerbação de DPOC, mas também em distúrbios \\neletrolíticos como hipomagnesemia ou uso de aminofilina ou teofilina2.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 95}, page_content='95 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n5.4.4. Diagnóstico \\nO ECG é essencial ao diagnóstico. No ECG da TAF, será encontrada uma FC > 100 bpm; o \\neixo da onda p costuma ser anormal, com QRS estreito. Apresenta tipicamente RR regular com \\nRP longo, e uma característica que a diferencia do flutter é a presença de linha isoelétrica entre \\nondas P. A figura 8 traz um exemplo de TAF2. \\n \\nFigura 8 - Eletrocardiograma de TAF.  \\n \\nNo ECG da TAM, obse rva-se FC > 100 bpm, ritmo irregular com ondas P de pelo menos \\ntrês morfologias diferentes com intervalos PR irregulares. A figura 9 traz um exemplo de TAM. \\n \\nFigura 9 - Eletrocardiograma de TAM.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 96}, page_content='96 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n5.4.5. Tratamento \\nO tratamento deve ser dirigido à causa de base, com correção da hipoxemia e eletrólitos. \\nA frequência ventricular pode ser controlada com bloqueadores de canal de cálcio, como \\nverapamil e diltiazem ou amiodarona2. \\n5.5. TAQUICARDIA POR REENTRADA NODAL \\n5.5.1. Epidemiologia \\nA taquicardia por reentrada nodal (TRN) é uma taquicardia supraventricular e é a causa \\nmais comum de palpitações em pacientes sem alterações cardíacas estruturais. É mais comum \\nem mulheres, contando com aproximadamente 75%, e geralmente bem tolerada2. Pode ocorrer \\nem qualquer idade, porém, é mais provável de ser vista em jovens adultos, embora uma série \\nde 231 pacientes com TRN apresentou a idade média de início dos sintomas como sendo de 32 \\nanos18. \\n5.5.2. Fisiopatologia \\nQuanto à fisiopatologia, a TR N pode ser dividida em “típica” e “atípica”. Na TRN típica \\n(80% dos casos), um batimento atrial prematuro chega até o nó AV quando a via rápida está em \\nseu período refratário, então, a condução anterógrada pela via rápida está bloqueada. Dessa \\nforma, o batimento prematuro será conduzido pela via lenta até a via final comum no feixe de \\nHis (o que explica por que o intervalo PR estará aumentado). Se a via rápida tiver recuperado \\nsua excitabilidade quando o impulso elétrico tiver atingido a junção final das du as vias, o \\nimpulso pode se conduzir retrogradamente pela via rápida, gerando um ciclo repetitivo de \\ncondução anterógrada lenta e retrógrada rápida. A TRN atípica (20% dos casos) possui \\nfisiopatologia mais complexa, podendo envolver condução anterógrada ráp ida e retrógrada \\nlenta ou múltiplas vias lentas18. \\n5.5.3. Etiologias \\nA TRN é tipicamente paroxística e pode ocorrer espontaneamente ou pode ser \\nprovocada por exercícios físicos, ingestão de café, chá ou álcool. Pode estar presente em \\nsíndromes coronarianas agudas  como a doença arterial coronariana, sendo acompanhada de \\ndor torácica anginosa2. \\n5.5.4. Diagnóstico \\nO ECG é essencial ao diagnóstico. Em sua forma típica, observa -se no ECG: 1) FC entre \\n150 e 250 bpm; 2) ausência de onda P precedendo o QRS; 3) QRS em geral estreito e RR regular;'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 97}, page_content='97 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\ne pode haver presença de onda pseudo -s em DII/DIII e onda pseudo -r’ em V1 (onda P \\nretrógrada). Além disso, são comuns alterações do segmento ST com infradesnivelamento \\ndifuso e supra em aVR, em geral sem correlação clínica e que se resolv em após reversão ao \\nritmo sinusal. Com relação à forma atípica, a maior diferença é que o RP é longo (na forma típica \\né curto). A figura 10 traz um exemplo de ECG de um paciente com TRN típica, ao passo que a \\nfigura 11 mostra um ECG de uma TRN atípica. \\n \\nFigura 10 - Eletrocardiograma de TRN típica.  \\n \\n \\nFigura 11 - Eletrocardiograma de TRN atípica.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 98}, page_content='98 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n5.5.5. Tratamento \\nNa presença de uma TRN estável, pode -se inicialmente fazer uso de manobras vagais \\npara o diagnóstico e o tratamento. A tabela 7 traz as principais manobras vagais utilizadas na \\ncondução de uma TRN e a descrição de sua técnica. \\n \\nTabela 7 - Principais manobras vagais e sua técnica \\nCompressão dos seios carotídeos \\nComprimir continuamente uma das carótidas, na região do ângulo \\nda mandíbula, por pelo menos 10s. Deve -se auscultar a artéria \\nantes, e se houver sopro, a manobra é contraindicada (risco de \\ninstabilização de placa aterosclerótica) \\n \\nManobra de Valsalva \\nSolicitar que o paciente faça contração abdominal sustentada, \\nassoprando uma seringa vazia de 20 ml, tentando movimentar o \\nêmbolo \\nManobra de Valsalva modificada \\nSolicitar que o paciente faça a manobra de Valsalva mencionada por \\n15s, sentado a 45°. \\nDepois abaixa -se a cabeceira para 0°, elevando os membros do \\nindivíduo passivamente a 45° por mais 15s. A taxa de sucesso dessa \\nmanobra (estudo REVERT) é de 43% \\n \\nCaso não haja reversão para ritmo sinusal com as manobras vagais, pode-se fazer uso da \\nadenosina, um fármaco que atua no nó AV interrompendo a condução do estímulo elétrico \\noriundo dos átrios. Devem ser administrados 6 mg da droga com 20 mL de soro fisiológico, em \\nbolus, seguidos de elevação do membro, uma vez que sua meia -vida é muito curta (segundos). \\nA dose pode ser repetida até duas vezes, em caso de falha (12 mg e 18 mg). Na medida em que \\na adenosina bloqueia a condução AV, observa-se a alteração da linha de base durante a infusão \\npor meio de um ECG contínuo, evidenciando o distúrbio elétrico por trás da TRN (ex: FA)2. \\nÉ de suma importância explicar ao paciente antes da infusão que essa medicação causa \\nbastante desconforto (alguns autores descrevem uma sensação de “morte iminente”). No caso \\nde pacientes jovens com TRN, uma boa alternativa ao tratamento com adenosina são os \\nbloqueadores de canal de cálcio EV (diltiazem e verapamil), pois revertem a taquicardia sem \\ncausar esse desconforto importante da adenosina2. \\nNão revertendo a TRN com essas estratégias, assume-se que se trata de arritmia que não \\nenvolve o nó AV (ex: FA ou flutter atrial), sendo indicado controle da FC com drogas específicas \\njá citadas. Pacientes com TRN revertida e assintomáticos podem receber alta hospitalar com \\nacompanhamento ambulatorial sem necessidade de exames complementares2.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 99}, page_content='99 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n5.6. TAQUICARDIA POR REENTRADA ATRIOVENTRICULAR (VIA ACESSÓRIA) \\n5.6.1. Epidemiologia \\nQuando se discute a prevalência da taquicardia por reentrada atrioventricular (TAV),  \\ndeve-se obrigatoriamente discutir a prevalência da síndrome de Wolff -Parkinson-White \\n(WPW). É importante que se distinga entre o padrão de WPW no ECG (isto é, anormalidades no \\nECG de pacientes assintomáticos) e a síndrome de WPW (presença dessas taquiarri tmias de \\nmodo sintomático). Ambos são infrequentes, ocorrendo em menos de 1% da população geral, \\ncom o padrão de WPW no ECG sendo 10 a 100 vezes mais comum que a síndrome de WPW. \\nDiferentes tipos de taquiarritmia supraventricular podem ocorrer na síndrome de WPW, sendo \\nque as principais são: taquicardia por reentrada em via acessória (80% dos casos), FA (20%) e \\nflutter atrial (5%)19. \\n5.6.2. Fisiopatologia \\nNo coração normal, o impulso elétrico atrial chega aos ventrículos após passar pelo nó \\nAV e sofrer um retardo fisiológico, permitindo assim que a contração ventricular venha após a \\natrial. A via acessória é uma via de condução extranodal que liga o miocárdio atrial ao \\nventricular através de um sulco atrioventricular, permitindo uma pré-excitação ventricular2. \\nA síndrome de WPW é definida como a combinação entre presença de via acessória e \\nepisódios de taquiarritmias sintomáticas. Está associada a um pequeno risco de morte súbita. \\nAs TAV são facilitadas pela formação de um circuito de reentrada envolvendo a via aces sória, \\nsendo divididas em ortodrômicas e antidrômicas, baseadas na direção da reentrada e \\nmorfologia do ECG. \\nNa TAV ortodrômica, o estímulo desce dos átrios para os ventrículos em sentido horário, \\npassando inicialmente pelo nó AV e retornando aos átrios por meio da via acessória de maneira \\nretrógrada. Na TAV antidrômica, é o contrário: o estímulo desce em sentido anti -horário, \\npassando inicialmente pela via acessória, despolarizando os ventrículos e retornando aos átrios \\npor meio do nó AV. Outro mecanismo é a ativação direta ventricular pela via acessória, vista em \\nfibrilação atrial ou flutter atrial associada a WPW.  \\n5.6.3. Etiologias \\nOs indivíduos com síndrome de WPW e, consequentemente, TAV, apresentam uma \\nalteração anatômica em seu coração cuja causa ainda não foi devidamente esclarecida. Todavia, \\nestudos atuais acreditam haver relação genética para o advento dessa síndrome, já que, dentre'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 100}, page_content='100 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nos pacientes com síndrome de WPW, 3.4% apresentam parentes de primeiro grau com esta \\nmesma síndrome19. \\n5.6.4. Diagnóstico \\nO ECG é fundamental para o diagnóstico. No ECG da síndrome de WPW em ritmo sinusal, \\nencontramos predominantemente três alterações: 1) Intervalo PR curto (<120 ms); 2) QRS \\nalargado (>110 ms) com empastamento na porção inicial (onda delta), que corresponde à fusão \\nentre a ativação inicial causada pela passagem do impulso elétrico pela via acessória e a \\nativação final; 3) alterações secundárias do ST-T opostas à polaridade da onda delta2. A figura \\n12 traz um exemplo de ECG de um padrão de WPW em ritmo sinusal. \\n \\nFigura 12 - Eletrocardiograma em padrão de WPW em ritmo sinusal. \\n \\nCom relação a TAV ortodrômica, no ECG observa -se uma taquicardia de QRS estreito e \\nRR regular, já que a despolarização ventricular se dá por meio das fibras de condução \\nespecializadas (condução rápida), podendo, ainda, ser observada uma onda P retrógrada que \\ncorresponde à ativação tardia dos átrios pela via acessória. A onda delta desaparece durante \\nessa taquicardia e é praticamente indistinguível de uma TRN. O diagnóstico se dá pela \\nidentificação do padrão de WPW no ECG após a reversão da taquiarritmia.  \\nQuanto à TAV antidrômica, a despolarização ventricular ocorre pela via acessória, com \\ncondução ventricular lenta, e, portanto, com QRS alargado, indistinguível da TV monomórfica. \\nÉ muito men os comum (5% dos pacientes com WPW), sendo seu diagnóstico também feito \\nretrospectivamente após observar o ECG pós-cardioversão2.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 101}, page_content='101 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nNa FA com WPW, observa -se a condução direta do estímulo aos ventrículos, gerando \\numa FC muito elevada que pode degenerar a fibrilação ventricular (FV). No ECG, observa-se: 1) \\ntaquicardia irregular; 2) QRS alargado e com morfologia alternante; 3) FC extremamente \\nelevada > 250-300 bpm.  \\n5.6.5. Tratamento \\nNo caso da taquicardia ortodrômica, é mais fácil a reversão da arritmia pela inibiçã o do \\nnó AV. As drogas de maior eficácia neste caso são a adenosina e o verapamil EV.  \\nDrogas que inibem o nó AV são contraindicadas na taquicardia antidrômica, uma vez que \\naumentam a condução pela via acessória e podem resultar em FV. Dentre elas: \\nbetabloqueadores, bloqueadores do canal de cálcio, adenosina, digitálicos e amiodarona. A \\núnica droga que pode ser usada é a procainamida, pois inibe o feixe acessório. No entanto, é \\nindisponível no Brasil2. \\nEm caso de instabilidade, está indicada a cardioversão e létrica sincronizada, iniciando \\ncom 150 J. Para o tratamento crônico, tanto para a TAV ortodrômica como a antidrômica, as \\ndrogas de escolha são a propafenona ou a flecainida, que inibem especialmente a via acessória, \\ncom alguma inibição do nó AV (especialm ente a propafenona). Para o tratamento definitivo, \\npacientes com WPW devem ser encaminhados para ablação do feixe acessório2. \\n5.7. TAQUICARDIAS VENTRICULARES \\n5.7.1. Epidemiologia \\nSão muito menos frequentes que as taquicardias supraventriculares, no entanto, \\nrepresentam maior gravidade. Elas podem ser de 4 tipos: extrassístoles ventriculares; \\ntaquicardia ventricular não sustentada (TVNS); ritmo idioventricular acelerado; e taquicard ia \\nventricular sustentada (TVS)20. \\nAs extrassístoles ventriculares ocorrem em 70 -95% dos pacientes com IC, sendo \\nfrequentes (incluindo bigeminismo ou trigeminismo). A TVNS foi observada em 50 -80% dos \\npacientes ambulatoriais com IC ou cardiomiopatia. Ritmo idioventricular acelerado ocorre em \\naproximadamente 8% dos pacientes com IC ou cardiomiopatia. Por último, a TVS, em contraste \\ncom a grande prevalência da TVNS e extrassístoles ventriculares em pacientes com \\nIC/cardiomiopatia, é infrequente, ocorrendo em menos de 5% desses pacientes20.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 102}, page_content='102 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n5.7.2. Fisiopatologia \\nO mecanismo pelo qual se acredita ser responsável pela formação da maior parte das \\narritmias ventriculares é a reentrada, já bem discutida ao longo deste capítulo. Múltiplos fatores \\npodem contribuir para a form ação desses focos de reentrada em pacientes com IC e \\ncardiomiopatia, como doença estrutural cardíaca, fatores mecânicos, fatores neuro -humorais, \\ndistúrbios hidroeletrolíticos, isquemia miocárdica e drogas (exemplo clássico é as drogas que \\nprolongam o intervalo QT)20. \\n5.7.3. Etiologias \\nComumente, as arritmias ventriculares estão associadas a cardiomiopatias (dilatada, \\nhipertrófica, doença de Chagas, estenose aórtica, etc) e representam uma complicação \\nimportante do IAM. A torsades de pointes, em específico, pode se r causada por etiologias \\nadquiridas, como distúrbios hidroeletrolíticos (principalmente hipomagnesemia) e \\nmedicamentos que prolongam o intervalo QT, assim como etiologias congênitas, como a rara \\nsíndrome do QT longo2. \\n5.7.4. Diagnóstico \\nAs taquicardias ventricula res (TV) podem ser classificadas em monomórficas ou \\npolimórficas. As TVs monomórficas, em geral, possuem FC > 130 bpm, QRS alargado e regular, \\ncom a mesma morfologia, dissociação entre as ondas P e complexo QRS 2. A figura 14 traz um \\nexemplo de ECG de uma TV monomórfica. \\n \\nFigura 14 - Eletrocardiograma de uma TV monomórfica.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 103}, page_content='103 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nPor outro lado, na TV polimórfica há vários estímulos elétricos de diferentes focos \\nventriculares, resultando em complexos QRS com duração, amplitude, eixos e morfologias \\ndiferentes. É classificada em TV polimórfica com QT normal ou com QT longo2.  \\nQuando associada ao intervalo QT longo é chamada de torsades de pointes (TdP), sendo \\nque é impossível diferenciar os dois tipos de TV polimórfica no ECG da crise, uma vez que a TdP \\nrequer a presença de QT longo em ECG de base.  A TdP geralmente ocorre quando QTc é > 500 \\nms, possuindo a característica de alternância da polaridade e da amplitude dos QRS, formando \\num traçado em fusos, como  se as pontas do ECG fossem torcidas. A TdP inicia-se quando uma \\ncontração ventricular prematura atinge a onda T (fenômeno “R sobre T”)2. A figura 15 traz um \\nexemplo de ECG de uma TV polimórfica. \\n \\nFigura 15 - Eletrocardiograma de uma TV polimórfica.  \\n \\nAs arritmias ventriculares também são classific adas em sustentadas e não sustentadas. \\nAs TVS ocorrem por mais de 30s ou geram instabilidade hemodinâmica. Já as TVNS ocorrem \\npor menos de 30 segundos e não geram instabilidade. \\n5.7.5. Tratamento \\nO tratamento das TVNS consiste em procurar e tratar a causa de base , não devendo ser \\nadministrados antiarrítmicos. Por outro lado, todo paciente com TVS deve ser levado para a \\nsala vermelha e mantido monitorizado, visto que frequentemente há degeneração para um \\nritmo de parada, como fibrilação ventricular2. \\nNas TVs monomó rficas instáveis e com pulso, deve -se realizar cardioversão elétrica \\nsincronizada a princípio com 100 J bifásico, podendo-se aumentar a carga progressivamente. A'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 104}, page_content='104 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\ncardioversão elétrica também é a opção mais segura para os pacientes estáveis. Pacientes que \\npossuem cardiopatia estrutural com FE reduzida podem não tolerar o uso das drogas \\nantiarrítmicas e evoluir com instabilidade hemodinâmica2. A figura 16 traz um fluxograma de \\nconduta simplificado para as taquicardias ventriculares. \\n \\nFigura 16 - Conduta nas taquicardias ventriculares sustentadas. Adaptado de Marchini et al., 2020. \\n \\nEm caso de opção pela terapia medicamentosa, pode -se utilizar inicialmente a \\nadenosina, uma vez que cerca de 15% dos pacientes que inicialmente se classificavam como TV, \\nna verdade eram TSV com aberrância, além de que 10% das TVs revertem com adenosin a. \\nTodavia, a medicação de primeira linha para o tratamento da TV monomórfica estável é a \\nprocainamida, que não está disponível no Brasil. No caso de pacientes com isquemia ativa ou IC \\ngrave, prefere-se a utilização da amiodarona e da lidocaína ao invés da  procainamida, pois a \\nprocainamida, por meio de seu efeito inotrópico negativo (mesmo que discreto), pode reduzir \\no débito cardíaco e agravar essas condições. Todos os pacientes com TV devem ser admitidos \\nem UTI para investigação etiológica e avaliar neces sidade de cardioversor desfibrilador \\nimplantável (CDI)2. \\nO tratamento das TVs polimórficas é semelhante ao da TV monomórfica. A maioria das \\nTdP são autolimitadas, porém, se não reverter espontaneamente, a conduta é desfibrilar com \\n200 J em caso de instabilidade. Todos os pacientes com TdP devem receber magnésio, mesmo \\nse os níveis séricos estiverem normais, mantendo os níveis séricos elevados com  alvo de 3,5 a \\nMOVE (Monitorização, O2 se necessário, acesso \\nvenoso e ECG) \\nCardioversão elétrica, \\nsincronizada a 100-200 J \\nNÃO \\nSIM \\nSIM \\n Amiodarona 150 mg EV em 10 \\nmin ou Lidocaína 1 mg/kg EV \\nem 2-5 min \\nPaciente instável, com pulso? \\nPaciente deseja sedação e cardioversão elétrica? \\nHá possibilidade de isquemia ativa ou \\ninsuficiência cardíaca grave? \\nProcainamida 10 mg/kg EV a 100 mg/min (em \\n10 a 20 min) \\nNÃO \\nNÃO \\nSIM'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 105}, page_content='105 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n5 mg/dL, até a retirada do agente causador, exceto pacientes com doença renal crônica superior \\nao estágio 42.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 106}, page_content='106 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nFLUXOGRAMA'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 107}, page_content='107 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\nREFERÊNCIAS BIBLIOGRÁFICAS \\n1. Pastore CA, Pinho JA, Pinho C, et al. III Diretrizes da Sociedade Brasileira de Cardiologia \\nsobre Análise e Emissão de Laudos Eletrocardiográficos. Arq Bras Cardiol. 2016; v. 106 \\n(n. 4): 1-23. \\n2. Velasco IT. Manual de Emergência: Abordagem Prática. 14. ed. São Paulo: Manole, 2020. \\n3. Spragg DD, Tomaselli GF. Princípios de eletrofisiologia. In: Kasper DL. Medicina interna \\nde Harrison. 19 ed. Porto Alegre: AMGH Editora; 2017. 6140-6143. \\n4. SANCHES, P.C.R.; MOFFA, P.J. Eletrocardiograma: uma abordagem didática, 1a ediç ão. \\nRio de Janeiro: Roca, 2010 \\n5. Mann DL et al. Braunwald: tratado de doenças cardiovasculares. 10. ed. Rio de Janeiro: \\nElsevier, 2018.  \\n6. Prutkin, Jordan M .Overview of the acute management of tachyarrhythmias.  In: Post TW, \\ned. UpToDate. Waltham: UpToDate, 2022.  \\n7. Bradley P Knight. Narrow QRS complex tachycardias: Clinical manifestations, diagnosis, \\nand evaluation. In: Post TW, ed. UpToDate. Waltham: UpToDate, 2022.  \\n8. Friedmann, Antonio Américo. Eletrocardiograma em 7 aulas: temas avançados e outros \\nmétodos - 2.ed. - Barueri, SP: Manole, 2016.  \\n9. Thaler, Malcolm S. ECG essencial: eletrocardiograma na prática diária / Malcolm S Thaler \\n; tradução e revisão técnica: de Jussara N. T. Burnier. – 7. ed. - Porto Alegre : Artmed, \\n2013.  \\n10. Santos Neto, FR. Análise de um novo critério de interpretação no diagnóstico diferencial \\ndas taquicardias de complexo QRS largo [tese]. São Paulo: Faculdade de Medicina USP, \\n2015.   \\n11. Michaud GF, Stevenson WG. Abordagem às taquiarritmias supraventriculares. In: Kasper \\nDL. Medicina interna de Harrison. 19 ed. Porto Alegre: AMGH Editora; 2017.  \\n12. Magalhães LP, Figueiredo MJO, Cintra FD et al. II Diretrizes Brasileiras de Fibrilação \\nAtrial. Arq Bras Cardiol. 2016; v. 106 (n. 4): 1-22. \\n13. Phang R, Prutkin JM, Ganz LI. Overview of atrial flutter. In: Post TW, ed. UpToDate. \\nWaltham: UpToDate, 2021. \\n14. Granada J, Uribe W, Chyou PH, et al. Incidence and predictors of atrial flutter in the \\ngeneral population. J Am Coll Cardiol. 2000; v. 36 (n. 2242).  \\n15. Homoud MK, Piccini J, Yeon SB. Sinus tachycardia evaluation and management. In: Post \\nTW, ed. UpToDate. Waltham: UpToDate, 2021.  \\n16. Kistler P, Lévy S, Yeon SB. Focal atrial tachycardia. In: Post TW, ed. UpToDate. Waltham: \\nUpToDate, 2021.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 108}, page_content='108 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IV | TAQUIARRITMIAS \\n17. Buxton A, Ganz LI, Yeon SB. Multifocal atrial tachycardia. In: Post TW, ed. UpToDate. \\nWaltham: UpToDate, 2021.  \\n18. Knight BP, Link MS, Yeon SB. Atrioventricular nodal reentrant tachycardia. In: Post TW, \\ned. UpToDate. Waltham: UpToDate, 2021.  \\n19. Biase LD, Walsh EP, Dardas TF. Wolff -Parkinson-White syndrome: anatomy, \\nepidemiology, clinical manifestations, and diagn osis. In: Post TW, ed. UpToDate. \\nWaltham: UpToDate, 2021. \\n20. Podrid PJ, Ganz LI, Dardas TF. Ventricular arrythmias: Overview in patients with heart \\nfailure and cardiomiopathy. In: Post TW, ed. UpToDate. Waltham: UpToDate, 2021.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 109}, page_content='109 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nCAPÍTULO V  \\nBRADIARRITMIAS \\nJoão Matheus Girão Uchôa ¹ \\nGiovanna Lídia Gondim Oliveira Dias ¹ \\nDaniel Salmito Chaves ¹ \\nMateus de Sousa Cavalcante 1 \\nLeandro Cordeiro Portela 2 \\nDoi: 10.51859/amplla.ceg164.1123-5 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral,  Ceará, Brasil. \\n² Médico cardiologista eletrofisiologista. Hospital do Coração de Sobral. Sobral, Ceará, Brasil.  \\nCASO CLÍNICO  \\nMulher de 65 anos, trazida de domicílio, em nível de consciência reduzido, chega ao \\npronto-socorro com história de confusão mental há 2 dias. A acompanhante relatou queixas \\nprévias de náuseas e vômitos. Um eletrocardiograma havia sido realizado em consulta de rotina \\nhá duas semanas, o qual foi laudado com apresentação de infradesnivelamento do segmento ST \\ndifuso em aspecto “colher de pedreiro”, pois a paciente consultou -se com cardiologista para \\nacompanhamento de insuficiência cardíaca, com fração de ejeção  reduzida, na qual teve sua \\ndose de digoxina aumentada de 0,125mg para 0,250mg ao dia. \\nAo exame físico,  a paciente encontra -se discretamente pálida, confusa e com \\ndesidratação leve. A frequência cardíaca está regular em 27 bpm e a pressão arterial é de \\n90X50mmHg. A ausculta cardíaca revela bradicardia regular sem sopros e a ausculta pulmonar, \\nestertores crepitantes em bases bilaterais com frequência respiratória de 26 rpm.  \\nPERGUNTAS NORTEADORAS \\n1. Qual afecção aguda acomete este paciente? Há sinais de gravidade? Se sim, quais?  \\n2. Quais exames complementares você solicitaria diante da sua suspeita diagnóstica para esta \\npaciente?  \\n3. Qual medicamento, possivelmente utilizado por essa paciente, que é considerado principal \\nresponsável  para este quadro? \\n4. Como você conduziria esta paciente no departamento de Emergência? E a longo prazo?'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 110}, page_content='110 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\n1.  INTRODUÇÃO: \\nEssencialmente as bradiarritmias são definidas como distúrbios da condução elétrica \\ncardíaca, em quais a frequência cardíaca (FC) se encontra inferior a 50 bpm, não \\nnecessariamente apresentando um ritmo irregular. Já que, de acordo com a III Diretriz da SBC \\npara Análise e Emissão de Laudos Eletrocardiográficos, a FC considerada normal estaria entre \\n60-100 bpm. Acima de 100 bpm teremos as taquiarritmias que serão abord adas em outro \\ncapítulo. \\nAs bradiarritmias podem ocorrer devido a um defeito na automaticidade (função) das \\ncélulas marcapasso, quanto devido a um bloqueio atrioventricular (BAV). Em ambas essas \\nsituações ocorre uma disfunção ou bloqueio do ritmo sinusal, l evando a que um sítio distal ao \\nnós sinusal assuma o controle do ritmo cardíaco, ditando um ritmo menos que o normal. \\nEssa condição também pode ser fisiológica, por exemplo, durante o sono ou entre atletas \\ntreinados, onde temos a bradiarritmia assintomática.  \\n2. FISIOPATOLOGIA: \\nPrimeiramente é importante relembrarmos que o ritmo cardíaco é ditado pelo nó \\nsinoatrial (NSA), mas ele não é a única célula cardíaca com um potencial de ditar o ritmo \\ncardíaco. Logo, na presença de algum defeito no NSA a FC pode altera r devido a mudança no \\nlocal do sítio de nascimento do impulso elétrico ou alteração no ritmo do NSA, por exemplo, \\ncom a dominância do NAV assumindo o lugar do NSA na função de marcapasso principal do \\ncoração.  O NAV tem um ritmo de impulso elétrico próximo  de 40-55 BPM, enquanto o NSA \\napresenta um ritmo em torno de 60-100 BPM, logo o NAV tem um ritmo menos que o NSA.  Essa \\nsituação é chamada de ritmo de escape.  \\nSituações que levam a alguma alteração da função do NSA, levando a um ritmo de escape, \\nque ocorram acima da junção atrioventricular são chamadas de disfunções do nó sinusal e serão \\nmelhor mencionadas mais a frente. \\nOutra situação ocorre quando o problema é na junção atrioventricular, e um defeito \\nnessa região impede que o impulso elétrico se propague , parcialmente ou totalmente para o \\nventrículo, configurando um BAV.  Nesse caso o ritmo é corretamente gerado pelo NSA mas é \\nbloqueado durante a sua condução. No BAV o ritmo pode ser “de escape juncional”, quando o \\nbloqueio de condução é no NAV, ou “de es cape ventricular”, quando o bloqueio é no feixe de \\nHis. A maior diferença entre eles é que no ritmo juncional o novo estímulo ainda vem de dentro'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 111}, page_content='111 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nda junção nodal, gerando um ritmo mais \"fisiológico\", enquanto no juncional o novo estímulo é \\ngerado fora da junção, sendo tido como mais caótico.  \\nÉ sempre válido relembrar, que apesar de o NSA ter a capacidade de deflagração \\nautomática de impulso elétrico ele não está isento de regulação externa. Logo, por exemplo, \\nestímulos simpáticos podem aumentar o automatis mo do NSA, enquanto parassimpáticos \\nreduzem o automatismo. Assim, a FC pode aumentar ou diminuir em resposta ao ambiente. As \\noutras células com capacidade de gerar impulso também podem sofrer essa regulação. \\n3. ETIOLOGIA: \\nPara que uma redução da FC ocorra existe um compilado de fatores que atuam tanto de \\nmaneira extrínseca quanto intrínseca, mas que de maneira particular ou conjunta vão levar à \\nredução da FC<50bpm.  \\nLogo, devido a termos diversos processos patológicos em ação, conjunta ou particular, \\nfica simples compreender que as etiologias responsáveis pela redução do ritmo cardíaco são \\ninúmeras. Doenças sistêmicas, medicamentos e até mesmo adaptações fisiológicas relacionadas \\nao ambiente podem causar bradiarritmias.  \\nUma das principais seria a degeneração i diopática do sistema de condução do impulso \\nelétrico, que é mais comum em idosos. Nela ocorrem alterações, devido ao envelhecimento \\norgânico, que altera a funcionalidade normal, geralmente, do NSA, NAV ou de outros \\ncomponentes da via. Se manifesta mais comumente na forma de bloqueio. \\nOs medicamentos mais comuns que podem causar bradiarritmias são bloqueadores do \\ncanal de cálcio (BCC), betabloqueadores (BB) e anestésicos gerais. Doença isquêmica é uma \\ncausa importante. Doenças sistêmicas que podem levar a esse quadro  são, por exemplo, \\nhipotireoidismo, hipotensão e distúrbios hidroelétricos.  \\nAs causas mais comuns se encontram na tabela a seguir. \\nIntrínseca Extrínseca \\nDegeneração idiopática Autonômico \\nInfarto/Isquemia Medicamentos \\nInfecção Hiper/hipocalemia \\nInfiltrativa Hipotireoidismo \\nAutoimune Hipotermia \\nIatrogênico Neurológico \\nFisiológico  \\nFonte: adaptado de Mangrum e DiMarco, 2000. 3'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 112}, page_content='112 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nA forma crônica prevalece em idosos, devido a situações como: esclerose do NSA, \\ndiabetes, miocardiopatia chagásica e ação de fármacos. Podendo também aparecer em jovens \\ndevido às alterações idiopáticas e genéticas do NSA. \\n4. QUADRO CLÍNICO: \\nMuitas vezes se trata de uma situação assintomática. \\nQuando tem-se sintomatologia ele ocorre, normalmente, apenas abaixo de 50 bpm. \\nNa presença de manifestações clínicas as mais presentes são: astenia, fraqueza, \\nintolerância ao esforço, dispneia, mal-estar indefinido, tonturas e, mais raramente, pré-síncope \\nou síncope. \\nSituações de maior gravidade, como bloqueio s de alto grau, podem cursar com, por \\nexemplo, claudicação cerebral. \\nBOX 17. QUAL O DIAGNÓSTICO? HÁ SINAIS DE GRAVIDADE, SE SIM, QUAIS? \\nEssa paciente apresenta-se com uma bradiarritmia instável. A hipótese diagnóstica é \\nembasada por repercussões hemodinâmicas instáveis caracterizadas por: rebaixamento de \\nnível de consciência, angina, hipotensão, síncope ou sinais de choque. A história pregressa \\nde confusão mental e exame físico com baixos níveis pressóricos contribuem para a \\nsuspeita. Entre os sinais que reforçam a hipótese, tem-se presentes estertores crepitantes \\nem bases bilaterais do pulmão. Diante de um paciente com essa sintomatologia, deve-se \\natentar a outros diagnósticos diferenciais, principalmente, para este caso, insuficiência \\ncardíaca aguda, pneumonia aguda e tromboembolismo pulmonar. Essa paciente apresenta \\nsinais de gravidade, sendo eles: rebaixamento de nível de consciência e hipotensão. \\n5. DIAGNÓSTICO: \\nBaseia-se no exame clínico mais exame físico mais alguma prova eletrocardiográfica que \\ncomprove a condi ção.As provas eletrocardiográficas podem ser: ECG, Holter de 24h, \\nEcocardiografia doppler, teste ergométrico e estudo eletrofisiológico. \\n• O ECG tanto o convencional quanto o de 12 derivações são excelentes métodos, \\nmas, se possível, sempre optar pelo de 12 derivações devido a maior riqueza de \\ndados que ele disponibiliza.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 113}, page_content='113 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\n• O Holter de 24h é de grande valia pois ele permite encontrar estados \\nassintomáticos ou até episódios mais agudos e transitórios, além de analisar \\natividade cardíaca durante o sono ou atividades normais do dia a dia.  \\n• O ecocardiograma Doppler é importante na avaliação da integridade do coração, \\nauxiliando na busca de algum defeito estrutural que possa levar a bradicardia \\n• O teste ergométrico, mesmo que seja mais utilizado nas taquiarritmias, é  útil na \\nobservação do paciente bradicárdico ao esforço físico.  \\n• O estudo eletrofisiológico é importante na avaliação da funcionalidade do NSA e \\ndas vias de condução do impulso elétrico, usado principalmente quanto outros \\nexames não foram suficientemente elucidativos. \\nBOX 18. QUAIS EXAMES COMPLEMENTARES SOLICITA -SE DIANTE DESSA \\nHIPÓTESE DIAGNÓSTICA?  \\nSolicitou-se para esse paciente eletrocardiograma, hemograma completo, glicemia de \\njejum, função renal, função hepática, eletrólitos, gasometria, troponina, radiografia de tórax \\ne ecocardiograma transtorácico e dosagem de medicamentos conforme a suspeita c línica. \\nResultados mais significativos abaixo: \\n• Digoxina: 5.0mg/ dL (Digoxina terapêutica normal - 0,5 a 2,0ng/mL) \\n• Potássio sérico  2.8mg/dL (Nível de potássio no sangue é de 3,6 a 5,2 mmol/L) \\n• Eletrocardiograma de paciente com bloqueio atrioventricular de 3 º grau ou \\nBAV total - Leandro \\n• Radiografia de tórax: sem alterações. \\n• Troponina T: 0,01 ng/ml (valor de referência 0,00 ng/ml a 0,04 ng/ml) \\n• Ecocardiograma transtorácico: ritmo cardíaco regular bradicardico, sem \\naumento cameral, função sistólica ventricular esquerda reduzida (FE = 35%). \\nDiante desses exames, confirmou -se que a paciente apresentava níveis elevados de \\ndigoxina e hipocalemia. \\n6. CLASSIFICAÇÃO: \\n6.1. DISFUNÇÕES DO NÓ SINUSAL: \\nSão alterações manifestações clínicas e eletrocardiográficas que ocorrem quando a \\ngeração e/ou propagação do impulso nervoso do NSA está comprometida.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 114}, page_content='114 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nPodem ser precipitadas por: uso de fármacos, vagotonia e intoxicações. A causa mais \\nfrequente é a degeneração do NSA  \\n6.1.1. BRADICARDIA SINUSAL: \\nÉ a redução fisiológica da FC<60bpm, muitas vezes devido a um aumento do estímulo \\nparassimpático. Nesse caso a onda P é sinusal é o QRS tem um relação 1:1. Pode ocorrer \\nnormalmente em atletas em repouso e durante o sono. É uma condição muitas vezes não \\npatológica, mas pode vir a se tornar na presença de disfunção do nó sinusal. \\n \\nImagem 1 - Bradicardia sinusal. \\n \\n6.1.2. PAUSA SINUSAL: \\nÉ causada quando não ocorre a geração de um estímulo elétrico no NSA. \\nNo ECG a principal característica é que a pausa deve durar 1,5X o tempo basal do \\nintervalo PP basal. Na maioria dos casos não é um acontecimento patológico que cause \\nprejuízos, muitas vezes sendo assintomática.  \\n \\nImagem 2 - Pausa Sinusal.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 115}, page_content='115 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\n6.1.3. SÍNDROME BRADI-TAQUI: \\nÉ caracterizado no ECG como o acontecimento de episódios de bradicardia seguidos por \\ntaquicardia (fibrilação ou flutter). A taquicardia tem resolução espontânea, produzindo uma \\npausa prolongada. Pacientes com essa síndrome podem apresentar sintomatologia exuberante \\nmas inespecífica, ex: dispneia de esforço, fraqueza, palpitações e síncope. \\n \\nImagem 3 - Síndrome Bradi-Taqui.  \\n \\n6.1.4. BLOQUEIO SINUSAL: \\nOcorre devido a um distúrbio na condução do estímulo elétrico do NSA para os átrios e \\nventrículos. Na maioria das vezes o NSA é funcional, mas a um problema nas fibras de condução. \\nO diagnóstico se dá pelo achado no ECG de pausas com tempo de duração duas vezes o RR basal \\ne não precedidas de onda P. Esse bloqueio pode ser classificado em: BSA de 1º grau, BSA d e 2º \\ngrau tipo I, BSA de 2º grau tipo II e BSA de 3 grau. \\n1.4.1. No BSA 1º grau o impulso demora a ser conduzido do NSA aos átrios de maneira \\nfixa. Porém esse impulso (ativação sinusal) não é detectado no ECG.  \\n \\nImagem 4 - BSA 1º grau \\n \\n1.4.2. No BSA 2º grau I ocorre um encurtamento progressivo do intervalo P -P até que \\nsurge um P-P mais longo, que é menor que a soma de 2 intervalos consecutivos, devido a um \\nimpulso bloqueado.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 116}, page_content='116 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nImagem 5 - BSA 2 º grau I \\n \\n1.4.3. No BSA 2º grau II ocorre uma pausa com ausência de ondas P que equivale a 2x o \\nintervalo P-P anterior. \\n \\nImagem 6 - BSA 2º grau II. \\n \\n1.4.4. No BSA 3º grau  só pode ser confirmado com um ECG prévio do paciente que \\nmostra ritmo sinusal ou um estudo eletrocardiográfico, já que ele se caracteriza pela ausência \\nde ondas P.  \\n \\nImagem 7 - BSA 3º grau (Necessita de um estudo eletrocardiográfico. ECG funciona como se fosse uma \\nparada sinusal).  \\n \\n6.2. BLOQUEIO ATRIO-VENTRICULAR (BAV):  \\nSão anormalidades da condução que ocorrem durante a passagem da corrente elétrica \\ndos átrios para os ventrículos por meio do sistema juncional composto do NAV e tronco de feixe \\nde His. Nesses casos, o defeito de condução pode tanto estar no NAV (bloqueio n odal) quanto \\nno feixe de His e seus ramos (infranodal). Como já mencionado, um bloqueio do NAV gera um'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 117}, page_content='117 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nritmo de escape juncional, em quando um bloqueio do feixe de his gera um ritmo de escape \\nventricular.  \\nNo ECG ritmo juncional tem: QRS estreito, FC 40 -55 bpm e um comportamento mais \\nprevisível, enquanto ritmo ventricular tem: QRS alargado, FC 25 -40 bpm e são pouco \\nprevisíveis (podem causar assistolia repentina). \\n6.2.1. BAV 1º grau: caracteriza-se pelo aumento do intervalo  P-R >200ms , onda P \\nsinusal e condução P-QRS 1:1 (todas as ondas P são conduzidas). Logo ele não é um bloqueio \\npropriamente dito, mas sim um retardo na condução do impulso elétrico. \\n \\nImagem 8 - BAV 1º grau. Intervalo PR >200ms.  \\n \\n6.2.2. BAV 2º grau: caracteriza-se pela presença de ondas P bloqueadas. Nesse caso, a \\nregularidade de ondas P advindas do NAS é normal, porém algumas ondas passam pela junção \\natrioventricular (são conduzidas), enquanto outras são bloqueadas (não são conduzidas). \\nExistem 4 subtipos desse BAV: \\n6.2.2.1. BAV 2º Mo bitz I: nesse subtipo a condução se torna progressivamente mais \\nlenta (aumento do intervalo PR) até que subitamente a condução para (onda P não \\nconduzida). Esse, na maioria das vezes tem uma origem nodal, logo é de baixo risco ao paciente. \\n \\nImagem 9 - BAV 2º grau Mobitz I.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 118}, page_content='118 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\n6.2.2.2. BAV 2º Mobitz II : aqui temos uma condução normal da onda P até uma \\nrepentina parada da condução , sem a progressão como no tipo I. Normalmente, tem uma \\norigem infranodal que acarreta maior risco ao paciente. Atenção pois nesse caso pode haver \\numa progressão para BAV total. \\n \\nImagem 10 - BAV 2º grau Mobitz II.  \\n \\n6.2.2.3. BAV 2º 2:1 : como o nome já sugere para cada 2 ondas P conduzidas 1 é \\nbloqueada, mostrando o padrão 2:1. Pode ser observado tanto com QRS estreito quanto \\nalargado. \\n \\nImagem 11 - BAV 2º grau 2:1. \\n \\n6.2.2.4. BAV de alto grau: pode ser dita como uma evolução do tipo 2:1, onde a condução \\nestá ainda mais prejudicada, tendo condução de 3:1, 4:1 ou ainda menores. \\n \\nImagem 12 - BAV de alto grau.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 119}, page_content='119 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\n6.2.3. BAV de 3º grau ou total (BAVT): nesse subtipo nenhuma onda P é conduzida ao \\nventrículo. Tem-se uma completa dissociação entre a atividade atrial (onda P) e ventricular \\n(QRS) no ECG, com frequências diferentes, onde a frequência de P -P é maior que a R-R. Toda a \\natividade ventricular acontece devido a um ritmo de escape, logo veremos um intervalo R -R \\nregular.  \\n \\nImagem 13 - BAV 3º grau ou BAVT.  \\n \\nBOX 19. APÓS CONFIRMAÇÃO DIAGNÓSTICA, QUAL MEDICAMENTO, UTILIZADO \\nPOR ESSE PACIENTE, PODERIA SER RESPONSÁVEL PELO QUADRO \\nAPRESENTADO? \\nComo e sse paciente apresentava, além do quadro clínico já explanado de \\nbradiarritmia instável, o diagnóstico de insuficiência cardíaca, com consulta recente para \\nadequação da dose de digoxina, suspeitou-se de uma situação comum na prática clínica, em \\nindivíduos que fazem uso crônico do medicamento, que é a intoxicação digitálica, pois \\naumentam o automatismo de focos ectópicos atriais, juncionais e ventriculares ao mesmo \\nem tempo que retardam a condução do nó sinoatrial e do nó AV, assim, produzindo \\nbloqueios na c ondução quando predominam os efeitos sobre o nó AV. Essa suspeita foi \\nconfirmada pelos exames laboratoriais, que mostraram níveis de digoxina e potássio sérico \\nmedidos em 5.0mg/ dL e 2.8mg/dL, respectivamente \\n7. CONDUTA \\n A conduta no paciente com bradicardia  visa corrigir a frequência cardíaca, com o \\nobjetivo de amenizar os sinais e sintomas causados por essa condição. Inicialmente, deve -se \\ninvestigar por sinais de repercussão hemodinâmica devido ao baixo débito cardíaco e à baixa \\nperfusão, como dispneia, alteração do estado mental, hipotensão, congestão pulmonar e'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 120}, page_content='120 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\ndor torácica.  Além disso, é necessário seguir uma ordem de prioridade do atendimento do \\npaciente no Departamento de Emergência:7 \\n1.      Avaliação inicial: \\nA: Verificar e manter permeabilidade das vias aéreas \\nB: Analisar a ventilação, identificar frequência respiratória e SpO2, realizar ausculta \\npulmonar em busca de sinais de congestão e oferecer oxigenioterapia se hipoxemia. \\nC: Checar tempo de enchimento capilar, pulso periférico, pressão arterial e  ausculta \\ncardíaca. \\n2.      Monitorização \\nMonitorizar o ritmo do paciente, realizar um ECG de 12 derivações, acompanhar sinais \\nvitais do paciente. \\n3.      Se sinais de instabilidade, obter um acesso venoso periférico calibroso. \\n4.      Identificar diagnósticos diferenciais e tratar causas reversíveis, como:8 \\n- Uso de medicamentos (betabloqueadores, bloqueadores do canal de cálcio, digoxina, \\nantiarrítimicos, lítio, antidepressivos tricíclicos) \\n- Distúrbios eletrolíticos (ex: hipercalemia, hipercalcemia, hipomagnesemia) \\n- Hipoxemia \\n- Hipertensão intracraniana \\n- Reflexo Vagal \\n- Isquemia miocárdica \\nApós avaliação primária do paciente, a conduta na bradiarritmia depende da \\nestabilidade do paciente: \\n7.1. Bradicardia Estável \\nQuando o paciente permanece com FC < 50 bpm e não apresenta sinais e sintomas de \\ninstabilidade hemodinâmica, deve-se monitorá-lo e mantê-lo em observação, sem necessidade \\nde aumento imediato da frequência cardíaca. 7 Posteriormente, ao realizar o ECG de 12 \\nderivações, é importante avaliar a presença de algum bloqueio avançado, como BAV de 2º grau \\nMobitz II e BAVT, que necessite da avaliação do cardiologista sobre a necessidade da passagem \\nde um marcapasso transvenoso.8'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 121}, page_content='121 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\n7.2. Bradicardia Instável \\n7.2.1. Atropina \\nPrimeira escolha nas bradicardias instáveis. Deve ser administrada numa dose de 0,5 mg \\nem bolus, intravenoso, podendo ser repetida num intervalo de 3 a 5 minutos até completar a \\ndose de 3 mg. Em caso de BAVT ou BAV de 2º grau Mobitz II, a atropina não será tão efetiva, \\nsendo necessário providenciar um marcapasso transcutâneo (MCP TC) ou realizar dopamina \\nou adrenalina em bomba de infusão contínua. \\n7.2.2. Adrenalina \\nUtilizada em casos refratários à atropina ou ao marcapasso transcutâneo. Pode ser \\nrealizado na dose de 2 a 20 ug/kg/min, titula da de acordo com a resposta do paciente. 6 Tem \\npotência superior à dopamina para elevar a FC.8 \\n7.2.3. Dopamina \\nTambém utilizado nos casos refratários às medidas iniciais, podendo ser associado à \\nadrenalina ou usada de forma isolada, na dose de 2 a 20 ug/kg/min, ti tulada de acordo com a \\nresposta do paciente.6 \\n7.2.4. Marcapasso Transcutâneo (MCP TC): \\nEste dispositivo tem como finalidade oferecer condição hemodinâmica até a reversão do \\nritmo, tratamento da causa desencadeante ou implante de um Marca -Passo Transvenoso \\n(MPTV). Utilizado em casos refratários à atropina ou em BAV avançado. O MPC TC oferece uma \\ncorrente elétrica por eletrodos aderidos à pele do paciente que fornece a despolarização \\nelétrica rítmica na frequência desejada para o paciente.6,8 \\nInicialmente, verifica-se a opção de MCP TC no desfibrilador/cardioversor. Se o paciente \\nestiver consciente, deve -se orientá-lo sobre o procedimento que será realizado e prosseguir \\ncom a analgesia e sedação. Posteriormente, ao fixar as pás na pele do paciente, seleciona -se a \\nopção de MCP TC e determina -se a frequência cardíaca desejada (60 -80 bpm). Além disso, é \\nnecessário ajustar a amperagem até que se encontre a perda de captura elétrica, e deixar 5 a \\n10mA acima do limiar de captura. Pode-se palpar o pulso braquial ou femoral para reconhecer \\na captura.8'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 122}, page_content='122 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\n7.2.5. Cálcio \\nEm casos de intoxicação por bloqueador do canal de cálcio, pode ser administrado cálcio \\nendovenoso,  como gluconato de cálcio 10% 3 -6 g a cada 10 -20 minutos ou em BIC 0,6 -1,2 \\nmg/kg/min. \\n7.2.6. Glucagon \\nSe o paciente tiver história de intoxicação por betabloqueadores, há indicação de utilizar \\nglucagon endovenoso, na dose de 3-10 mg EV em infusão de 3-5 mg/h. \\n7.2.7. Anticorpo Antidigoxina \\nEm caso de intoxicação por digitálico. \\nBOX 20. COMO PODE SER REALIZADO O MANEJO DESSE BAVT NO DEPARTAMENTO \\nDE EMERGÊNCIA?  \\nApós a identificação de dois itens da instabilidade hemodinâmica (rebaixamento de nível \\nde consciência e hipotensão), optou-se pela internação da paciente, com monitorização \\ncardíaca, oximetria de pulso, porém sem administração de oxigênio (satO2 estava 94%), e \\nresolução do quadro de intoxicação por digitálico, indicando-se o fragmento de anticorpo \\nantidigoxina. A dosagem conforme a digoxinemia ou quantidade ingerida. Uma ampola \\nneutraliza 0,5 mg de digoxina. Deve ser administrado em pelo menos 30 minutos e pode \\nser repetido. Dessa forma, diante da condição de bloqueio atrioventricular de 3º grau, um \\nmarcapasso temporário foi implantado por via percutânea por um dia até a recuperação \\nparcial da condução atrioventricular da paciente. A digoxina foi interrompida por alguns \\ndias e o potássio reposto por via intravenosa. A paciente recebeu alta com uma dose de \\n0,125mg da droga.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 123}, page_content='123 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nFLUXOGRAMA \\n \\nAdaptado de 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With \\nBradycardia and Cardiac Conduction 9'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 124}, page_content='124 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO V | BRADIARRITMIAS \\nREFERÊNCIAS \\n1. Magalhães CC, Serrano CV Jr, Consolim -Colombo FM, Nobre F, Fonseca FAH, Ferreira JFM. \\nTratado de Cardiologia SOCESP. 3th ed. São Paulo: Manole; 2015. \\n2. Oliveira LAT, Takeda, LK, Figueiredo ET. Bradiarritmias. In: Figueiredo ET. Manual de \\nClínica Médica. São Paulo: Sanar; 2019. p.119-24. \\n3. Mangrum JM, Dimarco J. The Evaluation and Management of Bradycardia. N Engl J Med  \\n2000 mar;342(10):703-709.  \\n4. LONG DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscaizo J. Medici na Interna de \\nHarrison. 18th ed. Porto Alegre: AMGH; 2013. \\n5. Pastore CA, Pinho JA, Samesima N, Pereira Filho HG, Kuse JCL, et al. III DIRETRIZES DA \\nSOCIEDADE BRASILEIRA DE CARDIOLOGIA SOBRE ANÁLISE E EMISSÃO DE LAUDOS \\nELETROCARDIOGRÁFICOS. Arquivos Brasileiros de Cardiologia [online]. 2016[Acessado 5 \\nMarço 2022]; 106(4) Disponível em: \\n<https://www.scielo.br/j/abc/a/BkbtSMLnNpD5ttRk8ccxh5P/?lang=pt#> \\n6. Bernoche C, Timerman S, Polastri TF, Giannetti NS, Siqueira AWS, Piscopo A et al. \\nAtualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados de Emergência da \\nSociedade Brasileira de Cardiologia – 2019. Arq Bras Cardiol. 2019; 113(3):449-663 \\n7. Disque K. Advanced Cardiac Life Support. Las Vegas: Sartori Continuum Publishing, 2016.  \\n8. Velasco IT. Manual de Emergência: Abordagem Prática. 14. ed. São Paulo: Manole, 2020. \\n9. Kusumoto, FD; Schoenfeld, MH; Barrett, C; Edgerton, JR; Ellenbogen, KA; Gold, MR; \\nGoldschlager, NF; et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management \\nof Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American \\nCollege of Cardiology/American Heart Association Task Force on Clinical Practice \\nGuidelines and the Heart Rhythm Society.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 125}, page_content='125 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nCAPÍTULO VI  \\nSÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nFelipe Salim Habib Buhamara Alves Nasser Gurjão ¹ \\nLuís Eduardo Oliveira Mattos ¹ \\nPaulo Carvalho Ximenes de Aragão Filho ¹ \\nPedro José Leite de Almeida Mendonça 1 \\nJoaquim David Carneiro Neto 2 \\nDOI: 10.51859/amplla.ceg164.1123-6 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Cardiologista Intervencionista. Hospital do Coração de Sobral. Curso de Medicina, Universidade Federal do Ceará \\n(UFC), Campus Sobral. Sobral, Ceará, Brasil. \\nCASO CLÍNICO \\nHomem de 70 anos, hipertenso, chega ao hospital com dor no peito em caráter opressivo \\nque começou a 30 min. O paciente refere ter pai que morreu de infarto aos 50 anos.  \\nNo exame físico encontramos os seguintes achados: \\n• Ectoscopia: Estado geral comprometido, lúcido, orientado, sudoreico e com fácies de dor. \\n• Sinais vitais: FC: 96bpm / PA: 170x110 mmHg / SatO2: 93% \\n• Exame Cardiovascular: Ritmo cardíaco regular, presença de B4, sem sopros ou atrito \\npericárdico. Pulsos simétricos. \\n• Exame Pulmonar: Murmúrios vesiculares presentes e universais. Ausência de crepitações. \\nPERGUNTAS: \\n1. Qual a definição de lesão aguda do miocárdio? \\n2. Qual a definição de infarto agudo do miocárdio? \\n3. Qual a diferença entre infarto agudo do miocárdio sem supra do segmento st e angina \\ninstável? \\n4. Quais os exames diagnósticos de uma SCA sem supra de segmento st? \\n5. Como realizar a estratificação de risco de uma SCA sem supra de segmento ST? \\n6. Como definir o tratamento em uma SCA sem supra de segmento ST?'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 126}, page_content='126 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\n1. INTRODUÇÃO E CONCEITOS \\nA dor torácica aguda é uma das mais frequentes causas de atendimento nas emergências, \\nonde mais de 40% das admissões são devido à dor torácica1. A maioria destes pacientes recebe \\nalta com diagnóstico de dor torácica não especificada ou causa não cardíaca, entretanto, \\naproximadamente 25% dos pacientes internados apresentam o diagnóstico final de síndrome \\ncoronariana aguda (SCA)2. \\nO grupo de pacientes que não apresentam supradesnível  do segmento ST no \\neletrocardiograma (ECG) e contêm sintomas ou achados em exames compatíveis com etiologia \\ncoronariana compõem as síndromes coronarianas agudas sem supradesnível do segmento ST \\n(SCASSST)2.  \\nPor definição, os pacientes que se encaixam nas S CASSST são os pacientes com dor \\ntorácica aguda sem supradesnivelamento persistente do segmento ST, associado ou não a \\noutras alterações de ECG que sugerem isquemia miocárdica com algum grau de gravidade, \\ncomo: elevação transitória do segmento ST; infradesnivelamento transitório ou persistente do \\nsegmento ST; inversão de onda T; outras alterações inespecíficas da onda T (plana ou \\npseudonormalização, ou mesmo ECG normal. Neste grupo, estão os pacientes com angina \\ninstável (AI), ou seja, sem marcadores de necr ose miocárdica, e aqueles com infarto agudo do \\nmiocárdio sem supradesnivelamento do segmento ST (IAMSSST), quando há elevação de \\nmarcadores de necrose miocárdica 2. Neste capítulo, será abordado, de forma sintética, nos \\naspectos mais relevantes que envolvem  a SCASSST, dividindo -a didaticamente nos tópicos \\npreviamente listados no sumário da obra. \\n2. QUADRO CLÍNICO \\nExistem duas entidades clínicas na suspeita de SCASSST: a AI e o IAMSSST. A angina \\ninstável é provocada por aporte insuficiente de O2 aos miócitos cardíacos, sem provocar \\nnecrose. É definida como angina pectoris (ou equivalente anginoso), com pelo menos um a das \\ncaracterísticas: 1) ocorre em repouso, com duração em geral de 20 minutos (se não for \\ninterrompida por nitrato ou outro medicamento); 2) ser grave e descrita como dor franca; 3) \\nocorre em crescendo ao longo do tempo (dor com cada vez menos esforço, dor cada vez pior)3. \\nA dor torácica é o principal sintoma de isquemia, porém, esta pode apresentar-se apenas \\ncomo equivalente anginoso: epigastralgia, dispepsia, dispneia, náuseas e vômitos, sudorese, \\nhipotensão e síncope. Idosos, mulheres, portadores de di abetes e doentes renais crônicos se \\napresentam mais comumente com equivalentes anginosos 3. A clínica do IAMSSST é bastante'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 127}, page_content='127 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nsemelhante à da AI, sendo que, se o indivíduo com diagnóstico clínico de AI tiver elevação dos \\nmarcadores de necrose miocárdica, diz-se que ele sofreu um IAMSSST2. \\n3. EPIDEMIOLOGIA E FATORES DE RISCO \\nO Infarto Agudo do Miocárdio (IAM) é a principal causa de morte no mundo. Em dados \\ncoletados do ano 2017, pelo DATASUS, 7,06% (92.657) dos óbitos e 10,2% de todas as \\ninternações no Sistema Único de Saúde ocorreram devido a IAM. Em estudo realizado no Brasil, \\nem 72 hospitais, as SCASST representaram 45% das internações, sendo que destas ⅔ foram por \\nIAMSST e ⅓ por AI2.  \\nOs principais fatores de risco estão listados abaixo:  \\n• Idade (homens >45 anos e mulheres > 55 anos) \\n• Dislipidemias: triglicerídeos >= 150mg/dL \\n• LDL > 100 mg/dL; HDL< 40mg/dL \\n• Diabetes Melito \\n• História familiar prematura de doença cardiovascular: homens < 55 anos e \\nmulheres < 65 anos \\n• Hipertensão arterial sistêmica \\n4. FISIOPATOLOGIA \\nA SCASST é resultado de um desequilíbrio entre oferta e demanda de oxigênio. O IAMSST \\npode ser resultado de uma obstrução causada por placa ateromatosa (maioria dos casos) ou \\npor outras condições, como a obstrução dinâmica na angina de Prizmetal 4. A interação ent re \\nquatros elementos explica o mecanismo desse quadro: 1) ruptura da placa de ateroma instável, \\n2) vasoconstrição arterial coronariana, 3) desequilíbrio entre oferta e demanda de oxigênio \\npelo miocárdio e 4) estreitamento intraluminal. Pequenas fissuras na  placa ateromatosa \\nexpõem o conteúdo lipídico presente dentro delas. Esse conteúdo estimula a ativação da cascata \\nde coagulação bem como da ativação plaquetária, principalmente pela atuação do fator de Von \\nWillebrand5. Com isso, há o surgimento de trombos que geram uma oclusão de grau variável \\ndas artérias coronarianas. No IAMSST ocorre uma suboclusão desse vaso (> 70%) de forma \\naguda, gerando redução da oferta de oxigênio para o tecido irrigado por aquela artéria. Caso \\nessa isquemia persista, poderá gerar necrose dessa região. Evento esse, que não ocorre na \\nangina instável.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 128}, page_content='128 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\n5. DIAGNÓSTICO E EXAMES COMPLEMENTARES  \\nComo o quadro clínico decorrente de uma SCA, caracterizado primariamente por dor \\nprecordial, não é suficiente para determinar a causa dessa sintomat ologia, deve -se utilizar \\nexames complementares. Nesse sentido, a abordagem inicial de pacientes com suspeita de uma \\nSCA é feita por meio da análise da história clínica, realização de ECG de 12 derivações, da curva \\nde marcadores de necrose miocárdica e análise dos fatores de risco para o desenvolvimento de \\ndoença coronariana. Dessa forma, por meio desta propedêutica básica pode -se classificar o \\npaciente de acordo com risco cardiovascular de complicações, o que será decisivo na \\ndeterminação da conduta do paciente.  \\n5.1. ELETROCARDIOGRAMA  \\nO eletrocardiograma de 12 derivações corresponde à primeira ferramenta diagnóstica \\nno manejo do paciente com suspeita de SCA. Tal exame pode ser feito tanto em ambiente pré -\\nhospitalar como hospitalar. De forma geral prima -se para que o ECG seja realizado até no \\nmáximo 10 minutos da admissão do paciente. As alterações típicas do ECG em pacientes com \\nSCASSST são infra do segmento ST e inversão de onda T³. Em alguns casos pode ocorrer um \\nsupra de segmento ST momentâneo que pode marcar pior prognóstico.  \\nAlém disso, vale destacar que cerca de 1% a 6% dos pacientes não apresentam \\nalterações eletrocardiográficas sugestivas de SCASSST. Nestes casos, caso a dor persista, indica-\\nse repetir o exame em 15 a 30 minutos com a adição das derivações posteriores e laterais direita \\n(V3R-V4R, V7-V9). \\n \\nFigura 1 - Eletrocardiograma mostrando infra do segmento st em derivações precordiais (V4, V5 e V6)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 129}, page_content='129 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nFigura 2 - Eletrocardiograma das derivações precordiais mostrando inversões simétricas de onda T \\n(V2, V3, V4, V5 e V6) \\n \\n5.2. BIOMARCADORES  \\nOs biomarcadores têm grande importância no diagnóstico e prognóstico de pacientes \\ncom SCA. Tais moléculas são depositadas no sangue quando ocorre uma lesão e morte de células \\nmiocárdicas4. Os principais marcadores disponíveis para avaliação são:  troponina e \\ncreatinofosfoquinase, sendo a troponina o marcador mais relevante.  \\nAdemais, deve -se ressaltar o importante conceito de lesão miocárdica, que é \\ndeterminada quando ocorre, em pelo menos  uma amostra, a dosagem de troponina acima do \\npercentil 99. Tal lesão é dita aguda quando a dosagem de troponina tem caráter dinâmico, isto \\né, com ascensão e/ou queda dos valores basais. Por outro lado, caso a dosagem de troponina \\npermaneça elevada a lesão  é considerada crônica. Dessa forma deve -se ressaltar a relevância \\ndas dosagens seriadas marcadores e da análise de outros exames diagnósticos, visto que tais \\nmarcadores podem ser alterados em outras condições não sejam isquêmicas.  \\n5.2.1. Troponinas  \\nAs troponinas são estruturas componentes dos sarcômeros. Existem três tipos de \\ntroponinas: I, T e C. As troponinas específicas do tecido cardíaco são as troponinas T e I, \\nenquanto a troponina C é coexpressa pelo tecido muscular esquelético. Nesse sentido, foram \\ndesenvolvidas técnicas sorológicas para avaliar a troponina C cardíaca (TnTc) e troponina I \\ncardíaca (TnIc). A dosagem de tal marcador de necrose miocárdica corresponde à primeira \\nescolha para avaliação diagnóstica de pacientes com suspeita de IAM 5. Além disso, pacientes \\ncom valores altos de troponina têm maior risco de eventos cardíacos nos primeiros dias de'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 130}, page_content='130 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\ninternação e identificam um subgrupo de SCASSST com maior benefício com o manuseio \\ninvasivo6. \\nVale, porém, destacar que a dosagem desses marcado res de forma tradicional não \\ncostuma ser eficaz em pacientes em que o quadro clínico tem menos de 6h de duração. Dessa \\nforma, com a introdução de troponinas ultrassensíveis (Trop -US) a determinação diagnóstica \\npode ser feita de forma mais rápida, facilitan do o diagnóstico precoce principalmente em \\nquadros clínicos com menos de 6h de duração7.  As Trop-Us tem sensibilidade cerca de 10 a 100 \\nvezes mais que as das troponinas convencionais. \\nDessa forma, caso o serviço tenha disponibilidade de troponina ultrasse nsível deve-se \\nutilizá-la, sendo desnecessário a dosagem de outros biomarcadores. A dosagem de Trop -US \\ndeve ser feita, preferivelmente, no momento da admissão do paciente e repetida em 1h ou até \\n2h. Caso não se tenha troponina ultrassensível deve -se optar pela troponina convencional que \\ndeve ser avaliada no momento da admissão do paciente e reavaliada após 3h ou até 6h.  \\n5.2.2. Creatinofosfoquinase  \\nAntes da consolidação das troponinas como melhor marcador dava-se preferência para \\no uso de creatinofosfoquinase MB (CK-MB). O CK-MB tem duas formas de avaliação, o CK -MB \\nmassa e o CK-MB atividade, dentre esses o preferível para o diagnóstico de lesões cardíacas é o \\nCK-MB massa, devido a sua maior sensibilidade e especificidade para o diagnóstico de IAM em \\nrelação ao CK-MB atividade. Cabe, porém, destacar que o CK-MB massa tem a grande limitação \\nde elevar-se com lesões não cardíacas, aumentando o número de falsos-positivos. Diante disso \\ndeve-se optar pelo uso de troponinas para o diagnóstico de lesão miocárdica, sendo utilizado o \\nCK-MB massa apenas em casos em que não se tem disponível a dosagem de troponina. \\nBOX 21. EXAMES  \\nECG: Ritmo sinusal, infra de segmento st em D2, D3 e AVF, inversão difusa de onda T. \\nTroponinas: Troponinas ultrassensíveis positivas. \\n5.3. EXAMES DE IMAGEM NÃO INVASIVOS NA SALA DE EMERGÊNCIA \\n5.3.1. Teste ergométrico  \\nO teste ergométrico ou teste da esteira corresponde a uma opção para avaliação de \\npacientes na vigência de dor torácica com risco baixo ou intermediário. A grande vantagem \\ndesse teste é seu alto valor preditivo negativo. Assim, pacientes com teste ergométrico normal \\npodem receber alta com segurança para posterior avaliação ambulatorial. Vale destacar que'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 131}, page_content='131 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\ndevem ser afastadas situações de SCA de moderado a alto risco e alto risco, doenças agudas da \\naorta, tromboembolismo pulmonar, miocardite e pericardite, visto que são contraindicações \\nabsolutas para realizar esse exame. \\nAs indicações de realização de teste ergométrico para estratificar o risco após a avaliação \\nclínica inicial são: \\n• ECG basal e biomarcadores sem alterações \\n• Ausência de sintomas  \\n• Estabilidade hemodinâmica e condições adequadas para o esforço físico. \\nPacientes que não podem realizar o teste ergométrico podem ser submetidos a exames \\nprovocativos de isquemia associados a imagem não invasiva. \\n5.3.2. Ecocardiografia  \\nO ecocardiograma transtorácico corresponde a uma importante ferramenta que pode \\nser utilizada para avaliação complementar na da dor torácica na emergência. Nesse sentido, \\nessa técnica pode auxiliar no diagnóstico diferencial de outras etiologias,  como dissecção de \\naorta, doenças do pericárdio, embolia pulmonar e valvopatias. Além disso, em alguns casos \\npacientes em vigência de dor podem ser avaliados por ecocardiograma para verificar a \\npresença de alterações compatíveis com etiologia isquêmica. \\nAlém disso, a ecocardiografia de estresse vem adquirindo crescente aceitação na \\navaliação de pacientes na emergência, sendo útil para a estratificação funcional de pacientes \\nsem dor torácica recorrente e sem evidências eletrocardiográficas de isquemia e/ou  elevação \\nde troponina. \\n5.3.3. Cardiologia nuclear \\nA cintilografia miocárdica corresponde a um exame bastante útil no diagnóstico e \\nestratificação de pacientes com SCA de baixo risco². Esse exame pode ser feito em repouso para \\nestratificação de pacientes com suspeita de SCA e ECG não específico. Além disso, o exame pode \\nser feito em pacientes na ausência de dor, com ECG normal ou inespecífico com cessação do \\nsintoma há menos de 6h. Nesse contexto, apesar de ser um método relativamente seguro e \\neficaz para avaliação cardíaca em pacientes com suspeita de SCA, as principais limitações desse \\nexame são a baixa disponibilidade e o alto custo. \\n5.3.4. Angiotomografia das artérias coronárias  \\nCorresponde a um método que vem ganhando adesão para a avaliação das artérias \\ncoronárias, com acurácia de diagnóstico de estenose luminal já bem demonstrada quando'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 132}, page_content='132 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\ncomparada à angiografia coronariana invasiva 8. Além disso, deve -se destacar a grande \\nrelevância devido ao alto valor preditivo negativo dessa técnica permitindo que a alta \\nhospitalar seja mais realizada com mais segurança.  \\nOutrossim, a relevância da angiotomografia torna -se maior em casos nos quais o \\ndiagnóstico diferencial da etiologia da dor torácica é duvidoso, visto que esse exame permite a \\nrealização do descarte triplo que consiste na avaliação das coronárias, de anomalias da aorta e \\ndos vasos pulmonares (descartando a presença de tromboembolismo pulmonar). Por outro \\nlado, as desvantagens desse método devem ser ressaltadas, que são: custo elevado, uso de \\nradiação ionizante, uso de contraste iodado e uso limitado a pacientes que não podem usar \\nbetabloqueadores ou que tem frequência cardíaca acima de 80 bpm. Dessa forma a \\nangiotomografia torna-se uma opção em pacientes com dor torácica aguda de probabilidade \\nbaixa a intermediária d e DAC, com ECG não diagnóstico e marcadores de necrose tumoral \\nnegativos ou em pacientes cuja etiologia da dor torácica não foi bem esclarecida. \\n6. ESTRATIFICAÇÃO DE RISCO \\nA abordagem inicial compreende a estratificação de risco de pacientes com suspeita de \\nSCA³. Dessa forma, utilizamos escores para determinar a probabilidade de o paciente \\ndesenvolver eventos cardiovasculares nos próximos meses a anos 9. Assim, o grau de risco do \\npaciente irá determinar a conduta médica a ser tomada, a qual pode ser desde alta para \\navaliação ambulatorial até técnica invasiva imediata.  \\nDentre os escore que temos disponíveis para a avaliação do risco cardiovascular 5 dos \\npacientes com suspeita de SCASSST os principais são: GRACE, TIMI e HEART, dos quais o que \\nse revelou com método  mais eficiente foi HEART SCORE². Tal escore foi desenvolvido para \\navaliar o risco de um evento cardíaco maior (infarto, necessidade de revascularização ou \\nmorte) em 6 semanas da apresentação inicial dos sintomas. \\nESCORE HEART \\nHISTÓRIA 2 - altamente suspeita  \\n1 - moderadamente suspeita \\n0 - pouco/nada suspeita \\nECG 2 - depressão significativa do segmento ST \\n1 - distúrbios de repolarização inespecíficos  \\n0 - normal \\nANOS (IDADE) 2 - ≥  65 anos  \\n1 - ≥  45 anos e < 65 anos  \\n0 - < 45 anos'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 133}, page_content='133 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nESCORE HEART \\nRISCO (FATORES) 2 - ≥  3 ou história de doença arterosclerótica \\n1 - 1 ou 2 \\n0 - nenhum  \\nTROPONINA  2 - ≥  3x o limite superior  \\n1 - 1 a 3x o limite superior  \\n0 - menor que o limite superior  \\nBaixo risco: escore HEART < ou = 3 \\n \\n \\nOutro escore que pode ser usada de forma mais simples corresponde ao TIMI RISK \\nSCORE que por ser mais simples pode ser usado de forma mais rápida para avaliação do risco \\ndo paciente  \\nESCORE TIMI \\nIdade ≥ 65 anos \\nPresença de pelo menos três fatores de risco para \\ncoronariopatia \\nEstenose coronariana ≥ 50%, previamente documentada \\nInfradesnível de ST > 0,5 mm no ECG admissional \\nPelo menos dois episódios anginosos nas últimas 24h \\nUso de AAS nos últimos sete dias \\nElevação dos marcadores de necrose miocárdica \\n(cTnl, cTnT, ou CK-MB). \\nBaixo risco = 0-2 \\nMédio risco = 3-4 \\nAlto risco = 5-7'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 134}, page_content='134 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nO escore GRACE foi desenvolvido para fornecer uma estimativa de óbito intra-hospitalar \\nou óbito e IAM 6 meses após a alta, posteriormente esse escore foi validado como estimativa de \\nrisco de 1 a 3 anos após a alta. A principal limitação do escore GRACE corresponde a sua \\ncomplexidade necessitando de utilização de computador ou aparelho digital para o cálculo de \\nrisco. \\n \\n7. CONDUTA \\nO tratamento é baseado no risco cardiovascular do paciente, determinando -se então a \\nestratégia conservadora ou estratégia invasiva7.  \\n7.1. PACIENTES DE BAIXO RISCO \\nNesse paciente basicamente deve ser feita a conduta conservadora que é caracterizada \\npela analgesia, terapia anti -isquêmica e terapia antitrombótica, as quais serão descritas com \\ndetalhe adiante10. \\n7.2. PACIENTES DE RISCO INTERMEDIÁRIO/ALTO \\nNesses pacientes é indicado a monitorização contínua dentro da unidade coronariana \\ncom terapia anti -isquêmica, terapia antitrombótica e oxigenoterapia se necessário, para \\nposterior conduta invasiva.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 135}, page_content='135 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\n7.3. OXIGENIOTERAPIA: \\nA oxigenioterapia está indicada em pacientes de risco alto e intermediário caso a SatO2 \\nestiver menor que 90% ou estiver com  sintomas de desconforto respiratório. É importante \\nressaltar que a oxigenioterapia em pacientes com SatO2 maior que 90% não mostrou benefícios \\nem reduzir a mortalidade e a oxigenação excessiva pode ter efeitos deletérios para o paciente, \\ncomo vasoconstrição sistêmica. \\n7.4. ANALGESIA  \\nA  analgesia com sulfato de morfina pode ser uma opção em pacientes que mantêm dor \\ncontínua, apesar da terapia anti-isquêmica otimizada. \\n7.5. TERAPIA ANTI-ISQUÊMICA \\nA terapia anti -isquêmica corresponde a administração de nitratos e beta bloqueadores \\nos quais auxiliam a reduzir o trabalho miocárdico diminuindo a demanda miocárdica por \\noxigênio. \\n7.5.1. Nitratos  \\nO benefício do uso dessas drogas está relacionado aos seus efeitos na circulação \\nperiférica e coronariana. Nesse sentido, tais drogas possuem um efeito venodilatador, gerando \\nredução do retorno venoso para o coração e o volume diastólico final do ventrículo esquerdo, o \\nque diminui o consumo de oxigênio pelo miocárdio. Além disso, pode -se observar efeitos \\nvasodilatadores sobre as artérias co ronarianas melhorando o aporte de oxigênio para o \\ncoração. \\nA administração dessa droga é feita inicialmente de modo sublingual e as principais \\nopções para uso são nitroglicerina, mononitrato de isossorbida ou dinitrato de isossorbida. \\nCaso não ocorra melho ra rápida da dor pode -se administrar de forma intravenosa, as \\nformulações disponíveis nesta apresentação são nitroglicerina e mononitrato de isossorbida. O \\ntratamento intravenoso deve ser mantido por 24 a 48h da última dor anginosa e sua suspensão \\ndeverá ser feita de forma gradual. \\nDeve-se, porém, destacar que o uso de nitratos está contraindicado na presença de \\nhipotensão arterial importante (PAS <100 mmHg) ou uso prévio de sildenafila nas últimas 24h \\nou uso de tadalafila nas últimas 48h.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 136}, page_content='136 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\n7.5.2. Betabloqueadores \\nO efeito benéfico dessa classe de drogas no contexto da síndrome coronariana ocorre \\ndevido ao bloqueio dos receptores cardíacos beta 1, gerando redução do cronotropismo e \\ninotropismo cardíaco, o que diminui a demanda cardíaca por oxigênio. Dessa forma, es sas \\ndrogas devem ser usadas em todos os pacientes caso não haja contraindicação. Não há \\nevidências de superioridade de um betabloqueador sobre outro. Entretanto, caso o paciente \\ndesenvolva disfunção ventricular deve -se optar pelas drogas dessa classe que \\ncomprovadamente reduzem a mortalidade em pacientes com insuficiência cardíaca \\n(metoprolol, carvedilol e bisoprolol).  \\nDeve-se, porém, destacar que os betabloqueadores não devem ser utilizados em \\npacientes com fatores de risco para choque cardiogênico e em vigência de broncoespasmo. \\n7.6. TERAPIA ANTITROMBÓTICA INICIAL \\nA terapia antitrombótica visa impedir a ativação plaquetária exacerbada que ocorre na \\ninstabilidade coronariana após sua ruptura. Dessa forma, desenvolveu -se a terapêutica da \\ndupla antiagregação plaquetária que consiste na administração de Ácido Acetilsalicílico (AAS) \\ne um inibidor do receptor plaquetário P2Y12. \\n7.6.1. Ácido Acetilsalicílico \\nDeve ser administrado para todos os pacientes sem contraindicação em dose de ataque \\nde 150 a 300 mg VO oral na admissão. Posteriormente deve ser feita a manutenção a uma dose \\nde 75 a 100mg VO. Em pacientes alérgicos a AAS está indicada a monoterapia com inibidores \\nda P2Y12. \\n7.6.2. Inibidores da P2Y12  \\nAs drogas pertencentes a essa classe são: clopidogrel, prasurgrel e ticagrelor. A intenção \\ndo uso dessas drogas corresponde a inibição da ativação plaquetária exacerbada. A manutenção \\ndo tratamento após uma SCA sem supra de ST deve ser de 12 meses. \\n7.6.2.1. Clopidogrel  \\nCorresponde a uma droga da classe das tienopirinas que atua inibindo de forma \\nirreversível o receptor plaquetário P2Y12. Em pacientes que serão submetidos a angioplastia a \\ndose de ataque é de 600 mg. Caso opte -se por um tratamento conservador a dose de ata que é \\n300 mg.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 137}, page_content='137 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\n7.6.2.2. Prasugrel \\nCorresponde a uma tienopiridina moderna que mostrou superioridade ao clopidogrel, \\nsendo cerca de dez vezes mais potente que o clopidogrel. Assim esse medicamento é utilizado \\nem pacientes submetidos a ICP na sala de hemodinâmica. Su a dose de ataque é de 60 mg VO \\ncom uma dose de manutenção de 10 mg.  \\nCabe, porém destacar que em pacientes com histórico de AVC, AIT ou anatomia \\ncoronariana desconhecida o uso de prasugrel é contraindicado. Ou seja, seu uso deve ser \\niniciado, durante a abordagem a uma síndrome coronariana aguda, na sala de hemodinâmica. \\n7.6.2.3. Ticagrelor \\nCorresponde a um inibidor reversível das tienopiridinas. Apresenta a vantagem de ser \\nsuspenso de 48 a 72 horas antes da CRVM e não aumentar o sangramento pós -operatório. Em \\ntermos de eficácia, o ticagrelor, assim como o prasugrel, é superior ao clopidogrel. Essa droga \\né usada com dose de ataque de 180 mg, seguida de 90 mg 2 vezes ao dia independentemente \\nda estratégia terapêutica adotada (clínica, cirúrgica ou percutânea). \\n7.6.3. Antagonistas dos receptores da glicoproteína IIb/IIIa \\nA ativação de receptores da  glicoproteína IIb/IIIa corresponde ao mecanismo final da \\nagregação plaquetária. De forma que a alteração morfológica sofrida pelo receptor aumenta a \\nafinidade dessa molécula de se ligar ao fibrinogênio, o elemento formador das “pontes entre as \\nplaquetas”.  \\nDessa maneira, fármacos antagonistas desses receptores têm sido utilizados em \\nsituações clínicas com grande potencial de ativação plaquetária, como ICPs complexas e \\ncomplicações tr ombóticas como no -reflow após angioplastia. Os fármacos disponíveis são: \\nabciximab, tirofiban e eptifibatide. \\nDevido ao aumento do risco de sangramento tais drogas devem ser indicadas como \\nterceiro antiagregante plaquetário em pacientes com alto risco trom bótico e baixo risco \\nhemorrágico. \\n7.7. ANTICOAGULANTES \\nO uso de anticoagulantes deve ser feito o mais rápido possível em todos os pacientes \\ncom SCASSST, visto que essa medida diminui a incidência de IAM e óbito, sendo empregada \\npoucas horas após o diagnóstico².'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 138}, page_content='138 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nOs principais anticoagulantes disponíveis são: enoxaparina, fondaparinux e heparina \\nnão fracionada (HNF) \\n7.7.1. Enoxaparina \\nA enoxaparina corresponde a uma heparina de baixo peso molecular que, em termos \\ngerais, é a droga preferencial na escolha do tratamento de SCA sem supra de ST. \\nCabe, porém, destacar que a enoxaparina não deve ser administrada em pacientes com \\nmais de 150 kg, com disfunção renal grave ou previsão de cirurgia de revascularização \\nmiocárdica nas próximas 24h. \\n7.7.2. Heparina não fracionada \\nA heparina não fracionada, devido a maior facilidade de poder ser revertida com o uso \\nde protamina, corresponde a droga de escolha quando há o planejamento de cirurgia de \\nrevascularização miocárdica nas próximas 24h. Além disso, o uso da HNF torna-se preferencial \\nquando o paciente tem disfunção renal grave (clearence < 15 ml/min), são obesos com peso \\nacima de 150 kg ou em pacientes na emergência com o estudo hemodinâmico realizado de \\nforma imediata. \\n7.7.3. Fondaparinux \\nCorresponde a um inibidor indireto do fator Xa que necess ita níveis adequados de \\nantitrombina no sangue. Em pacientes cuja conduta terapêutica corresponde ao tratamento \\nconservador, o fondaparinux pode ser uma alternativa a enoxaparina. Entretanto, quando a \\nconduta indicada é angioplastia deve -se administrar HNF no momento da ICP visto que o uso \\nisolado de fondaparinux está associado ao aumento do risco de trombose de cateter e \\nfenômenos embólicos secundários. \\n8. TERAPIA INTERVENCIONISTA \\nEm pacientes de baixo risco a terapia conservadora deve ser aplicada. Por outro  lado, \\npara pacientes de risco intermediário a alto a estratégia intervencionista está indicada. Nesse \\ncontexto, a terapia intervencionista corresponde à intervenção coronariana percutânea ou à \\ncirurgia de revascularização miocárdica. De toda forma, para a  decisão da estratégia \\nintervencionista, deve ser feita a avaliação da coronariana por meio da cinecoronariografia. \\nA decisão de quando deve ser feita a cinecoronariografia depende do estado e dos fatores \\nde risco do paciente. Nesse sentido, pacientes de r isco intermediário devem ter sua avaliação \\ninvasiva feita em até 72h (estratégia invasiva). Pacientes de risco alto devem ter sua avaliação'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 139}, page_content='139 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nem até 24h (estratégia invasiva precoce) e pacientes com muito alto risco devem ter sua \\navaliação em até 2h (estraté gia invasiva imediata). Na tabela abaixo é determinado o perfil de \\nrisco dos pacientes. \\n \\nMUITO ALTO RISCO ALTO RISCO RISCO INTERMEDIÁRIO \\nESTRATÉGIA INVASIVA \\nIMEDIATA \\nESTRATÉGIA INVASIVA \\nPRECOCE \\nESTRATÉGIA INVASIVA \\nInstabilidade hemodinâmica \\nou choque cardiogênico \\nTroponina positiva DM ou insuficiência renal \\nAngina recorrente ou \\npersistente refratária ao \\ntratamento clínico \\nAlteração dinâmica ST/T ICC ou FEVE < 40% \\nArritmia ventricular maligna \\nou PCR \\nGRACE >140 Angina pós-IAM \\nComplicações mecânicas   ICP ou CRVM prévios \\nIC aguda   GRACE 109-140 ou sintomas \\nrecorrentes ou teste \\nfuncional positivo \\nAlterações dinâmicas ST/T \\nrecorrentes \\n    \\n \\nBOX 22.  \\nPaciente, recebeu terapia anti isquêmica (nitroglicerina) associada a terapia \\nantitrombótica (dupla antiagregação plaquetária). Assim, o paciente recebeu dose de \\nataque de AAS e, como foi submetido ao cateterismo em menos de 24h, não recebeu pré-\\ntratamento com tienopiridínico, recebendo 600 mg de clopidogrel durante a ICP. O \\ncateterismo foi indicativo de angioplastia, a qual foi realizada com a implantação de um \\nstent. Dessa forma, ocorreu melhora clínica e reversão do quadro de precordialgia. Após o \\npós operatório o paciente foi liberado para casa com medicação otimizada.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 140}, page_content='140 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nFLUXOGRAMA'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 141}, page_content='141 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VI | SÍNDROME CORONARIANA SEM SUPRA DE ST (SCA SSST) \\nREFERÊNCIAS \\n1. Barstow C, Rice M, McDivitt JD. Acute Coronary Syndrome: Diagnostic Evaluation. Am Fam \\nPhysician. 2017;95(3):170-177. \\n2. Nicolau JC et al. Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e \\nInfarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021.Arquivos Brasileiros \\nde Cardiologia, 2021;  p 181 a 264 \\n3. Martins HS, Brandão Neto RA, Scarlabrini Neto A, Velasco IT. Emergências Clínicas: \\nAbordagem Prática. 10th rev. ed. e atual. São Paulo: Manole; 2015. \\n4. Kasper, Dennis L. Medicina interna de Harrison. 19 ed. Porto Alegre: AMGH Editora, 2017 \\n5. Braunwald.  Tratado de doenças cardiovasculares, 9.ed. Rio de Janeiro: Elsevier, 2013 \\n6. Silverthorn, D. Fisiologia Humana: Uma Abordagem Integrada, 7ª Edição, Artmed, 2017 \\n7. Guyton AC,  Hall JE. Tratado de Fisiologia Médica. Editora Elsevier. 13ª ed., 2017 \\n8. Barbisan, JN. Cardiologia na Sala de Emergência uma abordagem para o clínico. São Paulo: \\nAtheneu 2013. \\n9. Gach O, El HZ, Lancellotti P. Syndrome coronarien aigu .Rev Med Liege. Maio 2018; p:243 a \\n250. French. PMID: 29926562. \\n10. Hedayati T, Yadav N, Khanagavi J. Non-ST-Segment Acute Coronary Syndromes. Cardiol Clin. \\n2018 Feb;36(1):37-52. doi: 10.1016/j.ccl.2017.08.003. PMID: 29173680.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 142}, page_content='142 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nCAPÍTULO VII  \\nSÍNDROME CORONARIANA COM SUPRA DE ST (SCA \\nCSST) \\nDara Medeiros Mendes ¹ \\nIran Magalhães ¹ \\nLara Cabral ¹ \\nPedro José Leite de Almeida Mendonça 1 \\nJoaquim David Carneiro Neto 2 \\nDOI: 10.51859/amplla.ceg164.1123-7 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Cardiologista Intervencionista. Hospital do Coração de Sobral. Curso de Medicina, Universidade  \\nCASO CLÍNICO \\nHomem, 62 anos, negro, aposentado , natural e residente em Tocantins, Palmas, \\nprocurou o Hospital de urgência de Palmas com queixas de “forte dor no peito”. Dor em aperto \\nem região precordial de forte intensidade (Escala Visual Analógica – EVA: 8)*, com irradiação \\npara o membro superior es querdo de início há aproximadamente 6 horas. Referiu ainda \\npalpitações, náuseas e tonturas. Tem história de hipertensão, diabetes, obesidade e tabagismo. \\nPai falecido de infarto aos 50 anos. \\nAo exame físico, regular estado geral, lúcido, orientado em tempo  e em espaço, afebril, \\nleve cianose em extremidades (1+/4+), anictérico, hidratado, taquipneico (26 irpm), \\ntaquicárdico (128 bpm) e com pressão arterial de 170/130 mmHg e Saturação de Oxigênio de \\n88%. Apresentava sudorese, edema em membros inferiores (1+/4 +), pulsos irregulares e \\nestase jugular. Na ausculta pulmonar, apresentava murmúrio vesicular amplamente \\ndistribuídos em ambos hemitórax, presença de estertores creptantes bibasais. Na ausculta \\ncardíaca: bulhas arrítmicas normofonéticas em 3 tempos, com ri tmo de galope, com discreto \\nsopro sistólico em foco aórtico e sopro diastólico em foco mitral. Abdômen flácido, globoso, com \\nruídos hidroaéreos presentes, som timpânico, fígado e baço não palpáveis e indolor à palpação \\nsuperficial e profunda. \\nPERGUNTAS NORTEADORAS \\n1. Na suspeita de um infarto, quais as características de uma dor tipicamente anginosa? \\n2. Como diagnosticar uma SCACSST?'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 143}, page_content='143 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n3. Qual a diferença entre “tempo porta-agulha” e “tempo porta-balão?” \\n4. Quais medicações são essenciais ao paciente com um IAMCST em curso? \\n5. Qual conduta o médico deverá adotar na emergência, de acordo com a situação do paciente? \\n6. Quais as principais indicações para uma cirurgia de revascularização miocárdica de \\nemergência? \\n1. INTRODUÇÃO \\nA dor torácica é uma das principais causas de atendimento de emergência no mundo não \\nrelacionadas a trauma, correspondendo a cerca de 10% dos atendimentos.1 A maioria deles, no \\nentanto, não possui diagnóstico definido, recebendo alta por dor torácica não especificada e \\ncerca de 25% é diagnosticado com Síndrome Coronariana Aguda (SCA).1,2 \\nDentre estes, destacam -se, pela gravidade, as Síndromes Coronarianas Agudas Com \\nSupradesnível do Segmento ST (SCACSST).2 Patologia que cursa com elevação do segmento ST \\nem seu principal achado eletrocardiográfico, a qual nos debruçaremos a estudar neste capítulo. \\n2. EPIDEMIOLOGIA \\nO Infarto agudo do Miocárdio é responsável por cerca de um sexto das mortes na \\npopulação brasileira. 3 Nas últimas décadas, essa doença vem sendo apontada como o maior \\nproblema de saúde pública nos países des envolvidos e crescente questão nos países em \\ndesenvolvimento, possivelmente pela maior facilidade de diagnóstico atualmente, com acesso \\na exames, notadamente o aumento da acurácia das troponinas ultrassensíveis. \\nAlguns estudos, como Carvalho et al (1996), apontaram a mortalidade por Doença \\nArterial Coronariana (DAC), sobretudo a Síndrome Coronariana Aguda Com Supradesnível do \\nSegmento ST (SCACSST), em idades cada vez mais jovens, ressaltando a questão do gênero, com \\naumento significativo de casos e mortes em mulheres e apontando, ainda, os principais fatores \\nde risco relacionados com os estilos de vida e os fatores psicossociais. 4 Tal fato mostra a \\nimportância de esse tema ser abordado com profundidade ao longo do capítulo. \\n3. FISIOPATOLOGIA \\nApesar de existirem subtipos da Síndrome Coronariana Aguda, o mecanismo \\nfisiopatológico é semelhante entre eles. Na maioria dos casos, ocorre a ruptura da placa \\naterosclerótica e consequente trombose superposta, produzindo isquemia miocárdica aguda. \\nEssa i squemia decorre de prolongada obstrução ou redução de fluxo das artérias. E se faz'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 144}, page_content='144 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nnecessário entendermos o que motiva esse processo a fim de propor um melhor tratamento e \\npossibilitar a prevenção dessa doença. \\nA doença coronariana aterosclerótica é hoje e ntendida como tendo um forte \\ncomponente inflamatório endotelial e subendotelial, em especial quando existe infiltração e \\ndeposição de partículas lipídicas, notadamente o colesterol de baixa densidade (LDL) 5. Essa \\ninflamação é desencadeada por proliferação de macrófagos e linfócitos T no interior da placa \\nde ateroma, o que pode levar à diminuição do colágeno pelos vasos e degradação da capa de \\nfibrótica. Devido a esse processo inflamatório, a Proteína C reativa, importante citocina pró -\\ninflamatória produzida pelo fígado, prediz maior gravidade quanto maior sua concentração.6 \\n  Quando o corpo não consegue mais combater essa inflamação, a placa aterosclerótica \\npode se romper, produzindo ativação das plaquetas e produzindo agregação no local de \\nruptura. Paralelamente, o fator tecidual da placa rota ativa a cascata de coagulação, gerando \\nformação de trombina (o mais potente agente coagulante do organismo) que produz fibrina e \\nque, junto com as plaquetas, formam o trombo intraluminal e posterior isquemia da parede \\nirrigada pela artéria em questão.6,7 \\nExistem outros mecanismos fisiopatológicos menos frequentes na SCA, em que o \\nfenômeno isquêmico pode decorrer de vasoconstrição coronária transitória localizada ou \\ndifusa ou, até mesmo, por trombose coronariana aguda le vando a dificuldade de irrigação da \\nmusculatura cardíaca.7 \\n4. DIAGNÓSTICO \\nPara que um IAMCST seja diagnosticado, faz-se necessário atentar-se a um tripé: \\nI-                Clínica do paciente \\nII-              Eletrocardiograma \\nIII-           Curva dos Marcadores de Necrose Miocárdica (MNM) \\nA maioria dos pacientes, que estão no curso de um infarto, apresentam dor torácica \\nanginosa, a qual precisa ser destrinchada na anamnese. Uma dica prática se dá pelo mnemônico \\n“CLINICA” (Caráter, Localização, Intensidade, “N itrato”, Irradiação, Curso no tempo e \\n“Associados”), o qual ajuda ao médico a não esquecer nenhum aspecto na caracterização da dor. \\nSendo assim, a dor definitivamente anginosa (Tipo A) é a que mais se associa a essa emergência \\ncardiológica e é demarcada por: \\n• Precordialgia constritiva (ou seja, dor “em peso” ou “em aperto”);'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 145}, page_content='145 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n• Localização precordial ou subesternal – importante salientar que o paciente não \\nconsegue demarcar um ponto específico da dor quando questionado, afirmando \\nser uma dor difusa (o que justi fica a mão no peito característica do Sinal de \\nLevine); \\n• Forte intensidade; \\n• Melhora com nitrato, entretanto, na maioria das vezes, não se resolve por \\ncompleto; \\n• Pode irradiar para o epigástrio, dorso, MMSS, mandíbula/pescoço – entretanto, \\ntal dor não se irradia para os trapézios e nem para região abaixo do umbigo (essa \\nirradiação é mais típica de pericardite); \\n• Longa duração, normalmente superior a 20 minutos; \\nOs sintomas geralmente associados são náuseas e vômitos, dispneia, sudorese fria, \\nansiedade e, até mesmo, sensação de morte iminente. \\nTodavia, em alguns grupos de pacientes – mulheres, idosos, diabéticos e indivíduos que \\nforam submetidos a transplante cardíaco, por exemplo – os sintomas supracitados podem não \\nse manifestar, cursando com uma “dor atípica” ou apenas com os chamados equivalentes \\nanginosos, como: \\n• Dor torácica “em queimação” ou “em facada” – e não a precordialgia constritiva; \\n• Sintomas de baixo débito, como lipotimia ou síncope, além de cansaço; \\n• Choque cardiogênico – por sinais de hipoperfusão, como confusão mental, \\nhipotensão arterial, pulsos finos; \\n• IVE aguda \\n• Edema agudo de pulmão (EAP) – quando há a presença de estertores acima da \\nmetade inferior dos pulmões. \\nNo exame físico, o paciente com IAMCST pode apresentar bradicardia ou taquicardia \\nsinusal, hipertensão arterial e presença de B4. Entretanto, é importante salientar que sinais \\ncomo hipotensão sistólica (PAS abaixo de 110mmHg), presença de estertores pulmonares e \\ntaquicardia sinal são maus preditores ao quadro do paciente, atuando como um “a viso prévio” \\nde que existe a chance de eventos adversos nas próximas 72h. \\nQuando se soma a positividade da história clínica com um eletrocardiograma que \\napresenta supradesnível do segmento ST em 2 ou mais derivações contínuas ou BRE novo ou \\nsupostamente no vo, deve -se pensar em IAMCST até que se prove o contrário! Como nessa'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 146}, page_content='146 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nemergência o tempo é essencial, o paciente deve ser conduzido imediatamente como IAMCST \\ndiagnosticado antes mesmo dos resultados dos Marcadores de Necrose Miocárdica (MNM) 8. \\nPor fim, no s casos em que a clínica não esteja tão bem estabelecida, porém esteja \\nassociada a um eletrocardiograma que apresente alterações eletrocardiográficas suspeitas ou \\nnos casos em que a clínica esteja bem estabelecida, entretanto o ECG admissional esteja normal \\n(cerca de 50% dos casos), a dosagem de troponina, principalmente a ultrassensível (o mais \\nimportante Marcador de Necrose Miocárdica), é de grande valia para apontar a presença de \\numa lesão miocárdica em curso, a qual precisa de uma intervenção imediata8. \\n5. ESTRATIFICAÇÃO PROGNÓSTICA \\nApesar de o paciente com IAMCST já ser considerado de alto risco, faz -se necessário \\nestratificá-lo para que a equipe médica possa se preparar para a possibilidade de desfechos \\nadversos. \\nCLASSIFICAÇÃO DE KILLIP \\nEsta classificação se dá por meio da avaliação de sintomas e sinais clínicos da presença \\nde IVE. \\nKillip I Não há evidências de IVE. \\nKillip II Presença de dispneia e poucos estertores pulmonares, B3 ou turgência jugular. \\nKillip III EAP instaurado. \\nKillip IV Choque cardiogênico. \\n \\nQuanto mais alta a classe do paciente, pior o prognóstico, uma vez  que a mortalidade \\nrelacionada foi de 6%, 17%, 338% e 81%, respectivamente 18. \\nCLASSIFICAÇÃO HEART SCORE \\nNos casos em que o ECG e a troponina não se alterem, mas o paciente ainda possua uma \\nclínica suspeita, pode-se utilizar esse escore para estabelecer uma conduta mais adequada: alta \\nambulatorial ou tratar como SCA? \\nESCORE HEART \\nHISTÓRIA 2 - altamente suspeita  \\n1 - moderadamente suspeita \\n0 - pouco/nada suspeita \\nECG 2 - depressão significativa do segmento ST \\n1 - distúrbios de repolarização inespecíficos  \\n0 - normal'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 147}, page_content='147 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nESCORE HEART \\nANOS (IDADE) 2 - ≥  65 anos  \\n1 - ≥  45 anos e < 65 anos  \\n0 - < 45 anos  \\nRISCO (FATORES) 2 - ≥  3 ou história de doença arterosclerótica \\n1 - 1 ou 2 \\n0 - nenhum  \\nTROPONINA  2 - ≥  3x o limite superior  \\n1 - 1 a 3x o limite superior  \\n0 - menor que o limite superior  \\nBaixo risco: escore HEART < ou = 3 \\nPacientes com o escore HEART < ou = 3 possuem baixo risco e podem receber alta \\nhospitalar. Entretanto, pacientes com o escore > 4 precisam ser submetidos a um teste invasivo, \\ncaso este negative, pode receber alta hospitalar, todavia, caso positive, o caso deve ser \\nconduzido como uma SCA.  \\n6. EXAMES COMPLEMENTARES \\n6.1. ELETROCARDIOGRAMA \\nEm todo paciente suspeito, um ECG deve ser obtido e interpretado em menos de dez \\nminutos. Na maioria dos infartos, o ECG irá revelar o diagnóstico correto. Alterações \\neletrocardiográficas características acompanham o infarto do miocárdio, e as alterações mais \\nprecoces ocorrem quase imediatamente com a instalação do comprometimento miocárdico. \\nEntretanto, o ECG inicial nem sempre pode ser diagnóstico, e a evolução das alterações \\neletrocardiográficas varia de pessoa para pessoa. Dessa forma, é necessário obter \\neletrocardiogramas seriados quando o paciente é admitido ao hospital. Durante um infarto \\nagudo do miocárdio, o ECG evolui por três estágios: 1. a onda T se torna apiculada (hiperaguda) \\nseguida por uma inversão; 2. o segmento ST se eleva; 3. novas ondas Q aparecem.9 \\nOnda T:  Com a instalação do infarto, as ondas T se tornam altas e estreitas, esse \\nfenômeno é chamado de apiculação.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 148}, page_content='148 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n \\nGeralmente algumas horas depois, as ondas T se invertem. A inversão da onda T, por si, \\né indicativa apenas de isquemia e não é diagnóstica de infarto do miocárdio. A inversão da onda \\nT é um achado muito inespecífico, pois muitas situações podem levar uma onda T a se inverter, \\npor exemplo, bloqueio de ramo e a hipertrofia ventricular com anormalidades da repolarização \\nestão associadas com inversão da onda T. Apesar dessa inespecificidade uma característica \\ndiagnóstica útil é que as ondas T do infarto do miocárdio são invertidas simetricamente, ao \\npasso q ue, na maioria das outras circunstâncias, elas são assimétricas, com uma inclinação \\nsuave para baixo e ascensão rápida.9 \\n \\nSegmento ST:  A elevação do segmento ST significa lesão miocárdica. A lesão \\nprovavelmente reflete um grau de dano celular além da simp les isquemia, mas ela é \\npotencialmente reversível e, em alguns casos, os segmentos ST podem retornar rapidamente \\nao normal. Na maioria dos casos, contudo, a elevação do segmento ST é um sinal confiável de'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 149}, page_content='149 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nque um infarto verdadeiro ocorreu e que o quadro eletrocardiográfico completo de um infarto \\nirá evoluir, a não ser que haja uma intervenção terapêutica agressiva e imediata. Contudo, assim \\ncomo a inversão da onda T, a elevação do segmento ST pode ser vista em inúmeras outras \\ncondições além de em um infarto do miocárdio em evolução, por exemplo, pericardite, embolia \\npulmonar e síndrome de abaulamento apical.9 \\n \\nOnda Q: O aparecimento de novas ondas Q indica que ocorreu morte celular miocárdica \\nirreversível. A presença de ondas Q é diagnóstica de infarto do m iocárdio. Essas ondas \\ngeralmente aparecem dentro de algumas horas do início do infarto, mas, em alguns pacientes, \\nelas podem levar vários dias para aparecer. Em geral, o segmento ST já retornou à linha de base \\nquando as ondas Q aparecem. As ondas Q tendem a persistir durante toda a vida do paciente.9 \\n6.2. TROPONINA \\nAs troponinas são proteínas do complexo de regulação miofibrilar, que não estão \\npresente no músculo liso. Existem três subunidades: Troponina T (TnTc), Troponina I (TnIc) e \\ntroponina C. A troponina C é coexpressa nas fibras musculares esqueléticas de contração lenta \\ne não é considerada como um marcador específico cardíaco. Acredita-se que as troponinas têm \\nduas principais vantagens em relação à CK-MB: maior especificidade para lesão miocárdica, na \\nmedida em que a CK -MB é encontrada em tecidos não cardíacos e habilidade em detectar \\npequenas quantidades de lesão miocárdica, não detectável pelos ensaios de CK -MB. TnTc ou \\nTnIc são atualmente os marcadores bioquímicos de escolha para detecção de necrose \\nmiocárdica em pacientes com suspeita de SCA, por sua alta sensibilidade e quase completa'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 150}, page_content='150 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nespecificidade, metanálises de ensaios de primeira e segunda geração demonstraram que TnIc \\ntem sensibilidade e especificidade clínica para o diagnóstico de IAM na ordem de  90 e 97%, \\nrespectivamente. \\nNos últimos anos, os ensaios para detecção de troponinas na corrente sanguínea \\nevoluíram com relação à sua sensibilidade, os ensaios ultrassensíveis. Esses ensaios têm \\npermitido a dosagem de concentrações muito baixas de troponi nas, com excelente nível de \\nprecisão. \\n As troponinas na admissão estão dentro do valor de normalidade em até um quinto dos \\npacientes que depois confirmam diagnóstico de IAM. Naqueles que se apresentam em menos \\nde 3 horas do início dos sintomas, esse número  é ainda maior, sendo sempre necessária a \\nmensuração seriada do marcador. A medida seriada da troponina também é importante para o \\ndiagnóstico correto de infarto agudo, na medida em que mais casos de aumento do marcador \\nsão detectados em outras condições a gudas e crônicas. É fundamental a demonstração de \\naumento e/ou queda da concentração de troponina para diagnóstico diferencial. \\nApesar do importante papel das troponinas no contexto do IAM, vale ressaltar que níveis \\nanormais de marcadores bioquímicos, incluindo as troponinas, não traduzem obrigatoriamente \\ndiagnóstico de IAM, nem o mecanismo de lesão miocárdica. Qualquer dano agudo ou crônico ao \\ncardiomiócito pode levar a aumento de troponinas. Se a apresentação clínica não é típica de \\nSCA, devem ser buscada s outras causas de lesão cardíaca relacionadas com aumento de \\ntroponinas, como insuficiência cardíaca, embolia pulmonar, insuficiência renal crônica ou \\nsepse.8 \\n6.3. CREATINOQUINASE E MIOGLOBINA \\nA CK-MB é um marcador ainda muito utilizado na prática clínica, embora tenha diversas \\nlimitações conhecidas. Idealmente, a CK-MB deve ser mensurada por meio de imunoensaio para \\ndosagem da sua concentração no plasma ao invés da sua atividade, por sua comprovada \\nsuperior sensibilidade. Metanálises de diagnósticos retrospect ivos de infarto do miocárdio \\ndemonstram sensibilidade de 97% e especificidade de 90% para diagnóstico de IAM. A CK -MB \\nmassa apresenta como principal limitação elevar-se após dano em outros tecidos não cardíacos \\n(falso-positivos), especialmente lesão em mús culo liso e esquelético. As subformas da CK -MB \\nforam empregadas como marcadores precoces (menos de 6 horas) de lesão miocárdica; \\nentretanto, sua menor especificidade e a dificuldade técnica para reprodução dos resultados \\nlimitaram sua utilização.8'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 151}, page_content='151 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nA mioglo bina é um marcador muito precoce de necrose miocárdica, precedendo a \\nliberação de CK-MB em 2 a 5 horas. Por não ser um marcador cardioespecífico, a sua principal \\nvantagem parece ser na detecção de IAM nas primeiras horas de evolução.8 \\n6.4. CINECORONARIOGRAFIA \\nA cinecoronariografia representa elemento central na avaliação e tomada de decisão \\nterapêutica em pacientes com IAMCSST. Este exame deve ser realizado não apenas para iniciar \\num procedimento de revascularização, mas também para determinar o grau de \\ncomprometimento da artéria coronária e estabelecer a presença e extensão de lesão do \\nmiocárdio. O número de vasos e a extensão do acometimento aterosclerótico podem auxiliar na \\nclassificação de risco e na tomada de decisão sobre a melhor estratégia de tratamento p ara \\nesses pacientes.8 \\nNo entanto, existem algumas peculiaridades da cinecoronariografia no IAMCSST que \\ndevem ser observadas para manter os potenciais benefícios que ela pode proporcionar. Idosos, \\ndiabéticos, pacientes com disfunção miocárdica/renal preexistente conhecida, pacientes que já \\nforam revascularizados e pacientes com índice de massa corporal baixo ou muito alto devem \\nreceber atenção especial, pois são uma população de mau prognóstico.8 \\n7. CLASSIFICAÇÃO \\nAs alterações eletrocard iográficas no infarto com supra do segmento ST não \\ncorrespondem a uma classificação propriamente dita, mas sim a uma determinação das paredes \\nmiocárdicas acometidas de acordo com a presença de alterações elétricas em suas paredes \\ncorrespondentes. Apesar de  classificar o infarto de acordo com o local que a oclusão pelo \\ntrombo está causando isquemia, a conduta será praticamente a mesma para todos os casos. \\nAs paredes miocárdicas são analisadas por suas derivações equivalentes: \\n• Lateral alta: corresponde às derivações D1 e aVL; \\n• Inferior: corresponde às derivações D2, D3 e aVF; \\n• Anterior: corresponde às derivações V1, V2, V3 e V4; \\n• Lateral baixa: corresponde às derivações V5 e V6; \\n• Anterior extensa: corresponde às derivações D1 e  aVL + V1-V6.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 152}, page_content='152 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n \\nAdemais, é important e ressaltar que o ventrículo direito, apesar de possuir uma \\nirrigação bastante superior ao ventrículo esquerdo (isso se explica pelo fato de o VD ser irrigado \\ntanto na sístole, quanto na diástole, enquanto o VE é irrigado apenas na diástole), ainda está \\nsujeito a ser foco de um infarto e, portanto, alvo de necrose. Na suspeita de infarto de VD, é de \\nsuma importância rodar as derivações eletrocardiográficas à direita – V3R e V4R, sendo esta \\nainda mais importante –, uma vez que essas derivações possibilitam a valiar apropriadamente \\na atividade elétrica do VD. Nessas derivações, podem ser observadas as mesmas alterações \\nnuma situação de IAM com supra do segmento ST nas quais são observadas nas derivações \\n“clássicas”. \\n• Ventrículo direito: corresponde às derivações V3R, V4R, V1.8 \\nBOX 23.  \\nO paciente foi encaminhado para realização de eletrocardiograma que mostrou supra \\ndesnivelamento do segmento ST de 2 mm na parede anterior. Após 6h, desenvolveu \\ninversão na onda T, onda Q patológica, além da presença de onda U invertida transitória. \\nNa pesquisa de marcadores bioquímicos de lesão miocárdica houve elevação das \\ntroponinas acima do percentil 99 do limite máximo de referência, porém a CK-MB massa \\nestava dentro da normalidade.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 153}, page_content='153 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n8. CONDUTA \\n8.1. PASSOS INICIAIS \\nO paciente com IAMCST em cur so, na grande maioria das vezes, apresenta sintomas de \\nhipoxemia, dor e ansiedade, sintomas estes que o médico responsável deve tentar extingui -los \\nou, pelo menos, amenizá -los. Além disso, outras condutas, antes mesmo de uma terapia de \\nreperfusão propriamente dita seja feita, são importantes ao prognóstico e desfecho do quadro \\ndo paciente.8 \\nOXIGENOTERAPIA \\nRecomenda-se a monitorização da saturação sanguínea de oxigênio por meio da \\noximetria de pulso, visando ao conhecimento da necessidade, ou não, da oxigenoterapia. Esta \\nestá indicada quando o paciente cursa com dispneia, saturação < 90%, congestão pulmonar ou \\npossui risco cardiovascular moderado/alto. \\nPode ser suplementada por meio de máscara ou cateter nasal (2 a 4L/min), visando à \\nmanter a saturação entre 90-99%. \\nEstá indicado uso de pressão positiva ou intubação orotraqueal (IOT) quando a máscara \\nou cateter nasal forem insuficientes, como em situações de falência ventricular aguda \\nacentuada, edema pulmonar ou caso o paciente seja portador de alguma doença pulmonar \\n(desde que esta ajude no processo de instauração de hipoxemia mais grave).8 \\nMANEJO DA DOR \\nApesar de a administração da dor não mudar o prognóstico do paciente, ela ainda se faz \\nrelevante, demandando atenção para sua resolução, uma vez que n ão existe explicação para \\nfazer com que o paciente permaneça em sofrimento – principalmente em uma situação tão \\nestressante, na qual o controle da dor pode até diminuir os sintomas ansiosos expressos pelo \\npaciente e, portanto, diminuir a descarga adrenérgi ca associada (esta aumenta a demanda de \\noxigênio pelo miocárdio). \\nInicialmente, recomenda -se o uso de nitratos – atuam na formação de óxido nítrico, \\nportanto têm ação vasodilatadora coronariana, promovendo o aumento de fluxo e oferta \\nnutricional ao miocárdio. \\n• Dinitrato ou mononitrato de isossorbida 5mg via sublingual a cada 5 minutos \\n(dose máxima de 15mg)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 154}, page_content='154 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nAs contraindicações ao uso de nitrato são: hipotensão, bradicardia, taquicardia, infarto \\nde VD e uso de inibidores da fosfodiesterase nas últimas 24h a 72 h. Caso a dor persista \\nmediante a administração dos nitratos, pode-se utilizar a: \\n• Nitroglicerina endovenosa, doses iniciais 5-10mcg/min \\nEm pacientes complicados com edema agudo de pulmão e em pacientes que não \\nresponderam ao uso de nitrato está indicado o uso de sulfato de morfina, o qual atua como \\nanalgésico, ansiolítico e ainda possui certa ação vasodilatadora. \\n• Sulfato de morfina IV, dose 2 a 4 mg diluída – pode ser repetida em intervalos de \\n5 a 15 min \\nSua administração é recomendada até que que a dor ces se ou que comecem a surgir \\nsintomas de toxicidade, como hipotensão ou vômitos. As contraindicações ao seu uso são: \\nhistória de alergia ao medicamento, IAM de parede inferior e bradicardia reflexa no IAM \\ninferior (suspeita de infarto de VD).8 \\nANTIPLAQUETÁRIOS \\nA dupla antiagregação plaquetária (AAS + inibidor do receptor da P 2Y12) é um dos \\nprincipais elementos na terapêutica da isquemia, devendo ser iniciada em até 10 minutos após \\no início do atendimento. \\nÁCIDO ACETILSALICÍLICO (AAS): atua bloqueando a ciclooxigenase (inibe a formação \\nde tromboxano A2) deve ser usado em todos os pacientes. Contraindicações consistem na \\nhipersensibilidade conhecida, úlcera péptica ativa grave, discrasia sanguínea ou hepatopatia \\ngrave. \\n• Dose única de ataque de 160mg a 325mg – deve ser mastigado –, a dose mais \\ncomum no Brasil está entre 200-300mg \\n• Dose de manutenção 100mg/dia – uso contínuo. \\nCLOPIDOGREL: tienopiridina que atua bloqueando a ligação do ADP com o receptor \\nespecífico P 2Y12 na superfície das plaquetas. A dose de ataque v aria conforme a idade do \\npaciente e conforme a terapia de reperfusão adotada: \\n• Idade ≥ 75 anos: 75mg de ataque + 75mg/dia de manutenção – a dose de ataque \\né menor pelo maior risco de hemorragia intracraniana \\n• Idade < 75 anos + \\n▪ Angioplastia primária: 600mg de ataque + 75mg/dia de manutenção \\n▪ Trombólise química ou não submetido à terapia de reperfusão:  300mg \\nde ataque + 75mg/dia de manutenção'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 155}, page_content='155 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nÉ importante definir, também, o tempo de uso da dupla antiagregação após a \\nangioplastia, uma vez que varia de acordo com o tipo de stent inserido no paciente: \\n• Stent convencional: no mínimo, 1 mês; \\n• Stent farmacológico: no mínimo, 6-12 meses \\nCaso o paciente tenha previsão de cirurgia cardíaca, é necessário realizar a interrupção \\ndo clopidogrel 5 dias antes do procedimento. \\nTICAGRELOR: não tienopiridina que atua inibindo o receptor P 2Y12 de ADP, sendo um \\nantiagregante mais rápido e potente que o clopidogrel. Está indicado nos pacientes que serão \\nsubmetidos à angioplastia primária, não devendo ser utilizado em pacientes que serão \\nsubmetidos à trombólise química. \\n• Dose de ataque de 180 mg + dose de manutenção de 90 mg 2 vezes ao dia \\nPRASUGREL: tienopiridina de terceira geração, portanto é um fármaco mais recente que \\no clopidogrel. \\n• Dose de ataque 60 mg + dose de manutenção de 10 mg/dia \\nApesar de o prasugrel ter apresentado superioridade sobre o clopidogrel (ação mais \\nrápida e mais potente), isso ocorreu em conjunto com o aumento de episódios de sangramentos \\nmaiores, sendo, dessa maneira, contraindicado seu uso em pacientes com histórico de AVC e \\ndeve ser evitado em pacientes com idade superior ou igual a 75 anos (motivo já explicitado) e \\npeso menor qu e 60Kg. Ademais, não deve ser utilizado em pacientes que serão submetidos à \\ntrombólise química.8 \\nBETABLOQUEADORES \\nOs betabloqueadores são fármacos que atuam inibindo os receptores beta-adrenérgicos, \\nproporcionando redução da frequência cardíaca, do inotropismo e da pressão arterial, ao passo \\nque também age aumentando a disponibilidade de oxigênio na rede de colaterais e no \\nsubendocárdio (proporciona maior fluxo sanguíneo), ajudando no combate à isquemia. \\nSeu uso está indicado tanto na fase aguda quanto tardia, sendo o uso precoce de extrema \\nimportância para melhor desfecho do quadro do paciente – é comprovada sua eficácia na \\nredução de fibrilação ventricular primária e morte súbita cardíaca. \\nEntretanto, seu uso imediato não está recomendado na presença de:  \\n• FC < 60bpm; \\n• PAS < 100 mmHg; \\n• Intervalo PR aumentado (> 240ms); \\n• Bloqueio atrioventricular de 2º ou 3º graus;'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 156}, page_content='156 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n• Doença pulmonar (asma ou DPOC grave) \\n• Disfunção grave de VE grave; \\n• Doença arterial periférica grave. \\nAdemais, mesmo que o paciente não apresente contraindicações diretas, caso apresente \\nfatores de risco para choque cardiogênico nas primeiras 24h – como FC > 110bpm, idade \\nsuperior a 70 anos, PA sistólica < 120mmHg e Killip > I – o betabloqueador não deverá ser usado \\nimediatamente. \\n• Metoprolol 50 mg VO 6/6 h no 1º dia, seguindo de 100 mg VO 12/12h (uso \\ncontínuo) – esquema padrão \\nA via preferencial de administração se dá pela via oral. A administração intravenosa está \\nindicada apenas em casos refratários, crises hipertensivas ou taquiarritmias. \\n• Metoprolol IV de 5mg de 5 em 5 minutos (podem ser administradas até 3 doses) \\n+ uso contínuo por via oral na fase tardia \\nUma ressalva importante é que o fármaco pindolol deve ser evitado, uma vez que este \\nbetabloqueador apresenta efeito simpatomimético intrínseco.8 \\nTERAPIA ANTICOAGULANTE \\nParte muito importante da terapêutica, uma vez que, quando combinada com a dupla \\nantiagregação plaquetária, potencializa a capacidade de reduzir os desfechos cardiovasculares. \\nO tipo de anticoagulante utilizado varia de acordo com a terapia de reperfusão escolhida. \\nNa terapia trombolítica, utiliza -se uma heparina de baixo peso molecular, sendo a \\nrepresentante mais comum a enoxaparina. É necessário avaliar também a função renal do \\npaciente. \\n• < 75 anos: 30 mg IV em bolus, depois de 15 minutos, 1 mg/Kg subcutâneo 2x/dia \\n– atenção para o uso máximo de 100mg/dose \\n• ≥ 75 anos: 0,75 mg/Kg subcutâneo 2x/dia \\n• Clearance de creatinina < 30ml/min/1,73m²: 1mg/Kg uma vez ao dia \\nNa angioplastia primária, existem duas opções: heparina de baixo peso mole cular ou \\nheparina não fracionada (HNF). A HBPM é administrada no laboratório de hemodinâmica \\n(0,5mg/Kg), enquanto a HNF numa dosagem de 70-100UI/Kg em bolus e é, geralmente, a mais \\nutilizada.8'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 157}, page_content='157 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n8.2. TERAPIAS DE REPERFUSÃO \\nAs medidas iniciais supracitadas, quando  feitas isoladamente, são insuficientes para a \\nrestauração do fluxo sanguíneo em uma coronária que está ocluída por um trombo. Logo, é de \\nextrema importância o paciente ser submetido à uma estratégia de reperfusão, uma vez que \\nexiste uma máxima sobre o manejo de um IAMCST: “tempo é músculo!” – quanto maior o tempo \\npara que o miocárdio volte a ser irrigado, maior o foco de necrose miocárdico, o qual é \\nirreversível. \\nExistem dois tipos de estratégia de reperfusão: trombolíticos ou angioplastia, sendo esta \\núltima comprovadamente superior a primeira, porquanto possibilita realizar o diagnóstico \\nanatômico e avaliar prontamente o resultando da intervenção, enquanto com o uso de \\ntrombolíticos, a certeza acerca da reperfusão não tem como ser dada (isso justifica o porquê de, \\nmuitas vezes, pós-trombólise, o indivíduo ser submetido a uma angioplastia). Apesar disso, não \\nsão todos os hospitais que possuem a estrutura necessária, como um laboratório de \\nhemodinâmica, para realização da intervenção coronariana percutânea (ICP), por esse motivo, \\na maior parte da realidade brasileira (e do mundo) consiste no uso de trombolíticos. \\nEstá indicada a reperfusão coronariana nos casos: \\n1. Pacientes com sintomas compatíveis com IAMCSSST \\n2. Delta-T de clínica de dor de até 12h – depois desse  período, a necrose está \\ninstaurada \\n3. Supra de ST em duas ou mais derivações contínuas (em relação à parede) ou BRE \\nnovo ou presumidamente novo. \\nA prioridade sempre será enviar o paciente a um centro com hemodinâmica para ser \\nsubmetido à angioplastia. Em vista disso, caso o hospital possua laboratório de hemodinâmica, \\no paciente deve ser enviado o mais rapidamente para o procedimento, com tolerância de espera \\nde 90 minutos, o chamado “tempo porta-balão” – desde o momento que o paciente entra pela \\nporta até o momento que ele está na ICP e o médico hemodinamicista insufla o balão. \\nCaso o hospital não possua disponibilidade para angioplastia, deve -se averiguar, \\nprimeiramente, a possibilidade de transferência do paciente para um centro próximo que \\npossua hemodinâmica, se isso for possível, o tempo de transferência não pode exceder a 120 \\nminutos. \\nCaso o hospital não possua angioplastia e seja inviável transferir o paciente para que ele \\nseja transferido em tempo menor que 120 minutos (seja por grande distância ou gra nde \\ndemanda de um centro próximo, por exemplo), realiza -se a trombólise química em até 30'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 158}, page_content='158 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nminutos desde a chegada do paciente, sendo esta meta de tempo chamada “tempo porta -\\nagulha”. \\nÉ importante salientar que pacientes graves precisam ser transferidos \\nindependentemente do tempo porta -balão. São considerados pacientes graves aqueles que \\nestão em situação de choque, de insuficiência cardíaca grave e de contraindicação ao uso de \\ntrombolíticos.8 \\nTROMBOLÍTICOS \\nA trombólise química, quando escolhida, quanto mais cedo for administrada, mais eficaz \\nela se torna, sendo as três primeiras horas a janela de maior benefício. Entretanto, quando o \\ndelta T de 12h for ultrapassado, o uso de trombolíticos não se faz mais necessário, uma vez que \\na necrose já foi estabelecida. \\nPara que a trombólise possa ser realizada, é preciso descartar a presença de \\ncontraindicações absolutas ou relativas. As contraindicações absolutas são: \\n• Qualquer sangramento intracraniano prévio \\n• AVC isquêmico nos últimos 3 meses \\n• Dano ou neoplasia no SNC \\n• Sangramento ativo ou diátese hemorrágica \\n• Qualquer lesão vascular cerebral conhecida (malformação arteriovenosa) \\n• Dissecção aguda de aorta \\n• Discrasia sanguínea \\nJá as contraindicações relativas, resumidamente, são: \\n• AVC isquêmico há mais de 3 meses ou doenças intracranianas que não se \\nenquadram nas contraindicações absolutas \\n• Gravidez \\n• Uso de antagonistas da vitamina K \\n• Sangramento interno recente (<2-4 semanas) \\n• Ressuscitação cardiopulmonar traumática e prolongada ou cirurgia de grande \\npor há menos de 3 semanas \\n• HAS não controlada \\n• Punções não compressivas \\n• História de HAS crônica importante não controlada \\n• Úlcera péptica ativa'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 159}, page_content='159 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n• Exposição previa à estreptoquinase – induz a formação de anticorpos e pode \\ninduzir processos alérgicos \\nTENECTEPLASE (TNK): recomenda-se seu uso em pacientes com idade < 75 anos, pois \\napresenta menores riscos de sangramento não cerebral e pode ser feita em bolus único. \\nESTREPTOQUINASE (SK): seu maior benefício encontra -se no fato de provocar menos \\nsangramentos intracranianos quando comparado com a TNK. Por esse motivo, é o trombolítico \\nde escolha para pacientes com idade > 75 anos. \\n• SK: 1,5 milhões UI em 100ml de SG5% ou SF 0,9%. Correr em 30-60 minutos \\n• rtPA: 15mg IV em bolus, depois 0,75mg/Kg em 30 minutos, seguido de 0,5mg/Kg \\nem 60 minutos – cuidado com a dose total máxima de 100mg \\n• TNK: bolus único de acordo com o peso do paciente: \\n▪ < 60Kg = 30mg \\n▪ 60-70Kg = 35mg \\n▪ 70-80Kg = 40mg \\n▪ 80-90Kg = 45mg \\n▪ > 90Kg = 50mg \\nComo ao usar o trombolítico não existe a possibilidade de estabelecer uma garantia de \\nreperfusão, recomenda-se o encaminhamento do paciente para que ele possa, posteriormente, \\nser submetido a cateterismo e, quando indicada, angioplastia. \\nANGIOPLASTIA OU INTERVENÇÃO CORONARIANA PERCUTÂNEA (ICP) \\nA angioplastia pode ser: \\n(1)  Primária: quando é a primeira estratégia de reperfusão a ser utilizada, ou seja, não \\nhá tentativa prévia de reperfusão com trombolíticos; \\n(2)  Resgate: quando a primeira tentativa de reperfusão é pela trombólise química, \\nporém há o insucesso na trombólise \\n(3)   Eletiva/Fármaco-invasiva: quando é realizada em um paciente após uma \\ntrombólise que funcionou – esta é realizada, porquanto não há como se confirmar \\nverdadeiramente o sucesso da reperfusão. \\nANGIOPLASTIA PRIMÁRIA: Essa estratégia é, incomparavelmente, a melhor escolha \\nterapêutica, pois é superior ao uso de trombolíticos e à posterior possibilidade da realização de \\numa angioplastia de resgate ou eletiva. A via de acesso preferível é pela artéria radial, a qual se \\ncorrelacionou a menores taxas de complicações hemorrágicas,  pela qual um stent \\n(preferencialmente farmacológico) deverá ser implantado na referida artéria ocluída que'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 160}, page_content='160 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\ncausou a clínica de IAMCST. Deve ser realizada até, no máximo, 12h, reforçando a ideia de que \\na necrose miocárdica se estabelece após tal período de “janela terapêutica”. \\nANGIOPLASTIA DE RESGATE: nesse caso, faz-se necessário estabelecer critérios para \\nafirmar a falha da trombólise, os quais, geralmente, se dão empiricamente pela clínica ou pela \\neletrocardiografia do paciente. Após 60 a 90 minutos da administração de trombolítico no \\npaciente, se e ste ainda apresentar dor torácica (a qual deve ser mais valorizada quando \\nassociada a outros sintomas, como dispneia, sudorese fria e hipotensão arterial) ou \\npermanência do supra nas referidas derivações ou uma nova elevação (após uma queda inicial) \\npode-se dizer que houve falha na trombólise química e o paciente deve ser submetido a uma \\nangioplastia de resgate em até 180 minutos. Ademais, é importante ressaltar que o indivíduo \\nque mais se beneficia nesse caso é aquele que apresenta IAMCST anterior extenso,  porque \\nexiste uma quantidade muito relevante de músculo que pode ser perdida. \\nANGIOPLASTIA ELETIVA:  esta é recomendada para todos os pacientes em que a \\nestratégia da fibrinólise foi escolhida e realizada com sucesso. Este deve ser feito num período \\nentre 3 a 24h depois da trombólise química, visando um melhor diagnóstico anatômico e \\npossíveis correções de lesões residuais ou falhas pela estratégia anterior escolhida – o que \\ninfluencia diretamente na ocorrência de um reinfarto.8 \\nCIRURGIA DE REVASCULARIZAÇÃO MIOCÁRDICA (CRM) \\nQuando essa estratégia é adotada por uma urgência, sendo uma espécie de “carta na \\nmanga” para situações mais graves, recomenda -se sua realização, num período de 4 a 6 horas \\ndo início do infarto, quando nenhuma das outras 2 terapias de rep erfusão, a trombólise e a \\nangioplastia, sejam viáveis, como por contraindicação, ou falharem. Entretanto, para que o \\npaciente seja submetido à CRM, é necessário que ele apresente uma anatomia coronariana \\nfavorável associada a ocorrência recorrente de isque mia, a choque cardiogênico ou a \\ncomplicações mecânicas do próprio infarto (que serão abordadas posteriormente).   \\nQuando a CRM é realizada de maneira eletiva, dentro do período de 3 a 7 dias após a \\nocorrência do infarto, suas principais indicações são: \\n(1)  Lesão no tronco da coronária esquerda – suspeitar quando o eletrocardiograma \\napresentar o padrão de supra do segmento ST em aVR e infra do segmento ST difuso (demais \\nderivações); \\n(2)    Doença trivascular; \\n(3)    Doença bivascular, mas que há uma oclusão  proximal no ramo interventricular \\nanterior;'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 161}, page_content='161 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n(4)    Doença bivascular associada a disfunção de VE.8 \\n8.3. ALTA HOSPITALAR \\nÉ imprescindível que o paciente receba alta com algumas medicações que o ajudarão na \\natenuação do seu risco cardiovascular e, portanto, na recorrência de um episódio de infarto. \\n1.      Aspirina (AAS) \\n2.      Estatina – seu uso independe dos níveis lipídicos prévios do paciente \\n3.      Betabloqueador \\n4.      Clopidogrel \\n5.      IECA \\nAlém disso, o reforço em relação a mudança de estilo de vida, como a prática de atividade \\nfísica e o consumo de uma dieta adequada, devem ser realizados.8 \\n9. COMPLICAÇÕES \\n9.1. DISFUNÇÃO MIOCÁRDICA \\nA disfunção miocárdica pode ocorrer durante as fases aguda e subaguda da IAMCSST. \\nIsso pode ser transitório (ou seja, atordoamen to miocárdico) ou persistente dependendo da \\nduração da isquemia e integridade da reperfusão. A melhora da função ventricular geralmente \\nocorre após repercussão miocárdica precoce bem -sucedida , mas pode levar semanas e nem \\nsempre acontece. \\n9.1.1. Disfunção ventricular esquerda \\nDisfunção sistólica do VE:  Esta é a consequência mais frequente do IAMCSST e ainda é \\num poderoso preditor independente de mortalidade. É causada por perda miocárdica ou \\ndisfunção isquêmica (atordoamento), em alguns casos pioram pela presença  de arritmias, \\ndisfunção valvar ou complicações mecânicas. A disfunção do VE pode ser clinicamente \\nsilenciosa ou causar insuficiência cardíaca. O diagnóstico é feito pela clínica e técnicas de \\nimagem, mais frequentemente ecocardiografia.10,11 \\nTrombo no VE: a formação de trombo no VE é uma complicação frequente em pacientes \\ncom IAM anterior, mesmo na ausência de aneurisma apical. Para trombos murais, uma vez \\ndiagnosticados, a terapia anticoagulante oral deve ser considerada por até 6 meses, guiada por \\necocardiograma repetido e com consideração do risco de sangramento e necessidade de terapia \\nantiplaquetária concomitante.10,11'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 162}, page_content='162 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nAneurisma do VE: Menos de 5% dos pacientes com IAM transmural grande irão sofrer \\nremodelação adversa com subsequente desenvolvimento  de aneurisma do VE. Os pacientes \\nfrequentemente desenvolvem insuficiência cardíaca, que deve ser tratada de acordo com \\ndiretrizes específicas. A cirurgia pode ser considerada em pacientes com grandes aneurismas e \\ninsuficiência cardíaca não controlada ou a rritmias ventriculares recorrentes não passíveis de \\nablação.10,11 \\n9.1.2. Disfunção ventricular direita \\nO envolvimento do VD ocorre mais frequentemente com IAMCSST de parede inferior. \\nPacientes com infarto do VD podem desenvolver a tríade típica de hipotensão, aus culta \\npulmonar normal e aumento da pressão venosa jugular. Também apresentam mais \\nfrequentemente arritmias ventriculares, bloqueio AV, complicações mecânicas, baixo débito \\ncardíaco e choque. O manejo do VD isquemia inclui reperfusão precoce, com cuidado es pecial \\nna abertura ramos do VD, evitar terapias que reduzam a pré -carga (ou seja, nitratos e \\ndiuréticos) e correção de assincronia AV e/ou bloqueio AV, com estimulação sequencial se \\nnecessário.10,11 \\n9.2. INSUFICIÊNCIA CARDÍACA \\nA insuficiência cardíaca é a complicação mais frequente e uma dos mais importantes \\nfatores prognósticos  em pacientes com IAMCSST. Diagnóstico durante a fase aguda do \\nIAMCSST baseia-se em sintomas típicos, exame físico e radiografia de tórax. A avaliação de risco \\né baseada na classificação Killip. Ao contrário da insuficiência cardíaca crônica, os peptídeos \\nnatriuréticos são de valor limitado para o diagnóstico de insuficiência cardíaca aguda após IM \\ndevido à falta de valores de corte definitivos para diagn óstico nestes pacientes. Determinar o \\nmecanismo de insuficiência cardíaca no paciente com IAMCSST é essencial, visto que interfere \\nprofundamente na conduta. Embora a disfunção sistólica do VE seja a causa mais frequente, \\ndistúrbios hemodinâmicos, bem como distúrbios do ritmo, complicações mecânicas e disfunção \\nvalvar devem ser investigados. Portanto, a avaliação precoce pela ecocardiografia transtorácica \\né obrigatória para avaliar a extensão do dano miocárdico, avaliar as funções e volumes \\nsistólicos e dias tólicos do VE, função valvar e detectar complicações mecânicas. Qualquer \\ndeterioração inesperada do estado clínico do paciente, com evidência de comprometimento \\nhemodinâmico, deve desencadear uma reavaliação clínica, incluindo uma repetição do exame \\necocardiográfico, procurando especificamente evidências de Disfunção do VE, regurgitação \\nmitral ou complicações mecânicas.10,11'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 163}, page_content='163 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n9.2.1. Formas de apresentação \\nCongestão pulmonar : pode variar de leve a moderada (Killip classe 2) para edema \\npulmonar evidente (Killip classe 3), resolver logo após reperfusão e terapia médica, ou evoluir \\npara insuficiência cardíaca crônica.10 \\nHipotensão: é definida como PAS persistente < 90 mmHg. Pode ser devido a diferentes \\ncausas, incluindo disfunção do VE ou VD, baixo débito cardíaco, dist úrbios do ritmo, \\ncomplicações mecânicas, disfunção, hipovolemia ou excesso de medicação. A hipotensão pode \\nser assintomática ou levar à turvação da consciência ou síncope. Se prolongada, a hipotensão \\npode causar disfunção renal aguda ou outras complicações  sistêmicas. Portanto, hipotensão \\ngrave deve ser revertida o mais rápido possível.10 \\nChoque cardiogênico : O choque cardiogênico é definido como hipotensão (PAS < 90 \\nmmHg) apesar do estado de enchimento adequado com sinais de hipoperfusão. Ocorre em 6 -\\n10% de todos os casos de IAMCSST e continua a ser uma das principais causas de morte, com \\ntaxas de mortalidade hospitalar ≥ 50%, podendo chegar a 90%. Choque cardiogênico não \\ncostuma se apresentar antes da admissão; em metade dos casos desenvolve-se nas primeiras 6 \\nh, e em 75% nas primeiras 24 h. Os pacientes geralmente apresentam hipotensão, evidência de \\nbaixo débito cardíaco (por exemplo, taquicardia em repouso, estado mental alterado, oligúria e \\nperiferia fria) e congestão pulmonar. Choque é também considerad o presente se inotrópicos \\nintravenosos e/ou suporte mecânico são necessários para manter uma PAS > 90 mmHg. \\nGeralmente está associada a lesão extensa do VE, mas pode ocorrer no infarto do VD. A \\nmortalidade parece estar associada à sistólica inicial do VE d isfunção e gravidade da \\nregurgitação mitral. Outros parâmetros, como níveis séricos de lactato e creatinina, predizem \\nmortalidade. A presença de disfunção do VD na ecocardiografia precoce também é importante \\npreditor de prognóstico adverso, especialmente no caso de disfunção biventricular.11,12 \\n9.2.2. Manejo \\nCongestão pulmonar : Pacientes com congestão pulmonar e SatO2 < 90% ou pressão \\nparcial de oxigênio (PaO2) < 60 mmHg necessitam de oxigenoterapia e monitoramento de \\nSatO2 para corrigir a hipoxemia, com meta de 9 5%, podendo exigir avaliação gasométrica \\nperiódica. O tratamento farmacológico inicial inclui diuréticos de alça IV (por exemplo, \\nfurosemida 20 - 40 mg IV com doses repetidas em intervalos conforme evolução clínica e \\ndiurese) e, se a pressão arterial permite, nitratos IV, evitando hipotensão ou quedas excessivas \\npressão sanguínea. O uso precoce de betabloqueadores, IECA/ BRAs  são recomendados na \\nausência de hipotensão, hipovolemia ou disfunção renal. O tratamento causal é essencial.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 164}, page_content='164 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nPacientes gravemente si ntomáticos com congestão pulmonar podem também precisar \\nde morfina IV para reduzir a dispneia e a ansiedade, mas o uso rotineiro não é recomendado \\ndevido a preocupações com sua segurança, pois pode induzir náusea e hipopneia. Ventilação \\nnão invasiva por pressão positiva ou cânula nasal de alto fluxo é eficaz no tratamento do edema \\npulmonar e deve ser considerado pacientes com desconforto respiratório (frequência \\nrespiratória > 25 irpm, SatO2 < 90%). Intubação endotraqueal e suporte ventilatório podem ser \\nnecessários em pacientes incapazes de atingir a oxigenação adequada, ou naqueles com excesso \\nde trabalho ou evidência de hipercapnia por exaustão respiratória. A ultrafiltração para reduzir \\na sobrecarga hídrica pode ser considerada em pacientes refratários a diuréticos, especialmente \\nem pacientes com hiponatremia.10 \\nHipotensão: Em pacientes com hipotensão e perfusão normal sem evidência de \\ncongestão ou sobrecarga de volume, carga de volume suave deve ser tentada após descartar \\ncomplicações, como regurgitação mitral, com monitoramento central da pressão. Bradicardia \\nou taquiarritmias devem ser corrigidas ou controladas. Em pacientes com infarto do VD, a \\nsobrecarga de volume deve ser evitada porque pode causar piora hemodinâmica. Se a \\nhipotensão persistir, terap ia inotrópica, preferencialmente com dobutamina, pode ser \\nconsiderada.10 \\nChoque cardiogênico:  O primeiro passo em pacientes com choque cardiogênico é \\nidentificar o mecanismo e corrigir qualquer causa reversível, como hipovolemia, hipotensão \\ninduzida por dr ogas ou arritmias; alternativamente, iniciar o tratamento de possíveis causas \\nespecíficas, como complicações mecânicas ou tamponamento. \\nRecomenda-se o monitoramento invasivo com uma linha arterial. O cateter de artéria \\npulmonar pode ser considerado, a fim de realizar um ajuste cuidadoso das pressões de \\nenchimento e avaliação do débito cardíaco ou em casos de choque de causa inexplicada. A \\nhipovolemia deve ser descartada primeiro e corrigida com oferta de fluidos. A terapia \\nfarmacológica visa melhorar a perf usão dos órgãos aumentando o débito cardíaco e a pressão \\narterial. A terapia diurética é recomendada quando a perfusão adequada é alcançada. \\nGeralmente são necessários agentes inotrópicos intravenosos ou vasopressores para manter \\numa PAS > 90 mmHg e aument ar o débito cardíaco e melhorar a perfusão de órgãos vitais. A \\ndobutamina é a terapia inicial para pacientes com baixo débito cardíaco predominante, \\nenquanto a noradrenalina pode ser mais segura e eficaz do que a dopamina em pacientes com \\nchoque cardiogêni co e hipotensão grave. O levosimendan pode ser considerado uma \\nalternativa, especialmente para pacientes em terapia crônica com betabloqueador, porque seu'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 165}, page_content=\"165 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nefeito inotrópico é independente da estimulação beta -adrenérgica. Os inibidores da \\nfosfodiesterase III não são recomendados em pacientes com IAMCSST. \\nDispositivos mecânicos de assistência do VE têm sido usados em pacientes que não \\nrespondem à terapia, incluindo inotrópicos, fluidos, mas evidências sobre seus benefícios são \\nlimitados. Portanto, suporte c irculatório pode ser considerado como terapia de resgate para \\nestabilizar os pacientes e preservar a perfusão dos órgãos (oxigenação) como uma ponte para \\na recuperação da função miocárdica, transplante cardíaco.10,12,13 \\n9.3. ARRITMIAS \\nArritmias e distúrbios de condução são comuns durante as primeiras horas do IAMCSST \\ne são importantes fatores prognósticos. Apesar do aumento da conscientização e da melhoria \\ndo suporte básico e avançado de vida, a incidência de morte súbita cardíaca, principalmente \\ndevido à taquic ardia ventricular (TV) e fibrilação ventricular (FV) na fase pré -hospitalar, \\npermanece alta. A terapia de reperfusão precoce reduz o risco de arritmias ventriculares e \\nmorte cardiovascular. A presença de arritmias com risco de vida requer um tratamento rápido \\ne revascularização completa em IAMCSST. A evidência de benefícios de drogas antiarrítmicas \\nem pacientes com IAMCSST é limitada e foram demonstrados efeitos negativos de drogas \\nantiarrítmicas na mortalidade precoce. O uso cuidadoso de drogas antiarrítmicas é geralmente \\nrecomendado e opções alternativas de tratamento, como cardioversão elétrica, uma estratégia \\nde 'esperar para ver' para arritmias sem ou com moderada relevância hemodinâmica ou, em \\ncasos selecionados, estimulação cardíaca e ablação por cate ter devem ser considerados. \\nCorreção de desequilíbrios eletrolíticos e tratamento precoce com betabloqueadores, \\nIECA/BRAs e estatinas é recomendado.10,14 \\n9.4. COMPLICAÇÕES MECÂNICAS \\n9.4.1. Ruptura de parede livre \\nA ruptura da parede livre do VE pode ocorrer em < 1% dos pacientes durante a primeira \\nsemana após o infarto transmural e pode apresentar dor súbita e/ou colapso cardiovascular, \\ncom ou sem dissociação eletromecânica. Idade avançada, falta de reperfusão ou atraso da \\nfibrinólise parece estar associada a um aument o da incidência de ruptura cardíaca. O \\ndesenvolvimento de hemopericárdio e tamponamento, levando a um choque profundo súbito, \\ngeralmente é rapidamente fatal. O diagnóstico é confirmado por ecocardiografia. Como a \\nruptura é caracteristicamente serpiginosa a través das diferentes camadas da parede\"), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 166}, page_content='166 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nventricular, o selamento parcial do local rompido pela formação de trombo e do pericárdio pode \\npermitir tempo para a pericardiocentese e estabilização hemodinâmica seguida de cirurgia \\nimediata. Recomenda -se o reparo ventricular com remendo de pericárdio (ou outros \\nmateriais). As taxas de mortalidade são da ordem de 20 -75%, dependendo da condição do \\npaciente e do tamanho e morfologia da ruptura. Em pacientes adequados, a RMC pode \\ncomplementar o diagnóstico identificando a ruptura cardíaca e suas características anatômicas \\npara orientar a intervenção cirúrgica.10 \\n9.4.2. Ruptura do septo interventricular \\nA ruptura do septo ventricular geralmente se apresenta como deterioração clínica de \\ninício rápido com insuficiência cardíaca aguda ou choque cardiogênico, com um sopro sistólico \\nintenso ocorrendo durante a fase subaguda. Pode ocorrer dentro de 24 h a vários dias após o \\nIM e com igual frequência no IAM anterior e posterolateral. O diagnóstico é confirmado pelo \\necocardiograma e Doppler, que irão diferenciar da regurgitação mitral aguda, definir o tamanho \\nda ruptura e quantificar o shunt da esquerda para direita, o que pode ser confirmado com mais \\nprecisão por um Cateter Swan-Ganz. O shunt pode resultar em sinais e sintomas de insuficiência \\ncardíaca direita aguda de início recente. O balão intra -aórtico (BIA) pode estabilizar pacientes \\nem preparação para angiografia e cirurgia. Diuréticos endovenosos e vasodilatadores devem \\nser usados com cautela em pacientes hipotensos. O reparo ci rúrgico pode ser necessário com \\nurgência, mas não há consenso sobre o momento ideal para a cirurgia. A cirurgia precoce está \\nassociada a uma alta mortalidade, relatada como 20-40%, e um alto risco de ruptura ventricular \\nrecorrente, enquanto a cirurgia tardia permite reparo septal mais fácil em tecido cicatricial, mas \\ntraz o risco de extensão da ruptura e morte enquanto espera pela cirurgia. Por esta razão, a \\ncirurgia precoce deve ser realizada em todos os pacientes com insuficiência cardíaca grave que \\nnão responde rapidamente à terapia agressiva, mas o reparo cirúrgico eletivo tardio pode ser \\nconsiderado em pacientes que respondem bem à terapia agressiva para insuficiência cardíaca. \\nFechamento percutâneo do defeito com dispositivos projetados pode em breve s e tornar uma \\nalternativa à cirurgia.10.15 \\n9.4.3. Ruptura do músculo papilar \\nA regurgitação mitral aguda pode ocorrer de 2 a 7 dias após o IAM devido à ruptura do \\nmúsculo papilar ou das cordas tendíneas. A ruptura pode ser completa ou envolver uma ou mais \\ndas cabeças e é de 6 a 12 vezes mais frequente no músculo papilar póstero -medial devido ao \\nseu suprimento sanguíneo ser feito por apenas uma artéria (CD ou CX). A ruptura do músculo'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 167}, page_content='167 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\npapilar geralmente apresenta-se como deterioração hemodinâmica súbita com dispneia aguda, \\nedema pulmonar e/ou choque cardiogênico. Um sopro sistólico é frequentemente subestimado. \\nA ecocardiografia de emergência é a principal forma de realizar o diagnóstico. O tratamento \\nimediato é baseado na redução da pós-carga para reduzir o volume regurgitante e a congestão \\npulmonar. Diuréticos intravenosos e vasodilatador/inotrópico, bem como BIA, podem \\nestabilizar os pacientes em preparação para angiografia e cirurgia. Cirurgia de emergência é o \\ntratamento de escolha, embora tenha alto índice de mo rtalidade (20–25%). A substituição da \\nválvula é frequentemente necessária, mas os casos de reparo bem -sucedido por sutura do \\nmúsculo papilar têm sido cada vez mais relatados e parecem ser uma opção melhor se o \\nprocedimento for realizado por cirurgiões experientes.10,16 \\n9.5. PERICARDITE \\n9.5.1. Pericardite associada ao infarto precoce e tardia \\nA pericardite precoce pós -IAM geralmente ocorre logo após o IAMCSST e é transitória, \\nenquanto a pericardite tardia associada ao infarto (síndrome de Dressler) geralmente ocorre 1 \\na 2 semanas após o IAMCSST e é presumido que sua patogênese seja uma resposta \\nimunomediada desencadeada por dano ao tecido pericárdico causado por necrose miocárdica. \\nTanto a pericardite precoce quanto a tardia são raras na era da intervenção coronariana \\npercutânea primária e geralmente estão relacionadas à reperfusão tardia ou falha reperfusão \\ncoronária e infartos com uma grande área de miocárdio afetado. Os critérios diagnósticos não \\ndiferem daqueles para pericardite aguda incluindo dois dos seguintes critérios: (i) dor torácica \\npleurítica (85-90% de casos); (ii) atrito pericárdico (≤  33% dos casos); (iii) Alterações de ECG \\n(≤ 60% dos casos), com novo supradesnivelamento generalizado do segmento ST, geralmente \\nleve e progressiva, ou depressão PR na fase aguda; e (iv) derrame pericárdico (<_60% dos casos \\ne geralmente leve). A terapia anti -inflamatória é recomendada na pericardite pós -IAMCSST \\ncomo nas síndromes pericárdicas pós -lesão cardíaca para alívio de sintomas e redução de \\nrecorrências. A aspirina é rec omendada como primeira escolha da terapia anti -inflamatória \\npós-IAMCSST na dose de 500–1000 mg a cada 6–8 h por 1–2 semanas, diminuindo a dose total \\ndiária em 250 -500 mg a cada 1 -2 semanas. A colchicina é recomendada como terapia de \\nprimeira linha como adj uvante à terapia com aspirina/anti -inflamatórios não esteróides (3 \\nmeses) e é recomendada para as formas recorrentes (6 meses). Os corticosteroides não são \\nrecomendados devido ao risco de afinamento da cicatriz com o desenvolvimento ou ruptura do'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 168}, page_content='168 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\naneurisma. A pericardiocentese é raramente necessária, exceto nos casos de comprometimento \\nhemodinâmico com sinais de tamponamento.10,17 \\n9.5.2. Derrame pericárdico \\nPacientes pós -IAMCSST com derrame pericárdico que preenchem pericardite os \\ncritérios de diagnóstico devem se r tratados como tendo pericardite. Pacientes sem sinais \\ninflamatórios nos quais é detectado um derrame pericárdico com circunferência > 10 mm ou \\nnaqueles com suspeita de tamponamento, deve ser investigada possível ruptura subaguda por \\necocardiografia ou po r RMC se a ecocardiografia for inconclusiva. A pericardiocentese \\nraramente é necessária. A ecocardiografia detectará e quantificará o tamanho do derrame. Se \\nfor sangue e se acumular rapidamente, a cirurgia exploratória é recomendada.10,17 \\n \\nBOX 24.  \\nDiante dos achados e diagnóstico de Infarto agudo do miocárdio, o paciente foi internado \\nem unidade coronária de terapia intensiva, sendo administrado ácido acetilsalicílico (300 \\nmg/dia), estatina 80mg, betabloqueador (Metoprolol 100 mg), sulfato de morfina (VI) na \\ndose de 3mg diluídos a cada 5 minutos e oxigênio a 100% (3 l/min), por meio de máscara \\nnasal, e nitroglicerina (VI). Realizou-se avaliação refinada da anatomia coronária \\nutilizando-se o SYNTAX que classificou o paciente no tercil de menor complexidade \\n(primeiro tercil), sendo o mesmo encaminhado para o tratamento percutâneo. \\nFoi encaminhado para hemodinâmica para realizar uma angioplastia. Não houve outras \\nintercorrências durante o período que o paciente ficou no hospital. O mesmo teve alta uma \\nsemana depois do procedimento. O paciente foi incentivado a aderir uma dieta saudável \\nassociada a atividade física regular e abandono do tabagismo.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 169}, page_content='169 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nFLUXOGRAMA \\n \\nATC: angioplastia transluminal coronariana; ECG: eletrocardiograma; SCA: síndrome coronariana \\naguda;'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 170}, page_content='170 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\nREFERÊNCIAS: \\n1. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of \\nacute chest pain. Heart. 2005;91(2):229-30. \\n2. Barstow C, Rice M, McDivitt JD. Acute Coronary Syndrome: Diagnostic Evaluation. Am Fam \\nPhysician. 2017;95(3):170-7. \\n3. Laurenti R, Buchalla CM, Caratin CVs Doenças isquêmicas do coração: internações, tempo \\nde permanência e gastos. Brasil, 1993 a 1997. Arq. Bras. Cardiol. 2000; 74 (6): 483-7. \\n4. Cesse EAP, Carvalho EF, Souza WV, Luna CF. Tendência da mortalidade por doenças do \\naparelho circulatório no Brasil: 1950 a 2000. Arq. Bras. Cardiol 2009; 93(5): 490-97. \\n5. Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and highrisk plaque: Part I: Evolving \\nconcepts J Am Coll Cardiol 2005; 46:937- 954. \\n6. Libby P. Molecular basis of acute coronary syndromes. Circulation 1995;91:2844-2850. \\n7. Heeschen C, Dimmeler S, Hamm CW, et al. Serum level of the antiinflammatory cytokine \\ninterleukin-10 is an important prognostic determinant in patients with acute coronary \\nsyndromes. Circulation 2003;107:2109-2114. \\n8. V Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto Agudo do \\nMiocárdio com Supradesnível do Segmento ST. \\n9. Thaler, M.S. ECG Essencial eletrocardiograma na prática diária. 7ª edição. Editora: \\nArtmed;2013. Isquemia e infarto do miocárdio; 219-260. \\n10. Ibanez, B., James, S., Agewall, S., Antunes, M. J.,  et al. (2018). 2017 ESC Guidelines for the \\nmanagement of acute myocardial infarction in patients presenting with ST -segment \\nelevation. European Heart Journal, 39(2), 119–177. \\n11. McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S.,  et al. (2021). 2021 ESC Guidelines for \\nthe diagnosis and treatment of acute and chronic heart failure. European Heart Journal , \\n42(36), 3599–3726. \\n12. Cheng, J. M., Helming, A. M., van Vark, L. C., & Kardys, I., et al. (2016). A simple risk chart for \\ninitial risk assessment of 30 -day mortality in patients with cardiogenic shock from ST -\\nelevation myocardial infarction. European Heart Journal: Acute Cardiovascular Care , 5(2), \\n101–107. \\n13. Hussain, F., Philipp, R. K., Ducas, R. A., Elliott, J.,  et al. (2011). The ability to achieve complete \\nrevascularization is associated with improved in-hospital survival in cardiogenic shock due \\nto myocardial infarction: Manitoba cardiogenic shock registry investigators. Catheterization \\nand Cardiovascular Interventions, 78(4), 540–548. \\n14. Gorenek, B., Blomström Lundqvist, C., Brugada Terradellas, J., Camm, A. J.,  et al. (2015). \\nCardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, \\nACCA, and EAPCI task force. EuroIntervention, 10(9), 1095–1108.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 171}, page_content='171 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VII | SÍNDROME CORONARIANA COM SUPRA DE ST (SCA CSST) \\n15. Topaz, O., & Taylor, A. L. (1992). Interventricular septal rupture complicating acute \\nmyocardial infarction: From pathophysiologic features to the role of invasive and \\nnoninvasive diagnostic modalities in current mana gement. The American Journal of \\nMedicine, 93(6), 683–688. \\n16. Bajaj, A., Sethi, A., Rathor, P., Suppogu, N.,  et al. (2015). Acute Complications of Myocardial \\nInfarction in the Current Era. Journal of Investigative Medicine, 63(7), 844–855. \\n17. Adler, Y., Charron,  P., Imazio, M., Badano, L., & et al. (2015). 2015 ESC Guidelines for the \\ndiagnosis and management of pericardial diseases. European Heart Journal, 36(42), 2921–\\n2964. \\n18. Mello, B.H., et al. Validação da Classificação de Killip e Kimball e Mortalidade Tardia A pós \\nInfarto Agudo do Miocárdio. Arq Bras Cardiol. 2014; 103(2):107-117'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 172}, page_content='172 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nCAPÍTULO VIII  \\nEMERGÊNCIAS HIPERTENSIVAS \\nBruna de Almeida Freixedelo 1 \\nJoão Marcos de Fontes Carneiro 1 \\nPaulo Roberto Matos Neto 1 \\nBenedito Mesley Lima Portela 1 \\nDiego Levi Silveira Monteiro ² \\nDOI: 10.51859/amplla.ceg164.1123-8 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médico cardiologista e intensivista. Hospital do Coração de Sobral. Sobral, Ceará, Brasil.  \\nPERGUNTAS NORTEADORAS \\n1. Qual a diferença entre urgência e emergência hipertensiva? \\n2. Quais são as principais etiologias? \\n3. Quais exames devem ser solicitados aos pacientes com crise hipertensiva? \\n4. Qual a conduta no manejo de uma urgência hipertensiva? \\n5. Qual a conduta geral no manejo de uma emergência hipertensiva?   \\nCASO CLÍNICO \\nHomem, 52 anos, pardo, agricultor. Chega ao departamento de emergência \\nacompanhado da filha após apresentar 3 episódios de vômitos, associado a uma queixa de \\ncefaleia, turvação visual e sonolência. Os sintomas iniciaram há 1 dia. O paciente relata ter sido \\ndiagnosticado com hipertensão há 6 anos, e nega outras comorbidades. Nega etilismo e \\ntabagismo. Faz uso irregular de hidralazina 25mg via oral 2 vezes ao dia, e captopril 50mg 1 vez \\nao dia. \\n1. CONCEITOS E EPIDEMIOLOGIA \\nA hipertensão arterial é uma doença crô nica, de etiologia multifatorial e extremamente \\ncomum no Brasil, sendo mais prevalente em homens e com o aumento da idade. 1 Em razão do \\nenvelhecimento da população e do aumento da prevalência de obesidade, é esperado que em \\ntorno de 33% da população mundial seja acometida por essa condição2.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 173}, page_content='173 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nNo pronto-socorro, de 3% até 25% dos atendimentos são decorrentes de elevação da \\npressão arterial. Estes ocorrem, principalmente, pela inadequação do tratamento \\nambulatorial.3 \\nA crise hipertensiva é definida pelo aumento acentuado da pressão arterial (PA), quando \\na pressão arterial sistólica (PAS) é maior ou igual a 180 mmHg e/ou a pressão arterial diastólica \\n(PAD) é maior ou igual a 120 mmHg. A partir disso, é imprescindível definir o tipo de crise, se é \\numa urgência ou uma emergência, uma vez que a conduta e os riscos são diferentes.1 \\nA diferença é que na emergência hipertensiva (EH) ocorre lesão aguda e progressiva de \\nórgão-alvo (LOA) (e.g. coração, retina, cérebro, rins e vasos sanguíneos), com risco imediato de \\nmorte. Na EH, devemos dar atenção ao quadro clínico, que pode ter manifestações de \\nacometimento renal, cerebrovascular, cardiovascular, de múltiplos órgãos e até mesmo de pré-\\neclâmpsia.1,4 \\nOutro conceito importante é o de pseudocrise hipertensiva (PCH), onde nã o há LOA \\naguda e nem risco de morte iminente. Costuma ocorrer em pacientes já hipertensos, que são \\ntratados (e não controlados) ou não tratados, em que o nível pressórico diverge dos sintomas, \\nisto é, a PA está muito elevada, mas o indivíduo se encontra assintomático ou oligossintomático. \\nA elevação da PA devido a um evento de grande carga emocional, doloroso ou qualquer \\ndesconforto (e.g. tontura rotatória, enxaqueca, cefaleias vasculares, sintomas da síndrome do \\npânico) também se enquadra como PCH.1 \\nNos Pronto-Atendimentos, a crise hipertensiva corresponde de 0,45 a 0,59 de cada 100 \\ncasos atendidos na emergência. Destes, 25% são emergências hipertensivas, sendo o edema \\nagudo de pulmão (EAP) e o acidente vascular encefálico isquêmico (AVEi) os mais prevalent es \\ndas EH.1 \\n2. ETIOPATOGENIA \\nA Pressão Arterial (PA) é uma medida da tensão exercida na parede das artérias pelo \\nfluxo de sangue circulante que pode ser matematicamente representada pela multiplicação do \\nDébito Cardíaco (que é diretamente proporcional ao Volume Sistólico e a Frequência Cardíaca) \\npela Resistência Vascular Periférica. Sua medida é de extrema importância, pois está \\ndiretamente relacionada à situação perfusional de órgãos importantes e, quando \\npatologicamente elevada, ao dano endotelial e orgânico . Assim, a sobrevivência do indivíduo \\nrequer que a pressão seja mantida no leito arterial em todos os momentos, com fino controle \\npara variação de acordo com as atividades exercidas. Para esse fim, o corpo dispõe de alguns'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 174}, page_content='174 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nmecanismos próprios de percepção e regulação de fluxo e pressão que atuam basicamente a \\ncurto e longo prazo.5 \\nO mecanismo de rápida resposta que altera os valores tensionais no controle \\ncardiovascular é a resposta neuro -humoral, efetivada pelos componentes simpático e \\nparassimpático do Si stema Nervoso Autônomo. Os componentes sensoriais -aferentes do \\ncontrole rápido ocorrem pela ativação de diversos barorreceptores especializados localizados, \\npor exemplo, nos seios carotídeos e no arco aórtico. Quando há uma alteração notada por estes \\nreceptores, o barorreflexo é iniciado em resposta para a regulação da PA. Essa ação autônoma \\ncontrola a pressão a nível vascular e cardíaco, modulando o tônus da vasculatura, e alterando o \\ncomponente da pós -carga, além de agir sobre receptores adrenérgicos e mu scarínicos \\ncardíacos, controlando o inotropismo e o cronotropismo. Desta forma ocorre um impacto direto \\ntanto na Resistência Vascular Periférica quanto no Débito Cardíaco.6 \\nEntretanto, existe um obstáculo para o reflexo de regulação de curto prazo: as alterações \\nprolongadas na pressão arterial. Esse prolongamento no valor alterado desloca a sensibilidade \\ndo sistema que compõe a aferência do barorreflexo para um valor -gatilho mais elevado, isto é, \\ndessensibiliza os barorreceptores. Tal explicação justifica o fato de pacientes com Hipertensão \\nArterial Sistêmica (HAS) não possuírem uma normalização para níveis pressóricos fisiológicos \\ncomo uma resposta à PA alterada.5 \\nDe forma congruente, o mecanismo de controle de longo prazo envolve a modulação da \\nvolemia e da ação de vasoconstritores. Esse reflexo é composto por vias que requerem de 24 a \\n48 h para efetivar a sua ação e seu principal órgão efetor é o Rim. O sistema aferente renal \\nocorre pelo aparelho Justaglomerular que realiza o chamado feedback tubuloglomerular. Nesse \\nmecanismo, a mácula densa percebe alterações da perfusão renal pela diminuição ou aumento \\nda Taxa de Filtração Glomerular, controlando de forma parácrina as arteríolas aferentes e \\neferentes e, também, sinalizando para a produção de Renina, quando há um hipofluxo por uma \\nPA média baixa. A Renina é o pontapé inicial do Sistema Renina -Angiotensina-Aldosterona \\n(SRAA), que é uma cascata com diversas substâncias responsáveis, de uma forma geral, por \\naumentar a pressão arterial, tanto pela ação vaso constritora da Angiotensina II, quanto pela \\nretenção hidrossalina promovida pela Aldosterona.5 \\nAssim, diversos sistemas efetores possuem a função de regular positivamente a pressão \\narterial, utilizando-se de componentes que alteram o Débito Cardíaco, com a  ação inotrópica e \\ncronotrópica direta ou a retenção de sódio e água no Túbulo Contorcido Distal, aumentando o \\nvolume efetivo de sangue circulante, ou modulando a Resistência Vascular Periférica no ajuste'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 175}, page_content='175 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\ndo tônus do músculo liso das artérias e arteríolas, seja por ação adrenérgica direta ou pela ação \\nde outros vasoconstritores. \\nPor meio da compreensão dos sistemas regulatórios, a fisiopatologia da Hipertensão \\nArterial Sistêmica pode ser esclarecida como sendo um desbalanço dos componentes neuro -\\nhumorais. A  desregulação inicial pode ocorrer por um aumento generalizado do Débito \\nCardíaco e da Resistência Vascular Periférica, como, por exemplo,  em situações de \\nexacerbações adrenérgicas (Feocromocitoma; uso de substâncias simpaticomiméticas, como as \\nanfetaminas). O aumento do débito cardíaco pode estar relacionado à sobrecarga volêmica (ex.: \\nIngesta excessiva de sal, glomerulonefrites, doença renovascular, etc.), e até mesmo por \\nproblemas sistêmicos renais, suprarrenais, hormonais, que são capazes de afetar o feedback \\ntubuloglomerular, o S.R.A.A. e até mesmo o endotélio vascular (ex.: Estenose da Artéria  Renal, \\nHiperaldosteronismo Primário, Acromegalia, Aterosclerose, etc).6 \\nA H.A.S. pode causar complicações quando não tratada. Tais complicações se traduzem \\nna forma de lesões orgânicas, ou de órgão alvo, que variam conforme a velocidade e o grau de \\ninstalação da hipertensão. \\nOs órgãos possuem um fino controle de autorregulação de fluxo arterial. Tal qual o já \\ncitado feedback tubuloglomerular, a modulação do fluxo orgânico varia de acordo com o estado \\nde perfusão dos órgãos, e esta manutenção permite um fluxo fisiológico, até certo ponto, \\nconstante. A autorregulação se dá pela alteração do tônus das arteríolas que suprem o órgão, \\nou seja, um aumento da PAM induz a  vasoconstrição reflexa, “protegendo” o órgão do \\nhiperfluxo, e a queda da PAM causa uma vasodilatação como resposta, mantendo o fluxo \\nconstante nessa situação.7 \\n𝑃𝐴𝑀 = 𝑃𝐴𝑆 +  2 ∗ 𝑃𝐴\\n3  \\nTodavia, existe um limite para esse reflexo: ocorre que o fluxo só pod e ser mantido \\nquando a PAM está dentro de uma faixa de variação passível de controle, que em indivíduos \\nnormotensos, por exemplo, se encontra entre 60 e 120 mmHg. Dessa forma, uma hipotensão \\nsevera (PAM < 60 mmHg), por exemplo, não consegue ser superada po r este mecanismo, \\nfazendo com que a hipoperfusão se mantenha mesmo que uma vasodilatação máxima seja \\nexercida. E, de forma semelhante, um aumento superior ao limite máximo da faixa de regulação \\n(PAM> 120 mmHg) não pode ser corrigido pelo reflexo, que mesmo  no ápice da sua \\nvasoconstrição resposta, não impede o hiperfluxo deletério para o órgão. Assim ocorre, por'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 176}, page_content='176 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nexemplo, na eclâmpsia e na criança com Glomerulonefrite Pós -Estreptocócica, que são \\npreviamente normotensos e acabam sendo acometidos pela brusca elevação pressórica.3 \\nNo Hipertenso Crônico, como seus níveis pressóricos são habitualmente mais elevados, \\na faixa de variação para a autorregulação do fluxo orgânico também se encontra alterada para \\nvalores mais elevados. Por exemplo, no indivíduo com HAS, este reflexo consegue manter o \\nfluxo constante quando a PAM está em um nível entre 120 a 160 mmHg. Por isso, em pacientes \\nhipertensos de longa data, situações de hiperfluxo, como a Encefalopatia Hipertensiva, por \\nexemplo, só ocorrerão em níveis tensionais extremamente elevados (PAM > 160 mmHg), já que \\nseu intervalo de controle está deslocado. Da mesma forma, valores levemente diminuídos na \\nPAM (PAM < 120 mmHg), nesses pacientes, já podem acarretar situações de hipoperfusão. \\nDestarte, é possível perceber que  o risco de uma situação deletéria não só depende dos níveis \\npressóricos, mas também da situação do indivíduo e de sua história.3 \\nTabela 1 - Emergências Hipertensivas  \\nEmergências Hipertensivas \\nNeurológicas Encefalopatia Hipertensiva \\nHemorragia Intraparenquimatosa \\nHemorragia Subaracnóide \\nAVCI \\nCardiovasculares Edema Agudo de Pulmão \\nSíndrome Coronariana Aguda \\nDissecção Aguda de Aorta \\nCrises Adrenérgicas Feocromocitoma \\nIngestão de simpaticomiméticos \\nGestacionais Eclâmpsia \\n \\nTabela 2 - Emergências Hipertensivas \\nUrgências Hipertensivas \\nCardiovasculares Insuficiência Coronariana Aguda \\nInsuficiência Cardíaca \\nAneurisma de Aorta \\nHipertensão Acelerada Maligna \\nNeurológicas AVCI* \\nRenais Glomerulonefrites agudas \\nGestacionais Pré-Eclâmpsia \\n(Tabela 1 e 2 - Referência 3)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 177}, page_content='177 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\n3. QUADRO CLÍNICO \\n3.1. APRESENTAÇÃO GERAL \\nNas emergências hipertensivas, as manifestações ocorrerão de acordo com o órgão-alvo \\nacometido pela elevação níveis pressóricos. \\n3.2. ENCEFALOPATIA HIPERTENSIVA \\nO cérebro tem um mecanismo próprio de regulação do fluxo sanguíneo, a fim de evitar \\nque oscilações sistêmicas causem prejuízo. No entanto, diante de uma súbita e grave elevação \\nda pressão arterial (PA), esse mecanism o é excedido, de modo que a pressão sanguínea causa \\numa brecha na barreira hematoencefálica. Logo, o fluido vascular extravasa, levando ao \\ndesenvolvimento de edema cerebral. Isso, por sua vez, gera manifestações clínicas, como \\ncefaleia, vômitos, náuseas, confusão mental, letargia até convulsões e coma.3,8 \\nAlterações visuais, como escotomas visuais e turvação da visão podem ocorrer. Além \\ndisso, ao exame físico, o paciente pode apresentar alteração do nível de consciência e, ao exame \\ndo fundo de olho, papiledema, hemorragia retiniana e exsudatos.3,8 \\n3.3. ACIDENTE VASCULAR ENCEFÁLICO \\nNo Acidente vascular encefálico hemorrágico (AVEh), geralmente, o paciente apresenta \\numa cefaleia intensa e súbita. Esta pode ser acompanhada de convulsões, rebaixamento do nível \\nde con sciência, vômitos, déficit neurológico focal súbito, como afasia, hemianopsia e \\nhemiparesia. Na hemorragia subaracnoide (HSA), o paciente, na maioria dos casos, descreve a \\ncefaleia como a pior da sua vida (“cefaleia em trovoada”), também costuma causar vôm itos, \\nnáuseas, além dos outros sintomas descritos anteriormente, sendo os déficits focais menos \\nfrequentes.9,10 \\nNo acidente vascular encefálico isquêmico (AVEi), os achados mais preditivos são \\nparesia facial, desvio ou fraqueza do braço e distúrbio da fala . O nível de consciência costuma \\nnão estar alterado, mas, se estiver, o diagnóstico não pode ser descartado.11 \\n3.4. SÍNDROME CORONARIANA AGUDA \\nO quadro clínico pode ser visto detalhadamente no capítulo de SCA. No entanto, vale \\ndescartar que a isquemia cardíaca aciona um reflexo da elevação da pressão arterial. Visto isso, \\no aumento da resistência vascular periférica piora a isquemia e, consequentemente, a angina,'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 178}, page_content='178 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\numa vez que intensifica a demanda do miocárdio por oxigênio. Dessa forma, a redução da \\npressão visa diminuir a pós-carga.1,3 \\n3.5. DISSECÇÃO AÓRTICA AGUDA \\nA Dissecção Aguda de Aorta (DAA) é uma emergência com gravidade diretamente \\nproporcional à Pressão Arterial Média do indivíduo acometido. Isso se deve ao fato de que a \\ndissecção da aorta representa uma lesão  em ruptura da camada íntima do vaso, fazendo com \\nque o sangue adentre o espaço entre a íntima e a média, um espaço denominado de “falsa-luz”. \\nPor vezes o sangue pode percorrer esse caminho não fisiológico e acabar retornando à luz do \\nvaso em outra perfuração da camada íntima. Assim, como os fatores etiopatogênicos incluem a \\nfraqueza da parede do vaso e a força de cisalhamento, que aumenta com a pressão intraluminal, \\no quadro clínico da DAA está quase sempre relacionado com uma PA elevada. \\nDe uma forma gera l, é extremamente importante considerar a Dissecção de Aorta em \\npacientes com dor precordial súbita, de forte intensidade e PA elevada. A dor é comumente \\ndescrita como abrupta ou aguda e “lancinante”, isto é, como se uma lança atravessasse o peito \\ndo pacie nte, podendo irradiar para as costas e para a região lombar, além de acompanhar \\nsudorese, náuseas e palidez cutânea. O caráter agudo e migratório da dor ajuda no diagnóstico \\ndiferencial da dor torácica. A diferença pressórica entre membros acontece em cerc a de 50% \\ndos casos, pode haver, também, pulso assimétrico, sopro de insuficiência aórtica, sinais de \\ntamponamento cardíaco (hipofonese de bulhas, estase jugular e pulso paradoxal) e, menos \\nfrequentemente, disfagia e rouquidão aguda.1,3 \\n3.6. EDEMA AGUDO DE PULMÃO \\nO Edema Agudo de Pulmão (EAP) é uma emergência associada à Insuficiência Cardíaca \\nAguda (ICA), ocorrendo, de forma geral, quando um aumento importante da pós -carga gera \\numa sobrecarga pressórica, aumentando o estresse e o consumo de Oxigênio pelo miocárd io \\ninsuficiente. No geral, o EAP acompanha quadros de disfunção diastólica, onde a queda do \\ndébito se deve primariamente a uma dificuldade de enchimento ventricular por redução da \\ncomplacência do ventrículo.3 \\nOs principais achados nesse tipo de emergência hipertensiva incluem: dispneia, \\nortopneia, uso de musculatura acessória, estertores crepitantes difusos à ausculta pulmonar, \\noximetria de pulso < 90%, ansiedade, sudorese, má perfusão periférica e cianose.3'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 179}, page_content='179 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\n3.7. CRISES ADRENÉRGICAS \\nAs crises de estado hiperadre nérgico são quadros agudos causados por excesso de \\nfunção catecolaminérgica, como ocorre, por exemplo, na crise do Feocromocitoma. Este tumor \\nhipersecretante de catecolaminas causa hipertensão arterial severa associada a sudorese, \\ntaquicardia e fadiga. Out ro fator etiológico importante da crise adrenérgica é o uso de \\nsubstâncias simpaticomiméticas (ex.: cocaína, anfetaminas). O quadro abrupto de elevação \\npressórica pode causar uma encefalopatia hipertensiva ou mesmo um Edema Agudo de Pulmão. \\nNo geral, no qu adro clínico é possível observar que, dentre os sinais e sintomas do paciente, \\nexistem sinais adrenérgicos clássicos da crise como taquicardia, sudorese, e midríase.³ \\n3.8. ECLÂMPSIA E PRÉ-ECLÂMPSIA \\nA Eclâmpsia é uma complicação grave da gestação, sendo descrita como uma síndrome \\ncomposta por Hipertensão Arterial, Edema, Proteinúria e Encefalopatia Hipertensiva que \\naparece por volta da 21ª semana de gestação. A fisiopatologia ainda não é muito bem \\nesclarecida, mas acredita-se que um evento inicial de hipoperfusão placentária gera isquemia \\nplacentária e causa um desequilíbrio entre a produção de fatores inflamatórios e pró -\\ncoagulantes (Tromboxano A2, leucotrienos e citocinas). Quando há um estado de risco \\npotencial de evolução para um quadro de eclâmpsia, como elevação dos níveis pressóricos, \\nepigastralgia, encefalopatia, proteinúria, trombocitopenia, edema de papila ou exsudatos \\nretinianos, está classificada a Pré-Eclâmpsia. \\nEssas manifestações são mais comuns em primíparas, e um aumento da PA>170x100 \\nmmHg em uma mulher inicialmente normotensa já é capaz de desencadear alguns sinais e \\nsintomas da síndrome. De um modo geral, o quadro clínico apresentado pela gestante, além da \\nPressão Arterial elevada, envolve sinais  e sintomas de alguma complicação, como o \\naparecimento de edema de  membros, proteinúria e sinais de Encefalopatia Hipertensiva, por \\nexemplo.1 \\n3.9. HIPERTENSÃO ACELERADA/MALIGNA \\nÉ um tipo de crise que envolve lesões vasculares progressivas, sobretudo acometendo  \\nrins e retinas. Frequentemente evolui com EH (emergência hipertensiva). Antes o termo \\n“maligna” era empregado quando o paciente apresentava papiledema (Grau 4 da classificação \\nde Keith -Wagener), enquanto “acelerada” se referia a alterações até Grau 3 (hem orragias'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 180}, page_content='180 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nretinianas e exsudatos ao exame do fundo de olho). Hodiernamente, por terem prognósticos \\nparecidos, são descritas juntas.1,3 \\nA população negra é a mais afetada. As manifestações incluem cefaleia, turvação visual, \\nnoctúria, astenia e alteração da função renal.1,3 \\n4. DIAGNÓSTICO E EXAMES COMPLEMENTARES \\n4.1. EXAME FÍSICO \\nA primeira medida empregada deve ser a aferição da pressão arterial. Esta deve ser \\navaliada nos dois braços, com o paciente deitado e em pé, se possível. Desse modo, a pressão \\narterial deve s er aferida continuamente, enquanto a estabilização do quadro, sendo \\npreconizado um mínimo de três aferições em situações ideais. Além disso, é importante \\nverificar a simetria, regularidade e amplitude dos pulsos nos membros inferiores e \\nsuperiores.1,3  \\nÉ importante buscar sinais de insuficiência cardíaca, verificar a presença de taquipneia, \\nestase jugular, crepitações pulmonares, 3ª bulha, ictus desviado, hepatomegalia e edema de \\nmembros inferiores.3 \\nNa sequência, utilizamos o exame neurológico como uma importante etapa da avaliação \\ndo paciente hipertenso, em decorrência dos possíveis acometimentos neurológicos nos \\nquadros de crises hipertensivas. Deve -se avaliar o nível de consciência e orientação tempo -\\nespaço do paciente, bem como a presença de sinais de i rritação meníngea (sinais de Kernig ou \\nLasegue) ou de déficits focais. Além disso, é importante examinar os campos visuais e realizar \\na fundoscopia.3 \\nPor fim, o profissional de saúde deve procurar sinais clínicos característicos, baseado na \\nprincipal hipótese diagnóstica. Por exemplo, quadros de dissecção aguda de aorta costumam se \\napresentar de forma bem típica, com assimetria de pulsos, pressão arterial divergente nos dois \\nbraços, sopros de regurgitação aórtica e sinais de tamponamento cardíaco, e massas pulsáteis.3'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 181}, page_content='181 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nBOX 25.  \\nAo exame físico, paciente apresenta-se em estado geral regular, letárgico, orientado \\ntemporal e espacialmente, afebril, acianótico, anictérico, normocorado e sem edema. \\nGlasgow:15; FC: 103bpm; FR: 19irpm; PA: 230/145mmHg (PAM=173mmHg). Ausculta \\ncardíaca com ritmo cardíaco regular, em dois tempos, bulhas normofonéticas, sem sopros. \\nAparelho respiratório com murmúrio vesicular presente, sem ruídos adventícios. \\nExtremidades bem perfundidas, com pulsos periféricos palpáveis e amplos. Exame \\nneurológico sem déficits neurológicos focais. Fundoscopia evidenciou edema do disco \\nóptico bilateralmente, com margens borradas e hiperemiadas, sugestivo de papiledema. \\n \\n4.2. EXAMES COMPLEMENTARES GERAIS \\n4.2.1. Exames Laboratoriais \\nAvaliação de função renal, eletrólitos, hemograma, sumário de urina e coagulograma são \\nimportantes para avaliar possíveis fontes de descompensação do quadro hipertensivo (e.g. \\ninsuficiência renal, distúrbios hidroeletrolíticos, anemia severa e infecções). Desse modo, estes \\ndevem ser solicitados em todos os pacientes que apresentam o pico hipertensivo.3, 12  \\n4.2.2. Eletrocardiograma (ECG) \\nO ECG é uma ferramenta importante no direcionamento do raciocínio clínico, uma vez \\nque pode apresentar isquemia, sobrecarga de câmaras, bloqueios de condução, ou ainda, sinais \\nde pericardite.3, 12  \\nNesse contexto, nos casos de dissecção aórtica, eventualmente, pode haver sinais de \\nhipertrofia ventricular esquerda, decorrentes da hipertensão arterial de longa data, entretanto, \\na avaliação eletrocardiográfica na dissecção pode não apresentar alterações relevantes. Apesar \\ndisso, a ausência de alterações isquêmicas é útil para afastar infarto do miocárdio.6 \\nContudo, vale ressaltar que, anormalidades eletrocardiográficas agudas podem est ar \\npresentes na dissecção aórtica, sobretudo, em parede inferior, quando há acometimento de \\nóstio coronariano direito, apesar de não ser tão comum. Um exemplo desse cenário é o \\nsupradesnivelamento do segmento ST em derivações inferiores, que pode ser uma dissecção de \\naorta, se acompanhado de quadro clínico compatível.3,6'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 182}, page_content='182 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\n4.2.3. Radiografia de tórax (RX de tórax)  \\nEste exame pode apresentar sinais de congestão pulmonar, derrame pleural e \\ncondensações localizadas nos quadros de crises hipertensivas, a depender da etiologia.3, 12 \\nSob esse viés, nos quadros de dissecção de aorta, a radiografia costuma apresentar \\nalterações inespecíficas, como um alargamento do mediastino e um contorno aórtico anormal. \\nAlém disso, sinais de derrame pericárdico e pleural são comuns nesses quadros.3 \\n4.3. EXAMES COMPLEMENTARES BASEADOS NA SUSPEITA CLÍNICA \\n4.3.1. Marcadores de Necrose Miocárdica: troponinas ou CKMB. \\nSão solicitados nas apresentações cardiológicas agudas, nos quadros sugestivos de \\nisquemia miocárdica, como pacientes com dor torácica de apresentação aguda ou pacientes \\ncom sinais de falência cardíaca aguda.3, 12 \\n4.3.2. Marcadores de hemólise: reticulócitos, haptoglobina, bilirrubina indireta e \\ndesidrogenase láctica. \\nSão solicitados na suspeita de HAS maligna, quando há presença de papiledema ou \\noutros sinais sugestivos desse quadro.3 \\n4.3.3. Gasometria arterial \\nÉ útil em pacientes dispneicos, quando se suspeita de insuficiência respiratória.3 \\n4.3.4. BNP ou NT-proBNP \\nPode ser solicitado na suspeita de insuficiência cardíaca associada a edema agudo de \\npulmão hipertensivo.3, 12 \\nNesse contexto, valores de BNP acima de 400pg/ml ou NT-proBNP acima de 2000pg/ml \\nsão altamente sugestivos de insuficiência cardíaca, a qual, no contexto das crises hipertensivas, \\npode surgir como fator desencadeante ou como consequência do quadro.3 \\n4.3.5. Tomografia computadorizada (TC) de crânio sem contraste \\nDeve ser solicitada nos quadros neurológicos agudos, com diminuição do nível de \\nconsciência ou presença de déficits neurológicos focais. 3, 12  \\nDesse modo, a TC de crânio pode sugerir o diagnóstico de encefalopatia hipertensiva se \\nhouver leucoencefalopatia posterior com acometimento predominante da substância branca \\nparieto-occipital bilateral. Por outro lado, este exame possibilita ainda o diagnóstico diferencial \\nde outras doenças com quadro cl ínico semelhante, como é o caso dos acidentes vasculares'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 183}, page_content='183 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\ncerebrais. Sob esse viés, a TC de crânio possibilita a definição do tipo de AVE e o território \\nenvolvido, de modo que o tipo isquêmico representa 85% dos casos. Por fim, é válido salientar \\nque a ressonância magnética é mais sensível do que a TC para os infartos incipientes, contudo, \\nem virtude de sua disponibilidade mais restrita, a tomografia acaba sendo mais utilizada. 1, 3, 13, \\n14 \\n4.3.6. Punção liquórica \\nDeve ser solicitada nos pacientes com alta suspeita de acometimento neurológico, \\nporém com TC de crânio sem alterações compatíveis. Dessa forma, avalia -se possíveis \\nalterações na composição do líquor, dosando glicorraquia, proteinorraquia, celularidade total \\ne diferencial, cultura do líquor, dentre outros. Uma alteração liquórica relacionada à crise \\nhipertensiva é a hemorragia subaracnóidea, que confere ao material presença de eritrócitos e \\naspecto xantocrômico .3 \\n4.3.7. Ecocardiografia transtorácica \\nO ecocardiograma transtorácico pode ser útil em situações especia is, como na \\ninsuficiência cardíaca, para avaliar fração de ejeção ventricular e disfunção de prótese valvar.3 \\nEsse exame pode mostrar sinais de dissecção aórtica, apesar dessa modalidade ter \\nsensibilidade total de 60 a 85%. Além disso, ele pode evidenciar sinais de insuficiência cardíaca, \\natravés de hipocinesia ou acinesia segmentar na isquemia.6, 12  \\n4.3.8. Ecocardiografia transesofágica, tomografia helicoidal, angiorressonância e \\narteriografia \\nEsses métodos englobam diferentes possibilidades de invest igação para quadros com \\nsuspeita de dissecção de aorta, para confirmar ou excluir o diagnóstico.3 \\nSob esse viés, merecem destaque o ecocardiograma transesofágico e a TC helicoidal. O \\nprimeiro apresenta sensibilidade de até 98%, sendo um excelente exame par a os pacientes na \\nsala de emergência. Por outro lado, a tomografia helicoidal atinge excelente acurácia, e \\napresenta vantagem perante o ecocardiograma transesofágico na rapidez de execução, \\nentretanto, sua disponibilidade nos pronto-atendimentos ainda é restrita.3,6 \\n4.3.9. Ultrassonografia (USG)  dos Rins \\nA USG renal deve ser solicitada quando há sinais de insuficiência renal, uropatia \\nobstrutiva, nefrolitíase, ou ainda, suspeita de estenose de artéria renal, como possível etiologia \\ndo pico hipertensivo.12'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 184}, page_content='184 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\n4.3.10. Triagem de Drogas na Urina  \\nDeve ser solicitada em casos de suspeita de intoxicação por uso de metanfetaminas ou \\nde cocaína.12  \\nBOX 26.  \\nDiante do quadro clínico apresentado pelo paciente, a equipe médica concluiu que se \\ntratava de uma emergência hipertensiva. Nesse sen tido, a principal hipótese diagnóstica \\npara essa situação foi encefalopatia hipertensiva. Dessa forma, foram solicitados os \\nseguintes exames complementares para prosseguir a investigação e realizar o manejo \\nadequado: \\n• Eletrocardiograma: ritmo sinusal com sobrecarga de ventrículo esquerdo.  \\n• Radiografia de tórax: sem alterações.  \\n• Exames laboratoriais: hemograma, ureia, creatinina, eletrólitos e sumário de \\nurina dentro dos parâmetros da normalidade.  \\n• Tomografia computadorizada de crânio sem contraste: áreas hip odensas, \\nsugerindo edema cerebral difuso e edema de substância branca parieto -occipital \\nbilateral. Sem evidências de acidente vascular encefálico. \\nDiante dos resultados acima, a hipótese de encefalopatia hipertensiva foi confirmada, \\ne o paciente foi intern ado, para ser devidamente tratado. Entretanto, durante a internação, \\no paciente evoluiu com uma crise convulsiva.  \\n \\n5. CONDUTA \\n5.1. Manejo Geral das Crises Hipertensivas \\nÉ importante identificar precocementeos  pacientes em emergência hipertensiva, uma \\nvez que a lesão de órgão -alvo (LOA) gera risco iminente de morte. Nesse contexto, cabe \\ndiferenciar os quadros de pseudocrises hipertensivas (PCH), quando há uma PA aumentada, \\nsem, entretanto, haver comprometimento de órgão-alvo. Dessa forma, é comum a presença de \\nfatores associados à descarga adrenérgica, a exemplo de ansiedade, medo, cefaleia e dores de \\nforma geral. Nesses casos, drogas anti -hipertensivas não estão indicadas, de forma que a \\nconduta inicial deve se r direcionada à condição principal, com manejo sintomático (e.g. \\nanalgésicos, ansiolíticos).3'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 185}, page_content='185 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nEm seguida, excluindo-se os casos de pseudocrise hipertensiva, é importante identificar \\nos pacientes com lesões de órgão-alvo agudas, e manejá-los adequadamente, a fim de diminuir \\na morbimortalidade desses casos.3 \\n5.1.1. Manejo Geral das Urgências Hipertensivas \\nNas urgências hipertensivas não há lesão aguda e progressiva de órgão -alvo, de modo \\nque, apesar dos níveis pressóricos elevados, preconiza-se o início da conduta anti-hipertensiva \\napós um período de observação do paciente em ambiente calmo, a fim de afastar os casos de \\nPCH, os quais exigem apenas manejo sintomático, como já citado anteriormente.1 \\nEm seguida, para a redução aguda da pressão arterial, utiliza -se o cap topril ou a \\nclonidina, os quais devem ser administrados por via oral (VO).1  \\n \\nTabela 3 - Terapia anti-hipertensiva na Urgência Hipertensiva \\nFármaco Posologia Pico de ação \\nCaptopril 25-50 mg VO 60 a 90 min \\nClonidina 0,1-0,2 mg VO 30 a 60 min \\n (Referência 1) \\n \\n5.1.2. Manejo Geral das Emergências Hipertensivas \\nNas emergências hipertensivas, a lesão aguda e progressiva de órgãos -alvo apresenta \\num risco iminente de morte, de modo que a redução da PA deve ser feita de forma rápida e \\nprecisa nessas situações, a fim de impedir a progressão da LOA e reduzir a morbimortalidade \\nnesses casos. 1 \\nSob esse viés, esses pacientes devem ser admitidos, preferencialmente, em unidade de \\nterapia intensiva (UTI), e tratados com anti -hipertensivos parenterais. Deve -se estabilizar os \\nórgãos-alvo afetados com intervenções específicas, além da reduzir a pressão arterial. Realizar \\num monitoramento cuidadoso, para evitar a hipotensão, evitando a isquemia tecidual. Em \\ntermos práticos, não se deve reduzir a PA diastólica para níveis abaixo de 100-110 mmHg.1, 3, 12 \\nAs  metas terapêuticas nas emergências hipertensivas são as seguintes:  \\n1. Reduzir 25% da PA média na 1ª hora;  \\n2. Manter a PA em torno de 160/100-110 mmHg nas próximas 2 a 6 horas;'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 186}, page_content='186 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\n3. Manter a PA em níveis próximos de 135/85 mmHg no período das 24 -48 horas \\nsubsequentes.13, 15 \\nNo que se refere às drogas utilizadas nessas situações, existem diversos anti -\\nhipertensivos parenterais que podem ser utilizados, de modo que a escolha deve ser baseada \\nno quadro clínico do paciente e no órgão-alvo acometido. Sob esse viés, a medicação ideal deve \\npossuir curta meia-vida, com o intuito de possibilitar a titulação cuidadosa da PA, e mensurar a \\nresposta terapêutica do paciente.1, 12 \\nEntretanto, de maneira geral, o fármaco utilizado na maioria  das emergências \\nhipertensivas é o nitroprussiato de sódio, um potente vasodilatador arterial e venoso. Este deve \\nser administrado em infusão contínua, na dose de 0,25 -10 mg/kg/min. Esse medicamento \\npossui início de ação imediato, e age diminuindo a pré e a pós -carga, melhorando a função \\nventricular esquerda e reduzindo a demanda miocárdica por oxigênio. Todavia, deve ser \\nressaltado o risco de intoxicação por cianeto e de hipotensão grave com o uso dessa substância, \\nalém de náuseas e vômitos serem efeitos colaterais comuns. Deve ser utilizada com cautela em \\nnefropatas e hepatopatas, em virtude da sua via de metabolização e excreção ser, \\npredominantemente, hepática e renal, respectivamente. Por fim, pacientes com pressão \\nintracraniana (PIC) aumentada também devem fazer o uso do nitroprussiato com cautela, uma \\nvez que pode haver um aumento adicional da PIC.1,3 \\n \\nTabela 4 - Anti-hipertensivos parenterais e indicações \\nFármacos  Posologia Indicações \\nNitroprussiato de Sódio \\n(Vasodilatador arterial e \\nvenoso) \\nInfusão contínua IV \\n0,25-10mg/kg/min \\nEmergências hipertensivas \\nem geral. \\nNitroglicerina \\n(Vasodilatador arterial e \\nvenoso) \\nInfusão contínua IV \\n5-15mg/h \\nInsuficiência coronariana. \\ninsuficiência ventricular \\nesquerda com EAP. \\nMetoprolol (Beta-\\nbloqueador seletivo) \\n5mg IV; repetir 10/10min, se \\nnecessário, até 20mg \\nInsuficiência coronariana, \\ndissecção aguda de aorta.  \\nEsmolol  (Beta-bloqueador \\nseletivo) \\nDose de ataque: 500ug/kg IV \\nInfusão intermitente IV 25-\\n50 ug/kg/min \\nDissecção aguda de aorta, \\nhipertensão pós-operatória \\ngrave. \\n*Fentolamina (Alfa-\\nbloqueador) \\nInfusão contínua IV \\n1-5mg, máximo de 15mg \\nExcesso de catecolaminas.  \\nHidralazina \\n(Vasodilatador de ação \\ndiret) \\n10-20mg IV OU \\n10-40 mg IM 6/6h \\nEclâmpsia.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 187}, page_content='187 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nFármacos  Posologia Indicações \\nDiazóxido (Vasodilatador \\nda musculatura lisa \\narteriolar) \\nInfusão IV 10-15min \\n1-3mg/kg \\nMáximo: 150mg \\nEncefalopatia Hipertensiva. \\n*Fenoldopam (Agonista \\nseletivo dopaminérgico) \\nInfusão contínua IV \\n0,1-1,6ug/kg/min \\nInsuficiência renal aguda.  \\n*Nicardipina (Bloqueador \\ndos canais de cálcio) \\nInfusão contínua IV \\n5-15mg/h \\nAVE, encefalopatia \\nhipertensiva, insuficiência \\nventricular esquerda com \\nEAP.  \\n*Labetalol (Alfa e beta-\\nbloqueador) \\nDose de ataque: 20-80 mg \\nIV; 10-10 min \\nInfusão contínua IV: \\n2mg/min \\nMáximo: 300mg/24h \\nAVE, dissecção aguda de \\naorta.  \\nFurosemida 20-60mg IV Insuficiência ventricular \\nesquerda com EAP, estados \\nhipervolêmicos.  \\n*Não disponíveis no Brasil \\n(Referência 1) \\n5.2. Encefalopatia Hipertensiva \\nO tratamento nos pacientes com encef alopatia hipertensiva deve ser baseado em uma \\nredução lenta e gradual da PA, uma vez que reduções intensas e rápidas podem gerar \\nhipoperfusão cerebral.1,6 \\nInicialmente, deve -se fornecer o suporte clínico adequado ao paciente, protegendo as \\nvias aéreas de v ômitos e aspiração, realizar a proteção das vias aéreas por meio da intubaçáo \\norotraqueal, se necessário, monitorar os sinais vitais, prover oxigênio e disponibilizar um \\nacesso venoso de grande calibre.3 \\nNo que se refere à terapia anti -hipertensiva, recomenda-se o uso do nitroprussiato de \\nsódio para a conduta anti -hipertensiva inicial, seguido do uso de medicamentos orais, para o \\nseguimento do paciente. Este é administrado em infusão intravenosa contínua, com doses de \\n0,25 a 10 mg/kg/min. Existem alternativ as superiores ao nitroprussiato (e.g. nicardipina, \\nlabetalol), entretanto, elas não estão disponíveis no Brasil. Nesse contexto, é preconizado que \\nhaja uma redução de, no máximo, 25% da PA média nas primeiras 2 horas, ou ainda que se \\natinjam níveis pressóricos na faixa de 160/100-110 mmHg.1, 6, 12 \\nDrogas anticonvulsivantes podem ser necessárias, se houver convulsões reentrantes ou \\nestado de mal epiléptico. Durante a crise, deve ser administrado 2 mg por minuto de diazepam \\nintravenoso, até que se atinja uma dose de 10 a 20mg. Em seguida, prescreve -se a fenitoína,'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 188}, page_content='188 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\npara a prevenção de novas crises. Esta deve ser administrada intravenosa em infusão contínua, \\nna dose de 15 a 30 mg/kg, diluída em soro fisiológico, com uma taxa de infusão máxima de \\n50mg/minuto.3 \\nPor fim, se deve tratar as condições associadas, evitando hipoxemia e distúrbios \\nhidroeletrolíticos, os quais podem piorar a encefalopatia.3 \\n5.3. Acidente Vascular Encefálico \\nQuanto ao manejo das emergências hipertensivas durante acidentes vasculares \\nencefálicos, é importante levar alguns pontos em consideração. Primeiramente, a hipertensão \\npode ter uma função protetora durante o evento agudo, no intuito de manter a perfusão \\ncerebral para as áreas que perderam o mecanismo de autorregulação. Assim, redu zir \\nexcessivamente a PA pode gerar hipoperfusão e isquemia tecidual, agravando o prognóstico do \\npaciente.3 Em segundo lugar, o paciente com AVE encontra -se ansioso e apreensivo, de modo \\nque a medida da pressão arterial inicialmente pode não ser um reflexo tão fidedigno do estado \\nhemodinâmico dele. Dessa forma, não se deve iniciar anti -hipertensivos parenterais \\nintempestivamente, com apenas uma medida pressórica. 3 Por fim, a hipertensão arterial é o \\nprincipal fator de risco para o AVE, sobretudo o tipo hemor rágico, de forma que a maioria \\ndesses pacientes já são hipertensos de longa data.16 \\n5.3.1. Acidente Vascular Encefálico Isquêmico \\nNo AVEi, a terapia anti -hipertensiva deve ser instituída com cautela, devido ao risco de \\nhipoperfusão das áreas isquêmicas. Além disso, vale ressaltar que a PA frequentemente diminui \\nespontaneamente em um período de 90 a 120 minutos durante a fase aguda.1 Por conseguinte, \\nna ausência de outras contraindicações à terapia aguda, e nos pacientes que não são candidatos \\nà trombólise, recomen da-se o uso de anti -hipertensivos apenas para valores de PA sistólica \\nacima de 220 mmHg, ou PA diastólica superior a 130mHg. Dessa forma, não há um agente \\nespecífico recomendado, devendo avaliar a disponibilidade dos anti-hipertensivos parenterais \\nda unidade de saúde.17 \\nPor outro lado, se a terapia trombolítica for uma opção, há uma meta pressórica a ser \\natingida antes da realização da trombólise, haja vista que o risco de hemorragia cerebral se \\ncorrelaciona com os valores da pressão arterial. Dessa forma, para se realizar a trombólise, \\ndeve-se atingir valores de PA sistólica inferiores a 185 mmHg, ou PA diastólica inferior a 110 \\nmmHg. Nesse contexto, as drogas de escolha são o metoprolol ou o esmolol. Em casos de \\ncontraindicação aos betabloqueadores (e.g. a sma, falência cardíaca ou disfunções cardíacas'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 189}, page_content='189 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nseveras), opta-se pelo uso de nitroprussiato de sódio. Por fim, vale ressaltar que a PA deve ser \\nmantida em valores abaixo de 180X110 mmHg nas primeiras 24 horas após a trombólise, \\ndevendo ser monitorada continuamente.18 \\n \\nTabela 5 - Terapia anti-hipertensiva no AVE isquêmico \\nFármaco Posologia \\nMetoprolol 5 mg IV a cada 10 min, a uma taxa de \\n1mg/min, com dose máxima de 20 mg. \\nEsmolol 500 ug/kg/min IV por 1 min, seguido de \\n50ug/kg/min IV por mais 4 min. \\nNitroprussiato de Sódio  0,5-0,8ug/kg/min IV, com ajuste de dose a \\ncada 10 min, se necessário. \\n(Referência 18) \\n5.3.2. Acidente Vascular Encefálico Hemorrágico (AVE) \\nNo caso do AVE hemorrágico, a elevação da PA aumenta o risco de expansão do \\nhematoma, o que piora o prognóstico e aumenta o risco de morte. Sob esse viés, o tratamento \\nanti-hipertensivo deve ser instituído o mais rápido possível, levando em consideração o quadro \\nclínico individual do paciente, a fim de evitar diminuir muito a pressão de perfusão cereb ral. \\nDessa forma, sugere -se a terapia anti -hipertensiva para valores de PA sistólica acima de 180 \\nmmHg, e valores de PA média acima de 130 mmHg, visando atingir uma PA em torno de 160X90 \\nmmHg, ou PA média abaixo de 110 mmHg. Pacientes com PA sistólica acim a de 200 mmHg ou \\nPA média acima de 150 mmHg devem ser submetidos a uma redução agressiva dos níveis \\npressóricos. Por último, se deve salientar que, pacientes com hipertensão intracraniana, a \\nsistólica deve ser mantida acima de 90 mmHg.9 \\nSeguindo este racio cínio, as medicações anti -hipertensivas comumente utilizadas na \\nfase aguda do AVE hemorrágico são o metoprolol, o diltiazem e o esmolol. Para casos mais \\ngraves ou refratários, utiliza-se o nitroprusssiato de sódio em infusão intravenosa com cautela, \\ndevido ao risco de aumento da pressão intracraniana.9 \\n \\nTabela 6 - Terapia anti-hipertensiva no AVE hemorrágico \\nFármaco Posologia \\nMetoprolol 5 mg IV a cada 10 min, a uma taxa de \\n1mg/min, com dose máxima de 20 mg. \\nEsmolol 500 ug/kg/min IV por 1 min, seguido de \\n50ug/kg/min IV por mais 4 min.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 190}, page_content='190 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nFármaco Posologia \\nDiltiazem 0,25-0,35mg/kg em 10 min, com uma taxa \\nmáxima de infusão de 5-15mg/h. \\n(Referência 9) \\n5.3.3. Síndrome coronariana aguda \\nO miocárdio isquêmico pode desencadear um reflexo de elevação da PA. Por \\nconseguinte, o aumento da resistência vascular periférica aumenta a demanda miocárdica por \\noxigênio, de modo que o aumento dos níveis pressóricos pode agravar o quadro das síndromes \\ncoronarianas agudas. Dessa forma, nesses casos, o objetivo é reduzir a pós -carga, sem, \\nentretanto, aumentar a frequência cardíaca ou reduzir a pré-carga, de modo a não incrementar \\nainda mais o trabalho cardíaco.1 \\nNesse sentido, a meta é chegar a uma PA sistólica abaixo de 140 mmHg, porém, mantê -\\nla acima de 120 mmHg, para evitar a hipoperfusão te cidual. No que se refere à diastólica, se \\nbuscam níveis entre 70 e 80 mmHg.1 \\nNo que diz respeito à terapia anti-hipertensiva, as drogas mais utilizadas são o esmolol, \\no metoprolol ou a nitroglicerina. Sob esse viés, os beta -bloqueadores atuam na modulação da \\nfrequência cardíaca, enquanto os nitratos reduzem a resistência vascular periférica e melhoram \\na perfusão coronariana. Vale lembrar que a hidralazina e o nitroprussiato de sódio não são \\nindicados, por promoverem roubo de fluxo coronariano. O mesmo ocorre com a nifedipina, um \\nmedicamento da classe dos bloqueadores dos canis de cálcio.1 \\nNo caso da nitroglicerina intravenosa, ela é indicada nas primeiras 48 horas após o \\nevento agudo, desde que não haja hipotensão, infarto de ventrículo direito ou uso de inibidores \\nda fosfodiesterase do tipo 5 nas 48 horas anteriores ao evento. Esta deve ser utilizada na dose \\nde 5 -15mg/h em infusão contínua. Vale lembrar que o uso dessa droga não exclui o uso de \\noutras intervenções de redução de mortalidade comprovadas.1 \\nPor outro lado, os betabloqueadores (e.g. esmolol e metoprolol) devem ser utilizados em \\nindivíduos com hipertensão que não apresentem sinais de IC ou evidência de baixo débito \\ncardíaco, ou ainda fatores de risco para choque cardiogênico ou contraindicações ao beta-\\nbloqueio. O esmolol é utilizado em uma dose de ataque de 500 ug/kg intravenosa, seguida de \\ninfusão intermitente de 25 -50 ug/kg/min, com aumento de 25ug a cada intervalo de 10 a 20 \\nmin, e dose máxima de 200 ug/kg/min. Por sua vez, o metoprolol é admini strado na dose de 5 \\nmg intravenosa, repetindo a cada 10 minutos, se necessário, até o máximo de 20 mg.1'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 191}, page_content='191 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\n5.3.4. Dissecção aórtica aguda \\nNas emergências hipertensivas associadas à dissecção aórtica, o tratamento clínico deve \\nser iniciado assim que o diagnóstico for considerado, uma vez que a progressão da lesão está \\nrelacionada com os níveis pressóricos e a velocidade de ejeção ventricular. Nesse sentido, com \\nexceção dos pacientes hipotensos, o tratamento deve ser direcionado às reduções da \\ncontratilidade cardíaca e da PA, além de fazer a analgesia do paciente, a fim de diminuir a tensão \\nvascular.1,6 \\nÉ importante manter a frequência cardíaca abaixo de 60, e a PA sistólica entre 100 e 120 \\nmmHg. A redução pressórica deve ser agressiva, devendo-se atingir valores sistólicos abaixo de \\n120 mmHg nos primeiros 20 minutos.1, 15, 19, 20 \\nNo que se refere à terapia anti-hipertensiva, o uso isolado do nitroprussiato de sódio não \\né ideal, uma vez que promove cronotropismo positivo e aumento da velocidade de ejeção \\naórtica. Deve -se associar um betabloqueador intravenoso de ação rápida e titulável (e.g. \\nmetoprolol, labetalol e esmolol), a fim de diminuir a frequência cardíaca. No caso de \\ncontraindicações aos betabloqueadores, como no caso dos pacientes asmáticos, os \\nbloqueadores dos canais de cálcio dihidropiridínicos (e.g. nicardipina) podem ser utilizados. 1, \\n15, 19, 20 \\n \\nTabela 7 - Terapia anti-hipertensiva na Dissecção Aórtica \\nFármaco Posologia \\nNitroprussiato de Sódio 0,25 a 10 mg/kg/min IV em infusão \\ncontínua. \\nMetoprolol 5 mg IV a cada 10 min, a uma taxa de \\n1mg/min, com dose máxima de 20 mg. \\nEsmolol 250 a 500ug/kg/min IV em bolus a cada \\n10min ou infusão de 15-300 ug/kg/min IV. \\nLabetalol 20 a 80 mg IV 10-10 min em dose de ataque, \\nseguido de infusão contínua 2mg/min IV, \\ncom um máximo de 300mg/24 horas. \\nNicardipina 5 a 15mg/h IV em infusão contínua. \\n(REFERÊNCIA  3) \\n5.3.5. Edema Agudo de Pulmão Hipertensivo \\nO Edema Agudo de Pulmão (EAP) hipertensivo está geralmente associado à \\ndescompensação da insuficiência cardíaca, e a elevação da PA demanda maior consumo de \\noxigênio pelo miocárdio, o que piora a função cardíaca. Sob esse viés, a conduta terapêutica \\ndeve v isar ao alívio dos sintomas, bem como à reversão das anormalidades hemodinâmicas'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 192}, page_content='192 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nagudas. Além disso, é importante reverter o edema pulmonar e tratar as causas da \\ndescompensação.3, 21, 22 \\nA emergência hipertensiva com EAP deve ser monitorada em UTI, com red ução \\ngradativa da PA. Os anti -hipertensivos mais utilizados são a nitroglicerina, na dose de 5 -\\n15mg/h IV em infusão contínua e o nitroprussiato de sódio, com administração em infusão \\ncontínua de 0,25 a 10 mg/kg/min IV.  Esses medicamentos diminuem a pré e a pós-carga. A \\nnitroglicerina oferece a vantagem de melhorar a perfusão coronariana, o que auxilia na melhora \\nda performance cardíaca.1,3 \\nO uso de diurético de alça (e.g. furosemida) diminui a sobrecarga volêmica, e, \\nconsequentemente, a PA. A furosemida é utilizada na dose de 20 a 60mg IV, podendo repetir a \\ndose de administração após 30 minutos. O uso de ventilação não invasiva com pressão positiva \\nnas vias aéreas pode ser indicado em casos mais graves, para reduzir o edema  pulmonar. 1, 19, \\n23, 24 \\n5.3.6. Crises adrenérgicas \\nO protótipo da hiperatividade a  adrenérgica é o feocromocitoma, tumor secretor de \\ncatecolaminas. Entretanto, os quadros mais comuns são relacionados ao uso de drogas ilícitas \\n(e.g. cocaína e anfetaminas), e à retirada abrupta de drogas que acumu lam catecolaminas nas \\nterminações nervosas (e.g. clonidina e metildopa).25 \\nDe forma geral, preconiza-se que a redução da PA nesses casos seja feita de forma rápida \\ne gradual, atingindo valores até 25% inferiores aos níveis iniciais da PA média, ou ainda, \\nreduzindo a diastólica para valores entre 100 e 110 mmHg. Além disso, é comum a associação \\nde AVE hemorrágicos e infarto agudo do miocárdio ao uso de drogas ilícitas, de modo que a \\nconduta deve ser direcionada ao órgão alvo acometido.25, 26  \\nO melhor grupo de drogas para controlar as crises adrenérgicas são os alfabloqueadores \\n(e.g. fentolamina). É importante evitar o uso isolado de betabloqueadores, uma vez que, desse \\nmodo, passariam a predominar os efeitos alfa -adrenérgicos, o que poderia piorar o quadro, \\ndevido ao espasmo de coronárias. Por conseguinte, uma vez que o paciente esteja alfa -\\nbloqueado, é possível usar betabloqueadores, para auxiliar o controle pressórico, caso seja \\nnecessário. Os nitratos (e.g. nitroglicerina e nitroprussiato de sódio) também podem ser \\nutilizados, isoladamente ou em associação com o alfa-bloqueador. Por fim, vale ressaltar que é \\npossível fazer a associação de diazepam ao regime de nitroprussiato e fentolamina, nos quadros \\ndesencadeados pelo uso de drogas ilícitas. 1, 25,  26,  27'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 193}, page_content='193 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nSob esse viés, a fentolamina deve ser utilizada em regime de infusão contínua de 1 a 5mg \\nintravenosa, com um limite de 15mg.1 \\n5.3.7. Eclâmpsia e Pré-eclâmpsia \\nAs emergências hipertensivas na gestante exigem uma conduta cautelosa, para evitar a \\nhipotensão. É p ossível utilizar tanto a nifedipina 10 mg por via oral, quanto a hidralazina \\nintravenosa. Atualmente, há uma preferência pela nifedipina, a qual pode ser repetida em doses \\nde 10 a 20mg, a cada 20 a 30 minutos. Caso a PA se mantenha alta após a terceira dos e, \\nadministra-se a hidralazina intravenosa, na dose de 5mg, a cada 20 a 30 minutos, até a dose de \\n15mg. 28 \\nEm situações excepcionais, como a presença de edema agudo de pulmão ou hipertensão \\nrefratária, é possível considerar o uso de nitroprussiato de sódio , para controle rápido da PA. \\nEntretanto, essa droga só pode ser administrada por até 4 horas, devido ao risco de \\nimpregnação fetal pelo cianeto.29 \\n \\nBOX 27.  \\nLevando em consideração o quadro de encefalopatia hipertensiva do paciente, é \\nimportante ter em mente as metas de redução pressórica para essa etiologia: a PA deve ser \\nreduzida em até 25% nas primeiras duas horas, ou atingir uma PA em torno de 160/100 -\\n110 mmHg. \\nNo que se refere à conduta, inicialmente, se deve monitorar os sinais vitais do \\npaciente, prover oxigênio suplementar e obter um acesso venoso calibroso. \\nQuanto à terapia anti-hipertensiva, a droga de escolha foi o nitroprussiato de sódio, o \\nqual foi administrado em infusão contínua, com doses variando de 0,25 a 10 ug/kg/min.  \\nPor fim, durante a crise c onvulsiva, o paciente recebeu diazepam intravenoso, em \\numa dose de 2mg por minuto, até o limite de 10mg. Em seguida, para a prevenção de novas \\ncrises, utilizou-se a fenitoína em infusão contínua, na dose de 15mg/kg, com taxa de infusão \\nmáxima de 50mg/min.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 194}, page_content='194 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nFLUXOGRAMA \\n  \\nECG= eletrocardiograma; TC= tomografia computadorizada, EAP= edema agudo de pulmão, PA= \\npressão arterial.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 195}, page_content='195 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\nREFERÊNCIAS \\n1. BARROSO, Weimar Kunz Sebba  et al. Diretrizes Brasileiras de Hipertensão Arterial –2020. \\nArquivos Brasileiros de Cardiologia, 2021; v. 116: p. 516-658. \\n2. OLIVEROS, Estefania; PATEL, Hena; KYUNG, Stella; FUGAR, Setri; GOLDBERG, Alan; MADAN, \\nNidhi; WILLIAMS, Kim A.. Hypertension in older  adults: assessment, management, and \\nchallenges. Clinical Cardiology, [S.L.], v. 43, n. 2, p. 99-107, 11 dez. 2019 \\n3. Martins HS, Brandão Neto RA, Scarlabrini Neto A, Velasco IT. Emergências Clínicas: \\nAbordagem Prática. 10th rev. ed. e atual. São Paulo: Manole; 2015. \\n4. BRAUNWALD, Tratado de doenças cardiovasculares, 9.ed. Rio de Janeiro: Elsevier, 2013 \\n5. GUYTON, A.C. e Hall J.E.– Tratado de Fisiologia Médica. Editora Elsevier. 13ª ed., 2017 \\n6. KASPER, Dennis L.. Medicina interna de Harrison. 19 ed. Porto Alegre: AMGH Editora, 2017 \\n7. SILVERTHORN, D. Fisiologia Humana: Uma Abordagem Integrada, 7ª Edição, Artmed, 2017 \\n8. Potter T, Schaefer TJ. Hypertensive Encephalopathy. 2021 Aug 11. In: StatPearls [Internet]. \\nTreasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32119386. \\n9. https://iweb04.itarget.com.br/itarget.com.br/newclients/sbavc/wp-\\ncontent/uploads/2021/06/Diretrizes_AVCH_2009.pdf \\n10. 10.1161/STR.0b013e3182587839 (Guidelines for the Management of Aneurysmal \\nSubarachnoid Hemorrhage); \\n11. Atendimento inicial e tratamento do AVC agudo. Autores: Jamary Oliveira Filho, MD, MS, \\nPhD, Michael T Mullen, MD Editores de Seção: Scott E Kasner, MD, Jonathan A Edlow, MD, \\nFACEP Editor-adjunto: John F Dashe, MD, PhD \\n12. WILLIAMS, Bryan et al. 2018 ESC/ESH Guidelines for the management of arterial \\nhypertension: The Task Force for the management of arterial hypertension of the European \\nSociety of Cardiology (ESC) and the European Society of Hypertension (ESH). European \\nheart journal, 2018; v. 39, n. 33: p. 3021-3104 \\n13. Malachias MVB, Souza WKSB, Plavnik FL, Rodrigues CIS, Brandão AA,Neves MFT, et al. 7a \\nDiretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol. 2016;107(3Supl.3):1-83.  \\n14. Truelsen T, Heuschmann PU, Bonita R, Arjundas G, Dalal P, Damasceno A, et al. Standard \\nmethod for developing stroke registers in low -income and middle -income countries:  \\nexperiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS \\nStroke). Lancet Neurol. 2007;6(2):134-9.  \\n15. Whelton PK, Carey RM, Aronow WS, Casey Jr. DE, Collins KJ, Himmelfarb CD, et al. 2017 \\nGuideline for Prevention, Detection, Evaluation and Management of High Blood Pressure in \\nAdults. J Am Coll Cardiol.; 201; 23976.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 196}, page_content='196 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO VIII | EMERGÊNCIAS HIPERTENSIVAS \\n16. O’Donnell MJ, Chin SL, Rangarajan S, Xavi er D, Liu L, Zhang H, et al. Global and regional \\neffects of potentially modifiable risk factors associated with acute stroke in 32 countries \\n(INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75. \\n17. https://journals.sagepub.com/doi/pdf/10.1177/23969873211012133 \\n18. MARTINS, Sheila Cristina Ouriques et al. Diretrizes para o tratamento do acidente vascular \\ncerebral isquêmico: parte II: tra tamento do acidente vascular. Arquivos de Neuro -\\nPsiquiatria, 2012. v. 70, n. 11; p. 885-893. \\n19. Vilela-Martin JF, Yugar-Toledo JF, Rodrigues MC, Barroso WS, Bronze L, Torres F, et al. Luso-\\nBrazilian Position Statement on Hypertensive Emergencies – 2020. Arq B ras Cardiol. \\n2020;114(4):736-51.  \\n20. Bossone E, La Bounty TM, Eagle KA. Acute aortic syndromes: Diagnosis and management, \\nan update. Eur Heart J. 2018;39(9):739−49.  \\n21. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, et al. The pathogenesis \\nof acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344(1):17-22.  \\n22. Kumar R, Gandhi SK, Little WC. Acute heart failure with preserved systolic function. Crit \\nCare Med. 2008;36(1 Suppl):pS52-6.  \\n23. van den Born BH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council \\non hypertension position document on the management of hypertensive emergencies. Eur \\nHeart J Cardiovasc Pharmacother. 2019;5(1):37-46.  \\n24. Comitê Coordenador da Diretriz de Insuficiência Cardíaca da Sociedade B rasileira de \\nCardiologia; Rohde LEP, Montera MW, Bocchi EA, Albuquerque DC, Clausell NO, Rassi S, et \\nal. Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arq Bras Cardiol. \\n2018;111(3):436-539.  \\n25. http://departamentos.cardiol.br/dha/revista/9-4/emergencias.pdf \\n26. https://docs.bvsalud.org/biblioref/2018/03/881319/rbh-v21n4_194-202.pdf \\n27. Pitts WR, Lange RA, Cigarroa JE, Hillis LD. Cocaine -induced myocardial ischemia and \\ninfarction: pathophysiology, recognition, and management. Prog Cardiovasc Dis. \\n1997;40(1):65-76.  \\n28. American College of Obstetricians and Gynecologists (ACOG). ACOG Committee Opinion No. \\n767: Emergent Therapy for Acute -Onset, Severe Hypertension During Pregnancy and the \\nPostpartum Period. Obstet Gynecol. 2019;133(2):e174-e180.   \\n29. Sass N, Itamoto CH, Silva MP, Torloni MR, Atallah NA. Does sodium nitroprusside kill babies? \\nA systematic review. Sao Paulo Med J. 2007;125:108-11.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 197}, page_content='197 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nCAPÍTULO IX  \\nTROMBOEMBOLISMO VENOSO (TEV) \\nMateus de Sousa Cavalcante 1 \\nBruna de Almeida Freixedelo 1 \\nJoão Marcos de Fontes Carneiro 1 \\nFelipe Salim Habib Buhamara Alves Nasser Gurjão 1 \\nJosé Antônio de Lima Neto 2 \\nDoi: 10.51859/amplla.ceg164.1123-9 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médico cardiologista ecocardiografista. Sobral, Ceará, Brasil. \\nCASO CLÍNICO \\nPaciente, sexo feminino, 30 anos, branca, natural e pr ocedente de Sobral -CE. Foi \\nadmitida no Pronto Socorro pela primeira vez com queixa de febre, tosse, dispneia e dor \\nabdominal há 02 dias. Realizou TC de tórax com opacidades em vidro fosco, compatíveis com \\npneumonia por SARS -CoV-2. Retornou após 03 dias com  piora da dispneia e escarro \\nhemoptoico. Relata apenas vacina recente para Influenza. \\nAo exame físico, paciente com estado geral regular, afebril, acianótico e anictérico, com \\nedema em MMII esquerdo. PA: 130x78 mmHg; FC 110 bpm; FR 29 irpm; SatO2 91%. Ausc ulta \\ncardíaca com ritmo regular, em dois tempos, sem sopros. Aparelho respiratório com murmúrio \\nvesicular presente e estertor crepitante em base pulmonar direita. Abdome globoso, indolor e \\nsem outras alterações. \\nPERGUNTAS NORTEADORAS \\n1. Qual a definição de Tromboembolismo venoso? \\n2. Qual o quadro clínico típico desse perfil de paciente? e qual o critério mais utilizado? \\n3. Quais exames complementares devem ser solicitados para elucidação diagnóstica?  \\n4. Qual deve ser a conduta do médico na emergência de acordo com o g rau de instabilidade \\nhemodinâmica? \\n1. INTRODUÇÃO E CONCEITOS \\nO termo Tromboembolismo Venoso (TEV) define a ocorrência do transporte (embolia) \\nde um conteúdo de origem trombótica, após o seu desprendimento inicial, pelo leito venoso. A'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 198}, page_content='198 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\ndefinição primordial do TEV engloba como componentes base a Trombose Venosa Profunda \\n(TVP), como sendo a origem do coágulo antes do seu transporte, e a Tromboembolia Pulmonar \\n(TEP) como o destino patológico final do conteúdo embolizado, uma vez que a circulação \\npulmonar funciona como uma transição final entre o leito venoso e arterial. Tal especificidade \\nda circulação pulmonar justifica o fato desses vasos separarem, como um filtro, eventuais \\nêmbolos de origem venosa do sistema arterial1.  \\nA TVP marca o ponto de início de uma possível complicação, visto que cerca de 90% dos \\ncoágulos se originam em veias profundas dos membros inferiores. Assim, quando a TVP ocorre \\nna topografia proximal do membro inferior, na região da veia femoral ou ilíaca, o prognóstico é \\npior, com maior risco de TEP associado1. \\n2. EPIDEMIOLOGIA E FATORES DE RISCO \\nEpidemiologicamente, devido a sua apresentação clínica de origem insidiosa e muitas \\nvezes despercebida ou confundida, o Tromboembolismo Pulmonar pode ser subestimado em \\nrelação a sua prevalência. Os dados da literatura são retirados de prontuários, atestados de \\nóbito ou autópsias, porém uma grande parcela dos casos de TEP permanece não confirmada, \\nsobretudo quando se trata de casos extra -hospitalares, ou mesmo de ocorrências não \\ndiagnosticadas. Segundo dados de hospitais americanos, anualmente, para cada 1000 pessoas, \\nhaverá 1 caso de TEP, revelando uma incidência de 200.000 a 300.000 casos por ano. Ao \\ncontrário dos EUA, no Brasil são raros os estudos sobre a epidemiologia do TEP, sendo a maioria \\nbaseado em dados obtidos de autópsias, os quais evidenciam uma prevalência entre 3,9% e \\n16,6%2.  \\nO perfil epidemiológico do indivíduo que é acometido pela forma aguda do \\nTromboembolismo Pulmonar engloba pacientes acima da meia-idade, com um aumento linear \\nda prevalência conforme a idade. No entanto, foi mostrado por um grupo de autores que o \\ncrescimento linear da incidência somente acontecia até os 65 anos, onde, a partir de tal, haveria \\numa queda brusca nesse índice, provavelmente pela baixa acu rácia do diagnóstico de TEP em \\nindivíduos mais idosos. Além da idade, alguns estudos mostram uma mortalidade 50% maior \\nem negros do que em brancos, sendo notada uma baixa prevalência em pessoas asiáticas. \\nOutrossim, não há consenso na literatura sobre uma maior prevalência em determinado sexo2.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 199}, page_content='199 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\n2.1. FATORES DE RISCO \\nConsiderando a fisiopatologia da Embolia Pulmonar, e conhecendo a origem trombótica \\ndessa patologia, pode -se perceber que qualquer fator de desequilíbrio na fisiologia da \\nhemostasia que influencie um  estado de pró -coagulabilidade pode ser considerado como um \\npossível componente que aumenta a chance de eventos trombóticos2.  \\nAssim, tomando por base a tríade de Virchow, é sabido que os fatores que promovem a \\ntrombose pertencem a três pilares: Lesão endotelial, hipercoagulabilidade, e anormalidades do \\nfluxo sanguíneo. Portanto, de forma geral, é possível inferir que estase sanguínea (ex.: \\nimobilização prolongada), fluxo turbulento (ex.: Hipertensão Arterial), inflamação endotelial \\n(ex.: aterosclerótica ou  não), hipercoagulabilidade hereditária (ex.: Fator V de Leiden, \\ndeficiência de Proteína C ou S, Protrombina Variante G20210A) ou adquirida (ex.: Câncer, \\nTrombocitopenia Induzida por Heparina, Síndrome do Anticorpo Antifosfolipídico, uso \\nfármacos que neutralizam a fibrinólise, etc)3. \\n3. ETIOPATOGENIA \\nEm termos fisiopatológicos, existem três alicerces principais que levam ao \\ndesenvolvimento do tromboembolismo venoso (TEV): (1) a inflamação e a ativação \\nplaquetária, (2) os estados pró-trombóticos, e (3) os fenômenos de embolização. \\nPrimeiramente, no que se refere aos fenômenos inflamatórios e à ativação plaquetária, \\ntemos a tríade de Virchow, que engloba 3 pré-requisitos que favorecem a trombogênese: estase \\nvenosa, hipercoagulabilidade e lesão endotelial. Nesse sentido, todos esses fatores corroboram \\no recrutamento e a ativação das plaquetas, as quais liberam micropartículas de mediadores pró-\\ninflamatórios. Com isso, formam-se armadilhas extracelulares de neutrófilos, as quais contêm \\nhistonas, o que estimula a agregação plaquetária e promove a síntese de trombina. Por fim, vale \\nressaltar que o ambiente de estase possui baixa tensão de oxigênio, o que favorece ainda mais \\na formação de trombos e aumenta a expressão de genes pró-inflamatórios1. \\nEm segundo lugar, os estados pró-trombóticos englobam as condições em que o paciente \\napresenta uma predisposição à formação de coágulos, seja de forma hereditária, como é o caso \\ndas trombofilias, ou de forma adquirida (e.g. câncer, obesidade, contracepção oral etc.)1. \\nEm terceiro lugar, no que diz respeito à embolização, o estágio final da história natural \\ndo TEV, ela ocorre quando os trombos se desprendem do seu local de formação, chegando à \\ncirculação pulmonar, o que gera a embolia pulmonar aguda. Nesse contexto, a maioria dos \\nêmbolos pulmonares se originam de trombos em veias profundas dos membros inferiores.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 200}, page_content='200 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nNessa topografia, a TVP com maior risco de embolia é a iliofemoral, ao passo que o risco de TEP \\ncom manifestações clínicas na TVP de panturrilha é baixo, uma vez que as es truturas \\nembolizadas costumam ser pequenas 1. Por fim, se deve salientar que, de maneira comum, a \\nembolização pulmonar é múltipla, de modo que muitos êmbolos passam despercebidos, antes \\ndo evento agudo. Nesse sentido, a trombose venosa pode persistir como u m estado subclínico, \\no que seria favorecido por um estado inflamatório crônico. Estudos mostram que \\nconcentrações elevadas de proteína C reativa de alta sensibilidade foram associadas ao risco \\naumentado de TEV4.  Paradoxalmente, em alguns casos, os trombos podem atingir a circulação \\narterial através de forame oval patente, ou comunicação interatrial. Finalmente, vale ressaltar \\nque muitos pacientes com fenômenos pulmonares agudos não apresentam evidências de TVP, \\nporque o trombo já embolizou para o pulmão1.  \\n3.1. REPERCUSSÕES FISIOLÓGICAS \\nA embolia pulmonar, por sua vez, possui repercussões fisiológicas importantes, sendo \\nas mais comuns a hipoxemia arterial e o aumento no gradiente de tensão de oxigênio entre os \\nalvéolos e a circulação arterial, o que representa a  ineficiência de transferir o oxigênio nos \\npulmões. Por conseguinte, o que ocorre é um aumento do espaço morto anatômico, haja vista \\nque a obstrução vascular impede o gás inspirado de chegar às unidades de troca, e um aumento \\ndo espaço morto fisiológico, p ois a ventilação nas unidades de troca excede o fluxo sanguíneo \\nvenoso que passa pelos capilares. Consequentemente, a perda de superfície de troca gasosa \\ncorrobora a formação de um shunt da direita para a esquerda. Vale ressaltar ainda que, a \\nisquemia dos ácinos alveolares libera mediadores inflamatórios que inibem os pneumócitos \\ntipo II, produtores de surfactante. Desse modo, há uma diminuição na produção de surfactante, \\ne atelectasia do tecido pulmonar saudável. \\nOutrossim, ocorre aumento da resistência va scular pulmonar, em virtude da obstrução \\nvascular e da liberação de agentes vasoconstritores pelas plaquetas. Esses mediadores \\nvasoativos geram um desequilíbrio na relação ventilação -perfusão em locais distantes do \\nêmbolo, o que explica a discordância entr e uma embolia pouco significativa associada a um \\ngrande gradiente alveolar-arterial de oxigênio. \\nPor último, ocorre uma hiperventilação alveolar, em virtude da estimulação reflexa dos \\nreceptores alveolares, e um aumento da resistência das vias respiratória s, decorrente da \\nconstrição das vias respiratórias distais aos brônquios, o que explica a dispneia característica'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 201}, page_content='201 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\ndos pacientes com evento agudo. Finalmente, há uma redução da complacência pulmonar, \\ndevido ao edema, à hemorragia pulmonar e à perda de surfactante4. \\n3.2. CONSEQUÊNCIAS CARDIOCIRCULATÓRIAS DO TEP \\nNo que se refere às consequências cardiocirculatórias da embolia, os principais achados \\nsão a hipertensão pulmonar, a disfunção ventricular direita e o microinfarto do ventrículo \\ndireito (VD), o que se explica pelo aumento da resistência vascular pulmonar. Nesse sentido, a \\nobstrução da artéria pulmonar, associada à hipoxemia, aumenta a pressão arterial pulmonar. \\nIsso aumenta as pressões no VD, câmara que, por sua vez, não tolera aumentos pressóricos, \\ndesencadeando dilatação e disfunção ventricular, e liberação de peptídeo natriurético cerebral. \\nAlém disso, há protrusão do septo interventricular para o interior do ventrículo \\nesquerdo (VE), o que cursa com disfunção diastólica e prejuízo do enchimento dessa câm ara. \\nCom isso, há uma queda no débito cardíaco, e, consequentemente, na pressão arterial sistêmica, \\ngerando um colapso hemodinâmico, e um quadro de cor pulmonale agudo.   \\nOutrossim, o aumento na tensão na parede do VD comprime a artéria coronária direita, \\no que reduz o suprimento sanguíneo ao miocárdio, resultando  no microinfarto de VD, com \\nliberação de marcadores de necrose miocárdica (e.g. Troponina)4.  \\n3.3. CONSEQUÊNCIAS DO TVP \\nAs obstruções mecânicas do sistema venoso profundo aumentam a pressão nesses \\nvasos, o que gera uma incompetência das valvas presentes no interior das veias, desencadeando \\num quadro de síndrome pós -flebítica. Esta é caracterizada por edema crónico e unilateral, na \\nmaioria das vezes, associado a alterações de coloração da pele (e.g. Dermatite ocre) e varizes4. \\n4. QUADRO CLÍNICO \\n4.1. EMBOLIA PULMONAR \\nA embolia pulmonar (EP) pode ser dividida em (1)maciça, (2)submaciça e de (3)baixo \\nrisco, de tal forma que esta corresponde a cerca de 70 -75% dos casos, e possui ótimo \\nprognóstico1. \\nNesse sentido, a E P maciça se caracteriza por trombose extensa, afetando, pelo menos, \\nmetade da vasculatura pulmonar. Com isso, no quadro clínico predomina a dispneia, associada \\na sinais de baixo débito, como síncope, hipotensão e cianose. Em casos mais graves, os pacientes \\npodem cursar com choque cardiogênico, podendo vir a óbito 1. Vale ressaltar que insuficiência'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 202}, page_content='202 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nrenal, disfunção hepática e alteração do estado mental são achados frequentemente \\nassociados4. \\nPor outro lado, a EP submaciça está associada à disfunção de VD, em bora a pressão \\narterial sistêmica permaneça normal. Dessa forma, há uma hipocinesia ventricular direita \\nmoderada a grave, bem como elevações da troponina, pró-BNP, ou BNP. Esses pacientes correm \\nrisco de embolia recorrente, mesmo com a terapia anticoagulan te adequada 4. Sob esse viés, \\nesses pacientes podem se apresentar clinicamente estáveis, porém, a presença de sinais de \\ninsuficiência cardíaca, associada à liberação de biomarcadores cardíacos, sugere piora clínica1.  \\nÉ válido salientar ainda outras apresen tações dos fenômenos tromboembólicos \\npulmonares: (1) infarto pulmonar e (2) embolia pulmonar não trombótica. \\nNesse contexto, o infarto pulmonar  é caracterizado por dor torácica pleurítica, \\nacompanhada de hemoptise. Nesses casos, o êmbolo costuma estar localizado na árvore arterial \\npulmonar periférica, e o infarto tecidual ocorre de 3 a 7 dias após a embolia. O paciente pode \\ncursar com febre, leucocitose e velocidade de hemossedimentação aumentada, e a radiografia \\nde tórax mostra evidências de infarto4. \\nNo que se refere à embolia pulmonar não trombótica, ela engloba os fenômenos \\nassociados a gordura, neoplasias, ar e líquido amniótico. Esses casos são incomuns, e estão mais \\nassociados a êmbolos sépticos, com risco de endocardite4. \\n4.2. TROMBOSE VENOSA PROFUNDA \\nNo caso da trombose venosa profunda (TVP), esta pode ser classificada em (1)TVP de \\nmembros inferiores e (2) TVP de membros superiores. Vale ressaltar que o acometimento dos \\nmembros inferiores é 10 vezes mais comum do que o de membros superiores, e a suspeita deve \\nexistir em qualquer paciente com dor ou edema em membros inferiores, sobretudo se este for \\nunilateral, assimétrico e depressível 5. Existem ainda os casos de trombose venosa superficial, \\nque cursam com eritema e  dor à palpação, e podem evoluir para um quadro de TVP1. \\nNesse contexto, a TVP de membros inferiores geralmente tem início na panturrilha, e se \\npropaga no sentido proximal. Êmbolos muito grandes podem se alojar na bifurcação da artéria \\npulmonar, formando uma embolia em sela1,4. \\nJá os fenômen os tromboembólicos nos membros superiores são comumente \\ndesencadeados pela instalação de marcapasso, desfibrador cardíaco ou cateteres venosos \\ncentrais1,4.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 203}, page_content='203 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nVale ressaltar que a TVP costuma gerar danos secundários às valvas do sistema venoso \\nprofundo, gerando microangiopatia venosa. Desse modo, o paciente passa a apresentar varizes, \\npigmentação anormal do maléolo medial e ulcerações cutâneas4.  \\n4.3. SUSPEITA CLÍNICA DE TEP \\nA suspeita clinica de um evento agudo de embolia pulmonar deve ser embasada na \\npresença de um quadro clínico compatível, associado aos fatores de risco do paciente em \\nquestão. Desse modo, não há um quadro clínico patognomônico de TEP agudo, uma vez que as \\nrepercussões sistêmicas dependem das condições prévias pulmonares e da carga embólica. \\nIndivíduos jovens podem ter TEP primário sem evidências clínicas significativas, e idosos \\npodem ter os sinais mascarados por uma doença de base6. \\nApesar disso, o grau de suspeição baseia -se na prevalência das apresentações mais \\ncomuns, as quais mostram que as principais manifestações nos eventos agudos são: taquipneia \\n(FR no adulto>20 ciclos/min), dispneia, dor torácica pleurítica, apreensão, tosse e hemoptise. \\nIndivíduos com TEP maciço e pouca reserva cardiopulmonar podem abrir o quadro já em \\ncolapso circulatório agudo, e a morte súbita, apesar de rara, pode ser possível. Todavia, deve -\\nse ressaltar que alguns casos de TEP podem ainda serem descobertos incidentalmente7. \\nNesse contexto, alguns cenários clínicos estão sob maior risco de desenvolverem um TEP \\nagudo8 \\n• Sintomas torácicos agudos na presença de TVP aguda, antecedentes de TEV, \\nfatores de risco, síncope, pós-operatórios e peri-parto ou puerpério; \\n• Pacientes clinicamente enfermos ou politraumatizados; \\n• Pacientes com taquiarritmias súbitas e inexplicáveis, sobretudo, se portadores de \\nfatores de risco; \\n• Pacientes com arritmias crônicas, que se apresentam com dor pleurítica e \\nhemoptise súbitas; \\n• Descompensação inexplicável de insuficiência cardíaca ou de pneumopatia \\ncrônica; \\n• Parada cardiorrespiratória. \\nVale ressalta r que a TVP sintomática está presente em menos da metade dos casos \\nconfirmados de TVP, contudo, em casos de TEP confirmada, 70% dos pacientes apresentam \\nTVP silenciosa9.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 204}, page_content='204 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nOs sintomas de dor pleurítica, tosse e hemoptise sugerem TEP pequena, próxima à \\npleura, enquanto síncope, cianose e hipoxemia estão mais associadas a embolias extensas7.  \\nA partir da suspeita inicial, é importante estabelecer a probabilidade de confirmação \\ndiagnóstica, a qual pode ser:6 \\n• Alta (subgrupo com prevalência igual ou maior de 80%): um ou mais fatores de \\nrisco maiores conhecidos, acompanhados de sintomas agudos não associados a \\noutra causa; \\n• Baixa (subgrupo com prevalência de 10% ou menos): sem fatores de risco \\nidentificador e anormalidades clinicas associadas a outras causas; \\n• Intermediária: combinação dos fatores descritos acima. \\nNão obstante, até 40% dos pacientes com TEP não apresentam nenhum fator de risco, e \\nmuitos sintomas são inespecíficos e têm prevalência variável. Nesse sentido, a hipoxemia é \\nbastante frequente, mas cerc a de 40% dos pacientes apresentam saturação normal. A \\nradiografia de tórax, apesar de anormal, costuma evidenciar sinais inespecíficos, mas é útil para \\nexcluir outras causas de dispneia e dor torácica7. \\nNesse contexto, alguns escores foram criados para fac ilitar a decisão da conduta em \\ncondições de pronto -atendimento. O escore simplificado de Wells et al. Engloba diversos \\nparâmetros clínicos e exames complementares não diagnósticos, e é bastante utilizado na \\nprática clínica. Assim, pontuações abaixo de 2 in dicam baixa probabilidade de TEP; escores de \\n2 a 6 pontos indicam uma probabilidade moderada, e pontuações acima de 6 indicam alta \\nprobabilidade. Como derivação, escores≤4 são considerados improváveis, enquanto valores>4 \\nsão considerados casos prováveis de TEP aguda6.  \\n \\nTabela 1 - Escore de Wells: regra para predição clínica para TEP \\nCritérios  Pontuação \\nSinais Objetivos de TVP (edema, dor à palpação). 3,0 \\nTaquicardia (FC>100bpm). 1,5 \\nImobilização≥3 dias consecutivos, com exceção de idas ao banheiro, \\nou cirurgia nas últimas 4 semanas.  \\n1,5 \\nTVP ou TEP prévias. 1,5 \\nHemoptise.  1,0 \\nNeoplasia maligna ativa ou término do tratamento há menos de 6 \\nmeses. \\n1,0 \\nDiagnóstico alternativo menos provável do que TEP. 3,0'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 205}, page_content='205 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nTabela 2 - Escore de Wells: regra para predição clínica para TVP \\nCritérios  Pontuação \\nSensibilidade dolorosa no sistema venoso profundo. 1,0 \\nAumento do volume de toda perna. 1,0 \\nAumento do volume da panturrilha >3 cm em relação à perna \\nassintomática (medido 10 cm abaixo da tuberosidade tibial).  \\n1,0 \\nEdema compressível (cacifo). 1,0 \\nVeias colaterais superficiais não varicosas. 1,0 \\nNeoplasia maligna ativa. 1,0 \\nParalisia, paresia ou imobilização de membros inferiores. 1,0 \\nImobilização no leito ≥3 dias ou grande cirurgia nas últimas 4 \\nsemanas.  \\n1,0 \\nDiagnóstico alternativo mais provável que TVP.  -2,0 \\n \\n5. DIAGNÓSTICO E EXAMES COMPLEMENTARES \\nInicialmente, é importante selecionar quais pacientes que chegam ao pronto \\natendimento com dor torácica ou dispneia devem ser submetidos a exames complementares. \\nPara isso, podemos utilizar o Pulmonary Embolism Rule -out Criteria (PERC), que pode ser \\nutilizado em serviços de emergência com o propósito já citado. Este critério utiliza 8 variáveis \\nclínicas que geralmente estão dissociadas da Embolia pulmonar (EP): idade < 50 anos; \\nfrequência cardíaca (FC) < 100 bpm; SaO2 > 94%; edema não unilateral; ausência de hemoptise; \\nausência de trauma recente ou cirurgia; ausência de histórico de TVP; e ausência de uso oral de \\nhormônio. A presença dos 8 critérios do PERC, associada a uma baixa suspeita clínica, sugere \\numa exclusão segura de EP10. \\n5.1. EXAMES AUXILIARES \\nRadiografia de tórax - Os achados são raramente conclusivos para diagnóstico de TEP \\naguda, porém é de grande importância para o diagnóstico diferencial. Na presença de dispneia \\nsem etiologia confirmada, um exame normal pode reforçar a suspeita de TEP aguda. Em exames \\nalterados, os achados mais comuns são: atelectasias laminares nas bases; elevação da cúpula \\ndiafragmática; derrame pleural; e achados de hipovolemia regional - aumento de artérias \\npulmonares centrais e opacidade periférica em cunha -. \\nEletrocardiograma - A principal relevância do exame é o diagnóstico diferencial, \\nprincipalmente com IAM ou pericardite. O achado padrão mais específico de TEP aguda é o S1-\\nQ3-T3. Porém, a alteração eletrocardiográfica mais frequente é uma taquicardia sinusal isolada. \\nOutros achados podem ser observados, mais comumente, em pacientes com TEP maciça, como:'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 206}, page_content='206 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\ndesvio do eixo QRS para a direita; inversão de onda T nas precordiais de V1-V3; BRD transitório; \\nonda P pulmonale; e taquiarritmias atriais. \\nEcocardiograma transesofágico  - O exame é importante, inicialmente, para \\ndiagnóstico diferencial na TEP. Porém, a grande utilidade deste é no diagnóstico e fator de \\ndecisão terapêutica em pacientes hemodinamicamente instáveis, à beira leito, com suspeita de \\nTEP maciça (choque ou durante ressuscitação cardiopulmonar) ou confirmação diagnóstica já \\nestabelecida. A decisão terapêutica - uso de trombolíticos - pode ser indicada se: visualização \\nde trombo proximal; dilatação aguda do VD; e presença de hipertensão pulmonar. É importante \\nsalientar que EP com importante repercussão hemodinâmica é incomum quando associado ao \\nEcocardiograma normal. \\nD-dímero - O valor preditivo negativo (VPN) do D -dímero é alto, logo, níveis normais \\ndeste tornam incomum a presença de EP ou TVP. Porém, é válido salientar que o valor preditivo \\npositivo (VPP) do D-dímero é baixo, logo, níveis elevados deste não confirmam o diagnóstico de \\nEP. Deve -se lembrar que diversas situações podem cursar com aumento de D -dímero, como \\ninfarto agudo do miocárdio, pneumonia, sepse, cân cer, estado pós -operatório e em mulheres \\nno segundo ou terceiro trimestre de gravidez. O teste do D -dímero é recomendado para para \\npacientes com baixa ou intermediária suspeita clínica, podendo ser utilizado o clássico valor de \\n500 ng/mL, porém, pacientes com alta probabilidade clínica não necessitam da mensuração do \\nD-dímero para indicação de testes confirmatórios. É válido lembrar que o D -dímero possui \\nvalores aumentados com o decorrer da idade, sendo recomendado utilizar, em pacientes > 50 \\nanos, o valor de referência adaptado à idade: idade em anos x 10 ug/L (valores menores que \\nestes descartam TVP em pacientes com baixa probabilidade clínica)11. \\n5.2. EXAMES CONFIRMATÓRIOS \\nOs exames confirmatórios dos quadros de TVP são: Ultrassonografia dos membros \\ninferiores e Flebografia. Já para TEP, os exames são: angio -TC; cintilografia pulmonar; e \\nangiografia pulmonar. \\nUltrassonografia dos membros inferiores  - Excelente método não invasivo para \\ndiagnóstico de TVP dos membros inferiores. Pode ser realizado junto ao leito de pacientes \\nacamados e não tem contraindicações. Esse exame encontra TVP proximal em 30 -50% dos \\npacientes com EP, o que é suficiente para autorizar anticoagulação sem outros testes. Porém, \\npacientes que são diagnosticados com TVP sem confirmação de TEP, d evem passar por uma \\navaliação de risco para tal condição antes de iniciar a anticoagulação. O principal critério'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 207}, page_content='207 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nutilizado para o diagnóstico é o teste da compressão. Se houver dúvida diagnóstica após um \\nteste negativo, é necessário refazer o exame após 1 semana. \\nFlebografia - Conhecida também como venografia, ainda persiste como o padrão -ouro \\nno diagnóstico de TVP de membros inferiores, porém possui cada vez menos uso no cenário \\natual. \\nAngio-TC - É o método de imagem de escolha para avaliação da vasculatur a pulmonar \\nem pacientes com suspeita de EP. Sensibilidade de 83% e especificidade de 96% para \\ndiagnóstico de EP 12. Esse exame possui alto VPP em pacientes com alta probabilidade clínica \\npara EP, assim como alto VPN em pacientes de baixa probabilidade clíni ca, se assemelhando \\ncom a cintilografia. Permite avaliar, além do que já foi mencionado, a aorta, parênquima \\npulmonar, caixa torácica e espaço pleural, permitindo a identificação de possíveis diagnósticos \\ndiferenciais. \\nCintilografia pulmonar de ventilação e perfusão  - Método classicamente \\ndocumentado, o qual se divide em três principais classificações: normal (excluindo EP); alta \\nprobabilidade; moderada probabilidade. Possui alto VPN quando o exame é normal, assim \\ncomo alto VPP quando o resultado é de alta probabilidade13. É importante ressaltar que exames \\ncom resultado de probabilidade intermediária não auxiliam no processo de decisão e conduta. \\nPacientes com alta suspeita clínica, mas com exame de “baixa probabilidade”, podem \\napresentar TEP em até 40% das vezes13. Resultados falso-positivos são possíveis em pacientes \\ncom asma ou com TEP prévia, logo, exames em pacientes sem comorbidades e com radiografias \\nnormais propiciam um melhor rendimento. \\nAngioressonância - Método classificado como uma alternativa à a ngio-TC. Porém, \\ndiversos estudos mostraram que esta possui uma baixa sensibilidade, alto número de exames \\ninconclusivos e baixa disponibilidade em serviços de emergências14. \\nAngiografia pulmonar - Exame invasivo consagrado como padrão ouro no diagnóstico \\nde EP. Porém, atualmente vem sendo substituído por exames não invasivos que possuem boa \\nacurácia (angio-TC). Seu emprego como método inicial é, geralmente, limitado aos pacientes \\ninstáveis com contraindicação ao uso de trombolíticos e que podem se beneficia r da \\ntrombectomia por cateter (nível de evidência C). Em pacientes estáveis, a indicação da \\nangiografia pulmonar é apontada quando resultados dos exames não invasivos são \\ninconclusivos, ou quando há discordância entre os mesmos e a clínica (nível de evidência A)15.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 208}, page_content='208 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\n5.3. ALGORITMO DIAGNÓSTICO \\nO algoritmo diagnóstico se baseia em diversos fatores, sendo o principal o \\nreconhecimento da instabilidade hemodinâmica do paciente, definida por hipotensão, síncope \\n(sinal de baixo débito) ou disfunção de ventrículo direito (VD) significativa. \\n5.3.1. PACIENTES HEMODINAMICAMENTE ESTÁVEIS \\nEm pacientes clinicamente estáveis com sintomas pulmonares agudos e sinais de TVP se \\npreconiza realizar inicialmente uma avaliação do membro inferior acometido, pois isso já \\ndefine o diagnóstico e r espectivo tratamento. Se o resultado for negativo, e ainda houver \\nsuspeita de TEP, deve-se investigar o componente pulmonar. \\nJá em pacientes com suspeita criteriosa de TEP, sem causa aparente nos exames de apoio \\niniciais ou sinais de TVP, deve -se aplicar o  escore de Wells. Caso haja um escore ≤ 4 (TEP \\nimprovável), se preconiza a solicitação de D -dímero de alta sensibilidade (ELISA, VIDAS, \\nhemaglutinação ou Liatest), que, caso negativo, exclui -se a suspeita diagnóstica. Nos pacientes \\ncom escore > 4 (suspeita  intermediária ou alta), não há necessidade de solicitar D -dímero, \\npodendo prosseguir com exames confirmatórios de TEP (cintilografia ou angio-TC). \\nResultados concordantes (angio -TC positiva/cintilografia de alta probabilidade com \\nprobabilidade clínica alt a, ou angio -TC negativa/cintilografia de baixa probabilidade com \\nprobabilidade clínica baixa) permitem, respectivamente, confirmar ou excluir TEP. Como já \\nmencionado, resultados discordantes entre exames confirmatórios e probabilidade clínica \\ndevem prosseguir com a investigação adicional (exames diagnósticos de TVP), e caso negativa \\n(mas com suspeita ainda mantida), deve-se utilizar da arteriografia pulmonar. \\nVale ressaltar que pacientes com suspeita clínica intermediária ou alta deverão receber \\nanticoagulantes, quando não presentes contraindicações. \\n5.3.2. PACIENTES HEMODINAMICAMENTE INSTÁVEIS \\nEm pacientes hemodinamicamente instáveis (hipotensão, sinais de baixo débito - PAS < \\n90 ou PAM < 70 mmHg - e hipoxemia significativa - PaO2 < 60 mmHg com FiO2 > 40 -) e com \\nsuspeita de TEP (geralmente com escore de Wells > 2) deve-se buscar rapidez no diagnóstico e \\nestabelecer tratamento imediato caso necessário. \\nCaso haja instabilidade hemodinâmica e confirmação diagnóstica, está indicado o uso de \\ntrombolíticos (única indica ção absoluta). Logo, em pacientes que não possuem \\ncontraindicações ao uso destes, a investigação diagnóstica deve ser feita com exames \\nconfirmatórios não invasivos disponíveis na unidade.. Em contrapartida, pacientes com'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 209}, page_content='209 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\ncontraindicações ao uso dos trombol íticos, devem prosseguir com a investigação com uma \\narteriografia convencional, que poderá ser utilizada para tratamento concomitante \\n(embolectomia por cateter ou filtro de veia cava). \\n \\nBOX 28. CONTINUAÇÃO CASO CLÍNICO \\nO paciente em questão apresentava intermediária/alta suspeita clínica (critério de \\nWells > 4), logo, foi solicitado um ECG como exame auxiliar, o qual demonstrou uma \\ntaquicardia sinusal. Não houve necessidade de solicitação de D -dímero para elucidação \\ndiagnóstica. \\nA partir do resultado dos exames previamente referidos, foi indicado a realização de \\nexames confirmatórios de TEP/TVP, sendo optado a realização da Angio -TC, que \\ndemonstrou uma pequena falha de enchimento em ramo arterial pulmonar segmentar para \\no lobo inferior esquerdo, relaciona da com tromboembolismo pulmonar associada a \\nalterações com alta probabilidade de COVID-19. \\n \\n6. CONDUTA \\n6.1. TVP \\nInicialmente, se o paciente possuir TVP extensa em veias femorais, iliofemorais  ou de \\nmembros superiores, deve -se realizar uma terapia primária para dissolução do coágulo, \\ngeralmente feito com trombólise em baixas doses guiada por cateter. Alguns estudos atuais \\ncomparam a eficácia da utilização da trombólise e da utilização de anticoagulação isolada, mas \\nsem conclusões definitivas até o momento. \\nPor outro lado, a profilaxia secundária é feita com anticoagulação ou instalação de filtro \\nna veia cava inferior (VCI). Pacientes que possuem edema de membros inferiores com \\ndiagnóstico definitivo de TVP podem utilizar de meias de compressão graduada para reduzir o \\ndesconforto gerado pela condição.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 210}, page_content='210 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\n6.2. EMBOLIA PULMONAR \\nInicialmente, é importante estratificar o risco de pacientes com TEP, utilizando critérios \\ncomo: instabilidade hemodinâmica; disfunção do VD na ecocardiografia; aumento do VD em TC \\nde tórax; ou aumento nos níveis de troponina (decorrentes de microinfartos de VD). \\nSe o paciente possui estabilidade hemodinâmica, VD normal, pode-se optar por realizar \\ntratamento somente com anticoagulação. Por outro lado, pacientes com sinais de instabilidade \\nhemodinâmica devem ser direcionados a uma terapia de trombólise inicialmente, para após ser \\nestabelecida a anticoagulação. Ademais, aqueles que possuírem estabilidade hemodinâmica, \\nmas apresentarem sinais de hipocinesia do VD, devem ter sua terapia individualizada. \\nÉ importante ressaltar que pacientes com EP maciça devem seguir uma restrição hídrica \\nrigorosa, pois qualquer administração excessiva de volume pode agravar o estresse da parede \\ndo VD, provocando ou piorando uma isquemia. Está indicado para esse perfil de paciente o uso \\nde agentes inotrópicos, como dopamina e dobutamina, para tratamento do choque relacionado \\nà EP, sendo iniciados com doses baixas e variando de acordo com cada paciente. Citare i mais \\nsobre esse perfil de paciente no decorrer deste tópico. \\n6.2.1. ANTICOAGULAÇÃO \\nA anticoagulação é o principal pilar no tratamento da TEV. Atualmente, estão disponíveis \\ntrês grandes estratégias para o manejo desses pacientes: (1) anticoagulação parenteral co m \\nHNF, HPBM ou fondaparinux, seguida de varfarina; (2) terapia parenteral por 5 dias, seguida \\nde um novo anticoagulante oral (NOACs); e (3) anticoagulação VO em monoterapia com dose \\nde ataque de rivaroxabana (3 semanas) ou apixabana (1 semana), seguida de doses de \\nmanutenção sem utilização da via parenteral1. \\nA duração da anticoagulação varia de acordo com a apresentação clínica do paciente. \\nPara aqueles com TVP isolada em membro superior ou panturrilha, que tenha etiologia em \\ncirurgia, traumatismo, estrogênio ou cateter venoso central/marca passo, o tempo de 3 meses \\né o ideal. Já para os pacientes com TVP de região proximal da perna ou com EP, a duração de 3 \\na 6 meses seria o período mais indicado. Para pacientes com câncer e TEV, deve-se ser utilizado \\na HB PM como monoterapia sem varfarina, por tempo indefinido ou até cura do câncer. É \\nimportante ressaltar que pacientes com TEV não provocado (sem etiologia aparente, incluindo \\naqueles após viagens longas) deve -se considerar a anticoagulação por tempo indefini do. Por \\nfim, os pacientes com síndrome antifosfolipídeo possuem indicação de anticoagulação por \\ntempo indeterminado, mesmo que o TEV possua causa aparente.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 211}, page_content='211 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nHeparina não fracionada - A dose de HNF tem meta de obter um tempo de \\ntromboplastina parcial ativada (TTPa) de 60-80 segundos. A mais clássica dosagem é um bolus \\nde 80 UI/kg, seguido de infusão inicial de 18 UI/kg/hora. A principal vantagem desta é a meia-\\nvida curta, sendo necessário controle rigoroso do grau de anticoagulação. \\nHeparinas de baixo peso mo lecular - Possuem maior biodisponibilidade maior e \\nmeia-vida mais longa do que a HNF, e se comprovaram superiores para pacientes \\nhemodinamicamente estáveis. Sua vantagem consiste no fato de não necessitar de monitoração \\nnem de ajuste de dose (exceto em pac ientes obesos ou com insuficiência renal crônica). Em \\nalgumas situações específicas há a necessidade de dosagem do antifator Xa (componente ativo \\nda HBPM), sendo estas: peso > 150 kg ou < 40 kg; gestantes; e disfunção renal (aguda ou \\ncrônica). Alguns exemp los de HBPM e suas posologias: Enoxaparina (clexane) 1 mg/kg, SC, \\n12/12 h; Nadroparina (fraxiparina) 225 U/kg, SC, 12/12 h; e Dalteparina (fragmin) 100 U/kg, \\nSC, 12/12h. \\nFondaparinux - Apresenta ação anti -Xa, administrado por via subcutânea, com dose \\ncalculada a partir do peso: Peso < 50 kg: 5 mg, SC, 1x/dia; peso entre 50 -100 kg: 7,5 mg, SC, \\n1x/dia; e peso > 100 kg: 10 mg, SC, 1x/dia. Sua vantagem consiste na não necessidade de \\nmonitoração laboratorial, além de não causar trombocitopenia induzida por heparina. A \\nprincipal desvantagem é o fato de não haver antídoto contra essa droga. \\nVarfarina - Consiste em um antagonista da vitamina K. É necessário cerca de 5 dias para \\nque esta exerça seu efeito completo, por isso é necessário medicações “pontes”, send o estas: \\nHNF; HBPM; ou fondaparinux. A posologia costuma ser de 5 mg, com meta de INR que varia \\nentre 2 e 3 (alvo de 2,5). É importante ressaltar que a varfarina pode causar hemorragia \\nsignificativa, mesmo que o INR esteja na faixa terapêutica. \\nNovos anticoagulantes orais (NOACs) - Os NOACs são administrados em dose fixa, não \\nexigindo monitoração laboratorial e possuindo poucas interações medicamentosas. Estes são \\ndivididos em dois grupos de ação principais: inibidores do fator Xa (rivaroxabana, apixabana e \\nedoxabana) e inibidores diretos da trombina (dabigratana).  A rivaroxabana e apixabana são \\naprovados para tratamento agudo e estendido no TEV, sem usar medicamentos de transição. Já \\na dabigatrana e a edoxabana são utilizadas como tratamento após um curso inicial de 5 dias \\ncom anticoagulação parenteral. Ademais, a betrixabana é indicada para profilaxia do TEV em \\npaciente durante a hospitalização e continuando por um tempo de 5 a 6 semanas no total.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 212}, page_content='212 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nTabela 3 - Os principais anticoagulantes \\nANTICOAGULANTE DOSE RECOMENDADA \\nHNF Bolus de 80 UI/kg, seguido de infusão inicial de 18 UI/kg/hora.  \\nMeta: TTPa de 60-80 segundos. \\nEnoxaparina 1 mg/kg SC, 12/12 horas. \\nFondaparinux \\nDose baseada no peso:  \\nPeso < 50 kg: 5 mg, SC, 1x/dia; \\nPeso entre 50-100 kg: 7,5 mg, SC, 1x/dia;  \\nPeso > 100 kg: 10 mg, SC, 1x/dia. \\nVarfarina 5 mg, com meta de INR que varia entre 2 e 3 (alvo de 2,5).  \\nNOACs Dose fixa, variando de acordo com a droga escolhida. \\n \\n6.2.2. FILTROS DE VEIA CAVA INFERIOR \\nAs principais indicações para a utilização de filtro de VCI são: sangramento ativo que \\ncontraindique anticoagulação; e TVP recorrente apesar de anticoagulação intensiva. Outras \\nindicações que podem ser consideradas para o uso do filtro é a recorrência de EP em pacientes \\ncom IC direita que não tem indicação de fibrinólise e a profilaxia de pacientes com risco elevado \\nde TEV. \\nÉ importante salientar que os filtros de VCI podem, paradoxalmente, aumentar a taxa de \\nTVP, por mais que evitem o aparecimento do EP. \\n6.2.3. FIBRINÓLISE \\nA única indicação aprovada pela FDA para o uso dessa estratégia terapêutica é na EP \\nmaciça. O esquema fibrinolítico recomendado é o de 100 mg de ativador do plasminogênio \\ntecidual (rtPA - alteplase) recombinante, administrado em infusão IV ao longo de 2 horas. Outro \\nesquema que pode ser utilizado é com a estreptoquinase, em dose de ataque de 250.000 UI em \\n30 min, seguida de 100.000 UI/h por 24 h. \\nAs contraindicações para este tratamento são: doença intracraniana; cirurgia recente e \\ntraumatismo. O rastreamento das contra indicações é importante para minimizar os riscos de \\nsangramento advindos dessa terapêutica. \\n6.2.4. TERAPIA FARMACOMECÂNICA POR CATETER \\nA principal utilização desta terapêutica consiste em pacientes com com EP maciça ou \\nsubmaciça que possu em contraindicações ao uso da trombólise. Essa terapia consiste em \\nfragmentação ou pulverização mecânica do trombo somada a trombólise em dose baixa'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 213}, page_content='213 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\ndirecionada por cateter. A dose de alteplase pode ser reduzida para uma faixa de 20 -25 mg \\n(substituindo a dose sistêmica de 100 mg IV). \\n6.2.5. EMBOLECTOMIA PULMONAR \\nEsta é uma opção para substituição do uso de fibrinolíticos, seja por contraindicações ou \\npor individualização da terapia. \\n6.2.6. TROMBOENDARTERECTOMIA PULMONAR \\nA principal indicação desta cirurgia é para pacient es com hipertensão pulmonar \\ntromboembólica crônica após episódio de EP (apenas 2-4% dos casos). \\n \\nBOX 29. CONTINUAÇÃO CASO CLÍNICO \\nPara o paciente abordado, optou -se pelo tratamento com enoxaparina 100mg \\nsubcutânea (SC) de 12/12 horas. Após 2 dias de enfermaria e t ratamento com \\nanticoagulante, o paciente evoluiu com taquipneia e hipoxemia, sendo necessário \\ntransferência para UTI. Após 2 dias de estabilização e monitorização houve melhora e \\nretorno para a enfermaria. No 5° dia após o ocorrido, evoluiu com alta hospit alar, \\nsubstituindo a medicação SC por rivaroxabana e seguimento ambulatorial. \\n \\n7. PROFILAXIA \\nÉ importante salientar que para o cenário de pronto-atendimento abordado no capítulo, \\na profilaxia se coloca como plano secundário no aprendizado do manejo do pacien te com \\ntromboembolismo venoso na emergência. Porém, citaremos os principais pontos que devem \\nser levados em consideração. \\nAs complicações advindas do TEV são diversas, incluindo quadros de hipertensão \\npulmonar e síndrome pós-trombótica. Sabe-se que a maioria dos casos são assintomáticos e/ou \\noligossintomáticos, suscitando a ideia de que a profilaxia seria eficaz para a prevenção da \\ncondição. A maioria dos pacientes internados possui ao menos um fator de risco para TEV e \\ncerca de 40% apresentam três ou mais16. Existem situações de risco que potencializam e \\naumentam o risco para a TVP: idade avançada; imobilização prolongada; grandes cirurgias; \\nobesidade; trombofilias; uso de hormônios; gestação; antecedentes de TVP; doenças venosas; \\ndoenças cardiopulmonares; presença de cateteres centrais; e neoplasias17.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 214}, page_content='214 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\n7.1. PROFILAXIA EM PACIENTES CLÍNICOS HOSPITALIZADOS \\nOs pacientes não cirúrgicos internados devem ser alocados para a avaliação de risco e \\ntromboprofilaxia caso possuam idade maior de 40 anos, com pelo menos um fator de risco e \\nque estejam com mobilidade reduzida há 3 dias, pelo menos 2. Para esse perfil de paciente, \\nutiliza-se o escore de pádua (tabela 4)16. \\n \\nTabela 4 - Escore de pádua \\nNeoplasia em atividade \\nTVP ou EP pregressa \\nMobilidade reduzida \\nTrombofilia conhecida \\n3 pontos \\nTraumatismo e/ou cirurgia <  30 dias 2 pontos \\nIdade > 70 anos \\nICC ou insuficiência respiratória \\nIAM ou AVCi \\nInfecção ou distúrbio reumatológico \\nIMC > 30 kg/m2 \\nSob tratamento hormonal \\n1 ponto \\nFonte: Adaptada de Barbar S et al., 201018 \\n \\nA interpretação do escore é feita da seguinte forma: alto risco de TEV (11%) se escore > \\n4; ou baixo risco (0,3%) se escore < 4. \\nA escolha do tipo de profilaxia se baseia no risco de sangramento e/ou presença de \\nsangramento ativo. Caso haja uma dessas situações, a escolha é direcionada para a profilaxia \\nmecânica (compressão pneumática intermitente - CPI). Logo, quando há reversão dos pontos \\ncitados, pode-se optar pela profilaxia química. É importante ressaltar que a profilaxia para esse \\nperfil de paciente deve durar até, no máximo, o fim do período de internação. \\nA seguir, segue a tabela 5 com as opções de profilaxia dependendo do risco estimado a \\npartir do escore citado: \\n \\nTabela 5 - Indicações de profilaxia \\nPacientes de baixo risco Estimular a deambulação precoce. Não se deve utilizar \\ntromboprofilaxia química \\nPacientes de alto risco Enoxaparina 40 mg por via SC, 1x ao dia \\nou \\nHNF, 5.000 UI de 8/8 horas. \\nou \\nFondaparinux 2,5 mg SC, uma vez ao dia.  \\nFonte: Adaptada do consenso e atualização de profilaxia do TEV da SBACVSP2.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 215}, page_content='215 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nComo já citado, se houver indicação de profilaxia mecânica, esta deve ser realizada com \\nmeias elásticas de compressão graduada ou compressão pneumática intermitente16. \\nPor fim, cita-se que pacientes com extremos de peso devem receber dose adaptada. Caso \\nIMC > 40 kg/m2, recomenda -se enoxaparina 40 mg SC, de 12 em 12 horas. Já para IMC > 50 \\nkg/m2, indica-se enoxaparina 60 mg SC, de 12 em 12 horas2. \\n7.2. PROFILAXIA DO TROMBOEMBOLISMO VENOSO EM PACIENTES CIRÚRGICOS \\nA incidência de TEV em pacientes cirúrgicos hospitalizados é variável, principalmente \\nnos grupos sem profilaxia, de acordo com o procedimento. Pacientes oncológicos possuem risco \\naproximado de 37%, enquanto os pacientes ortopédicos possuem 50%, e na cirurgia g eral, a \\n20%16. \\nNo perfil de pacientes abordados, deve -se utilizar a Escala de Caprini para basear a \\ndecisão terapêutica. A interpretação desta é realizada da seguinte forma: muito baixo risco \\n(escore 0); baixo risco (escores 1 -2); risco moderado (escore 3 -4); e alto risco (escore ≥ 5), \\nconforme a tabela 6. \\n \\nTabela 6 - Escala de Caprini \\nIdade 41 a 60 anos \\nCirurgia maior prévia (<1 mês) \\nCirurgia menor \\nDII \\nDoença pulmonar grave \\nDPOC \\nEdema de MMII \\nGravidez e pós-parto (<1 mês) \\nHormônio \\nIAM \\nICC \\nObesidade \\nPerda fetal/aborto \\nRestrição ao leito \\nSepse (<1 mês) \\nVarizes \\nOutros \\n1 ponto \\nIdade 61 a 74 anos \\nArtroscopia  \\nCâncer \\nCateter venoso central \\nCirurgia maior (>45 min) \\nImobilização gessada \\nLaparoscopia (>45 min) \\nRestrição ao leito (>72 h) \\n2 pontos'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 216}, page_content='216 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nIdade > 75 anos \\nAnticoagulante lúpico \\nAnticorpos anticardiolipina \\nFator V de Leiden \\nHistória familiar de TEV \\nHistória prévia de TEV \\nHomocisteína elevada \\nProtrombina 2021OA \\nTIH \\n3 pontos \\nAVC (< 1 mês) \\nArtroplastia \\nFratura de quadril/pelve \\nPolitraumatismo \\nTRM \\n5 pontos \\nFonte: adaptada de Caprini JA, 201019. \\n \\nEm pacientes de muito baixo risco (0,5, de chance de TEV)indica -se a deambulação \\nprecoce. Já para pacientes de baixo risco (1,5%), recomenda -se a profilaxia mecânica. Nos \\npacientes com risco moderado (3%), contanto que apresentem baixo risco de sangramento, \\nrecomenda-se a profilaxia medicamentosa. Para pacientes de alto risco de TEV e baixo risco de \\nsangramento, indica-se a profilaxia medicamentosa, associada ou não com profilaxia mecânica. \\nPor fim, em pacientes com alto risco de sangramento, deve-se utilizar a profilaxia mecânica. \\nPara pacientes com risco moderado e em cirurgia geral, é indicado HNF 5.000 UI SC, 2 \\nhoras antes do procedimento e mantendo de 12/12 horas após;ou HBPM (enoxaparina) 20 mg \\nSC, mantendo de 24/24 horas após. \\nEm casos de alto risco para TEV, indica -se HBPM (enoxaparina), 40 mg 12 horas antes \\nda cirurgia e de 24/24 horas após; ou fondaparinux 2,5 mg e mantendo de 24/24 horas após; \\nou HNF 5.000 UI, 2 horas antes do procedimento e se mantendo de 8/8 horas. \\nEm pacientes ortopédicos, indica -se HBPM 12 horas antes do procedimento e após 6 a \\n12 horas. Em cirurgias de joelho e quadril, é necessário estender a profilaxia, com duração \\nmínima de 10 a 14 dias. \\nPara pacientes obesos, que irão realizar cirurgia bariátrica,a dose deve ser de 40 mg de \\nHBPM, 2 vezes ao dia, por um período de 10 dias. \\nEm pacientes oncológicos, que serão submetidos a cirurgia abdominal ou pélvica, a \\nprofilaxia deve ser feita com HBPM por período prolongado.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 217}, page_content='217 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nFLUXOGRAMA \\n \\n \\nECG = eletrocardiograma; PERC = Pulmonary Embolism Rule-out Criteria; MMII = membros inferiores; \\nTVP = trombose venosa profunda; TEP = tromboembolismo pulmonar; VD = ventrículo direito. \\nPACIENTE COM SUSPEITA DE \\nTROMBOEMBOLISMO VENOSO \\nAvaliação Inicial \\n(Wells + PERC + ECG) \\nPERC = 8 \\nEstável \\nhemodinamicamente \\nExclusão segura de \\nTEV \\n Instável \\nhemodinamicamente \\nWells < 4 \\n Wells > 4 \\n Wells >2 \\nD-dímero > 500 \\nExames confirmatórios \\n(TVP = US MMII. / TEP = Angio-TC) \\nTVP \\n TEP \\nTrombólise guiada \\npor cateter \\nVD normal + \\nestabilidade \\nhemodinâmica \\nHipocinesia de \\nVD \\nInstabilidade \\nhemodinâmica \\nAnticoagulação \\n (Individualizar) \\nTrombólise \\n+ \\nAnticoagulação'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 218}, page_content='218 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\nREFERÊNCIAS \\n1. KASPER, Dennis L. Medicina interna de Harrison. 20 ed. Porto Alegre: AMGH Editora, 2020.  \\n2. Burihan M C; Júnior W C. Consenso e atualização na profilaxia e no tratamento do \\ntromboembolismo venoso. Rio de Janeiro: Guanabara Koogan, 2019. \\n3. KUMAR, V. et al. Robbins patologia básica.9ª Edição. Rio de Janeiro: Elsevier, 2013. \\n4. BRAUNWALD, Tratado de doenças cardiovasculares, 9.ed. Rio de Janeiro: Elsevier, 2013 \\n5. Velasco IT. Manual de Emergência: Abordagem Prática. 14. ed. São Paulo: Manole, 2020. \\n6. TERRA-FILHO,Mário; MENNA-BARRETO, Sérgio Saldanha. Recomendações para o manejo \\nda tromboembolia pulmonar, 2010. Jornal Brasileiro de Pneumologia, v. 36, p. 1-3, 2010. \\n7. Stavros V Konstantinides, et al: The Task Force for the diagnosis and management of acute  \\npulmonary embolism of the European Society of Cardiology (ESC), European Heart Journal, \\nVolume 41, Issue 4, 21 January 2020, Pages 543 –603, \\nhttps://doi.org/10.1093/eurheartj/ehz405. \\n8. Stein PD, Terrin ML, Hales CA, Palevsky HI, Saltzman HA, Thompson BT, et al. Clinical, \\nlaboratory, roentgenographic, and electrocardiographic findings in patients with acute \\npulmonary embolism and no pre -existing cardiac or pulmonary disease. Chest. \\n1991;100(3):598-603.  \\n9. Girard P, Musset D, Parent F, Maitre S, Phlippoteau C, Simonneau G. High prevalence of \\ndetectable deep venous thrombosis in patients with acute pulmonary embolism. Chest. \\n1999;116(4):903-8.  \\n10. Freund Y, Cachanado M, Aubry A, Orsini C, Raynal PA, Feral -Pierssens AL, Charpentier S, \\nDumas F, Baarir N , Truchot J, Desmettre T, Tazarourte K, Beaune S, Leleu A, Khellaf M, \\nWargon M, Bloom B, Rousseau A, Simon T, Riou B, Group PI. Effect of the pulmonary \\nembolism rule -out criteria on subsequent thromboembolic events among low -risk \\nemergency department patie nts: the PROPER randomized clinical trial. JAMA \\n2018;319:559566. \\n11. Righini M, Van Es J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, Rutschmann OT, \\nSanchez O, Jaffrelot M, Trinh -Duc A, Le Gall C, Moustafa F, Principe A, Van Houten AA, Ten \\nWolde M, Douma RA , Hazelaar G, Erkens PM, Van Kralingen KW, Grootenboers MJ, Durian \\nMF, Cheung YW, Meyer G, Bounameaux H, Huisman MV, Kamphuisen PW, Le Gal G. Age -\\nadjusted D- dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.JAMA \\n2014;311:11171124. \\n12. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV Jr, Popovich J \\nJr, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK; PIOPED \\nII Investigators. Multidetector computed tomography for acute pulmonary embolism.  N \\nEngl J Med 2006;354:23172327.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 219}, page_content='219 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO IX | TROMBOEMBOLISMO VENOSO (TEV) \\n13. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the \\nprospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED \\nInvestigators. JAMA. 1990;263(20):2753-9. \\n14. Revel MP, Sanchez O, Couchon S, Planquette B, Hernigou A, Niarra R, Meyer G, Chatellier G. \\nDiagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: \\nresults of the ‘IRM-EP’ study. J Thromb Haemost 2012;10:743750. \\n15. British Thoracic Society Standards o f Care Committee Pulmonary Embolism Guideline \\nDevelopment Group. British Thoracic Society guidelines for the management of suspected \\nacute pulmonary embolism. Thorax. 2003;58(6):470-83. \\n16. Kahn SR, LIM W, Dunn As et al. Prevention of VTE in nonsurgical patien ts: antithrombotic \\ntherapy and prevention of thrombosis.9. ed. American College of Chest Physicians Evidence-\\nbased Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e195s-e226s. \\n17. Okuhara A, Navarro TP, Procópio JR, Leite JO. Incidência de trombose veno sa profunda e \\nestratificação dos grupos de risco em serviço de cirurgia vascular de hospital universitário. \\nJ Vasc Bras. 2015 Abr.-Jun.; 14(2):139-44. \\n18. Barbar S, Noventa F, Rosseto V et al. A risk assessment model for the identification of \\nhospitalized medical patients at risk for venous thromboembolism: the Padua Prediction \\nScore. J Thromb Haemost. 2010;8(11):2450-7. \\n19. Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous \\nthromboembolism. Am J Surg. 2010 Jan;199(1 Suppl):S3-10.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 220}, page_content='220 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nCAPÍTULO X  \\nSÍNDROMES AÓRTICAS AGUDAS (SAA) \\nIgor Menezes Bambeko 1 \\nAntonio Iran Costa Magalhães Júnior 1 \\nNatanael Ponte de Oliveira 1 \\nDara Medeiros Mendes 1 \\nFernanda Rêgo Militão 2 \\nDOI: 10.51859/amplla.ceg164.1123-10 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil. \\n² Médica Cardiologista. Hospital de Messejana Dr. Carlos Alberto Studart Gomes. Fortaleza, Ceará, Brasil.  \\nCASO CLÍNICO \\nPaciente do sexo masculino, 66 anos, pardo, casado e procedente de zona rural, com \\nhistória de que , há 8 horas , apresentou, subitamente, dor tipo pontada intensa em região \\ninterescapulovertebral direita que se irradiou para região retroesternal. Apresentou dispneia \\nconcomitante, sialosquese, com sudorese profusa e fria, parestesia de membro superior direito \\ne cervicalgia que impossibilitava a movimentação do pescoço. \\nPERGUNTAS NORTEADORAS \\n1. Quais são as principais hipóteses diagnósticas? \\n2. Quais dados da anamnese e do exame físico levam a colocar a SAA nas hipóteses \\ndiagnósticas? \\n3. Que exames solicitar para confirmar o diagnóstico de SAA? \\n4. Após a confirmação do diagnóstico qual a melhor conduta a ser tomada? \\n1. INTRODUÇÃO E CONCEITOS \\nA aorta pode ser acometida por diversas doenças congênitas ou adquiridas, agudas ou \\ncrônicas, envolvendo os componentes torácicos e/ou abdominais. \\n As síndromes aórticas agudas englobam um conjunto de condições raras, mas com \\nevolução rápida e fatal e que que compartilham vias fisiopatológicas (comprometimento da \\ntúnica íntima e da túnica média), características clínicas e desafi os diagnósticos e terapêuticos \\nsimilares. Dentre as principais representantes desse conjunto podemos citar: hematoma \\nintramural (HI), úlcera aterosclerótica penetrante (UAP) e dissecção de aorta(DA). ¹'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 221}, page_content='221 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\n2. EPIDEMIOLOGIA E ETIOLOGIA \\nA úlcera aterosclerótica pen etrante compreende 2 -7% de todos os casos de SAA. Os \\npacientes com UAP são geralmente indivíduos mais velhos (com idade >65 anos) que fumam e \\ntem múltiplas comorbidades, nomeadamente hipertensão arterial sistêmica, diabetes, \\ndislipidemia, doença arterial c oronariana, doença pulmonar, insuficiência renal e/ou vascular \\ndoença (aterosclerose). ² \\nEstudos em pacientes hospitalizados sugerem uma incidência de dissecção aguda da \\naorta de cerca de três casos a cada 100.000 pessoas ao ano, o que representa metade da  \\nincidência dos aneurismas de aorta sintomática. Estudos populacionais na Suécia mostram \\ndissecção de aorta identificada como causa morte e 3 -4 casos a cada 100.000 óbitos. Estudos \\namericanos e europeus estimam a incidência anual de dissecção aórtica entre  2,6 a 3,5 casos a \\ncada 100.000 habitantes ao ano. A verdadeira incidência da dissecção de aorta pode ser \\nsubestimada, pois os dados são provenientes de registros retrospectivos em centros \\nespecializados. A idade média de apresentação é de 63 anos , com pre dominância do sexo \\nmasculino, representando cerca de 65% dos casos. Vários fatores podem contribuir para o risco \\naumentado de dissecção da aorta. Idade avançada, dislipidemia e hipertensão arterial podem \\npromover degeneração aterosclerótica da parede aórtica, levando a sua fragilidade. Além disso, \\na hipertensão aumenta a tensão sobre as paredes arteriais, podendo gerar uma ruptura na \\ntúnica íntima, dado que aproximadamente 80% dos pacientes que desenvolvem dissecção \\naórtica têm hipertensão. Ademais, alguns distúrbios genéticos, como a síndrome de Marfan, a \\nsíndrome de Loeys -Dietz, a síndrome de Ehler -Danlos e a síndrome de Turner, aumentam o \\nrisco de dissecção da aorta. ² \\nO hematoma intramural é responsável por 5-20% dos casos que apresentam SAA , com \\nincidência de aproximadamente 30 -40% em estudos asiáticos. Assim como os pacientes com \\nUAP, aqueles com HI são tipicamente mais velhos do que pacientes com dissecção aórtica (com \\nidade >65 anos). Os pacientes são mais propensos a ser do sexo masculino e cerca d e 53% \\npossuem hipertensão. A etiologia do HI pode ser dividida em causas não traumáticas e causas \\ntraumáticas. A maioria dos casos não foi traumática (94%). No grupo traumático, a causa do \\ntrauma foi predominantemente acidentes automobilísticos (75%)²,3. \\n3. FISIOPATOLOGIA \\nAs úlceras ateroscleróticas penetrantes  caracterizam -se por apresentarem placas \\nateromatosas que ulceram e desorganizam a lâmina elástica interna, penetrando'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 222}, page_content='222 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nprofundamente por meio da íntima até a camada média da aorta. Essas placas podem provocar \\ndissecção localizada, associada ao grau variável de hematoma na parede da aorta, podendo se \\nestender até a adventícia formando pseudoaneurismas, ou podem romper nas cavidades \\ntorácica, mediastinal e abdominal. Geralmente acometem a aorta descendente. 4,5 \\nAcredita-se que a dissecção da aorta surja de uma ruptura na camada íntima. A laceração \\níntima tende a ocorrer em áreas sujeitas a  maiores pressões, maior dP/dT  (taxa de aumento \\nda pressão arterial). A carga pulsátil é maior no aorta ascendente. As rupturas da túnica íntima \\nsão geralmente identificadas como locais de comunicação entre o lúmen e falso lúmen. O rasgo \\nda íntima permite que o sangue escape do lúmen do vaso e entre na túnica média subjacente. O \\nespaço preenchido de sangue criado dentro do plano da camada medial torna-se o falso lúmen. \\nA pressão arterial e a taxa de aceleração do fluxo pulsátil são fatores importantes na  \\npropagação da dissecção. A dissecção geralmente progride na direção anterógrada, embora \\ntambém possa prosseguir na direção retrógrada. Devido a diferenças de pressão, o falso lúmen \\npode comprimir ou obstruir o lúmen verdadeiro. A dissecção pode permanecer patente como \\num falso lúmen, ser obliterada por trombose, re -comunicar com o verdadeiro lúmen por \\nfenestração ou romper em esp aços, incluindo o pericárdio, cavidade pleural, ou cavidades \\nperitoneais. Extensão da dissecção pode levar ao envolvimento de vasos laterais, resultando em \\nisquemia cerebral, coronária, mesentérica, renal, ou de membros. 6 \\nJá a fisiopatologia do Hematoma I ntramural ainda não foi plenamente elucidada, uma \\nteoria, proposta em 1920, sugere que o HI é consequência da ruptura do vasa vasorum \\n(pequenos vasos sanguíneos encontrados ao redor de paredes de grandes vasos na camada \\nadventícia, que servem para sua nutr ição) na camada medial da parede da aorta, que então \\ncausa uma ruptura secundária n o lúmen aórtico. Este processo está tipicamente associado à \\nhipertensão e é iniciado pelo infarto da parede aórtica. Uma teoria mais recente sugere que o \\nHI é resultado de u ma laceração da túnica íntima do vaso,  permitindo que o sangue do lúmen \\naórtico entre na parede aórtica. Ocorre então a formação de um trombo dentro da camada \\níntima de forma que nenhum rasgo de entrada possa ser detectado. 4,5,7,8'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 223}, page_content='223 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nBOX 30.  \\nNa admissão, o paciente apresentava regular estado geral, hidratado, corado, \\ndispneico, afebril, consciente e orientado. A ausculta respiratória encontrava-se normal, \\ncom ritmo cardíaco regular sem sopros. A pressão arterial era de 130 x 90 mmHg e a \\nfrequência cardíaca de 96 bpm. Os pulsos pediosos e tibiais posteriores não eram \\npalpáveis, e o femoral encontrava-se diminuído. Os exames laboratoriais não \\napresentavam alterações. O eletrocardiograma era normal. A tomografia de tórax com \\ncontraste revelou um aneurisma dissecante da aorta, posterior à confirmação diagnóstica, \\no paciente foi submetido à cineangiocoronariografia e aortografia, que demonstrou \\ndissecção aórtica tipo A de Standford, estendendo-se até a artéria ilíaca direita com \\ncomprometimento da artéria renal homolateral. \\n \\n4. DIAGNÓSTICO \\nA dor das síndromes aórticas agudas, normalmente, possui uma elevada intensidade e é \\ndescrita como se estivesse ‘’rasgando’’ pelos pacientes. São dores que atingem um pico \\nrapidamente e costumam se localizar no centro do tórax, ocorrendo irradiação para os \\nmembros inferiores e/ou para o dorso. \\nLevando em consideração que tais condições clínicas acometem o mesmo órgão, existe \\numa certa sobreposição entre dissecção aguda da aorta (DAA), hematoma intramural (HIM) e \\núlcera aterosclerótica penetrante (UPA). Já foi relatado que um em cada oito pacientes com DAA \\npossuem, no momento do diagnóstico, HIM ou UPA. \\nComo as síndromes aórticas agudas são potencialmente fatais, é de suma importância \\num elevado grau de suspeição clínica e a rápida realização do diagnóstico, principalmente, nos \\ncasos em que é necessária uma intervenção cirúrgica. Portanto, pacientes que possuem \\nhipertensão no momento da consulta e que estão relatando dor torácica ou na região dorsal, \\ndevem ser encarados como possíveis portadores de alguma síndrome aórtica aguda, sendo, em \\nalguns momentos, necessária uma investigação quanto a essa possibilidade diagnóstica. \\nOs principais exames utilizados para o diagnóstico das SAA são: tomografia \\ncomputadorizada, ressonância magnétic a e ecocardiograma, sendo a escolha dependente da \\ndisponibilidade e experiência do hospital em particular. Normalmente, o exame de imagem \\nmais utilizado para o diagnóstico é a TC, seguida pela ETE, sendo que, em mais de 2/3 dos'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 224}, page_content='224 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\npacientes, é preciso dois exames de imagem para chegar ao diagnóstico. Portanto, em pacientes \\ncom elevado grau de suspeição de síndrome aórtica aguda e com exame inicial negativo, é \\nfundamental a realização de um segundo exame de imagem. \\nA seguir, encontram-se informações detalhadas sobre os principais exames de imagem \\nutilizados para o diagnóstico de SAA: \\n4.1. ECOCARDIOGRAFIA \\n O ecocardiograma transtorácico (ETT) é bastante utilizado durante as situações de \\nemergência, sendo de extrema utilidade para detectar as complicações fatais relaci onadas a \\ndissecção aórtica aguda, a exemplo de derrame pericárdico, tamponamento cardíaco, \\nregurgitação aórtica e movimentos anormais da parede aórtica. No entanto, sua sensibilidade \\npara o diagnóstico de dissecção aórtica aguda tipo A varia entre 78% e 10 0% e para dissecção \\naórtica aguda tipo B varia entre 31% e 55%. Dada a sua baixa sensibilidade diagnóstica, um \\nresultado negativo de ETT não exclui a possibilidade de DAA. Por outro lado, o ecocardiograma \\ntransesofágico (ETE) é eficiente para o diagnóstico  de DAA tipo A, possuindo sensibilidade e \\nespecificidade, respectivamente, de 99% e 89%. Além disso, como o ETE pode ser realizado à \\nbeira do leito e/ou no centro cirúrgico, isso oferece vantagem sobre a TC e a RNM. No entanto, \\npara uma visualização mais d etalhada da aorta e de seus ramos, como é necessário nos \\nacompanhamentos de longo prazo, o ecocardiograma transesofágico torna-se menos útil que a \\nTC e a RNM. \\n4.2. TOMOGRAFIA COMPUTADORIZADA \\nOs pacientes com suspeita de SAA devem, inicialmente, ser avaliados po r meio de uma \\nTC sem contraste, seguida de uma angiografia por TC, pois essa combinação possui uma elevada \\nacurácia diagnóstica, com sensibilidade de 100% e especificidade de 98%. Além do seu elevado \\npoder diagnóstico, a TC possui uma grande disponibilidad e e aceitação pelo paciente, \\noferecendo imagens de qualidade rapidamente, o que torna seu uso ideal no departamento de \\nemergência quando a suspeita é SAA. No entanto, vale ressaltar a alta carga de radiação a qual \\nos pacientes são submetidos, não sendo int eressante o acompanhamento de longo prazo, \\nsobretudo, nos pacientes do sexo feminino e jovens. Vale ressaltar, ainda, que caso seja \\nescolhida a angiotomografia computadorizada, deve-se ficar atento ao potencial nefrotóxico do \\ncontraste iodado.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 225}, page_content='225 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\n4.3. RESSONÂNCIA MAGNÉTICA \\nEsse exame, assim como a TC, possui um elevado potencial diagnóstico, com \\nsensibilidade e especificidade de 98%. É útil, também, para realizar uma avaliação anatômica \\nprecisa da aorta, possuindo um risco de nefrotoxicidade e uso de radiação signi ficativamente \\nmenores quando comparada a TC. Por outro lado, a sua demora (20 a 30 minutos), associada \\ncom algumas contraindicações, como o uso de implantes ferromagnéticos e pacientes com \\nclaustrofobia, limitam seu uso durante a emergência. \\nAlguns exames laboratoriais são, também, necessários: \\n• Contagem de linhagem vermelha: anemia, sangramento; \\n• Contagem de linhagem branca: infecção, inflamação (SIRS); \\n• Proteína C reativa: resposta inflamatória; \\n• Procalcitonina: diagnóstico diferencial entre SIRS e Sepse; \\n• CPK: injúria por reperfusão, rabdomiólise; \\n• Troponina: isquemia miocárdica; \\n• D-dímero: dissecção de aorta, tromboembolismo pulmonar, trombose; \\n• Creatinina: falência renal (existente ou em desenvolvimento); \\n• AST/ALT: isquemia hepática, doença hepática; \\n• Lactato: isquemia intestinal, desordem metabólica; \\n• Glicose: Diabetes mellitus; \\n• Gasometria: desordem metabólica, oxigenação; \\nO D-dímero é o biomarcador mais usado no contexto de DAA, com corte de 500ng/ml \\nsendo altamente sensível para descartar a hipótese de DAA nas primeiras 6 horas de sintomas. \\nContudo, o D-dímero não possui especificidade para o diagnóstico, encontrando-se elevado em \\noutras patologias, como Tromboembolismo Pulmonar ou outras tromboses. Se comparada a \\noutras patologias que cursam com elevaç ão de D -dímeros, a DAA, tipicamente, provoca uma \\nelevação imediata dos níveis desse marcador, em oposição à elevação gradual ocasionada pelas \\ndemais desordens. \\n5. MANEJO DIAGNÓSTICO \\nDurante o atendimento de emergência dos pacientes com suspeita de SAA, é nece ssária \\numa combinação de avaliação clínica, exames laboratoriais, incluindo d -dímero e troponina, \\neletrocardiograma e radiografia de tórax. O médico pode utilizar, ainda, o escore de risco para'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 226}, page_content='226 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nDAA, visto que essa é a principal das síndromes aórticas aguda s, classificando o paciente em \\nrisco baixo, intermediário e alto por meio das características da dor, fatores predisponentes e \\nachados da avaliação clínica. Assim, em emergências pouco equipadas, o grau de suspeição e o \\nuso do escore de risco são fundament ais para o diagnóstico de DAA e das demais SAA, \\npermitindo ao profissional encaminhar o paciente para um centro de referência em imagem e \\nconduta das doenças aórticas. \\n5.1. DAA \\nA investigação diagnóstica é dependente da classificação prévia de risco (pré -teste), \\nvisto que os diversos métodos diagnósticos possuem eficácia diferente de acordo com a \\nprobabilidade pré -teste. Em 2010, a American College of Cardiology/American Heart \\nAssociation (ACC/AHA) propôs um algoritmo diagnóstico baseado na classificação de risc o, o \\nque foi posteriormente endossado pelo guideline da European Society of Cardiology, em 2014. \\nA classificação de risco para a DAA é baseada em três grupos de informações – condições \\npredisponentes, características da dor e achados do exame clínico (Tabe la 3) –, atribuindo um \\nsistema de pontuação que considera o número desses grupos que estão envolvidos, variando \\nde 0 (nenhum grupo presente) a 3 (todos os grupos presentes). A presença de 0, 1, 2 ou 3 grupos \\nrelaciona-se à probabilidade pré -teste, sendo os  pacientes estratificados em baixo (0), \\nmoderado (1) ou alto (2 -3) risco. O algoritmo diagnóstico combina a probabilidade pré -teste, \\ncom dados clínicos, exames laboratoriais e exames de imagem. (Figura 3). \\n \\nTabela 3 \\n \\nFonte: Retirada de 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 227}, page_content='227 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nFigura 3 \\nFonte: Retirada de 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases \\n \\n5.2. HIM \\nOs métodos de escolha para o diagnóstico são a TC e RM, que evidenciam um \\nespessamento circular ou crescente >5mm da parede da aorta, sem evidência de fluxo \\nsanguíneo. Os HIM mais comumente são encontrados na aorta descendente (Tipo B: 60 -70%), \\nenquanto o envolvimento da aorta ascendente e do arco aórtico são menos comuns (Tipo A: \\n30% e 10% respectivamente. .UPA: O método de escolha para o diagnóstico é a TC com \\ncontraste, incluindo reconstruções axiais e multiplanares. Na maior parte das vezes, o \\ndiagnóstico de UPA ocorre como um achado incidental durante a avaliação de um exame de \\nimagem realizado por outra indicação. Ademais, esses achados de UPA não são incomuns \\ndurante a avaliação por imagem do sistema cardiovascular, o que, como citado, na maior parte \\ndas vezes, parece não implicar em sintomas clinicamente importantes. \\nTC (ou ETE)'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 228}, page_content='228 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nBOX 31.  \\nDecidiu-se pela correção cirúrgica, sendo observado que a aorta ascendente se \\napresentava dilatada. Procedida aortotomia com visualização da luz verdadeira e orifício \\nde entrada da dissecção. A valva aórtica era competente e os óstios das coronárias estavam \\nlivres. Foi realizada ressecção da aorta em plano supracoronário , tratamento das bocas \\nanastomóticas com prolene 5-0 e a anastomose primária da aorta com sutura contínua de \\nprolene 5-0, reaquecimento e reversão da fibrilação ventricular, com síntese da \\ntoracotomia por planos. \\n \\n6. CONDUTA \\nO objetivo inicial do médico que está atendendo uma SAA é diminuir o estresse que a \\nparede da aorta está sendo submetida, sendo essa medida fundamental nos casos de dissecção \\naguda da aorta, pois impede a progressão da dissecção e diminui a chance de isquemia de algum \\nórgão. Para isso, faz -se necessário o controle da dor, por meio de opióides endovenosos, da \\npressão arterial, estabelecendo metas de 100 mm Hg até 120 mmHg para a pressão arterial \\nsistólica e da frequência cardíaca, que deve ser limitada a 60 bpm. Para o controle adequado da \\npressão arterial e da frequência cardíaca, os betabloqueadores, sobretudo propranolol, \\nmetoprolol, labetalol ou esmolol, são os medicamentos de primeira escolha. Nos indivíduos que \\nnão podem fazer uso de betabloqueadores, os antagonistas dos canais de cálcio não \\ndihidropiridínicos, verapamil e diltiazem, podem ser utilizados sem grandes prejuízos. Alguns \\npacientes mais grav es podem se beneficiar de vasodilatadores (nitroprussiato de sódio), \\npossibilitando que as metas pressóricas sejam atingidas mais rapidamente. Vale ressaltar, \\nainda, que o uso do betabloqueador deve preceder a vasodilatação, com o intuito de impedir a \\ntaquicardia reflexa que ocorre após o uso de vasodilatadores. \\nApós a estabilização do paciente, é indicado que o médico realize uma avaliação de risco, \\ntendo em vista, principalmente, que pacientes com DAA de risco moderado ou grave devem ser \\nencaminhados para um centro terciário com a maior brevidade possível. \\nDissecção aórtica aguda (DAA)  - O tratamento da dissecção aórtica aguda depende, \\nbasicamente, da localização da dissecção e do comprometimento hemodinâmico, sendo \\nclassificada em complicada ou não complicada. Em linhas gerais, dissecções do tipo A \\n(envolvem a aorta ascendente), por possuírem maior risco de complicações fatais, são tratadas'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 229}, page_content='229 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\npor meio de cirurgia aberta. No caso das dissecções do tipo B (não envolvem a aorta \\nascendente), o tratamento vai depender da presença ou não de complicações, sendo \\nconsiderada dissecção do tipo B co mplicada a existência de hipertensão arterial sistêmica a \\ndespeito do uso adequado de medicações, dor recorrente ou persistente, expansão precoce ou \\nrápida da aorta, hemotórax, hematoma mediastinal ou periaórtico crescente, indicando \\npossível ruptura aórtica, e síndrome de má perfusão envolvendo os vasos viscerais, renais, dos \\nmembros inferiores e/ou espinhal. Caso a DAA tipo B seja classificada como complicada, é \\npreconizado o tratamento com TEVAR (reparo endovascular da aorta torácica), sendo \\nrecomendado apenas terapia clínica nos casos não complicados. Estudos relataram a \\ndiminuição da mortalidade intra -hospitalar das DAA tipo A, sem, no entanto, haver uma \\ndiminuição considerável das DAA tipo B. Tais estatísticas, provavelmente, são fruto de uma \\ndiminuição da mortalidade cirúrgica. Portanto, é importante uma análise quanto à classificação \\ndas DAA tipo B em complicada ou não complicada, visto que, provavelmente, um aumento das \\nintervenções cirúrgicas possa diminuir, também, as taxas de mortalidade das DAA tipo B. \\nHematoma intramural (HIM) e úlcera aterosclerótica penetrante (UPA)  - As \\nintervenções terapêuticas atuais são bastante semelhantes para essas duas condições clínicas, \\nno entanto, o curso da doença depende, principalmente, da região anatômica acometi da e do \\naspecto morfológico da lesão. Em suma, HIM e UPA tipo A devem receber tratamento cirúrgico, \\ntipo B não complicado devem receber terapia médica com beta -bloqueadores e tipo B \\ncomplicado é preconizado o tratamento endovascular (TEVAR). A associação entre HIM e UPA, \\ncondição não muito infrequente, torna o prognóstico pior, aumentando o risco de ruptura e \\ndissecção aórtica. Nos pacientes que possuem UPA com mais de 20 mm de diâmetro ou com \\nmais de 10 mm de profundidade e naqueles com dor recorrente, dev ido aos riscos de \\ncomplicações, recomenda-se o reparo endovascular precoce. De forma análoga, nos casos de \\nHIM complicado, representado por dor recorrente, expansão do HIM ou hematoma periaórtico, \\né indicado a realização do reparo endovascular precoce. \\n \\nBOX 32.  \\nO paciente evoluiu com melhora significativa do estado geral, apresentando \\nremissão completa dos sintomas. Optou-se por encaminhamento ambulatorial para \\nacompanhamento clínico.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 230}, page_content='230 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nFLUXOGRAMA \\n \\n  \\nDAA - Dissecção aórtica aguda; ECG - Eletrocardiograma; EF - Exame físico; ETE - Ecocardiograma \\ntransesofágico; ETT - Ecocardiograma transtorácico; HIM - Hematoma intramural; RX - Radiografia; \\nSAA - Síndromes aórticas agudas; TEVAR - Reparo endovascular da aorta torácica; UPA - Úlcera \\naterosclerótica penetrante.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 231}, page_content='231 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO X | SÍNDROMES AÓRTICAS AGUDAS (SAA) \\nREFERÊNCIAS \\n1. ANTONIO BRANDÃO NETO, Rodrigo et al. Síncope. Síncope, [S. l.], p. 808-809, 4 abr. 2022. \\n2. S. ODERICH, Gustavo et al. Cardiovasc Intervent Radiol . Penetrating Aortic Ulcer and \\nIntramural Hematoma, Springer Science+Business Media, LLC, part of Springer Nature and \\nthe Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2018, n. 9, ed. \\nPublished online: 9 November 2018, 4 abr. 2022. \\n3. F. MUSSA, Firas et al. Acute Aortic Dissection and Intramural Hematoma A Systematic \\nReview. Clinical Review & Education, American Medical Association, 3 abr. 2022. \\n4. BOSSONE, Eduardo et al. Clinical Update. Acute aortic syndromes: diagnosis and \\nmanagement, an update, European Heart Journal, ano 2018, v. 39, p. 739–749, 3 abr. 2022. \\n5. BOSSONE, Eduardo; A. EAGLE, Kim. Review. Epidemiology and management of aortic \\ndisease: aortic aneurysms and acute aortic syndromes,  Natural Review Cardiology,  3 abr. \\n2022. \\n6. V, Riambau et al. Editor’s Choice - Management of Descending Thoracic Aorta Diseases. \\nClinical Practice Guidelines of the European Society for Vascular Surgery (ESVS), European \\nJournal of Vascular and Endovascular Surgery, ano 2017, ed. 53, p. 17-18, 3 abr. 2022. \\n7. Bossone, E., & Eagle, K. A. (2021). Epidemiology and management of aortic disease: aortic \\naneurysms and acute aortic syndromes. Nature Reviews Cardiology, 18(5), 331–348. \\n8. Maraj, R., Rerkpattanapipat, P., Jacobs, L. E., Makornwattana, P., & Kotler, M. N. (2000). Meta-\\nanalysis of 143 reported cases of aortic intramural hematoma. The American Journal of \\nCardiology, 86(6), 664–668.  \\n9. Pereira, A. H. (2019). Hematoma intra mural e úlcera penetrante da aorta: incertezas e \\ncontrovérsias. Jornal Vascular Brasileiro, 18. \\n10. Oderich, G. S., Kärkkäinen, J. M., Reed, N. R., Tenorio, E. R., & Sandri, G. A. (2019). Penetrating \\nAortic Ulcer and Intramural Hematoma. CardioVascular and Interventional Radiology, 42(3), \\n321–334. \\n11. Patel, P. D., & Arora, R. R. (2008). Pathophysiology, diagnosis, and management of aortic \\ndissection. Therapeutic Advances in Cardiovascular Disease, 2(6), 439–468. \\n12. Pereira, A. H. (2010). Ruptura dos vasa vasorum e he matoma intramural da aorta: um \\nparadigma em mudança. Jornal Vascular Brasileiro, 9(2), 57–60. \\n13. Riambau, V., Böckler, D., Brunkwall, J., Cao, P., et al. ESVS Guidelines Committee, … Schmidli, \\nJ. (2017). Editor’s Choice – Management of Descending Thoracic Aor ta Diseases. European \\nJournal of Vascular and Endovascular Surgery, 53(1), 4–52.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 232}, page_content='232 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nCAPÍTULO XI  \\nINSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nLuís Eduardo Rodrigues Reis ¹ \\nPedro José Leite de Almeida Mendonça ¹ \\nMateus de Sousa Cavalcante ¹ \\nDara Medeiros Mendes ¹ \\nJefferson Luis Vieira 2 \\nDOI: 10.51859/amplla.ceg164.1123-11 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médica Cardiologista. Hospital de Messejana Dr. Carlos Alberto Studart Gomes. Fortaleza, Ceará, Brasil.  \\nCASO CLÍNICO \\nHomem de 57 anos procurou atendimento por dispneia intensa. Paciente relata história \\nsugestiva de IAM há 5 dias do atendimento, seguida de episódios de dor precordial associados \\na dispneia, desencadeados por esforços progressivamente menores. Há 2 dias houve o \\naparecimento de edema de membros inferiores e a dispneia passou a ocorrer mesmo no \\nrepouso e em decúbito dorsal. \\nO exame físico mostrou os seguintes resultados: \\nPA 80/50 mmHg, FC 110 bpm, presença de estase jugular, extremidades frias e discreto \\nedema de membros inferiores. \\nO exame dos pulmões revelou: Estertores e sibilos disseminados, até os ápices de ambos \\nos hemitórax.  \\nA ausculta cardíaca revelou a presença de 3ª bulha. \\nPERGUNTAS \\n1. Qual a definição de insuficiência cardíaca? E sua principal etiologia? \\n2. Como é a apresentação de uma paciente com IC? Quais critérios clínicos e laboratoriais \\npodem auxiliar nesse diagnóstico?  \\n3. Quais condições levam a um risco imediato à vida? Como deve ser a conduta nesses casos? \\n4. Como devemos classificar um paciente com ICA de acordo com os perfis hemodinâmicos? \\n5. Qual deve ser a conduta do médico na emergência de acordo com a classificação do \\npaciente?'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 233}, page_content='233 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\n1. INTRODUÇÃO  \\nA insuficiência cardíaca (IC) é considerada uma síndrome clínica complexa, definida pela \\nincapacidade do coração em manter um débito cardíaco adequado, ou que o faz à custa de altas \\npressões de enchimento; seja por alterações na sua função ou na sua estrutura. Desse modo, \\nessa síndrome vai se manifestar através de sinais e sintomas típicos, que resultam da  redução \\nno débito cardíaco e/ou das elevadas pressões de enchimento no repouso ou no esforço¹. \\nNesse contexto, se a IC crônica é, na maioria das vezes, o retrato final de uma condição \\nclínica progressiva e persistente, a IC aguda surge rapidamente, demand ando atendimento \\nurgente, pois o tempo é um fator crucial¹. \\nEm vista disso, a ICA pode apresentar -se de 2 maneiras: (1) ICA nova, na qual os \\nsintomas aparecem em um indivíduo nunca antes diagnosticado com IC e (2) quando ocorre a \\nagudização/descompensação do quadro de IC crônica¹. \\n2. EPIDEMIOLOGIA E ETIOLOGIA  \\nAtualmente, a IC é uma das principais causas de mortalidade e morbidade no mundo, \\nestando associada a elevados gastos com saúde e a um alto uso de recursos².  No contexto \\nbrasileiro, a prevalência de IC é de aproximadamente 2 milhões de pacientes, e sua incidência \\né de 240.000 novos casos por ano, desse modo, apenas no ano de 2017, o impacto das \\ninternações por IC nos custos hospitalares atingiu a quantia de R$ 339.719.216,50 gastos2,3. De \\nfato, dados do DATASUS demonstram que, anualmente, cerca de 190 mil pacientes são \\ninternados por ICA, além disso, o primeiro registro brasileiro de ICA, o BREATHE, mostrou \\ntambém uma elevada taxa de mortalidade intra -hospitalar (13%), bastante superior à taxa de \\n4% reportada nos registros internacionais de ICA1,4,5.    \\nDiversas são as causas de ICA, englobando tanto doenças cardiovasculares quanto não \\ncardiovasculares. Há fatores relacionados ao paciente, como ingesta inadequada de sal e água \\nou baixa adesão ao tratamento (os dois juntos correspondem a quase 40% das causas de \\ndescompensação). Além desses, há fatores relativos ao médico, como prescrição em doses \\ninsuficientes ou sobrecarga na hidratação intravenosa (IV) durante a internação6. \\nUm dos principais fatores precipitantes é a isquemia coronariana, responsável por cerca \\nde 1/3 das admissões hospitalares na América Latina6. A seguir, são apresentadas as principais \\ncausas de ICA (tabela 1) e IC crônica agudizada (tabela 2).'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 234}, page_content='234 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nTabela 1 - causas de ICA nova7. \\nCausas de insuficiência cardíaca aguda nova \\nSíndrome coronariana aguda (SCA) \\nTamponamento cardíaco \\nDoenças inflamatórias \\nIntoxicação \\nInsuficiência valvar aguda \\nSíndrome de Takotsubo \\nDoença cardíaca periparto \\nTrauma torácico \\nDistúrbios metabólicos \\nDoenças cerebrovasculares \\n \\nTabela 2 - causas de IC crônica descompensada7. \\nCausas de insuficiência cardíaca crônica descompensada \\nInfecção \\nAnemia \\nInsuficiência renal aguda (IRA) \\nHAS não controlada \\nArritmias cardíacas (bradi e taquiarritmias) \\nEmbolia pulmonar \\nPeríodo perioperatório \\nMá adesão terapêutica \\n \\n3. FISIOPATOLOGIA  \\nDe forma geral, a IC pode resultar de qualquer condição cardíaca que reduza a \\ncapacidade do coração em bombear sangue suficiente para satisfazer as necessidades do corpo, \\nsendo a via final comum de diversas doenças que acometem o coração 8.  Como visto \\nanteriormente, as etiologias da IC são diversas e incluem doenças que afetam o miocárdio, \\npericárdio, endocárdio, válvulas cardíacas e metabolismo, sendo as principais, causas \\nisquêmicas (30%), hipertensivas (20%), dilatada idiopática (15%), valvares (12%) e doença de \\nChagas (11%)1. \\nDesse modo, se o coração for, de modo súbito, gravemente lesado como por infarto do \\nmiocárdio, a capacidade de bombeamento do coração é diminuída de imediato. Como resultado, \\nocorrem dois efeitos principais: (1) débito cardíaco reduzido (responsável pela hipoperfusão \\ntecidual); e (2) acúmulo de sangue nas veias, resultando em aumento da pressão venosa8.   \\nDevido ao baixo débito, o sistema nervoso simpático é ativado através do reflexo \\nbarorreceptor e também por reflexos centrais quimiorreceptores devido a isquemia do sistema'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 235}, page_content='235 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nnervoso central. Esse sistema vai acarretar um aumento da frequência cardíaca (FC) e da força \\nde contração. Porém, normalmente a elevação da FC não é suficiente para a compensação, \\nmantendo o débito cardíaco diminuído. Essa deficiência, pode ser parcial ou totalmente \\ncompensada pela elevação na resistência vascular sistêmica, atra vés do sistema nervoso \\nautônomo e do sistema renina -angiotensina-aldosterona (SRAA), cujos efetores finais, \\nangiotensina II e aldosterona, também desempenham papel importante na elevação da \\nresistência vascular sistêmica e na retenção hidrossalina1,8.  \\nA curto prazo um aumento moderado dos líquidos corporais e do volume sanguíneo é \\num fator importante na ajuda para compensar a diminuição da capacidade de bombeamento \\ndo coração 8. Porém, o acúmulo excessivo de líquidos mediado pelo SRAA pode ter \\nconsequências fisiológicas deletérias, incluindo sobrecarga volêmica e pressórica; dilatação \\nventricular progressiva e edema pulmonar ou sistêmico. Dessa forma, podendo levar ao \\nprocesso de remodelamento cardíaco e progressão das alterações morfofuncionais, que \\nocasionam IC crônica1,8.  \\nAlém disso, também existem condições nas quais o débito cardíaco poderá ser normal \\nou até elevado, porém inadequado à demanda metabólica tecidual, como em condições de \\nanemias severas, fístulas arteriovenosas ou aumento da demanda tecidu al de nutrientes na \\ntireotoxicose, caracterizando a IC com débito cardíaco elevado (IC de alto débito)8.  \\n4. DIAGNÓSTICO \\nUm paciente com suspeita de ICA apresenta um quadro clínico de congestão pulmonar \\nou sistêmica, presente na maioria dos casos (90%), ou de  baixo débito cardíaco, em cerca de \\n10% dos casos 1. As tabelas a seguir listam os principais sinais e sintomas de congestão e de \\nbaixo débito cardíaco, respectivamente. \\n \\nTabela 3 – quadro clínico de congestão1. \\nQuadro clínico de congestão \\nDispneia progressiva aos \\nesforços \\nTaquipneia (FR > 22 irpm) \\nDispneia paroxística noturna Esforço respiratório \\nOrtopneia Edema agudo de pulmão \\nTurgência jugular à 45° Refluxo hepatojugular \\nGalope de B3 Estertores pulmonares crepitantes \\nEdema de membros inferiores Ascite \\nCardiomegalia ao Raio X de \\ntórax \\nHipertensão venocapilar ou derrame pleural ao raio X de \\ntórax'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 236}, page_content='236 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nTabela 4 – quadro clínico de baixo débito cardíaco1. \\nQuadro clínico de baixo débito cardíaco \\nPAS < 90 mmHg PAS < 110 mmHg em pacientes previamente hipertensos \\nFadiga Extremidades frias com perfusão reduzida \\nSudorese fria Largura de pulso < 25% \\nDesorientação Lactato elevado \\n \\nUtilizando os Critérios de Framingham  para analisar os achados clínicos é possível ter \\numa acurácia diagnóstica de até 75%, além disso, quando associados a uma história clínica \\nprévia ou internação anterior por IC, são fortes indicadores de diagnóstico positivo de ICA. O \\ndiagnóstico clínico p elos critérios de Framingham é feito quando há 2 critérios maiores ou 1 \\ncritério maior e 2 menores1. Os critérios são listados a seguir: \\n \\nTabela 5 – critérios de Framingham Modificados1. \\nCritérios de Framingham Modificados \\nCritérios maiores Critérios menores \\nDispneia paroxística noturna Edema de tornozelo bilateral \\nRefluxo hepatojugular Tosse noturna \\nTurgência jugular à 45° Dispneia aos mínimos esforços \\nEstertores pulmonares crepitantes Derrame pleural \\nGalope de B3 Taquicardia \\nCardiomegalia ao Raio X de tórax  \\nEdema agudo de Pulmão \\nPerda > 4,5kg em 5 dias após o início do \\ntratamento para IC \\n \\nAlém da anamnese e do exame físico, exames complementares (laboratoriais e de \\nimagem) devem ser solicitados na admissão. Eles auxiliam no diagnóstico, além de ajudar a \\ndefinir a causa da ICA, bem como detectar fatores agravantes e estabelecer o risco e prognóstico \\ndo paciente.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 237}, page_content='237 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nCASO CLÍNICO \\nForam solicitados exames complementares com os seguintes resultados: \\n• ECG: ritmo sinusal e frequência cardíaca de 127 bpm. Área eletricamente inativa na parede \\ninferior; \\n• BNP 758 pg/mL e NT-proBNP 1079 pg/mL; \\n• Radiografia de tórax: congestão pulmonar acentuada e cardiomegalia +++/4+; \\n• Ecocardiograma transtorácico: dilatação ventricular esquerda com fração de ejeção \\nestimada em 18%. O diâmetro do átrio esquerdo foi de 36 mm. O ventrículo direito e o átrio \\ndireito foram considerados normais; \\n• Exames laboratoriais: eletrólitos e coagulograma dentro dos valores considerados normais. \\nUreia 55 mg/dl, creatinina 1,8 mg/dl. Hemoglobina 13 g/dl, 39% hematócrito, 13.800 \\nleucócitos/mm³, 280.000 plaquetas/mm³. Glicemia 143 mg/dl. \\n4.1. Exames Complementares \\nPeptídeos Natriuréticos (BNP e NT -proBNP) - Devem ser utilizados na admissão da \\nemergência, quando disponíveis, para todos com suspeita de ICA. Eles afastam o diagnóstico de \\nICA quando estão baixos (BNP < 100 pg/mL e NT -proBNP < 300 pg/mL), enquanto que níveis \\nelevados (BNP > 500 pg/mL e NT-proBNP > 900 pg/mL) sugerem fortemente o diagnóstico de \\nICA. Níveis intermediários (BNP entre 100 e 500 pg/mL, ou NT-proBNP entre 300 e 900 pg/mL) \\ndevem ter uma correlação com a história clínica do paciente, pois outras condições podem \\nelevar os peptídeos natriu réticos. Dentre as causas não -cardíacas que elevam BNP e NT -\\nproBNP, pode -se citar: idade avançada, acidente vascular encefálico (AVE) isquêmico, \\nhemorragia subaracnóidea, doença pulmonar obstrutiva crônica (DPOC), dentre outras. Já \\nentre as causas cardíaca s, há: síndrome coronariana aguda, miocardite, valvopatia, \\ntaquiarritmias e outras 9. É importante lembrar que pacientes que fazem uso de sacubitril -\\nvalsartana têm uma diminuição da acurácia diagnóstica do BNP, pois esse fármaco eleva os \\nníveis séricos de BNP, mas não os de NT-proBNP1.  \\nEletrocardiograma (ECG) - É um exame em que a minoria se apresenta sem alterações \\n(13%), ajudando na identificação da etiologia e a causa da descompensação, sendo de grande \\nimportância para detecção de bradi ou taquiarritmias. Deve ser realizado na admissão, durante \\na hospitalização e antes da alta hospitalar9.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 238}, page_content='238 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nRadiografia de tórax - Por meio das incidências posteroanterior (PA) e perfil, são \\navaliadas: a área cardíaca e congestão pulmonar. Com isso, é possível diferenciar ca usas \\npulmonares e torácicas da dispneia, mas caso se apresente sem alterações, isso não afasta uma \\ncongestão pulmonar1. \\nEcocardiograma - Realizar em todos os pacientes em até 48 horas após admissão \\nhospitalar. Sua principal utilidade na ICA é a identificaç ão de choque cardiogênico, além de \\nidentificar outros aspectos (definição etiológica, disfunção ventricular, congestão pulmonar e \\nsistêmica) que auxiliam na conduta individual9. \\nUltrassonografia de tórax  - Apesar de não substituir o ecocardiograma, é um ót imo \\nexame para ser utilizado à beira de leito por um médico sem especialização em ecocardiografia, \\ntendo acurácia elevada para detectar congestão pulmonar/sistêmica e outros achados que \\npodem ser confirmados por um ecocardiograma posteriormente (o quanto antes)1. \\nExames laboratoriais - são solicitados diversos exames tanto para rastreio da etiologia \\nda ICA quanto para estabelecer a gravidade do quadro do paciente. Os principais estão listados \\nna tabela a seguir: \\n \\nTabela 6 - exames laboratoriais1. \\nExames Laboratoriais \\nEletrólitos (Na, K e Mg) \\nUreia e Creatinina (função renal) \\nProteína C-Reativa (PCR) \\nCoagulograma \\nProteínas totais e frações \\nhemograma completo \\nTGO, TGP e bilirrubinas \\nGlicemia \\nGasometria Venosa \\nLactato \\nTSH (> 60 anos ou suspeita ou doença tireoidiana) \\nTroponina (suspeita de doença arterial coronária, miocardite ou Takotsubo) \\n \\n5. PERFIS HEMODINÂMICOS NA ICA \\nOs pacientes com IC que chegam ao departamento de emergência (DE) devem ser \\ncategorizados em 4 perfis hemodinâmicos de acordo com a perfusão e nível de congestão, \\ndevendo ser divididos em:'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 239}, page_content='239 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\n• PERFIL A (Quente e Seco): Paciente sem sinais de congestão em repouso e sem \\nsinais de má perfusão tecidual1. \\n• PERFIL B (Quente e Úmido): Pacientes com sinais de congestão  em repouso e \\nsem sinais de má perfusão tecidual1. \\n• PERFIL C (Frio e Úmido): Paciente com sinais de congestão em repouso e com \\nsinais de má perfusão tecidual1. \\n• PERFIL L (Frio e Seco): Paciente sem sinais de congestão  em repouso e com \\nsinais de má perfusão tecidual1. \\n \\nTabela 7 – Classificação nos perfis hemodinâmicos na ICA10. \\nA  \\nQuente e seco  \\nB  \\nQuente e úmido \\nL \\nFrio e seco \\nC \\nFrio e úmido \\n \\nA classificação do paciente dentro dos 4 perfis hemodinâmicos é de fundamental \\nimportância para o estabelecimento do tratamento adequado, como veremos mais adiante. \\n5.1. APRESENTAÇÃO DO PACIENTE PERFIL A \\nPaciente não apresenta sinais de baixo débito nem de conges tão, normalmente esse \\npaciente representa o objetivo de compensação hemodinâmica do tratamento, sendo \\nnecessário, caso o paciente apresente dispneia ou outros sintomas buscar causas que não a IC \\npara justificá-los, realizando o diagnóstico diferencial com infecções pulmonares, exacerbação \\nde asma ou DPOC, síndrome do pânico, dentre outros10,11. \\n5.2. APRESENTAÇÃO DO PACIENTE PERFIL B  \\nÉ a apresentação clínica mais comum  da descompensação da IC, na qual o paciente \\nvai apresentar apenas sinais de congestão como: tu rgência jugular (TJ), ortopneia e edema de \\nMMII. Com ausência de sinais de hipoperfusão tecidual, apresentando extremidades quentes, \\nmanutenção do nível de consciência e ausência de hipotensão10,11.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 240}, page_content='240 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\n5.3. APRESENTAÇÃO DO PACIENTE PERFIL C \\nÉ a  apresentação clínica mais grave  da descompensação da IC, na qual o paciente \\napresenta sinais de congestão e baixo débito, com dispneia, edema de MMII, crepitações, TJ, \\nextremidades frias, pulsos finos, rebaixamento do nível de consciência, oligúria e \\nhipotensão10,11. \\n5.4. APRESENTAÇÃO DO PACIENTE PERFIL L \\nPaciente apresenta sinais de baixo débito, porém sem sinais de congestão (seco). \\nNormalmente esse perfil está relacionado com a perda excessiva de líquidos, geralmente \\ncausada por excesso de diuréticos10,11. \\n6. COMPLICAÇÕES \\n6.1. Choque Cardiogênico \\nO choque cardiogênico (CC) é uma condição grave que está associada a elevados níveis \\nde mortalidade. Nesse contexto, os pacientes em choque cardiogênico são uma população \\nheterogênea e o prognóstico pode variar amplamente co m base na etiologia, gravidade da \\ndoença e comorbidades12. \\nDevido a isso, em 2019, a SCAI propôs uma definição mais atual de choque cardiogênico, \\ncom o objetivo de fornecer um esquema de classificação simples que permitiria uma \\ncomunicação clara com o paci ente; adequado para uma avaliação rápida, pois pacientes em \\nchoque geralmente se deterioram rapidamente e útil para permitir que os ensaios clínicos \\ndiferenciem adequadamente os pacientes em subconjuntos12. \\nDessa forma, de acordo com a nova classificação, os estágios de choque podem ser \\nagrupados em 5 categorias: \\nEstágio A “At Risk”: Descreve um paciente que não tem sinais ou sintomas de CC, mas \\nestá em risco para o seu desenvolvimento. Pacientes com IAM prévio, bem como aqueles com \\ninsuficiência cardíaca s istólica ou diastólica descompensada podem entrar nessa \\nclassificação12. \\nEstágio B “Beginning”: Pré-choque ou choque compensado; descreve um paciente que \\ntem evidência clínica de hipotensão ( PAS <90 mmHg;  PAM <60 mmHg ou queda >30 mmHg \\nda linha de base) ou taquicardia sem hipoperfusão. O exame físico pode evidenciar sobrecarga \\nde volume leve e a avaliação laboratorial pode estar normal12.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 241}, page_content='241 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nEstágio C “Classic” : O CC clássico é um paciente com hipoperfusão que requer um \\nconjunto inicial de intervenções (inotrópicos, vasopressores, suporte mecânico ou oxigenação \\npor membrana extracorpórea) além da ressuscitação volêmica para restaurar a perfusão. Esses \\npacientes geralmente apresentam hipotensão. A avaliação laboratorial pode incluir função \\nrenal prejudicada, lactato elevado e aumento de peptídeo natriurético e/ou enzimas \\nhepáticas12. \\nEstágio D “Deteriorating” : Descreve um paciente que não se estabilizou apesar dos \\nesforços iniciais. A classificação nessa fase exige que o paciente tenha recebido algum grau de \\ntratamento apropriado/estabilização médica e, além disso, que pelo menos 30 minutos se \\npassaram e o paciente não respondeu com resolução da hipotensão ou hipoperfusão de órgãos-\\nalvo. Deve ser implementado um aumento no número ou na intensidade de terapias \\nintravenosas para abordar hipoperfusão ou adição de suporte circulatório mecânico12. \\nEstágio E “Extremis”:  É o paciente com colapso circulatório. Frequentemente em \\nparada cardíaca refratária e em ressuscitação cardiopulmonar (RCP). Esses são pacientes com \\nmuitos médicos à beira do leito para resolver vários  problemas simultâneos relacionados à \\nfalta de estabilidade do paciente12. \\n6.2. Transplante Cardiogênico  \\nNo cenário da IC, o transplante pode ser uma opção terapêutica; em caso de \\nrefratariedade da doença ca rdíaca subjacente. Apesar dos avanços dos dispositivos de \\nassistência ventricular mecânica, o transplante permanece como importante alternativa \\nterapêutica para melhorar a sobrevida em pacientes adequadamente selecionados com IC \\navançada1.  \\nNo entanto, a s obrevida de pacientes transplantados em estado clínico de gravidade é \\nbastante inferior à de outros cenários clínicos, levando a questionamentos acerca da alocação \\nde um recurso limitado (como são os órgãos para doação) a àqueles com maior mortalidade e, \\nportanto, menor chance de se beneficiarem. Porém, quando pacientes transplantados em \\nchoque cardiogênico sobrevivem a curto prazo, a estimativa de vida a longo prazo é semelhante \\na de pacientes transplantados em estado clínico mais estável. Desse modo, é de  fundamental \\nimportância que a avaliação da candidatura a transplante seja iniciada o quanto antes, durante \\nas tentativas de estabilização do choque, e que seja o mais completa possível1.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 242}, page_content='242 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\n7. CONDUTA \\nA conduta inicial frente a um paciente com ICAd deve segui r uma abordagem inicial \\ndentro dos 120 primeiros minutos (idealmente). É ideal que se siga uma sequência didática: \\n(1) Definição de risco imediato à vida e suas condutas; (2) Diagnóstico e definição do perfil \\nhemodinâmico; (3) Perfil de risco e prognóstico intra-hospitalar; e (4) Terapêutica. \\nInicialmente, deve-se identificar os pacientes com alto risco de vida imediato, atentando-\\nse para a identificação e manejo das seguintes condições. Estes devem ser reconhecidos e \\ntratados em até 30 minutos da admissão1. \\n \\nTabela 8 – condições de risco de vida e sua abordagem terapêutica1. \\nCondições de risco imediato de vida e sua abordagem terapêutica \\nIAM Angioplastia primária ou trombolítico \\nChoque cardiogênico Inotrópicos; balão intra -aórtico; suporte mecânico \\ncirculatório \\nTaquiarritmias Manejo conforme diretrizes, recomendando -se \\ncardioversão elétrica caso instabilidade \\nhemodinâmica \\nEmergências hipertensivas Nitroprussiato de sódio; nitroglicerina IV \\nEmbolia pulmonar Trombolítico (caso a embolia seja a causa da \\ninstabilidade) \\nSinais neurológicos de AVC \\nou confusão mental \\nAvaliação neurológica; protocolo de AVC \\nFator causal mecânico ou \\nlesão valvar aguda \\nEcocardiograma transesofágico; intervenção \\ncirúrgica ou percutânea \\n \\n7.1. Fluxograma de atendimento \\nOs pacientes com ICAD devem possuir sempre seu perfil hemodinâmico identificado e \\npressão arterial definida, além de receberem monitorização e oxigenação (quando \\nrecomendado). As medidas terapêuticas variam entre as classificações  do paciente e sua \\npressão arterial, porém, mais de 90% destes encontram -se hipertensos ou normotensos na \\nadmissão1. A seguir, o fluxograma mostra, resumidamente, como manejar os perfis:'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 243}, page_content='243 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nFigura 2: Fluxograma de atendimento ICAD1.  \\n \\n \\nO suporte respiratório  tem como alvos estabelecer saturação de Oxigênio (SatO2) > \\n90%, podendo ser utilizado oxigenoterapia com cateter nasal ou máscara, suporte ventilatório \\nnão invasivo com pressão positiva e suporte ventilatório invasivo com pressão positiva. O \\nsuporte venti latório não invasivo está indicado em todos os pacientes que não apresentem \\nmelhora com o uso de oxigenoterapia, além de estar recomendado em pacientes com edema \\nagudo de pulmão 1. O oxigênio não deve ser usado rotineiramente em pacientes não \\nhipoxêmicos, pois causa vasoconstrição e redução do débito cardíaco. \\nOs diuréticos são de extrema importância para redução da congestão (que está presente \\nem 85% dos pacientes). A furosemida é o diurético de escolha e deve ser utilizado o mais cedo \\npossível, com adminis tração intravenosa (dose inicial: 20 -40 mg em bolus). A dose para \\npacientes que já utilizam diuréticos deve ser, no mínimo, igual a dose já utilizada (estudo DOSE \\ndemonstrou que a administração de diuréticos de alça em doses 2,5x maiores que aquelas \\nutilizadas no regime ambulatorial estão associadas a melhora de sintomas do que diuréticos de \\nalça de baixa em pacientes com ICA). Os alvos clínicos com o uso destes devem ser observados: \\n(1) Diurese: 1L nas primeiras 6 horas, (1,5 a 2,5 mL/kg/hora); (2) ausênci a de ortopneia e \\nesforço respiratório em 24 horas; (3) ausência de dispneia aos esforços em 72 horas; (4) SatO2'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 244}, page_content='244 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\n> 90%; (5) FC < 100 bpm e FR < 22 irpm; e (6) PAS 110 a 130 mmHg. A tabela a seguir mostra \\nos principais diuréticos e suas doses1. \\n \\nTabela 9 – Posologia dos diuréticos1.  \\nPosologia dos diuréticos \\nDiuréticos de \\nalça \\nFurosemida IV \\n \\n \\nBumetanida IV \\n20 mg de 4 -4/6-6 horas (dose \\nmáxima: 240 mg) \\n \\n0,5-2,0 mg de 6 -6 horas (dose \\nmáxima: 10 mg) \\nTiazídicos Hidroclorotiazida VO \\n \\n \\nClortalidona VO \\n \\n \\nIndapamida VO \\n25 mg de 24 -24/12-12 horas \\n(dose máxima: 100 mg) \\n \\n12,5 mg de 24 -24/12-12 horas \\n(dose máxima: 50 mg) \\n \\n2,5 mg de 24 -24 horas (dose \\nmáxima: 5,0 mg) \\nPoupadores de \\npotássio \\nEspironolactona VO 25 mg de 24 -24/12-12 horas \\n(dose máxima: 50 mg) \\n \\nEm relação aos inotrópicos, a utilização destes depende dos níveis de pressão arterial do \\npaciente e tem como objetivo a melhora da perfusão e débito cardíaco. A recomendação é para \\naqueles com hipotensão arterial sintomática, baixo débito cardíaco com dis função orgânica ou \\nchoque cardiogênico. A dobutamina é inotrópico beta -agonista e o principal medicamento \\nutilizado nesses cenários, sendo importante atentar-se aos fatores limitantes do uso desta, que \\nsão: redução de sua ação em pacientes em uso prévio de  betabloqueadores. Em pacientes com \\nchoque cardiogênico, pode ser associada à noradrenalina. Outra opção que deve ser citada é o \\nsensibilizador dos canais de cálcio levosimendan, que apresenta efeito inotrópico positivo, além \\nde ação vasodilatadora arterial e vascular pulmonar, sendo possível sua utilização em pacientes \\nem uso prévio de BB. A milrinona, um inibidor da fosfodiesterase 3, é outro agente com \\npropriedades inotrópicas e vasodilatadoras que tem a possibilidade de ser utilizada em \\npacientes em uso  prévio de BB, mas apresenta potencial arritmogênico em pacientes \\nisquêmicos. Pacientes mais graves que cursam com importante hipotensão arterial ou choque \\ncardiogênico tem preferência o uso de noradrenalina, pois além de aumentar o débito cardíaco, \\npossui importante efeito vasoconstrictor, para melhorar a PA e redistribuição de fluxo. O \\ngrande detalhe no uso dos inotrópicos é o fato de estes apresentarem efeitos danosos quando'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 245}, page_content='245 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nutilizados em longo prazo ou sem indicações, como arritmias, agravamento de isqu emia \\nmiocárdica e indução de hipotensão arterial. Logo, estes só devem ser administrados quando \\nextremamente indicados, além de atentar-se para seu uso não prolongado1. A tabela mostra os \\nprincipais agentes inotrópicos e suas doses. \\n \\nTabela 10 – posologia dos inotrópicos e vasoconstritores1. \\nPosologia dos inotrópicos e vasoconstritores \\nDobutamina Dose inicial: 2,5 μg/kg/minuto (avaliar ajuste a cada 10 minutos) \\n \\nDose máxima: 10-20 μg/kg/minuto \\nMilrinona Dose inicial: 0,375 μg/kg/minuto (ajuste a cada 4 horas) \\n \\nDose máxima: 0,75 μg/kg/minuto (0,5 μg/kg/minuto na presença de \\ninsuficiência renal aguda) \\n \\nLevosimedana Dose inicial: 0,05 μg/kg/minuto (ajuste a cada 4 horas de 0,05 \\nμg/kg/minuto) \\n \\nDose máxima: 0,2 μg/kg/minuto \\nNoradrenalina Dose inicial: 0,1-0,2 μg/kg/minuto (ajuste a cada 15 minutos) \\n \\nDose máxima: 1,0 μg/kg/minuto \\n \\nOs vasodilatadores são outra classe de drogas que têm sido empregadas para a melhora \\ndos sintomas e dos distúrbios relacionados a ICA. Estes estão indicados nas seguintes situações: \\n(1) perfil hemodinâmico quente -congesto, quando na ausência de: hipotensão  arterial ou \\nchoque cardiogênico; hipovolemia; ou comorbidades como sepse. Essas medicações melhoram \\na congestão pulmonar por conta da venodilatação, além de reduzir as pressões e o consumo de \\nO2 do ventrículo esquerdo, somado ao seu efeito redutor de pós -carga (por redução do tônus \\narterial). As opções disponíveis de vasodilatadores incluem o nitroprussiato de sódio, bastante \\nutilizado em pacientes com níveis pressóricos mais altos e ausência de coronariopatias agudas. \\nJá a nitroglicerina, tem sido de extr ema importância em pacientes com insuficiência \\ncoronariana aguda associada ao quadro de ICA, melhorando os sintomas dado suas ações \\nsupracitadas. A dose inicial da nitroglicerina é de 10-20 μg/min (com máximo de 200 μg/min), \\npodendo ser titulada a cada 15 minutos (aumento de 10-20 μg/min)1.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 246}, page_content='246 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nUma outra classe medicamentosa para situações específicas são os opioides, que podem \\najudar com a sensação de desconforto, mas vem cada vez sendo menos utilizados na prática \\nclínica. Atualmente, é utilizada somente em al guns cenários, os quais incluem quase sempre \\npacientes com edema agudo de pulmão1. \\nUm detalhe a ser citado é a importância do cuidado no desmame dos agentes \\nendovenosos. Após alcançar a estabilidade hemodinâmica do paciente, deve -se iniciar a \\nretirada de f orma gradual, sendo as drogas endovenosas (inotrópicos e vasodilatadores) \\nsubstituídas por vasodilatadores orais. Esta estratégia permite a não ocorrência do efeito \\n\"rebote\" e piora da congestão e queda do débito cardíaco. Ou seja, nitrato oral em doses \\ncrescentes deve ser utilizado para substituição de agentes vasodilatadores endovenosos. Já em \\nrelação aos inotrópicos, pode-se optar por uma combinação de doses crescentes de IECA e/ou \\nhidralazina com nitrato1.  \\nPor fim, é importante relatar a relevância do surgimento de novas drogas no cenário da \\nICA. O estudo PIONEER-HF demonstrou que o sacubitril-valsartana obteve uma redução do NT-\\nproBNP em 29% logo na 1° semana, além de diminuir em 44% a taxa de readmissão dos \\npacientes13. O trial EMPULSE, utilizando a e mpagliflozina, demonstrou que esta apresentou \\nbenefício na ICA independente do perfil de admissão, principalmente nos primeiros 90 dias 14. \\nO estudo VICTORIA evidenciou que a incidência de morte era menor naqueles que utilizavam o \\nvericiguat quando comparad os aqueles que receberam placebo 15. Outros estudos \\ndemonstraram benefício de outras drogas na IC, como omencativ mecarbil 16 (GALACTIC) e \\nsotagliflozina17 (SOLOIST). Por outro lado, estudos de drogas como Tolvaptana, Alisquireno, \\nNesiritide, Rolofilina, Serelaxina e Tezosentana tiveram estudos com resultados negativos para \\nesse perfil de paciente. \\nEm relação às medicações orais, é importante citar que estas podem ser mantidas ou \\niniciadas somente em pacientes que mantêm estabilidade hemodinâmica (levando em \\nconsideração FC e PA). Logo, deve-se atentar para os betabloqueadores e inibidores da enzima \\nconversora da angiotensina, que devem ser mantidos ou iniciados de forma cautelosa e \\nvariando dentro da condição de cada paciente1.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 247}, page_content='247 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nCASO CLÍNICO \\nO tratamento ini cial do paciente incluiu suporte respiratório por máscara facial com \\npressão positiva bifásica ou dois níveis (BiPAP).  \\nFoi iniciado furosemida (por conta da congestão acentuada do paciente) e noradrenalina \\n(optado a partir da avaliação dos níveis pressóricos – 80x50 mmHg), com melhora subsequente \\ndo quadro.  \\nApós algumas horas, o paciente apresentou novo quadro de dispneia por edema \\npulmonar, sendo necessário intubação orotraqueal para suporte respiratório e continuação da \\nutilização de agentes vasoconstritores. \\nA monitorização hemodinâmica foi realizada com cateter de Swan -Ganz. O paciente \\nevoluiu com melhora clínica, sendo optado pela inclusão de um agente inotrópico \\n(Dobutamina) até estabilização hemodinâmica, além da manutenção de furosemida e \\nmonitorização de balanço hídrico rigoroso. \\nPosteriormente, o plano terapêutico seguiu com investigação etiológica específica e \\notimização medicamentosa do paciente: desmame progressivo de vasoconstrictores e \\ninotrópicos, com rigorosa avaliação clínica; e inclusão d e drogas orais reconhecidamente \\nredutoras de mortalidade na IC.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 248}, page_content='248 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nFLUXOGRAMA'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 249}, page_content='249 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\nREFERÊNCIAS \\n1. Comitê Coordenador da Diretriz de Insuficiência Cardíaca. Diretriz Brasileira de \\nInsuficiência Cardíaca Crônica e Aguda. Arq Bras Cardiol. 2018; v.111, n.3, p.436-539. \\n2. Cestari VRF, Garces TS, Sousa GJB, Maranhão TA, Souza Neto JD, Pereira MLD, Pessoa VLMP, \\net al. Distribuição Espacial de Mortalidade por Insuficiência Cardíaca no Brasil, 1996-2017. \\nArq. Bras. Cardiol. 2022;118(1):41-5. \\n3. Souza SC, Silva CMS, Reis HFC, Gomes Neto M. Número de internações hospitalares, custos \\nhospitalares, média de permanência e  mortalidade por insuficiência cardíaca nas regiões \\nbrasileiras, no ano de 2017. Rev Ciênc Med Biol 2018; 17(3):376 -80. doi: \\n10.9771/cmbio.v17i3.28626.  \\n4. Brasil. Ministério da Saúde. Datasus. Internações por insuficiência cardíaca. Brasília; 2017. \\n5. Albuquerque DC, Neto JD, Bacal F, Rohde LE, Bernardez -Pereira S, Berwanger O, et al; \\nInvestigadores Estudo BREATHE. I Brazilian Registry of Heart Failure - Clinical aspects, care \\nquality and hospitalization outcomes. Arq Bras Cardiol. 2015;104(6):433-42 \\n6. Arrigo M, J essup M, Mullens W, Reza N, Shah AM, Sliwa K, Mebazaa A. Acute heart failure. \\nNat Rev Dis Primers. 5 Mar 2020;6(1):16. \\n7. D’orio V, Ancion A, Lancellotti P. L’insuffisance cardiaque sévère et l’œdème  pulmonaire \\naigu. Rev Med Liege; 73 : 5-6 : 251-256 (2018). \\n8. Guyton, A.C. e Hall J.E.– Tratado de Fisiologia Médica. Editora Elsevier. 13ª ed., 2017. \\n9. Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, et al. 2021 \\nESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European \\nHeart Journal (2021) 00, 1 -128. Disponível em: \\nhttps://academic.oup.com/eurheartj/advance-\\narticle/doi/10.1093/eurheartj/ehab368/6358045. Acesso em: 21 Set 2021. \\n10. Bernoche C, Timerman S, Polastri TF, Giannetti NS, Siqueira AWS, Piscopo A, Soeiro AM , et \\nal. Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares \\nde Emergência da Sociedade Brasileira de Cardiologia – 2019. Arq. Bras. Cardiol. \\n2019;113(3):449-663. \\n11. Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harriso n Medicina Interna: volume \\nII. In: Mann DL. Insuficiência Cardíaca e cor pulmonale. 17 ed. McGraw -Hill; 2008. 1443 -\\n1455. \\n12. Baran  DA, Grines CL, Bailey S, Burkhoff  D, Hall SA, Henry TD, et al. SCAI clinical expert \\nconsensus statement on the classification of cardiogenic shock: this document was \\nendorsed by the American College of Cardiology (ACC), the American Heart Association \\n(AHA), the Society of Critical Care Me dicine (SCCM), and the Society of Thoracic Surgeons \\n(STS) in April 2019. Catheterization and Cardiovascular Interventions, v. 94, n. 1, p. 29 -37, \\n2019.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 250}, page_content='250 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO XI | INSUFICIÊNCIA CARDÍACA AGUDA (ICA) \\n13. Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, et al. Angiotensin–\\nNeprilysin Inhib ition in Acute Decompensated Heart Failure. New England Journal of \\nMedicine. 2019 Feb 7;380(6):539–48.  \\n14. Mikhail N. K., et al. Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality \\nof Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. \\nCirculation. 2022;146:279–288 \\n15. Armstrong, P. W. et al. Vericiguat in patients with heart failure and reduced ejection fraction. \\nN. Engl. J. Med 382, 1883–1893 (2020). \\n16. Teerlink JR, Diaz R, Felker M, McMurray JJV, Metra M, Solomon SD et al (2021) Cardiac \\nmyosin activation with omecamtiv mecarbil in systolic heart failure. N Engl J Med 384:105–\\n116. \\n17. Bhatt DL, Szarek M, Steg PG, et al. Sotagliflozin in patients with diabetes and recent \\nworsening heart failure. N Engl J Med. 2020;384(2):117–28.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 251}, page_content='251 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nCAPÍTULO XII  \\nPERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nPaulo Roberto Matos Neto 1 \\nLuís Eduardo Oliveira Matos 1 \\nManoel Vieira do Nascimento Junior 1 \\nBenedito Mesley Lima Portela 1 \\nBreno Cotrim Reis 2 \\nDoi: 10.51859/amplla.ceg164.1123-12 \\n¹ Acadêmico. Curso de Medicina, Universidade Federal do Ceará (UFC), Campus Sobral. Sobral, Ceará, Brasil.  \\n² Médico. Residente de Clínica Médica - Santa Casa de Misericórdia de Sobral, Ceará, Brasil.. \\n \\nCASO CLÍNICO \\nUm homem de 50 anos de idade, alcoólatra de longa data e diabético, procura o Pronto-\\nAtendimento com queixa de dor precordial contínua, de moderada intensidade há 4 dias, com \\nirradiação para o membro superior esquerdo e piora com o decúbito dorsal, além de dispneia \\nleve. Ao exame físico, apresenta frequência cardíaca de 120 bpm, pressão arterial 110/70 \\nmmHg em todos os membros, com pulsos simétricos, frequência respiratória de 22 i rpm e \\ntemperatura axilar de 38,5ºC. Havia diminuição do frêmito toracovocal na metade inferior à \\ndireita. A ausculta cardíaca estava normal, enquanto a pulmonar revelava diminuição do \\nmurmúrio vesicular também na metade inferior direita. \\n \\nBOX 33.  \\nPrincipais hipóteses diagnósticas: pericardite aguda, SCA, pneumonia com pleurisia, TEP \\n(diagnósticos de dor torácica). \\n \\n1. PERICARDITE AGUDA \\n1.1. INTRODUÇÃO E EPIDEMIOLOGIA \\nAnatomicamente, o pericárdio é uma membrana fibrosserosa que recobre o coração e a \\nraiz dos grandes vasos. Externamente, é formado pelo pericárdio fibroso, camada resistente \\ne inflexível, inferiormente fundida ao centro tendíneo do diafragma, que protege o coração'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 252}, page_content='252 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\ncontra o superenchimento súbito e funciona como  uma barreira física contra infecções. \\nInternamente, é constituído pelo pericárdio seroso. Este último possui uma lâmina parietal, \\naderida ao pericárdio fibroso, e uma lâmina visceral ou epicárdio, intimamente relacionada ao \\ncoração.1,2 \\nEssas duas faces sã o separadas pela cavidade do pericárdio , um espaço virtual que \\ncontém de 15 a 50 mL de ultrafiltrado plasmático em pessoas saudáveis, o qual permite a \\nmovimentação do coração sem atrito.3 \\nA inervação do pericárdio advém, sobretudo, dos nervos frênicos. A d or, por sua vez, \\ncostuma ser subesternal difusa, porém pode irradiar para outros locais.4 \\nA pericardite aguda é o principal acometimento do pericárdio. No Brasil, os dados \\nepidemiológicos são escassos. No entanto, estudos estrangeiros sugerem uma incidência de até \\n27,7 casos por 100.000 pessoas/ano. Além disso, acredita -se que cerca de 5% das admissões \\npor dor torácica na emergência são por pericardite, acometendo principalmente homens jovens \\n(20-50 anos).3,4,5,6 A maioria dos casos, nos quais a etiologia n ão é definida, não evolui com \\ncomplicações, enquanto quadros associados a causas específicas, como neoplasia e tuberculose, \\ntendem a complicar, incluindo o tamponamento cardíaco.6 \\n1.2. ETIOPATOGENIA \\nA pericardite aguda é um processo inflamatório do pericárdio, sendo geralmente \\nbenigno e autolimitado, com duração de até 1 a 3 semanas. Pode ter múltiplas causas, \\ninfecciosas ou não. Nos países desenvolvidos, em torno de 80% dos casos são conduzidos como \\nidiopáticos, apesar de a etiologia viral ser considerada a pri ncipal responsável. Nestes \\npacientes, o curso da doença costuma ser mais brando, de modo que a determinação da causa \\nespecífica não tem relevância na conduta adotada.3,4 \\nA pericardite bacteriana ou pirogênica tem um quadro sistêmico mais intenso e uma \\nparcela costuma evoluir com tamponamento cardíaco. No Brasil, assim como em outros países \\nem desenvolvimento, a tuberculose é uma causa importante. Neoplasias, doenças autoimunes, \\ncomo o Lúpus Eritematoso Sistêmico, e o próprio infarto agudo do miocárdio (IAM)  também \\npodem cursar com pericardite aguda. Neste último, tanto a pericardite precoce (1ª semana pós-\\nIAM) quanto a tardia (síndrome de Dressler) tornaram-se menos comuns em virtude da terapia \\nde reperfusão coronariana precoce.4,5,6,7'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 253}, page_content='253 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nTabela 1 - Principais causas de pericardite aguda (Adaptado de USP, 2020). \\nInfecções Virais (Coxsackie, Echovírus, adenovírus..) \\nBacterianas ( S. pneumoniae, N. meningitidis, S. aureus, \\nMycoplasma…) \\nMicobactérias (M. tuberculosis, M. avium) \\nHIV \\nFungos (coccidioidomicose, histoplasmose) \\nParasitárias (toxoplasma e equinococo) \\nAutoimunes ou doenças \\ninflamatórias \\nDoenças do tecido conjuntivo (lúpus eritematoso sistêmico, \\nartrite reumatoide, esclerodermia, síndrome de Sjögren…) \\nVasculites sistêmicas (síndrome de Behçet, doença de \\nTakayasu…) \\nInduzidas por medicações (hidralazina, isoniazida…) \\nSarcoidose \\nPós-IAM Síndrome de Dressler, pericardite pós-IAM \\nNeoplasias Carcinoma de mama, pulmão, linfomas, sarcoma de Kaposi \\nMesotelioma, fibrossarcoma (neoplasias primárias do \\npericárdio) \\nOutras condições \\nsistêmicas \\nHipotireoidismo, trauma, amiloidose, uremia, mixedema, \\nquilopericárdio, anorexia nervosa… \\nIatrogênica e traumática Lesão direta (ferimento perfurante, perfuração esofágica), lesão \\nindireta (radiação…) \\nSíndrome de lesão pericárdica, pós-traumática… \\n \\n1.3. QUADRO CLÍNICO \\nNa maioria dos casos, o paciente apresenta um pródromo, geralmente de etiologia viral, \\ncomposto por febre, fadiga, mialgia e sintomas do trato respiratório superior ou do \\ngastrointestinal.3,5 \\nO sintoma mais presente é a dor torácica, que tem características variáveis. No entanto, \\nem geral, a dor da pericardite aguda é pleurítica (ou seja, piora com a inspiração profunda, a \\ntosse e o espirro), em pontada, tem início abrupto, acentua-se com o decúbito dorsal e melhora \\nna posição sentada com o tronco inclinado para a frente. Tem localização subesternal, mas pode \\ncentrar-se no hemitórax esquerdo ou mesmo no epigástrio. Não raramente irradia para o \\nmembro superior esquerdo, porém o acometimento do músculo trapézio tem elevada \\nespecificidade para pericardite.4,8 \\nAlém disso, pode haver dispneia (g eralmente devido à respiração superficial para não \\npiorar a dor), tosse e até mesmo soluços (pela ativação do nervo frênico).4,8 \\nNo exame físico, quando não há complicações, o paciente apresenta -se taquicárdico, \\nansioso e um pouco taquipneico. Um achado importante é o atrito pericárdico, som áspero, que'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 254}, page_content='254 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nocorre em cerca de 85% dos casos. Este achado é causado pela fricção entre os folhetos visceral \\ne parietal inflamados, sendo mais audível na borda esternal inferior esquerda, com o tórax do \\nindivíduo inclina do para frente. Pode compreender de um a três tempos, de modo que, \\nclassicamente, consiste em três componentes relacionados à sístole ventricular, ao enchimento \\nprotodiastólico e à contração atrial. É dinâmico, isto é, pode desaparecer e retornar em \\nsequência. Em razão disso, é imprescindível repetir a ausculta quando não o identifica \\ninicialmente, mas a suspeita de pericardite persiste forte.3,4,8 \\nPode haver abafamento das bulhas cardíacas, derrame ou atrito pleural e, em torno de \\n15% dos casos, há miocard ite associada, o que propicia a elevação de marcadores de necrose \\n(troponina), devendo-se ser suspeitada na presença de disfunção ventricular aguda.4,5 \\nO histórico clínico de câncer ou de doenças autoimunes, bem como erupção cutânea, \\nperda ponderal ou febr e alta com calafrios podem sugerir afecções específicas. Logo, é \\nimportante estar atento a essas informações.8 \\n1.4. DIAGNÓSTICO E EXAMES COMPLEMENTARES \\nDe início, na suspeita de pericardite aguda, é recomendado a realização de \\neletrocardiograma (ECG), radiograf ia de tórax, hemograma, troponina, proteína C -reativa \\n(PCR) e ecocardiograma. Na presença de pelo menos dois requisitos característicos (tabela \\n2), de modo que a clínica (dor torácica pericárdica e/ou atrito pericárdico) também é \\nconsiderada, o diagnóstico de pericardite pode ser feito.4,9 \\n1.4.1. Eletrocardiograma: \\nO exame mais importante, que deve ser realizado de forma imediata, uma vez que há \\nqueixa de dor torácica. As alterações são dinâmicas e envolvem os segmentos PR e ST e o ritmo. \\nEm 60% dos casos, o ECG é típico e em até 6% pode ser normal.5,6,8 \\nÉ preciso ter atenção no ECG, pois neste exame, o maior diagnóstico diferencial é a \\nsíndrome coronariana aguda com supra de segmento ST, condição extremamente grave, que \\ndemanda intervenção hemodinâmica.6 \\nNa pericardite aguda, há quatro estágios de alterações eletrocardiográficas 4,5 , sendo \\nesses: \\n   Estágio I: Supradesnivelamento do segmento ST com concavidade para cima e difuso, \\nexceto em aVR e V1, derivações em que esses segmentos estão infradesnivelados. Onda T \\napiculada, com amplitude aumentada levemente, e infradesnível do segmento PR, com exceção \\nde aVR (aonde há supradesnível).'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 255}, page_content='255 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\n   Estágio II: Segmentos ST e PR retornam à linha de base e ocorre achatamento da onda \\nT (em geral, após duas semanas). \\n   Estágio III: Inversão de onda T generalizada (pode durar semanas). \\n   Estágio IV: Onda T retorna à normalidade (a inversão pode persistir por meses). \\nO ritmo cardíaco pode ser alterado em qualquer fase da pericardite no ECG, variando de \\numa taquicardia sinusal até taquiarritmias atriais variadas. \\nAlgumas características4,10 podem auxiliar a diferenciar o ECG da pericardite aguda com \\no da isquemia do miocárdio. Na pericardite: \\n1. Na maioria das vezes, as alterações do segmento ST não respeitam um território \\nde irrigação das coronárias, ou seja, são difusas, pois há casos em que o \\nacometimento é focal, o que dificulta a diferenciação pelo ECG; \\n2. Não há imagem-espelho do supra de ST, exceto em aVR e em V1 (há infradesnível \\nde ST); \\n3. Normalmente, a amplitude da onda T é mais baixa quando comparada a da \\nisquemia, que é mais pronunciada; \\n4. O supra do segmento ST tem concavidade para cima, enquanto na isquemia é para \\nbaixo; \\n5. Não há onda Q patológica, como ocorre no infarto tardio; \\n6. Há infradesnível do segmento PR, diferentemente da isquemia, que não o altera; \\n7. Há ausência de entalhe no ponto J nas derivações V2, V3 e V4 (padrão “fish hook”), \\no qual está presente na repolarização precoce; \\nA relação entre o supradesnível do segmento ST e a amplitude da onda T em V6 é útil \\ncaso ainda haja dúvida entre pericardite e  repolarização precoce. Se esse cálculo (ST/T) for \\nmaior ou igual a ¼ , isto é, a 0,25, é indicativo de pericardite aguda. Ao passo que se for menor \\nque 0,24, possivelmente é repolarização precoce.5'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 256}, page_content='256 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nFigura 1 - Eletrocardiograma evidenciando supradesnivelamento difuso do segmento ST, sem \\nrespeitar o território de irrigação das artérias coronárias. Ausência de imagem-espelho, com exceção \\ndas derivações aVR e V1, que têm infradesnível do segmento ST. Infradesnivelamento difuso do \\nsegmento PR. excetuando-se aVR e V1. ECG típico de pericardite aguda. \\n \\nBOX 34.  \\nFoi realizado um eletrocardiograma para afastar SCA. O ECG evidenciou supra do segmento \\nST difuso e infradesnivelamento do segmento PR que poupava aVR e V1. \\n \\n1.4.2. Radiografía de tórax \\nA maioria das radiografias na pericardite não complicada não revela alterações. Sua \\nimportância reside, em parte, na exclusão de diagnósticos diferenciais, como pleurite e \\npneumotórax. Pequenos derrames pleurais ou infiltrados pulmonares podem indicar infecções \\nvirais ou por bactérias atípicas. Achados compatíveis com pneumonia associam-se à pericardite \\nbacteriana, enquanto linfonodomegalias podem indicar etiologia neoplásica. A cardiomegalia, \\npor sua vez, ocorre diante de algumas circunstâncias, as quais s erão detalhadas no tópico de \\nderrame pericárdico.4,5,8 \\n1.4.3. Exames laboratoriais \\nEm torno de 75% dos pacientes têm elevação da PCR. Por ter uma certa relação com a \\nrecorrência dos sintomas, essa medida é útil na monitorização do curso da doença (resposta à'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 257}, page_content='257 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nterapêutica) e no auxílio na determinação da duração do tratamento. Valores dent ro do \\nparâmetro estão presentes em indivíduos que receberam anti -inflamatórios, que tiveram \\natendimento precoce ou mesmo nos imunocomprometidos. A normalização tende ser dentro \\nde duas semanas. Outros marcadores de fase aguda, como o VHS e a leucocitose ta mbém \\ncostumam estar alterados.5,8 \\nEm casos de miopericardite, a troponina I sérica, marcador de necrose do miocárdio, \\npode estar elevada, sendo mais frequente no segundo dia após o início do quadro.5,8 \\nNíveis de BNP (peptídeo natriurético atrial do tipo B)  e de NT -proBNP (fração N -\\nterminal do BNP), apesar de poderem estar aumentados, não são usados de rotina para o \\ndiagnóstico de pericardite, pois as evidências existentes são insuficientes até o momento.5 \\nOutros exames podem ser aplicados para auxiliar a definir o diagnóstico etiológico, como \\ndosagem de hormônios tireoidianos, marcadores reumatológicos, função renal, medição da \\nadenosina deaminase (na suspeita de origem tuberculosa), sorologias virais, entre outros.5 \\n1.4.4. Ecocardiograma \\nO ecocardiograma tem maior utilidade na avaliação da presença de derrame pericárdico \\ne/ou espessamento pleural e também da contratilidade do miocárdio, uma vez que pode haver \\nmiocardite associada. Entretanto, o exame normal não descarta pericardite aguda, pois há casos \\nsem a derrame, denominados de “pericardite aguda seca”.4,5 \\n1.4.5. Outros exames de imagem  \\nA tomografia computadorizada com contraste e a ressonância magnética do miocárdio \\npodem evidenciar espessamento, inflamação e derrame pericárdico. Estes exames, devido ao \\nmaior custo, são mais usados em casos de difícil diagnóstico.4,5,8 \\n \\nTabela 2 - Critérios diagnósticos de pericardite aguda (Diretriz europeia, ESC 2015) \\nCRITÉRIOS DIAGNÓSTICOS \\nPelo 2 dos 4 critérios abaixo: \\n1. Dor torácica pericárdica; \\n2. Atrito pericárdico; \\n3. Novo supradesnivelamento difuso do segmento ST ou infradesnivelamento do \\nPR no ECG; \\n4. Derrame pericárdico (novo ou agravamento de preexistente); \\nAchados adicionais que fortalecem o diagnóstico: \\n- Aumento dos marcadores inflamatórios (e.g. PCR, VHS, leucocitose); \\n- Evidência de inflamação do pericárdio em exames de imagem (TC, RMC); \\nECG: eletrocardiograma; PCR: proteína C-reativa; VHS: velocidade de hemossedimentação; TC: \\ntomografia computadorizada; RMC: ressonância magnética cardíaca;'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 258}, page_content='258 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nBOX 35.  \\nA partir do ECG e da clínica, a principal hipótese foi de pericardite aguda. Os sinais de mau \\nprognóstico foram avaliados. Neste caso, o paciente estava com febre alta (38,5ºC) e também \\napresentava um quadro subagudo. Logo, foi internado para investigação etiológica.  \\n \\n1.5. DIAGNÓSTICO DIFERENCIAL \\nComo o paciente com pericardite classicamente refere dor torácica, os diagnósticos \\nalternativos são inúmeros. Em contrapartida, clinicamente, o tromboembolismo ou infarto \\npulmonar, a pneumonia com pleurisia, a costocondrite e a doença do refluxo gastroesof ágico \\nsão os mais confundidos.8 \\n Em geral, a diferenciação entre pericardite e isquemia do miocárdio é simples, porém, \\nem alguns casos, a definição do diagnóstico pode demandar o uso da angiografia das \\ncoronárias.8 \\nAlém dessas condições, outras possibilida des incluem dissecção da aorta, processos \\nintra-abdominais, dor torácica e pneumotórax causados por herpes -zóster (precedendo o \\nsurgimento das vesículas na pele características da infecção).8 \\n1.6. CONDUTA \\nVisto que em torno de 80% dos casos de pericardite são i diopáticos, possivelmente \\nassociados à etiologia viral, nem todos os pacientes precisam de admissão hospitalar para \\ninvestigação da causa. Logo, é importante fazer uma triagem apropriada para selecionar \\ncorretamente quem tem maior risco de evoluir com comp licações, como o tamponamento \\ncardíaco.6 \\nPara isso, existem fatores de risco (tabela 3) associados a um pior prognóstico, que \\npodem auxiliar nessa decisão. Sendo assim, a presença de um fator (maior ou menor)  já \\nindica internamento hospitalar para definir o diagnóstico etiológico.6 \\nEntretanto, caso esses fatores estejam ausentes, o tratamento empírico com anti -\\ninflamatórios pode ser adotado, de modo que o paciente seja reavaliado após uma semana.6'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 259}, page_content='259 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nTabela 3 - Fatores de mau prognóstico na pericardite aguda (Manual de Emergência: Abordagem \\nPrática, 2020). \\nFATORES DE PIOR PROGNÓSTICO NA PERICARDITE AGUDA  \\nMAIORES MENORES \\n- Febre > 38ºC \\n- Início subagudo \\n- Derrame pericárdico volumoso (> 20 mm) \\n- Tamponamento cardíaco \\n- Ausência de resposta ao tratamento anti-\\ninflamatório (AAS/AINE) após 1 semana \\n- Miopericardite \\n- Imunossupressão \\n- Trauma \\n- Terapia anticoagulante oral \\n- Presença de pulso paradoxal \\n- Evolução atípica de ECG \\n- Aumento de proteínas de fase \\naguda \\nAAS: ácido acetilsalicílico; AINE: anti-inflamatório não esteroide; ECG: eletrocardiograma \\n \\nBOX 36.  \\nApós a admissão, foram solicitados hemograma, PCR, radiografia de tórax e um \\necocardiograma. \\nResultados: \\n• Leucocitose (18.000, com predomínio de neutrófilos); \\n• PCR 40 mg/dl; \\n• Radiografia de tórax: consolidação no lobo médio e inferior do pulmão direito, \\naumento da área cardíaca e derrame pleural à direita. \\n• Ecocardiograma: derrame pericárdico > 26 mm; \\n \\nAo identificar uma etiologia específica, a terapia direcionada deve ser adequadamente \\nestabelecida. Já em relação à terapêutica anti -inflamatória (tabela 4)  sua aplicação tem a \\nfunção de reduzir a dor do paciente e, é claro, de resolver o processo inflamatório. O Ibuprofeno \\né preferível, pois tem um ótimo perfil de segurança, raros efeitos colat erais e ações benéficas \\nao fluxo coronariano. O AAS é uma alternativa, principalmente em pacientes que já o usam por \\nconta de outras indicações, como pacientes com coronariopatias. A Indometacina (75 a 150 mg \\nao dia) também é uma opção, mas, por reduzir o processo cicatricial da região infartada, deve \\nser evitada nos casos de pericardite pós-IAM.5,11 \\nA Colchicina, por sua vez, tem papel no alívio da dor e, sobretudo, na prevenção da \\nrecorrência da pericardite. No primeiro evento, o seu uso deve ser feito por 3 meses, enquanto \\nem casos recorrentes, a utilização deve ser estendida por 6 a 12 meses. A dose depende do peso'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 260}, page_content='260 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\ne, em pacientes renais, deve ser reduzida. A diarreia é o seu principal efeito colateral, ao passo \\nque hepatotoxicidade, miotoxicidade e supressão da medula óssea são bem menos frequentes. \\nBoa parte dos pacientes a toleram bem, mas cerca de 5 a 8% descontinuam a medicação por \\nintolerância gastrointestinal.5,8,11 \\nO uso de inibidores da bomba de prótons, como omeprazol, deve ser feito \\nconcomitantemente, a fim de proteger a mucosa gástrica dos anti -inflamatórios. Caso a \\nassociação AINE + Colchicina tenha efeito lento, o uso de analgésicos narcóticos pode ser \\nfeito.5,8 \\nA eficácia da terapia pode ter como parâmetro a dosagem de PCR. A sua medição seriada \\né útil para monitorar a atividade inflamatória da doença e, consequentemente, auxiliar na \\ndefinição do tempo de tratamento. O nível de PCR < 3,0 mg/L, associado à resolução dos \\nsintomas, são indicativos de que a dose da medicação pode ser reduzida progressivamente.4,11 \\n \\nTabela 4 - Terapia anti-inflamatória. Adaptado da ESC, 2015. \\nTERAPIA ANTI-INFLAMATÓRIA \\nFÁRMACO POSOLOGIA \\nAAS 500 a 1000  mg a cada 6 ou 8 horas, por 7 a 10 \\ndias \\nIbuprofeno 600 a 800 mg de 8/8 horas, por 14 dias \\nColchicina  0,5 mg de 12/12 horas (pacientes > 70 kg) \\n0,5 mg a cada 24 horas (pacientes < 70 kg) \\nAAS: ácido acetilsalicílico. \\n \\nO uso de corticoides deve ser empregado em situações específicas, pois pode facilitar \\nque haja recorrências devido ao ancorament o imunológico que ocasiona as possíveis \\ncomplicações, como infecções bacterianas. Dessa forma, é indicado na ausência de resposta aos \\nAINES e à colchicina, ou quando a etiologia da pericardite é autoimune, urêmica ou relacionada \\na doenças do tecido conjunt ivo. A dose recomendada de prednisona é de 0,2 a 0,5 mg/kg/dia \\ncom duração de 2 a 4 semanas. Deve -se retirar lentamente e associar colchicina na dose de 1 \\nmg por dia. O desmame pode ser acompanhado, ou melhor, guiado pelo PCR, a fim de evitar \\nprolongar o uso de corticoides.4,5,6 \\nAlém dessas medidas, é importante que haja restrição à atividade física, devido à \\ntaquicardia induzida pelo exercício que pode piorar o processo inflamatório, até a resolução'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 261}, page_content='261 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\ndos sintomas e a normalização do PCR. O temp o de restrição varia, sendo indicado que \\npacientes atletas permaneçam, no mínimo, três meses sem exercícios.6,11 \\n \\nBOX 37.  \\nFoi realizado uma toracocentese para drenagem do líquido e avaliação laboratorial e \\niniciada a antibioticoterapia empírica com Ceftriaxone + Levofloxacina, associado à terapia \\nanti-inflamatória com 800 mg de Ibuprofeno 8/8h; \\nA toracocentese revelou derrame  pleural exsudativo (pH: 7,20; glicose: 45 mg/dl; \\nproteína: 37 g/dl; desidrogenase lática: 1.200 UI/l]. A coloração do líquido pleural revelou \\ndiplococos gram-positivos. \\n \\n2. DERRAME PERICÁRDICO E TAMPONAMENTO CARDÍACO \\n2.1. ETIOPATOGENIA \\nO saco pericárdico contém uma pequena quantidade de líquido (30 a 50 ml) que envolve \\no coração. Quando uma quantidade significativa de líquido se acumula entre os folhetos \\npericárdicos, chama -se de derrame pericárdico, e quando este ultrapassa a capacidade de \\ndistensão do tecido fi broelástico pericárdico, ocorre compressão progressiva de todas as \\ncâmaras cardíacas pelo aumento da pressão intrapericárdica, redução do volume de \\nenchimento cardíaco e maior interdependência ventricular, chamando -se este fenômeno de \\ntamponamento cardíaco.5 \\nQualquer causa de derrame pericárdico pode ocasionar tamponamento cardíaco. Não é \\no volume de derrame que causa o tamponamento, mas sim a velocidade de instalação: isto é, o \\ndesenvolvimento do tamponamento depende da velocidade de instalação e do fator causal.4 \\nDessa forma, o tamponamento cardíaco agudo ocorre em minutos, devido ao trauma, ruptura \\ndo coração e aorta, ou como complicação de procedimentos diagnósticos e terapêuticos (ex: \\nbiópsias cardíacas), resultando num quadro de choque. Já o tamponamento cardíaco subagudo \\nocorre entre dias e semanas e pode estar associado com dispneia e fadiga. Tamponamento de \\nbaixa pressão ocorre em pacientes hipovolêmicos, com consequente redução da pressão \\nintracardíaca, favorecendo a compressão extrínseca do derrame pericárdico. O tamponamento \\ncardíaco regional ocorre quando um derrame localizado ou um hematoma produz compressão'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 262}, page_content='262 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nregional em uma única câmara 5. A tabela 5  traz as principais causas de tamponamento \\ncardíaco. \\n \\nTabela 5 - Principais causas de tamponamento cardíaco. Adaptado de Manual de Emergência: \\nAbordagem Prática, 2020 \\nTrauma (penetrante, contuso, iatrogênico). \\nMalignidade metastática \\nPericardite idiopática aguda \\nUremia \\nPericardite bacteriana ou tuberculosa \\nPericardite idiopática crônica \\nHemorragia (anticoagulante) \\nOutros (lúpus eritematoso sistêmico, pós-radioterapia, mixedema, etc) \\n \\n2.2. QUADRO CLÍNICO \\nNo tamponamento cardíaco ocorre um aumento da restrição pericárdica com as \\npressões de enchimento no lado esquerdo e direito do coração se equilibrando. Assim, em \\nníveis elevados, aparece um pulso paradoxal com a inspiração. Fisiologicamente, há uma \\ndiminuição de até 10 mmHg na pressão arterial sistólica (PAS) durante a inspiração na posição \\nsupina. Quando o pulso paradoxal ocorre, há uma diminuição da PAS de mais de 10 mmHg com \\na inspiração. A presença desse pulso geralmente diferencia o tamponamento cardí aco \\nverdadeiro de situações com menor grau de restrição ao enchimento cardíaco4.  \\nO pulso paradoxal não é diagnóstico de tamponamento cardíaco e pode ser observado \\nem outros processos cardiopulmonares, como hipertensão pulmonar secundária a embolia \\npulmonar e eventualmente em pacientes com pericardite aguda significativa sem \\ntamponamento cardíaco. As veias do pescoço podem estar distendidas com o esperado \\ndescenso “y” ausente. A ausculta cardíaca pode revelar bulhas abafadas, sendo que os estertores \\npulmonares geralmente estão ausentes. Pode haver sensibilidade no quadrante superior \\ndireito devido à congestão venosa hepática4. \\nA famosa tríade de Beck – turgência jugular, hipofonese de bulhas e hipotensão – pode \\nestar presente em apenas 10 a 40% dos pacientes com tamponamento4. Em teoria, a hipofonese \\nde bulhas ocorre porque, com o acúmulo  de líquido no saco pericárdico, diminui -se a \\ntransmissão do som das bulhas; a hipotensão porque a redução do volume de enchimento'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 263}, page_content='263 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\ncardíaco culmina na diminuição do débito cardíaco; e a turgência jugular, pela síndrome \\ncongestiva decorrente do aumento da pressão intrapericárdica. \\nBOX 38.  \\nO paciente piorou. Estava mais taquipneico (33 irm), hipotenso (PA: 90x60 mmHg) e com \\nabafamento de bulhas na ausculta cardíaca. Foi necessário aumentar a FiO2 e transferi-lo \\npara a UTI. \\n \\n2.3. DIAGNÓSTICO E EXAMES COMPLEMENTARES \\nO diagnóstico do tamponamento cardíaco é sobretudo clínico baseado na combinação \\nde uma história sugestiva e sintomas (tipicamente dispneia ao esforço progredindo para \\nortopneia e dor torácica) juntamente a turgência jugular, pulso paradoxal, sons cardíacos \\ndiminuídos ou abafados e  frequentemente hipotensão. Na suspeita de derrame pericárdico é \\nmandatória a realização de um ecocardiograma transtorácico, o qual confirmará o diagnóstico. \\nAlém disso, exames como eletrocardiograma e radiografia de tórax também podem apresentar \\nachados que sugestionam o diagnóstico. Nos casos de suspeita de derrame pericárdico loculado, \\nde espessamento pericárdico e de massas pericárdicas deve ser considerada a realização de \\ntomografia computadorizada ou ressonância nuclear magnética5. \\nA radiografia de tórax pode ser normal , mas para derrames superiores a 200 mL uma \\nsilhueta cardíaca aumentada com perda da cintura hilar, um coração em forma de “saco de \\nágua”, ausência de congestão venosa pulmonar e ingurgitação da veia cava superior podem ser \\nalgumas das alterações identificadas5. \\nO eletrocardiograma mostra frequentemente baixa voltagem e, por vezes, alternância na \\nmorfologia ou amplitude do QRS, principalmente em situações de oscilações do coração por um \\ngrande derrame pericárdico5. \\nA ecocardiografia bidimensional permite avaliar a dimensão, a localização e o grau de \\nimpacto hemodinâmico do derrame pericárdico.  A avaliação semiquantitiativa da dimensão do \\nderrame pericárdico é baseada na medida do maior diâmetro telediastólico anecogén ico, em \\nvários planos ecocardiográficos. Um derrame pericárdico pequeno (< 10 mm) está geralmente \\nlocalizado posteriormente e adjacente à aurícula direita. Nos derrames moderados (10 – 20 \\nmm) e graves (> 20 mm), os derrames tornam -se circunferenciais. O ecocardiograma também \\npode oferecer informações sobre a etiologia, pois permite caracterizar a natureza do líquido (se'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 264}, page_content='264 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\ntransudato ou exsudato), verificar se existe fibrina (como na tuberculose), cálcio, coágulos, \\nmassas sugestivas de tumor ou cisto, permitin do portanto inferências sobre o diagnóstico \\netiológico5,6. \\n \\nFigura 2 - Eletrocardiograma evidenciando um derrame pericárdico. A primeira alteração é a baixa \\nvoltagem, que tem como parâmetro os complexos QRS menores que 5 mm nas derivações periféricas \\n(D1, D2, D3, aVR, aVL e  aVF) e menores que 10 mm nas derivações precordiais (V1 -V6). Além disso, \\ntambém pode ser visualizado a alternância elétrica, conhecida como  “swinging heart”, melhor vista  \\nno D2 longo, caracterizando-se pela alternância de amplitude do QRS devido ao movimento pendular do \\ncoração imerso no líquido pericárdico excessivo.  \\n \\n2.4. CONDUTA \\nQuando um derrame pericárdico é detectado, o primeiro passo consiste em avaliar a sua \\ndimensão, a importância hemodinâmica (especialmente a presença de tampona mento \\ncardíaco) e doenças possivelmente associadas (tanto cardiovasculares quanto sistêmicas). O \\nderrame pericárdico está muitas vezes associado (até 60% dos casos) a situações médicas \\nconhecidas ou desconhecidas (por exemplo o hipotireoidismo). Se estiver em presentes sinais \\ninflamatórios, o tratamento clínico deve ser o da pericardite. Dessa forma, a terapêutica do \\nderrame pericárdico é orientada para a sua etiologia6.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 265}, page_content='265 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nO tamponamento cardíaco, considerado uma causa tratável de choque, se não for \\nrapidamente reconhecido e tratado pode ser fatal. Na estabilização hemodinâmica inicial do \\npaciente, pode-se fazer a infusão rápida de cristalóide com objetivo de melhorar a perfusão, e \\nna presença de bradicardia indica -se a utilização de aminas ou atropina. O trata mento do \\ntamponamento cardíaco consiste na drenagem do líquido pericárdico, que ajuda a reduzir a \\npressão intrapericárdica e, dessa forma, melhora a hemodinâmica do paciente. De preferência, \\na drenagem deve ser feita por meio de pericardiocentese sob orien tação ecocardiográfica ou \\nfluoroscópica, que deve ser realizada sem atraso nos doentes instáveis5,6.  \\nA pericardiocentese pode ser feita à beira do leito do paciente sob anestesia local ou na \\nhemodinâmica com radioscopia. A via de acesso pode ser transtorácica, mediana ou subxifoide. \\nO acesso pela via subxifoide permite uma exposição limitada do pericárdio, resultando em baixo \\níndice de positividade. A agulha para punção pericárdica deve ser guiada por monitorização \\neletrocardiográfica ou por método de imag em. A pericardiocentese guiada pelo \\necocardiograma apresenta menor risco de complicações e maior sucesso. Após a introdução do \\ncateter é importante a aferição da pressão da cavidade pericárdica seguida da aspiração do seu \\nlíquido5,6.  \\nA pericardiocentese também pode ser realizada mediante um cateter guiado pela \\necocardiografia, o qual pode necessitar alguns dias e não deve ser removido até a drenagem ser \\ninferior a 20 –30 ml/24h. Outra alternativa é a drenagem cirúrgica, que tem a vantag em de \\npermitir a realização de biópsia pericárdica, sendo a forma recomendada em casos de recidiva \\ndo derrame após a drenagem via cateter e em casos de coágulos ou de derrames localizados \\nnão acessíveis pela via percutânea5. \\nA abordagem cirúrgica é uma  al ternativa a drenagem, em especial para a pericardite \\npurulenta ou em situações urgentes com hemorragia para o pericárdio5. \\n \\nBOX 39.  \\nO paciente estava tamponando. Logo, foi realizada uma pericardiocentese de alívio, \\nretirando cerca de 400 ml de líquido seropurulento. O paciente ainda recebeu drogas \\nvasoativas. Outros testes microbiológicos confirmaram infecção por pneumococo. A \\nantibioticoterapia foi ajustada, de modo que o paciente, após a drenagem do conteúdo \\npurulento, foi estabilizado.'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 266}, page_content='266 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nFLUXOGRAMA \\nECG = eletrocardiograma. EF = exame físico. IBP - inibidor da bomba de prótons. AINES - anti-\\ninflamatório não esteroidal. \\nPACIENTE COM SUSPEITA DE \\nPERICARDITE AGUDA NA \\nEMERGÊNCIA \\nAvaliação Inicial \\n(história clínica + EF + ECG) \\nDúvida \\ndiagnóstica? \\nNão, não é \\npericardite aguda \\nNão, é pericardite \\naguda \\nTroponina \\nPCR \\nOutros exames disponíveis \\n \\nOutros \\ndiagnósticos de \\ndor torácica \\nO paciente tem \\ncritérios de pior \\nprognóstico? \\nNão \\nSim \\nInternação para \\ninvestigar \\netiologia \\n \\nAINES + Colchicina \\nIBP ambulatoriais \\nConsulta para reavaliação \\nDefinição da \\netiologia \\nTratamento da \\ncausa base \\nEvolução com derrame \\npericárdico considerável  \\nToracocentese de alívio + \\navaliação do líquido drenado \\nTratamento direcionado \\nEvolução com \\ntamponamento cardíaco \\n  \\nDrenagem par alívio \\nCristaloides (p/ hipotensão); \\nAtropina (p/ bradicardia);'), Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 267}, page_content='267 Cardiologia na Emergência: Guia para o Pronto-Socorro \\ncapítulo xii | PERICARDITE AGUDA E TAMPONAMENTO CARDÍACO \\nREFERÊNCIAS BIBLIOGRÁFICAS \\n1. MOORE, K. L.; DALEY II, A. F. Anatomia orientada para a clínica. 8ª. edição. Guanabara \\nKoogan. Rio de Janeiro, 2019. \\n2. HANKIN, Mark H. Anatomia clínica : uma abordagem por estudos de casos. Porto Alegre: \\nAMGH, 2015. \\n3. TONINI, Márcio; MELO, Dirceu Thiago Pessoa de; FERNANDES, Fábio. Acute pericarditis. \\nRevista da Associação Médica Brasi leira, [S.L.], v. 61, n. 2, p. 184 -190, abr. 2015. \\nFapUNIFESP (SciELO). \\n4. Velasco IT. Manual de Emergência: Abordagem Prática. 14. ed. São Paulo: Manole, 2020. \\n5. Montera MW, Mesquita ET, Colafranceschi AS, Oliveira Junior AM, Rabischoffsky A, Ianni \\nBM, et al. Sociedade Brasileira de Cardiologia. I Diretriz Brasileira de Miocardites e \\nPericardites. Arq Bras Cardiol. 2013;100(4 supl. 1):1-36 \\n6. Adler Y, Charron P, Imazio M, Badano L, Barón -Esquivias G, Bogaert J, et al. 2015 ESC \\nGuidelines for the diagnosis and mana gement of pericardial diseases: The Task Force for \\nthe Diagnosis and Management of Pericardial Diseases of the European Society of \\nCardiology (ESC) Endorsed by: The European Association for Cardio -Thoracic Surgery \\n(EACTS). Eur Heart J. 2015;36:2921. \\n7. Solomon CG. Acute pericarditis. N Engl J Med. 2014;371:2410-6 \\n8. BRAUNWALD - TRATADO DE DOENÇAS CARDIOVASCULARES, 10ª EDIÇÃO, by Elsevier. \\n9. MCNAMARA, N. Acute pericarditis: a review of current diagnostic and management \\nguidelines. Future Cardiology, Ireland, v. 15, n. 2, 2019. \\n10. MARINELLA, Mark A.. Electrocardiographic manifestations and differential diagnosis of \\nacute pericarditis. Am Fam Médico, Dayton, Ohio, v. 4, n. 57, p. 699-704, fev. 1998. \\n11. CHIABRANDO, Juan Guido; BONAVENTURA, Aldo; VECCHIÉ, Alessandra; WOH LFORD, \\nGeorge F.; MAURO, Adolfo G.; JORDAN, Jennifer H.; GRIZZARD, John D.; MONTECUCCO, \\nFabrizio; BERROCAL, Daniel Horacio; BRUCATO, Antonio. Management of Acute and \\nRecurrent Pericarditis. Journal Of The American College Of Cardiology, [S.L.], v. 75, n. 1, \\np. 76-92, jan. 2020. Elsevier.')]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Divisão do documento em chunks\n",
        "\n",
        "O código abaixo divide um texto longo (por exemplo, as páginas de um PDF) em pedaços menores chamados \"chunks\".\n",
        "\n",
        "**Por que dividir em chunks?**  \n",
        "Dividir o documento em chunks é fundamental para facilitar o processamento de grandes textos por modelos de linguagem, que têm limites de tamanho de entrada. Além disso, trabalhar com chunks permite consultas mais rápidas, melhor aproveitamento do contexto relevante e melhora a precisão da recuperação de informações em sistemas RAG.\n",
        "\n",
        "**Passo a passo:**\n",
        "\n",
        "1. **Importa a ferramenta:** `RecursiveCharacterTextSplitter` é utilizada para dividir textos de forma inteligente, respeitando a estrutura do texto (frases, parágrafos, etc.).\n",
        "2. **Configura a ferramenta:** Define o tamanho máximo de cada chunk (1000 caracteres) e a sobreposição entre chunks (200 caracteres), o que ajuda a manter o contexto entre eles.\n",
        "3. **Divide o texto:** Aplica a ferramenta `text_splitter` nas páginas do PDF, gerando uma lista de chunks menores.\n",
        "\n",
        "O resultado é uma lista chamada `splits` contendo os chunks do texto original, prontos para serem processados por modelos de NLP ou sistemas de busca inteligente.\n"
      ],
      "metadata": {
        "id": "LTMkyUVnbSmi"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
        "# 1. Aqui estamos importando uma ferramenta chamada 'RecursiveCharacterTextSplitter' da biblioteca 'langchain_text_splitters'.\n",
        "# Ela é usada para dividir grandes textos em pedaços menores (ou \"fragmentos\") de forma inteligente, para que o texto possa ser processado mais facilmente.\n",
        "\n",
        "text_splitter = RecursiveCharacterTextSplitter(chunk_size=1000, chunk_overlap=200)\n",
        "# 2. Agora, estamos criando uma \"ferramenta\" chamada 'text_splitter' usando a função 'RecursiveCharacterTextSplitter'.\n",
        "# Estamos configurando essa ferramenta para dividir o texto em fragmentos de até 1000 caracteres ('chunk_size=1000').\n",
        "# Também definimos que haverá uma sobreposição de 200 caracteres entre os fragmentos ('chunk_overlap=200'), ou seja, os últimos 200 caracteres de um fragmento vão aparecer no começo do próximo.\n",
        "\n",
        "splits = text_splitter.split_documents(pages)\n",
        "# 3. Por fim, estamos aplicando essa ferramenta 'text_splitter' nas páginas do PDF (que foram carregadas antes).\n",
        "# O método 'split_documents' vai dividir cada página em pedaços menores, de no máximo 1000 caracteres, com uma pequena sobreposição entre eles.\n",
        "# O resultado ('splits') será uma lista contendo os fragmentos de texto prontos para serem usados em processamento de NLP.\n"
      ],
      "metadata": {
        "id": "xB7N32jZZAoK"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Sobre a divisão em chunks\n",
        "\n",
        "A função `RecursiveCharacterTextSplitter` foi usada aqui para dividir os textos em pedaços menores, chamados *chunks*, respeitando a estrutura do conteúdo e facilitando o processamento posterior por modelos de linguagem. Esse método é especialmente útil para garantir que informações importantes não fiquem cortadas de maneira abrupta entre os pedaços.\n",
        "\n",
        "Vale lembrar que existem diversos outros métodos para dividir textos em chunks, como divisões por sentenças, parágrafos, tokens, ou até mesmo pela semântica do texto. A escolha do melhor método depende do tipo de texto e da tarefa de NLP desejada.\n"
      ],
      "metadata": {
        "id": "wubxitg9928t"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Conferindo como foi feito os splits.\n",
        "print(splits[10])"
      ],
      "metadata": {
        "id": "3p6gy6YAaBGj",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "257d67cf-3bb1-4bf9-f7eb-8dc9815cad54"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "page_content='de Brasília \n",
            "Ricardo Leoni Gonçalves Bastos – Universidade \n",
            "Federal do Ceará \n",
            "Rodrigo da Rosa Pereira – Universidade Federal \n",
            "do Rio Grande \n",
            "Rubia Katia Azevedo Montenegro – \n",
            "Universidade Estadual Vale do Acaraú  \n",
            "Sabrynna Brito Oliveira – Universidade Federal \n",
            "de Minas Gerais \n",
            "Samuel Miranda Mattos – Universidade Estadual \n",
            "do Ceará \n",
            "Shirley Santos Nascimento – Universidade \n",
            "Estadual Do Sudoeste Da Bahia \n",
            "Silvana Carloto Andres – Universidade Federal \n",
            "de Santa Maria \n",
            "Silvio de Almeida Junior – Universidade de \n",
            "Franca \n",
            "Tatiana Paschoalette R. Bachur – Universidade \n",
            "Estadual do Ceará | Centro Universitário \n",
            "Christus \n",
            "Telma Regina Stroparo – Universidade Estadual \n",
            "do Centro-Oeste \n",
            "Thayla Amorim Santino – Universidade Federal \n",
            "do Rio Grande do Norte \n",
            "Thiago Sebastião Reis Contarato – Universidade \n",
            "Federal do Rio de Janeiro \n",
            "Tiago Silveira Machado – Universidade de \n",
            "Pernambuco \n",
            "Virgínia Maia de Araújo Oliveira – Instituto \n",
            "Federal da Paraíba' metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 4}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Indexação dos chunks em um banco de dados vetorial\n",
        "O código abaixo cria um banco de dados de \"embeddings\" de texto, que são representações numéricas do significado de cada pedaço do texto original.\n",
        "\n",
        "**Passo a passo:**\n",
        "\n",
        "1. **Importa ferramentas:** importa funções para gerar embeddings e criar um banco de dados.\n",
        "2. **Define a função de embedding:** escolhe um modelo pré-treinado (`intfloat/multilingual-e5-large`) para transformar texto em vetores numéricos.\n",
        "3. **Cria o banco de dados:** usa a biblioteca FAISS para criar um banco de dados que armazena os embeddings de cada chunk do texto, gerados pela função `embedding_function`.\n",
        "\n",
        "O código gera um banco de dados `db` que permite buscar pedaços de texto com base em seu significado, usando a similaridade entre seus embeddings. Isso é útil para, por exemplo, encontrar as partes do texto mais relevantes para responder a uma pergunta específica."
      ],
      "metadata": {
        "id": "yfzmAtJ2bfA1"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_community.embeddings.sentence_transformer import (\n",
        "    SentenceTransformerEmbeddings,\n",
        ")\n",
        "# 1. Estamos importando uma ferramenta chamada 'SentenceTransformerEmbeddings' da biblioteca 'langchain_community'.\n",
        "# Ela é usada para converter textos em vetores (números) que representam o significado de uma frase.\n",
        "# Isso é útil para que o computador possa entender e comparar o significado dos textos, usando uma técnica chamada \"embeddings\".\n",
        "\n",
        "from langchain_community.vectorstores import FAISS\n",
        "# 2. Aqui estamos importando uma ferramenta chamada 'FAISS', que é um tipo de banco de dados especializado em encontrar e organizar vetores de forma eficiente.\n",
        "# Ele nos ajuda a armazenar esses vetores e realizar buscas rápidas com base no significado dos textos.\n",
        "import torch\n",
        "\n",
        "embedding_function = SentenceTransformerEmbeddings(\n",
        "    model_name=\"intfloat/multilingual-e5-large\",\n",
        "    model_kwargs={\"device\": \"cuda\" if torch.cuda.is_available() else \"cpu\"}\n",
        ")\n",
        "# 3. Nesta linha, estamos criando a \"ferramenta\" que vai converter o texto em vetores.\n",
        "# Estamos usando o modelo \"intfloat/multilingual-e5-large\", que é capaz de transformar textos em diversos idiomas em vetores.\n",
        "# O 'embedding_function' é a função que vamos usar para transformar os textos em representações numéricas (embeddings).\n",
        "\n",
        "db = FAISS.from_documents(splits, embedding_function)\n",
        "# 4. Aqui estamos criando um banco de dados ('db') utilizando o FAISS, que vai armazenar os vetores (embeddings) gerados a partir dos textos.\n",
        "# O método 'from_documents' pega os fragmentos de texto (divididos antes em 'splits') e os converte em vetores usando a 'embedding_function' definida acima.\n",
        "# Com esse banco de dados, poderemos realizar buscas por similaridade entre textos, comparando o significado entre eles de maneira eficiente."
      ],
      "metadata": {
        "id": "F847t_XzaVDh",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 531,
          "referenced_widgets": [
            "e5e18bc3c3c342c9ac8a526877b4cb1e",
            "a7cade8268d64542a94de9792905ddc8",
            "281bc1a8b7484e3592a2ac97ce7bdf7e",
            "ca6c6f66dfb24b66923f40c4f39c7108",
            "7fd4d002083342fd9382ec0df9035b43",
            "361053b11a9a4325b14a66b80bf73b05",
            "138af7168445426aa0bdb435e2af4412",
            "59f932776e174d8f8c86d5fdc6f40ff9",
            "7a33e2a643344b9d854100b5afd7184e",
            "b65a8d002e324579a368b7f68fe63118",
            "9b9153a71c4e4322a8d7953a7b8700d8",
            "d62b1428700d44549f63aeee7c469106",
            "8c133b2ebc604b8ea7a5c3847242e322",
            "6daeb6dd3ca64b8085e8567c5c397ec5",
            "db7ba887252d49099dfb0bc0d16745ae",
            "3f4091ce899c429a8c53d61bf21cb4f8",
            "2a81c7960ee046dfa0676c6da2c8357c",
            "3ce42a028ce6468fb5cf73a5c9a6f2bb",
            "111ea3c615af477c8094acc3f55db7fc",
            "08f2d0a62982492ab522c48a00055856",
            "82fb7ff841c045f0aaf0f753d0114ba4",
            "00f1622f2c384c2d9c28346483878517",
            "d9e2f639c1504a30ace4c0e84a96e1d0",
            "c8dfc30aa446481a91284b1c12d6da12",
            "4eb812fb9f424ec690ac1563427e9920",
            "afddec816feb4a1d9ac22d041ccde51e",
            "f063908caecf481c9cc3b9766cdeec36",
            "8b0f8aed0022447593c4e59cc83f8ca7",
            "cb4e713b5990447795571c636dd7b233",
            "eab001fb2b0c4d3c90c0b17ff4d49b8b",
            "288500fc3c084b01ae37d2b408d9185e",
            "0c3769ad37064d5880776a8192613b26",
            "def3e4acfbe54552a42feafd0120f205",
            "4ac3682ec65d4d88b16e533c3179e224",
            "953331cd82994165917122dd2d02a1fa",
            "2a86bf38c07c431092e33e83febeb90c",
            "94ac5f53dbd94841abec19682c82572d",
            "e901b4086d1c4aa1ba2b24bec32ef5b8",
            "be22d9039e2842a0b4f185a41b0921d7",
            "1813879d6a824e2fb52a33115a1d9ccb",
            "f01687b60f534708bfc385613205b6ce",
            "a71d436b8f014da09e2bf3dab900d93d",
            "22eae06327254c81ae0c2ab666e5fe2e",
            "75c1e26c267a4c82af27a2d0f5e1b09b",
            "d1132cc70a3646bcb24daeaf7775d58f",
            "a28450a8c3064563a389b2420f290734",
            "9447ec42ea124fd0833527926c8e70b7",
            "8e3b7c92d542455f81a8241620a004e1",
            "7da065cef452466abc0e83e5b928bb07",
            "8472001b54934d6c957e413235641d99",
            "7327144ecc764a718011a44f1f2c7876",
            "1ae015a8247a486ba807ef12356202e0",
            "287118b1b93f4f41b6643eca640c9b92",
            "17b72cf6fb2b49eda0c0891a29afdc88",
            "06ec303a55be4842b2677eb0ada48100",
            "dac87753fe914aaa828acc15bc364488",
            "a51d6b10bd4f4474b3c05f26a3509d83",
            "f543a12a7211442694d3018d9840bee7",
            "5531b87614844432932c791100b9255d",
            "2884a5d1915e4a18afd894ab44a4f959",
            "0db8ed74a3434ff9ae5a512fe056fc18",
            "2b7c0a9cb34f4540b91cec3c70259898",
            "b60e227205f442bbbafb6d9750aba76f",
            "21a862f67c524ad2b10abfb13db8cd95",
            "3057d156645f4d3a979ab007db8b19c2",
            "40dec4b166fb430ab15f0d6f76d0569b",
            "37c79270654d4488b8c236a00684650c",
            "d4ea104c47d94346801c093c4c1e1ea4",
            "8bd4df566cc2438d938bcede86d0687c",
            "7996f15a9cd043de8c17ffe02f472d1b",
            "b78f5a9b5b684937b7f09dfc0ec8e906",
            "af6f38a8fe4e4a15b8f91d19e2f33a2f",
            "b23d752510124d0d8ed484a001590c3b",
            "67a447e8e1d049a6b8968e6205e0f564",
            "fb8313f5c91947748736569daff407bb",
            "b850cd17e56441348a0066b6dd6ec690",
            "9b4da66e9da44b4b982ea84fa1230cb7",
            "2357f1d3a3d34e62a19935b39e9d809f",
            "87e332bb8df14003a9cad342f54e7c8b",
            "644eaf75f5cd45a5b67ced0d6fcc981b",
            "60bc9d2d983c4a74bfa9f377b93c08fe",
            "93aaaf002a55440e83902584d0a04ba1",
            "6080604458874e708b6740a0cd6d7304",
            "dcefc9162874485c8d671b3b576b43a3",
            "ed3284d9f10946759a022544c2526f26",
            "b46fa33afb424b3889c0e18cfea87989",
            "1634cd9114fb41a6b9cfbcb4d72f7de9",
            "6e3be71b15084b78ae74b30f9cd2527b",
            "29efe5b446514c36b8807978f2754df8",
            "5bbc37fa54d947768c8f7b5bfa438121",
            "2d1479239a5748c89268a122bce23377",
            "5d17de7b3a794587a964ac674cff0740",
            "41da561fe83f426991b48af3cd79e464",
            "c0cb300f8d0f4702956762185b7874c7",
            "6b70e3ebe64d482a9399a57dca01a9b9",
            "c51d690ac08f4c05885ae115391128f2",
            "b54a4c64366b4bcfadb4887a68d52674",
            "be06da1080444ce88ba941c885012f83",
            "19a69851e2f74a3a94c877cde1a03962",
            "a513b0301e964553a535b3c089c386cb",
            "370b23730d6c43ac80830a85a9317db9",
            "1d83c9e8262f4adfb04c2e7dc34ab788",
            "3bd3802355f0455eba3009d46f877697",
            "95749b352d60458d8d206e3ca682913f",
            "eaeedd1cb8904539a1c8edc61a93d5af",
            "75a146adda24480e8dbdd2cd47c26326",
            "58f738534fb74bfebdf999151cfd9cb2",
            "f73816581b074b5bae1c552501df851c",
            "c8fb111764be4e3187d8b794d117402e",
            "5f9d65071876428ab508e0069db07c79"
          ]
        },
        "outputId": "e73468c5-ad36-452a-bf6b-122640c372b2"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/tmp/ipython-input-2927026958.py:13: LangChainDeprecationWarning: The class `HuggingFaceEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFaceEmbeddings``.\n",
            "  embedding_function = SentenceTransformerEmbeddings(\n",
            "/usr/local/lib/python3.12/dist-packages/sentence_transformers/cross_encoder/CrossEncoder.py:13: TqdmExperimentalWarning: Using `tqdm.autonotebook.tqdm` in notebook mode. Use `tqdm.tqdm` instead to force console mode (e.g. in jupyter console)\n",
            "  from tqdm.autonotebook import tqdm, trange\n",
            "/usr/local/lib/python3.12/dist-packages/huggingface_hub/utils/_auth.py:94: UserWarning: \n",
            "The secret `HF_TOKEN` does not exist in your Colab secrets.\n",
            "To authenticate with the Hugging Face Hub, create a token in your settings tab (https://huggingface.co/settings/tokens), set it as secret in your Google Colab and restart your session.\n",
            "You will be able to reuse this secret in all of your notebooks.\n",
            "Please note that authentication is recommended but still optional to access public models or datasets.\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "modules.json:   0%|          | 0.00/387 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e5e18bc3c3c342c9ac8a526877b4cb1e"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "README.md: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "d62b1428700d44549f63aeee7c469106"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "sentence_bert_config.json:   0%|          | 0.00/57.0 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "d9e2f639c1504a30ace4c0e84a96e1d0"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "config.json:   0%|          | 0.00/690 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "4ac3682ec65d4d88b16e533c3179e224"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model.safetensors:   0%|          | 0.00/2.24G [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "d1132cc70a3646bcb24daeaf7775d58f"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/418 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "dac87753fe914aaa828acc15bc364488"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "sentencepiece.bpe.model:   0%|          | 0.00/5.07M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "37c79270654d4488b8c236a00684650c"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/17.1M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "2357f1d3a3d34e62a19935b39e9d809f"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "special_tokens_map.json:   0%|          | 0.00/280 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "29efe5b446514c36b8807978f2754df8"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "config.json:   0%|          | 0.00/201 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "a513b0301e964553a535b3c089c386cb"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Sobre embeddings e armazenamento vetorial\n",
        "\n",
        "Neste trecho de código, utilizamos um modelo de *embeddings* para transformar textos em vetores numéricos, chamados *embeddings*. Esses vetores representam o significado das frases de uma forma que o computador pode entender e comparar.\n",
        "\n",
        "O modelo utilizado, `\"intfloat/multilingual-e5-large\"`, é um exemplo de modelo robusto e multilíngue, capaz de gerar embeddings de alta qualidade para textos em vários idiomas. Existem diversos outros modelos de embeddings, como os da família BERT, RoBERTa e os próprios `sentence-transformers`, cada um com suas características e indicações de uso.\n",
        "\n",
        "Depois de gerar os embeddings, armazenamos esses vetores em um banco de dados vetorial eficiente, como o FAISS. Isso permite que possamos buscar rapidamente textos semelhantes, comparando o significado das consultas com os textos armazenados.\n",
        "\n",
        "Em resumo, a combinação de modelos de embeddings com bancos vetoriais permite que sistemas de NLP entendam, comparem e encontrem textos relevantes de maneira muito eficiente e escalável.\n"
      ],
      "metadata": {
        "id": "3MpLsFgY-WJt"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Configuração do Retriever do RAG\n",
        "\n",
        "Nesta linha, estamos transformando o banco de dados FAISS ('db') em uma ferramenta chamada \"retriever\".\n",
        "Um \"retriever\" é usado para buscar informações relevantes dentro do banco de dados. Ele vai procurar por fragmentos de texto no banco de dados que sejam os mais parecidos com a consulta que for feita. Isso permite que a gente recupere os textos mais relevantes ou similares a partir dos embeddings (vetores) armazenados."
      ],
      "metadata": {
        "id": "JqiqotjqbqBz"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "retriever = db.as_retriever()"
      ],
      "metadata": {
        "id": "IeT7vfC2fRkD"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Pipeline do RAG\n",
        "\n",
        "O trecho de código abaixo define e executa uma cadeia RetrievalQA para responder a perguntas de usuários com base em um conjunto de documentos, com foco em um contexto de serviços hospitalares.\n",
        "\n",
        "O código cria um sistema de perguntas e respostas que recupera informações relevantes de um conjunto de documentos (indexados usando embeddings e um banco de dados vetorial como Faiss) e as usa para responder a perguntas de usuários. A prompt instrui o modelo de linguagem a adotar uma persona profissional de hospital, garantindo que as respostas sejam adequadas ao contexto. O resultado final é a resposta à pergunta do usuário, gerada com base no contexto recuperado e formatada de acordo com o template da prompt.\n",
        "\n",
        "**1. Definindo o template da prompt:**\n",
        "\n",
        "- `template`: Define um template de prompt em formato de string. Ele instrui o modelo de linguagem a se comportar como um assistente profissional de hospital e a usar o contexto fornecido para responder à pergunta do usuário.\n",
        "- `QA_CHAIN_PROMPT`: Cria um objeto `PromptTemplate` usando a string `template` e especificando que as variáveis `context` (contexto) e `question` (pergunta) serão inseridas no template posteriormente.\n",
        "   - A variável `context` será preenchida com os trechos recuperados do banco de dados.\n",
        "   - A variável `question` será preenchida com a pergunta do usuário.\n",
        "\n"
      ],
      "metadata": {
        "id": "nMPoiqu2oD2e"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain.chains import RetrievalQA\n",
        "from langchain.prompts import PromptTemplate\n",
        "\n",
        "# 1. Defina o template do prompt\n",
        "template = \"\"\"Atue com a personalidade de um assistente profissional especializado em tarefas de resposta a perguntas relacionadas a serviços hospitalares.\n",
        "\n",
        "Use os seguintes pedaços de contexto para responder à pergunta do usuário.\n",
        "Se você não souber a resposta, diga apenas que não tem informações suficientes para responder.\n",
        "\n",
        "Contexto: {context}\n",
        "Pergunta: {question}\"\"\"\n",
        "\n",
        "\n",
        "QA_CHAIN_PROMPT = PromptTemplate(\n",
        "    input_variables=[\"context\", \"question\"], template=template\n",
        ")\n"
      ],
      "metadata": {
        "id": "tKEWl3sEoFUj"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "**2. Criando a cadeia RetrievalQA:**\n",
        "\n",
        "- `qa_chain`: Cria a cadeia `RetrievalQA` usando:\n",
        "    - `GROQ_LLM`: modelo de linguagem grande (LLM) pré-definido. Esta variável foi criada previamente.\n",
        "    - `chain_type=\"stuff\"`: especifica o tipo de cadeia como \"stuff\", o que significa que todo o contexto recuperado será inserido diretamente na prompt.\n",
        "    - `retriever`: objeto retriever, criado anteriormente, responsável por buscar documentos relevantes do conjunto de dados com base na pergunta do usuário.\n",
        "    - `return_source_documents=True`: conjunto de passos (chain) que deve retornar os documentos de origem usados para gerar a resposta.\n",
        "    - `chain_type_kwargs={\"prompt\": QA_CHAIN_PROMPT}`: template da prompt definido anteriormente para a cadeia."
      ],
      "metadata": {
        "id": "r0G_ktBUrNY2"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# 2. Crie a cadeia RetrievalQA usando o retriever, o modelo de linguagem e o prompt\n",
        "qa_chain = RetrievalQA.from_chain_type(\n",
        "    llm=GROQ_LLM,\n",
        "    chain_type=\"stuff\",\n",
        "    retriever=retriever,\n",
        "    return_source_documents=True,\n",
        "    chain_type_kwargs={\"prompt\": QA_CHAIN_PROMPT},\n",
        ")"
      ],
      "metadata": {
        "id": "vxUUEi9IrM5w"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "**3. Pergunta do usuário e execução da cadeia:**\n",
        "\n",
        "- `query`: define a pergunta do usuário como uma string.\n",
        "- `result`: executa a cadeia `qa_chain` com a pergunta do usuário e extrai a resposta do resultado.\n",
        "- `print(result)`: imprime a resposta gerada pela cadeia."
      ],
      "metadata": {
        "id": "L8SVOae1rWKp"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# 3. Pergunta do usuário\n",
        "query = \"Como usar um desfibrilador em situações de emergência?\"\n",
        "\n",
        "# 3. Função para interagir com o usuário e obter respostas\n",
        "result = qa_chain({\"query\": query})[\"result\"]\n",
        "\n",
        "print(result)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2Iv96CPBrV1h",
        "outputId": "cd1b9e19-6959-4c8f-fc44-67161a7a201b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/tmp/ipython-input-3518441049.py:5: LangChainDeprecationWarning: The method `Chain.__call__` was deprecated in langchain 0.1.0 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
            "  result = qa_chain({\"query\": query})[\"result\"]\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Um desafio importante! Como assistente profissional, vou fornecer as instruções mais precisas para usar um desfibrilador em situações de emergência.\n",
            "\n",
            "**Preparação**\n",
            "\n",
            "1. Certifique-se de que o desfibrilador esteja funcionando corretamente e que os eletrodos estejam limpos e secos.\n",
            "2. Encontre um local seguro e estável para a vítima, com superfície rígida e sem obstáculos.\n",
            "3. Verifique se a vítima está em parada cardíaca (PCR) e se os sinais vitais estão ausentes.\n",
            "\n",
            "**Realização da Desfibrilação**\n",
            "\n",
            "1. Coloque os eletrodos na posição tradicional recomendada:\n",
            " * Um eletrodo na região apical (no centro do tórax, no lado esquerdo).\n",
            " * Outro eletrodo na região infraclavicular direita (abaixo da clavícula, no lado direito).\n",
            "2. Ative o desfibrilador e siga as instruções do aparelho.\n",
            "3. A carga recomendada depende do tipo de desfibrilador e do fabricante do aparelho. No caso de um desfibrilador monofásico, a carga recomendada é de 360J. Para um desfibrilador bifásico, use a carga preconizada pelo fabricante, geralmente entre 120-200J. Se houver dúvida, use 200J.\n",
            "4. Após a desfibrilação, recomece o ciclo de RCP (resuscitação cardíaca) imediatamente.\n",
            "\n",
            "**Importante**\n",
            "\n",
            "* A desfibrilação deve ser realizada apenas quando indicada e sempre que possível.\n",
            "* O desfibrilador pode identificar se o ritmo é \"chocável\" ou não.\n",
            "* A frequência das compressões torácicas deve ser de 100/120 por minuto.\n",
            "* Minimizar as interrupções nas compressões é fundamental.\n",
            "\n",
            "Lembre-se de que a desfibrilação é apenas um componente do tratamento de emergência e que a vítima deve ser encaminhada a um hospital o mais rápido possível após a realização da desfibrilação.\n",
            "\n",
            "Espero que essas instruções sejam úteis. Se você tiver alguma dúvida ou precisar de mais informações, não hesite em perguntar.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Aqui é possível ver que a resposta foi muito boa e parece ter tido um bom embasamento, o que de fato aconteceu. Quando executamos a `qa_chain`, o pipeline de RAG foi acionado: a consulta feita pelo usuário (\"Como usar um desfibrilador em situações de emergência?\") foi processada, os chunks de texto mais relevantes foram recuperados do banco vetorial e, em seguida, o modelo de linguagem gerou uma resposta com base nessas informações.\n",
        "\n",
        "Esse fluxo garante que a resposta apresentada seja fundamentada no conteúdo real do PDF carregado, e não apenas em conhecimento prévio do modelo. Assim, o sistema utiliza o contexto e as informações mais atualizadas presentes no documento, proporcionando respostas mais precisas e confiáveis para perguntas específicas.\n",
        "\n",
        "Vamos testar novamente esse sistema"
      ],
      "metadata": {
        "id": "0yEVpq8-jyrb"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# 3. Pergunta do usuário\n",
        "query = \"O que fazer depois de usar um desfibrilador em situações de emergência?\"\n",
        "\n",
        "# 3. Função para interagir com o usuário e obter respostas\n",
        "result = qa_chain({\"query\": query})\n",
        "\n",
        "print(result[\"result\"])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "hJuQKybZ_6Vz",
        "outputId": "2c0ca48d-cd8e-4f1e-e4bf-2bf882dabe9d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Excelente pergunta!\n",
            "\n",
            "Depois de usar um desfibrilador em situações de emergência, é fundamental que você siga os passos abaixo:\n",
            "\n",
            "1. **Ressuscitação Cardiopulmonar (RCP)**: Logo após a realização do choque, é recomendado recomeçar um novo ciclo de RCP. Isso é feito para garantir que a vítima continue a receber suporte de vida adequado.\n",
            "2. **Verificar o ritmo**: Após o novo ciclo de RCP, é importante verificar o ritmo da vítima novamente. Isso ajudará a determinar se o desfibrilador foi eficaz ou se é necessário realizar outro choque.\n",
            "3. **Continuar com o suporte de vida avançado (SAV)**: Se a vítima estiver em parada cardiorrespiratória, é importante continuar com o SAV, que inclui medidas como intubação orotraqueal, medicações e cuidados necessários.\n",
            "4. **Chamar reforço médico**: Com a chegada do Serviço de Atendimento Móvel de Urgência (SAMU) ou da equipe médica, é importante relatar o que foi feito e as medidas tomadas até então.\n",
            "\n",
            "Lembre-se de que a desfibrilação é apenas um passo no processo de ressuscitação cardiopulmonar. É fundamental continuar com o suporte de vida avançado e a verificação do ritmo até que a vítima seja estabilizada ou transferida para um ambiente de cuidado médico adequado.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Durante a análise da resposta gerada, é possível notar que o modelo até citou o SAMU (Serviço de Atendimento Móvel de Urgência) em sua explicação. Mas surge uma dúvida interessante: será que essa referência ao SAMU veio do conhecimento interno do modelo de linguagem, adquirido durante seu treinamento, ou foi baseada nos conteúdos dos documentos recuperados pelo pipeline RAG?\n",
        "\n",
        "Para descobrir isso, podemos investigar os documentos ou chunks de texto que foram efetivamente retornados pelo mecanismo de busca antes da geração da resposta. Essa verificação nos permite entender melhor se o modelo está realmente utilizando as informações do PDF carregado ou se está apenas se apoiando em conhecimentos prévios.\n",
        "\n",
        "A seguir, vamos examinar os trechos dos documentos que foram recuperados e utilizados como contexto para a geração da resposta.\n"
      ],
      "metadata": {
        "id": "WLbXm02ykqCz"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "result['source_documents']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "P3kl7vaVaWRF",
        "outputId": "703d448b-b85a-47b9-c71d-335ff92fb400"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 13}, page_content='forma automática, indicando ou não a desfibrilação, contribuindo para aumento das chances de \\nsobrevivência da vítima. A posição tradicional recomendada dos eletrodos é um na região apical \\ne outro na região infraclavicular direita. A carga recomendada depende do cardiodesfibrilador, \\nsendo indicado 360J no monofásico. Já no bifásico, a preferência é pela carga preconizada pelo \\nfabricante do aparelho, geralmente entre 120 -200 J, mas se dúvida, utilize 200J. Logo após a \\nrealização do choque, é recomendado recomeçar novo ciclo de RCP, para posteriormente ser \\nchecado o ritmo⁵,⁸. \\nBOX 3. APÓS A CHEGADA DA EQUIPE MÉDICA, QUE MEDIDAS DE SUPORTE MAIS \\nAVANÇADAS PODEM SER TOMADAS? \\nCom a chegada do Serviço de Atendimento Móvel de Urgência (SAMU), foram \\nrealizadas intubação orotraqueal, medicações e cuidados necessários condizentes com o \\nsuporte de vida avançado (SAV). \\nA vítima foi encaminhada para um hospital secundário, dando entrada inconsciente,'),\n",
              " Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 232}, page_content='4. Como devemos classificar um paciente com ICA de acordo com os perfis hemodinâmicos? \\n5. Qual deve ser a conduta do médico na emergência de acordo com a classificação do \\npaciente?'),\n",
              " Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 13}, page_content='13 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\nfeita sem proteção (boca a boca ou boca nariz) ou com proteção (uso de dispositivos e válvulas, \\ntais como dispositivos com válvula unidirecional, máscaras ou bolsa-máscara)⁵,⁸. \\n2.4. D (DEFIBRILLATION – DESFIBRILAÇÃO) \\nEste procedimento pode ser realizado assim que possível, quando corretamente \\nindicado, ou seja, na presença de ritmos de parada “chocáveis” (Taquicardia Ventricular s/ \\npulso e Fibrilação Ventricular). Existe o cardiodesfibrilador manual, utilizado em ambie nte \\nintra-hospitalar, e o Desfibrilador Externo Automático (DEA), que pode ser utilizado por leigos \\nem ambiente extra -hospitalar, já que identifica se o ritmo é “chocável” ou “não -chocável” de \\nforma automática, indicando ou não a desfibrilação, contribuindo para aumento das chances de \\nsobrevivência da vítima. A posição tradicional recomendada dos eletrodos é um na região apical'),\n",
              " Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 11}, page_content='realizada por pessoas leigas minimamente treinadas para tal, com auxílio dos Desfibriladores \\nExternos Automáticos (DEA)⁵,⁸. \\nA partir disso, podem ser iniciadas  as manobras de SBV, que consistem em quatro \\npilares, sendo representadas por meio de letras: C (ciculation), A (airway), B (Breathing) e D')]"
            ]
          },
          "metadata": {},
          "execution_count": 14
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Com o código acima, podemos visualizar todos os documentos (chunks) que foram retornados do banco vetorial para o modelo durante o processo de geração da resposta. Isso nos permite analisar exatamente quais trechos do PDF serviram de base para a construção da resposta final.\n",
        "\n",
        "Ao examinar esses chunks, é possível identificar um deles citando explicitamente o SAMU (Serviço de Atendimento Móvel de Urgência). Isso indica que a menção ao SAMU feita pelo modelo não foi resultado apenas do seu conhecimento prévio, mas sim de informações reais presentes nos documentos recuperados pelo pipeline RAG.\n",
        "\n",
        "Essa transparência é um dos grandes diferenciais dos sistemas RAG: conseguimos rastrear o caminho da informação e entender quais partes do documento fundamentaram cada resposta, garantindo maior confiança e precisão na utilização de dados contextuais.\n"
      ],
      "metadata": {
        "id": "B-GjXgxQlJr2"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Arquiteturas de RAG\n",
        "\n",
        "\n",
        "As arquiteturas de RAG variam em complexidade e refinamento do fluxo de dados:\n",
        "\n",
        "**Naive RAG:** É a forma mais simples e linear. Os documentos são indexados em vetores; ao receber uma consulta, recupera-se os trechos mais relevantes e simplesmente concatena-se esses trechos à pergunta, criando um único prompt para o LLM. Não há refinamentos intermediários – o LLM gera a resposta com base nessa concatenação direta. **É o método que aplicamos até agora**\n",
        "\n",
        "**Advanced RAG (Map-Reduce)**: Adiciona etapas de pós-processamento. Após a recuperação inicial de trechos, aplica-se re-ranking, sumarização ou fusão de documentos para melhorar a relevância antes de criar o prompt. Na prática, a cadeia “map-reduce” (mapear e reduzir) faz com que o LLM processe cada documento separadamente (map) e então combine os resultados (reduce), gerando respostas mais coerentes.\n",
        "\n",
        "**Modular RAG (Refine)**: A abordagem mais flexível. Trata cada etapa (busca, reranqueamento, reescrita, geração, etc.) como módulos independentes que podem ser encadeados. Em LangChain, o tipo “refine” executa o LLM iterativamente: primeiro gera uma resposta inicial com alguns trechos, depois “refina” essa resposta incluindo trechos adicionais, permitindo aprimoramentos passo a passo."
      ],
      "metadata": {
        "id": "0Uc3TRp9pXY6"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## **Advanced RAG (Map-Reduce)**\n",
        "A arquitetura avançada implementa o fluxo map-reduce. Na prática, isso significa que o LLM processa cada documento recuperado separadamente (“map”) e depois combina essas respostas parciais (“reduce”). No LangChain, utilizamos chain_type=\"map_reduce\". O chain map-reduce normalmente chama o LLM para sumarizar cada trecho ou responder à pergunta com base em cada trecho individual, e então pede ao LLM para unificar (reduzir) essas respostas em uma única resposta final."
      ],
      "metadata": {
        "id": "yQK1ATh7p5kA"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "chain_map = RetrievalQA.from_chain_type(llm=GROQ_LLM, chain_type=\"map_reduce\", retriever=retriever)\n",
        "\n",
        "response_map = chain_map.run(query)\n",
        "print(\"\\nResposta (Advanced RAG / Map-Reduce):\")\n",
        "print(response_map)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 562,
          "referenced_widgets": [
            "3a85d8e5fdc542b5806a6bd3e42673ff",
            "140a9f69445144f1aa42f6d8edceaa3b",
            "c0d347d4845142ec9cd2062eb024b3dc",
            "0ef6d67809fa45bb8b2436bc730ac77d",
            "8a1730e7909243a9b6482064c0c7298b",
            "d33a78d43c944cd6bc8a92a1b6866d95",
            "84c041404d5249608d44787e8d6c9262",
            "2d66f952b7044fabab57881ff2348fe4",
            "f03fe4e8eddc48beb5fe92d214280796",
            "03f5897da53e461ab0d360ef2ed57cb9",
            "5c2cddd38a864a88bcecaf3652babf4b",
            "b8d265c0257740dea15aac3604482a49",
            "a35fbeec89ca4b24be0590fa5c6eb775",
            "0f50f84a32054e9c8fcad17b68ff3632",
            "15cb6fc965824d0aa415deb6307c87e3",
            "a4952b408bdf46868eb354ced86fadb3",
            "ec9795c97bc0424b94492b250089ca4b",
            "64a902ab1def44ca8ebbecd48a3bf076",
            "e1927cdc5b3f40d790897129657af3a3",
            "78f01eb3b57240fe852d88217a859bb1",
            "62e35e60685e47ecaaf3765a3590216d",
            "87d6cf7ee6ef4d978c7d30d72708d07f",
            "db7d238611324b77bc513c1a272b4aa5",
            "63b0d43847da48608fed65c4c81793fe",
            "737f6fa768334399a19742e74d199886",
            "b22d708fa0054715bb7753795835e6c4",
            "fd0092ce70384e5b80a128a836cb55d5",
            "1583d626b3be4d299706dfdc3db843a0",
            "940d4d47b6474b699159173e463ab981",
            "181bbe09ffaf436ba5da797f0aad9cb0",
            "d0fa2d1fe49c4fe5ae4a6aa308767517",
            "f5da3252ddd24c2797e3d1069165df16",
            "74fb56bf6c1049c4aeb8cf832fc0aaa4",
            "ea09c9e86b5540ef96922b2c1f99b3e5",
            "237ddf96de6143b797e41b106d748b64",
            "251121e47cf1476985510a284de27caa",
            "6b98c9c771c74dad970e692c47bcbd0f",
            "d58761d9d1a34620979de45d8acfb9e3",
            "ab61c374546d4dc3a0b534ae708978b1",
            "da724e546d824aceb7d720ab5e2e4522",
            "aed0fd62700544f587c83e487ce32a59",
            "4f3e186082c14f7287d2226c46f9bd3f",
            "4d9637eb035f4154a5c1b9eb239a0e87",
            "994d09fd19f043b09de3a875979691ce",
            "72624c3c40184374ba0d6a00c4c1de62",
            "f9626bd94c294ca3b345e28d82431a05",
            "4040bf1216a54d269f0ab1e130e35f8a",
            "a4e4f401cb0244da84a99b70a0f53809",
            "348f078088de410d92b4104990e40cad",
            "06c09dde66d04e2db00b760e2267f491",
            "6f30b76c710b4572a19b876bbe7fad29",
            "7c387791a7024a398845ad3ebc20365f",
            "12611016611f413e851893d0cec5993a",
            "5ad47d875eac4c189508fc1e923a844c",
            "8546a84bfefb41ada2a82ee8a1a3e6a6"
          ]
        },
        "id": "iT41w74Lp2B4",
        "outputId": "2a227dda-3ef7-4a6f-f58f-8bd36c189db4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/tmp/ipython-input-2423667180.py:3: LangChainDeprecationWarning: The method `Chain.run` was deprecated in langchain 0.1.0 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
            "  response_map = chain_map.run(query)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/26.0 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "3a85d8e5fdc542b5806a6bd3e42673ff"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "vocab.json:   0%|          | 0.00/1.04M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "b8d265c0257740dea15aac3604482a49"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "merges.txt:   0%|          | 0.00/456k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "db7d238611324b77bc513c1a272b4aa5"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/1.36M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "ea09c9e86b5540ef96922b2c1f99b3e5"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "config.json:   0%|          | 0.00/665 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "72624c3c40184374ba0d6a00c4c1de62"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Token indices sequence length is longer than the specified maximum sequence length for this model (1183 > 1024). Running this sequence through the model will result in indexing errors\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Resposta (Advanced RAG / Map-Reduce):\n",
            "Após usar um desfibrilador em situações de emergência, é recomendado seguir as seguintes etapas:\n",
            "\n",
            "1. Verifique se a vítima está respirando e tem pulso. Se não estiver, inicie a Ressuscitação Cardiopulmonar (RCP).\n",
            "2. Continue a RCP até que a vítima comece a respirar e ter pulso espontâneo.\n",
            "3. Se a vítima estiver consciente e respirando normalmente, você pode parar a RCP.\n",
            "4. Contate os serviços de emergência locais (como o 192, por exemplo) para informar que você usou um desfibrilador e que a vítima está em uma situação de emergência.\n",
            "5. Se a vítima estiver em um ambiente hospitalar, você deve informar os profissionais de saúde sobre o uso do desfibrilador e a situação atual da vítima.\n",
            "\n",
            "Além disso, você pode seguir a sequência de ação ABCD (Airway, Breathing, Circulation, Disposition), que é uma sequência de manobras de suporte básico à vida recomendada pela American Heart Association (AHA) e outras organizações de saúde:\n",
            "\n",
            "- C: Verifique a circulação (circulação) - verifique se o coração está batendo e se há sinal de vida.\n",
            "- A: Abra a via aérea (airway) - verifique se a pessoa está respirando e se a via aérea está aberta.\n",
            "- B: Veja se a pessoa está respirando (breathing) - verifique se a pessoa está inspirando e expirando ar.\n",
            "- D: Disponha a pessoa para o transporte (disposition) - prepare a pessoa para ser transportada para um local de atendimento médico.\n",
            "\n",
            "Lembre-se de que essas são apenas sugestões e que a melhor abordagem depende da situação específica e do treinamento recebido. Se você não é um profissional de saúde, é sempre recomendável chamar ajuda médica o mais rapidamente possível.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Nesta abordagem, cada trecho contribui para uma sub-resposta que será posteriormente mesclada. Isso tende a produzir respostas mais coerentes quando a informação está espalhada em vários documentos, pois o modelo combina explicitamente as evidências antes de responder."
      ],
      "metadata": {
        "id": "eG5p0iOhqMUx"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## **Modular RAG (Refine)**\n",
        "A arquitetura modular (Refine) de RAG permite múltiplas etapas de refinamento. Usamos chain_type=\"refine\", que funciona assim: primeiro o LLM gera uma resposta inicial com base no primeiro conjunto de trechos; em seguida, para cada trecho adicional, o modelo refina a resposta existente incluindo o novo contexto. Isso cria uma cadeia iterativa de melhorias. É especialmente útil para integrações dinâmicas ou quando queremos controlar passo a passo a incorporação de informações."
      ],
      "metadata": {
        "id": "Qy84Nqo1qNF0"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Configura o chain Refine\n",
        "chain_refine = RetrievalQA.from_chain_type(llm=GROQ_LLM, chain_type=\"refine\", retriever=retriever)\n",
        "\n",
        "response_refine = chain_refine.run(query)\n",
        "print(\"\\nResposta (Modular RAG / Refine):\")\n",
        "print(response_refine)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "V9TPY-WGp2Em",
        "outputId": "3c1e9d2e-1044-4d66-a2d3-a1d0503a865e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Resposta (Modular RAG / Refine):\n",
            "Com o contexto adicional, posso fornecer uma resposta mais detalhada e refinada.\n",
            "\n",
            "Depois de usar um Desfibrilador Externo Automático (DEA) em situações de emergência, é recomendado continuar com as manobras de SBV (Sobrevivência Básica de Vítima), que consistem em quatro pilares:\n",
            "\n",
            "- **C (Circulação)**: Verificar o ritmo da vítima e determinar se é necessário repetir a desfibrilação.\n",
            "- **A (Airway)**: Garantir que a via aérea da vítima esteja livre e aberta, permitindo a respiração adequada.\n",
            "- **B (Respiração)**: Iniciar a respiração artificial (RCP) na vítima, seguindo os padrões recomendados (2 respirações por segundo, 10 a 12 respirações por minuto).\n",
            "- **D (Desfibrilação)**: Verificar se o ritmo da vítima é \"chocável\" e, se necessário, repetir a desfibrilação após 5 minutos de RCP.\n",
            "\n",
            "Se o DEA indicar que o ritmo é \"chocável\", é recomendado desfibrilar a vítima imediatamente. Se o ritmo for \"não chocável\", é importante continuar com as manobras de SBV, focando em garantir a circulação, a via aérea e a respiração adequada.\n",
            "\n",
            "Lembre-se de que a prioridade é a vítima e a realização de ações para tentar salvar sua vida. Se houver dúvidas, é sempre melhor errar do lado da cautela e buscar orientação profissional.\n",
            "\n",
            "A carga recomendada para o DEA depende do tipo de dispositivo e do fabricante, mas como regra geral:\n",
            "\n",
            "- Monofásico: 360J\n",
            "- Bifásico: 200J (ou a carga preconizada pelo fabricante)\n",
            "\n",
            "Além disso, é importante lembrar que a posição tradicional recomendada dos eletrodos para desfibrilação é um na região apical, um na região axilar esquerda e um na região anterior da perna esquerda. Isso ajuda a garantir a eficácia da desfibrilação e a reduzir o risco de lesões.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "O fluxo refine faz com que o LLM revise sua resposta inicial com base em informações adicionais, passo a passo. Em nosso exemplo simples, ele começa com os documentos mais relevantes e vai refinando a resposta à medida que processa mais trechos, oferecendo uma forma de “feedback” interno.\n"
      ],
      "metadata": {
        "id": "V0AWDrgTqkYU"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "# Pipeline do RAG com histórico\n",
        "\n",
        "Agora vamos adicionar o histórico da conversa para que o LLM consiga continuar a conversa com o usuário sabendo o contexto.\n"
      ],
      "metadata": {
        "id": "h_VqIWq6bwqR"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Configurando o histórico\n",
        "O código configura um chatbot que usa o histórico da conversa para entender melhor as perguntas do usuário em um contexto de serviços hospitalares, reformulando-as quando necessário e evitando marcar consultas duplicadas. Ele não responde às perguntas diretamente, apenas as prepara para serem respondidas por outro componente do sistema.\n",
        "\n",
        "**1. `contextualize_q_system_prompt`:**\n",
        "\n",
        "- É uma string que define as instruções para o chatbot.\n",
        "- Imagine como se você estivesse dando instruções para um atendente de hospital sobre como lidar com as perguntas dos pacientes.\n",
        "- **Instruções específicas:**\n",
        "    - **Reformular a pergunta:** se a pergunta do usuário se referir a algo que já foi dito antes na conversa, o chatbot deve reescrevê-la de forma independente.\n",
        "    - **Não responder:** o chatbot não deve tentar responder à pergunta, apenas reformulá-la.\n",
        "    - **Estilo formal:** o chatbot deve usar uma linguagem formal e clara, como se estivesse falando com pacientes e visitantes de um hospital.\n",
        "    - **Verificar histórico:** o chatbot deve verificar se uma consulta já foi marcada na conversa. Se sim, ele deve informar que não há disponibilidade.\n",
        "\n",
        "**2. `contextualize_q_prompt`:**\n",
        "\n",
        "- Define um modelo de prompt de chat usando a biblioteca `ChatPromptTemplate`.\n",
        "- **Componentes:**\n",
        "    - `(\"system\", contextualize_q_system_prompt)`: define a mensagem do sistema, que são as instruções que vimos acima.\n",
        "    - `MessagesPlaceholder(\"chat_history\")`: define um espaço para inserir o histórico da conversa.\n",
        "    - `(\"human\", \"\")`: define um espaço para inserir a pergunta do usuário.\n"
      ],
      "metadata": {
        "id": "vM3KJ5nJ_vHg"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# 1. Aqui estamos importando 'MessagesPlaceholder', que é uma ferramenta para \"guardar espaço\" para as mensagens anteriores do chat.\n",
        "# Isso ajuda a incluir o histórico da conversa dentro do processo, para que o sistema tenha contexto.\n",
        "from langchain_core.prompts import MessagesPlaceholder\n",
        "\n",
        "\n",
        "# 2. Aqui estamos criando um \"prompt do sistema\", que é um conjunto de instruções para o assistente virtual.\n",
        "# Esse texto orienta o assistente a reformular as perguntas que o usuário faz no chat para que fiquem claras, sem depender do histórico da conversa.\n",
        "# Além disso, o assistente deve adotar uma personalidade formal e profissional, direcionada a pacientes e visitantes de um hospital, e deve verificar se consultas já foram marcadas no histórico.\n",
        "# O assistente NÃO deve responder à pergunta, apenas reformulá-la, se necessário.\n",
        "contextualize_q_system_prompt = \"\"\"Dada a história do chat e a última pergunta do usuário, que pode referenciar o\n",
        "contexto na história do chat, reformule a pergunta de forma que possa ser entendida\n",
        "sem a necessidade da história do chat. NÃO responda à pergunta, apenas reformule-a\n",
        "se necessário e, caso contrário, retorne-a como está.\n",
        "O estilo de escrita é formal e claro, dirigido a pacientes e visitantes do hospital.\n",
        "Você deve ficar atento ao histórico do chat para determinar se uma consulta ja foi marcada, ou seja, se alguém marcou consulta antes da pessoa, você deve retornar que está indisponível.\"\"\"\n",
        "\n",
        "# 3. Nesta linha, estamos criando o 'contextualize_q_prompt', que define a estrutura do diálogo.\n",
        "# Primeiro, temos a parte \"system\" com o 'contextualize_q_system_prompt', que contém as instruções gerais para o assistente.\n",
        "# Depois, usamos 'MessagesPlaceholder' para reservar espaço para o histórico de mensagens anteriores do chat.\n",
        "# Finalmente, temos a parte \"human\", que corresponde à última entrada do usuário (\"{input}\"), que é a pergunta feita pelo usuário que precisa ser reformulada.\n",
        "# Essa estrutura completa serve para fornecer o contexto e a orientação necessários ao assistente virtual durante a interação no chat.\n",
        "contextualize_q_prompt = ChatPromptTemplate.from_messages(\n",
        "    [\n",
        "        (\"system\", contextualize_q_system_prompt),\n",
        "        MessagesPlaceholder(\"chat_history\"),\n",
        "        (\"human\", \"{input}\"),\n",
        "    ]\n",
        ")\n"
      ],
      "metadata": {
        "id": "g4QBK9vp5_z3"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Cria um objeto `history_aware_retriever` usando a função `create_history_aware_retriever`. O objetivo é criar um sistema que busca informações relevantes para responder à pergunta do usuário, levando em consideração o histórico da conversa.\n",
        "- **Componentes:**\n",
        "    - `GROQ_LLM`: LLM que será usado para entender e processar as perguntas.\n",
        "    - `retriever`: sistema de busca que encontra informações relevantes no banco de dados do hospital e vai usar para substituir o `context`.\n",
        "    - `contextualize_q_prompt`: O modelo de prompt que definimos anteriormente."
      ],
      "metadata": {
        "id": "HSIssA9F_oYM"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain.chains import create_history_aware_retriever\n",
        "\n",
        "history_aware_retriever = create_history_aware_retriever(\n",
        "    GROQ_LLM, retriever, contextualize_q_prompt\n",
        ")"
      ],
      "metadata": {
        "id": "YhR06Fje_lna"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Prompt da Perguntas e Respostas\n",
        "Este trecho de código define como um chatbot deve responder a perguntas sobre serviços hospitalares, usando informações contextuais. Vamos entender cada parte:\n",
        "\n",
        "- **qa_system_prompt:** string define as instruções para o modelo de linguagem, direcionando-o a usar o contexto fornecido para responder às perguntas de forma concisa. Se a resposta for desconhecida, o modelo é instruído a declarar isso explicitamente.\n",
        "\n",
        "- **ChatPromptTemplate.from_messages:** cria um modelo de prompt para interações de chat, integrando mensagens do sistema, histórico de chat e entrada do usuário, com espaços reservados permitindo a inserção dinâmica de conteúdo."
      ],
      "metadata": {
        "id": "aKmSc8x4Ak2g"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "### Answer question ###\n",
        "qa_system_prompt = \"\"\"Atue com a personalidade de um assistente profissional especializado em tarefas de resposta a perguntas relacionadas a serviços hospitalares.\n",
        "\n",
        "Use os seguintes pedaços de contexto para responder à pergunta do usuário.\n",
        "Se você não souber a resposta, diga apenas que não tem informações suficientes para responder.\n",
        "\n",
        "Contexto: {context}\"\"\"\n",
        "qa_prompt = ChatPromptTemplate.from_messages(\n",
        "    [\n",
        "        (\"system\", qa_system_prompt),\n",
        "        MessagesPlaceholder(\"chat_history\"),\n",
        "        (\"human\", \"{input}\"),\n",
        "    ]\n",
        ")"
      ],
      "metadata": {
        "id": "x-B72yzB59FR"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Cria uma cadeia de perguntas e respostas que combina um modelo de linguagem grande (LLM) com um prompt específico para responder perguntas com base em documentos. Vamos entender cada parte:\n",
        "\n",
        "**1. `question_answer_chain`:**\n",
        "\n",
        "- É uma variável que armazenará a cadeia de perguntas e respostas criada. Pense nisso como uma linha de produção que recebe uma pergunta e gera uma resposta.\n",
        "\n",
        "**2. `create_stuff_documents_chain`:**\n",
        "\n",
        "- É uma função que cria a cadeia de perguntas e respostas. Imagine essa função como a fábrica que monta a linha de produção.\n",
        "\n",
        "**3. `GROQ_LLM`:**\n",
        "\n",
        "- É o modelo de linguagem grande que será usado para entender e responder às perguntas.\n",
        "\n",
        "**4. `qa_prompt`:**\n",
        "\n",
        "- É o prompt que define como o modelo de linguagem deve se comportar ao responder perguntas, que já explicamos anteriormente."
      ],
      "metadata": {
        "id": "x0Uxqey2BIrs"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain.chains.combine_documents import create_stuff_documents_chain\n",
        "\n",
        "question_answer_chain = create_stuff_documents_chain(GROQ_LLM, qa_prompt)"
      ],
      "metadata": {
        "id": "AaQ41MxgAf-J"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "O código cria um sistema RAG que funciona da seguinte forma:\n",
        "\n",
        "1. O usuário faz uma pergunta.\n",
        "2. O `history_aware_retriever` busca documentos relevantes para a pergunta, considerando o histórico da conversa.\n",
        "3. Os documentos recuperados são passados para a `question_answer_chain`.\n",
        "4. A `question_answer_chain` usa o modelo de linguagem grande e o prompt para gerar a resposta final com base nos documentos."
      ],
      "metadata": {
        "id": "-3qEfqPpBS-a"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain.chains import create_retrieval_chain\n",
        "\n",
        "rag_chain = create_retrieval_chain(history_aware_retriever, question_answer_chain)"
      ],
      "metadata": {
        "id": "yBn8uyWvBDnL"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "A função `get_session_history` serve para gerenciar o histórico de conversas de diferentes sessões de chat. Ela verifica se já existe um histórico para a sessão especificada e, caso não exista, cria um novo histórico vazio. Em seguida, a função retorna o histórico da sessão, seja ele existente ou recém-criado.\n",
        "\n",
        "Essa função é importante para manter o contexto da conversa em cada sessão de chat, permitindo que o chatbot acesse as mensagens anteriores e forneça respostas mais relevantes e coerentes.\n",
        "\n",
        "Por exemplo, se um usuário fizer uma pergunta sobre um tópico que já foi discutido anteriormente na mesma sessão, o chatbot poderá usar o histórico da conversa para fornecer uma resposta mais completa e contextualizada."
      ],
      "metadata": {
        "id": "wd2YiLq8Bw-P"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_core.chat_history import BaseChatMessageHistory\n",
        "from langchain_community.chat_message_histories import ChatMessageHistory\n",
        "\n",
        "\n",
        "### Histórico do Chat ###\n",
        "store = {}\n",
        "\n",
        "def get_session_history(session_id: str) -> BaseChatMessageHistory:\n",
        "    if session_id not in store:\n",
        "        store[session_id] = ChatMessageHistory()\n",
        "    return store[session_id]"
      ],
      "metadata": {
        "id": "CUJDGIw37Ik1"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Este código transforma a cadeia RAG em uma cadeia RAG conversacional, adicionando a capacidade de gerenciar o histórico da conversa. Isso significa que o chatbot poderá:\n",
        "\n",
        "- Lembrar das perguntas e respostas anteriores na mesma sessão.\n",
        "- Usar o histórico da conversa para fornecer respostas mais contextuais e relevantes.\n",
        "- Adaptar suas respostas com base nas interações anteriores com o usuário.\n",
        "\n",
        "Por exemplo, se o usuário perguntar \"Quais são os horários de visita?\", o chatbot poderá responder com informações gerais sobre os horários de visita. Se o usuário, em seguida, perguntar \"E para a UTI?\", o chatbot poderá usar o histórico da conversa para entender que o usuário está perguntando sobre os horários de visita da UTI e fornecer uma resposta mais específica.\n",
        "\n",
        "Em outras palavras, a cadeia RAG conversacional torna o chatbot mais inteligente e capaz de manter uma conversa mais natural e fluida com o usuário, lembrando do contexto e adaptando suas respostas com base nas interações anteriores."
      ],
      "metadata": {
        "id": "LRuuKsxzCbf5"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_core.runnables.history import RunnableWithMessageHistory\n",
        "\n",
        "conversational_rag_chain = RunnableWithMessageHistory(\n",
        "    rag_chain,\n",
        "    get_session_history,\n",
        "    input_messages_key=\"input\",\n",
        "    history_messages_key=\"chat_history\",\n",
        "    output_messages_key=\"answer\",\n",
        ")"
      ],
      "metadata": {
        "id": "7FcTaJQq7FVs"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Este código envia a primeira pergunta \"Como usar um desfibrilador em situações de emergência?\" para a cadeia RAG conversacional, iniciando uma nova sessão de conversa com o ID \"gml_nlp\". A resposta do chatbot será armazenada na variável `first_question`.\n",
        "\n",
        "A partir deste ponto, a cadeia RAG conversacional está pronta para receber novas perguntas e usar o histórico da conversa (incluindo a primeira pergunta e sua resposta) para fornecer respostas mais contextuais e relevantes."
      ],
      "metadata": {
        "id": "FsphPy2PClen"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "first_question = conversational_rag_chain.invoke(\n",
        "    {\"input\": f\"Como usar um desfibrilador em situações de emergência?\"},\n",
        "    config={\"configurable\": {\"session_id\": \"gml_nlp\"}},\n",
        ")"
      ],
      "metadata": {
        "id": "6pkOJ5_j6xtT"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(first_question['answer'])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "I9sEBNWe7yPr",
        "outputId": "c731595c-af34-46de-8a36-94ba2adcf674"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Um desfibrilador é um dispositivo que ajuda a restaurar a circulação cardíaca em situações de parada cardíaca. Aqui estão as etapas básicas para usar um desfibrilador em situações de emergência:\n",
            "\n",
            "1. **Verifique se a vítima está em parada cardíaca**: Certifique-se de que a vítima não está respirando e não tem pulso.\n",
            "2. **Chame a equipe médica ou um desfibrilador automatizado**: Se estiver sozinho, chame o Serviço de Atendimento Móvel de Urgência (SAMU) ou outra equipe médica. Se estiver com um desfibrilador automatizado, siga as instruções do dispositivo.\n",
            "3. **Coloque a vítima em uma superfície rígida**: Certifique-se de que a vítima esteja em uma superfície plana e rígida, como uma mesa ou chão.\n",
            "4. **Retire qualquer acessório de peito**: Retire qualquer acessório que possa interferir com o desfibrilador, como pulseira ou aliança.\n",
            "5. **Limpe o peito da vítima**: Limpe o peito da vítima com um pano limpo para remover qualquer sujeira ou líquido.\n",
            "6. **Coloque os eletrodos**: Coloque os eletrodos do desfibrilador no peito da vítima, seguindo as instruções do dispositivo. A posição tradicional recomendada é um eletrodo na região apical e outro na região infraclavicular direita.\n",
            "7. **Verifique se o desfibrilador está em modo automático**: Certifique-se de que o desfibrilador esteja em modo automático e que o dispositivo esteja preparado para desfibrilar.\n",
            "8. **Desligue o desfibrilador**: Se o desfibrilador estiver em modo manual, desligue-o antes de prosseguir.\n",
            "9. **Realize a desfibrilação**: O desfibrilador automatizado fará a desfibrilação automaticamente se o ritmo da vítima for considerado \"chocável\". Se estiver em modo manual, pressione o botão para realizar a desfibrilação.\n",
            "10. **Recomece as compressões torácicas**: Depois de realizar a desfibrilação, recomece as compressões torácicas imediatamente.\n",
            "11. **Verifique o ritmo da vítima**: Depois de 2 minutos de compressões torácicas, verifique o ritmo da vítima para determinar se a desfibrilação foi bem-sucedida.\n",
            "\n",
            "Lembre-se de que o uso de um desfibrilador deve ser feito por alguém treinado e que a vítima deve ser encaminhada para um hospital o mais rápido possível após a desfibrilação.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(first_question['chat_history'])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2Sl1A780aDyH",
        "outputId": "33f5a14e-6214-4e98-8642-25d3b8e48582"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Este código envia a segunda pergunta \"O que fazer depois?\" para a cadeia RAG conversacional, dando continuidade à sessão de conversa \"gml_nlp\". A resposta do chatbot será armazenada na variável `second_question`.\n",
        "\n",
        "A chave aqui é que a segunda pergunta depende do contexto da primeira pergunta. O chatbot precisa lembrar que a primeira pergunta era sobre como usar um desfibrilador para entender que \"O que fazer depois?\" se refere aos passos seguintes após o uso do desfibrilador.\n",
        "\n",
        "Graças ao `RunnableWithMessageHistory` e ao `get_session_history`, a cadeia RAG conversacional consegue acessar o histórico da conversa e entender o contexto da segunda pergunta, fornecendo uma resposta mais precisa e relevante."
      ],
      "metadata": {
        "id": "KKZ5_RizDMCy"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "second_question = conversational_rag_chain.invoke(\n",
        "    {\"input\": f\"O que fazer depois?\"},\n",
        "    config={\"configurable\": {\"session_id\": \"gml_nlp\"}},\n",
        ")"
      ],
      "metadata": {
        "id": "zqC4OqUK-HUu"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(second_question['answer'])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "85TeQteP-PNB",
        "outputId": "6bbda65e-aedb-4493-a76f-79580d4b31a1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Depois de realizar a desfibrilação, é importante seguir as instruções abaixo:\n",
            "\n",
            "1. **Rocomecer as compressões torácicas**: Recomece as compressões torácicas imediatamente, mantendo a frequência de 100 a 120 compressões por minuto.\n",
            "2. **Verificar o ritmo da vítima**: Verifique o ritmo da vítima após 2 minutos de compressões torácicas para determinar se a desfibrilação foi bem-sucedida.\n",
            "3. **Realizar novas desfibrilações**: Se a vítima ainda não estiver em ritmo normal, pode ser necessário realizar novas desfibrilações a cada 5 minutos, até que o ritmo seja restabelecido.\n",
            "4. **Mantear a vítima confortável**: Certifique-se de que a vítima esteja confortável e segura, evitando que ela se mova ou se afaste da superfície de compressão.\n",
            "5. **Manter a comunicação**: Mantenha a comunicação com a equipe médica e com as pessoas ao redor, informando sobre a situação da vítima e as ações que estão sendo tomadas.\n",
            "6. **Encaminhar a vítima para um hospital**: Após a desfibrilação, encaminhe a vítima para um hospital o mais rápido possível, onde ela receberá cuidados médicos especializados.\n",
            "7. **Relatar o ocorrido**: Após a situação ter sido resolvida, relatar o ocorrido à equipe médica e às autoridades competentes, para que possam tomar as medidas necessárias para evitar futuras situações semelhantes.\n",
            "\n",
            "Lembre-se de que a desfibrilação é apenas uma parte do tratamento de uma parada cardíaca. A vítima necessitará de cuidados médicos especializados para recuperar e evitar danos ao coração e ao organismo.\n",
            "\n",
            "Além disso, é importante lembrar que:\n",
            "\n",
            "* A vítima pode precisar de oxigênio e suporte de vida avançado, como ventilação mecânica e terapia de resfriamento.\n",
            "* A vítima pode precisar de medicamentos para estabilizar o coração e o sistema circulatório.\n",
            "* A vítima pode precisar de cuidados de reanimação, como compressões torácicas e ventilação, durante um período prolongado.\n",
            "\n",
            "É fundamental que a vítima seja encaminhada para um hospital o mais rápido possível, onde ela receberá os cuidados necessários para recuperar e evitar danos ao coração e ao organismo.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "second_question['chat_history']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "0PVsnUo9Z-Fh",
        "outputId": "0411bdf0-f291-47d3-f115-a31ab337a4a7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[HumanMessage(content='Como usar um desfibrilador em situações de emergência?', additional_kwargs={}, response_metadata={}),\n",
              " AIMessage(content='Um desfibrilador é um dispositivo que ajuda a restaurar a circulação cardíaca em situações de parada cardíaca. Aqui estão as etapas básicas para usar um desfibrilador em situações de emergência:\\n\\n1. **Verifique se a vítima está em parada cardíaca**: Certifique-se de que a vítima não está respirando e não tem pulso.\\n2. **Chame a equipe médica ou um desfibrilador automatizado**: Se estiver sozinho, chame o Serviço de Atendimento Móvel de Urgência (SAMU) ou outra equipe médica. Se estiver com um desfibrilador automatizado, siga as instruções do dispositivo.\\n3. **Coloque a vítima em uma superfície rígida**: Certifique-se de que a vítima esteja em uma superfície plana e rígida, como uma mesa ou chão.\\n4. **Retire qualquer acessório de peito**: Retire qualquer acessório que possa interferir com o desfibrilador, como pulseira ou aliança.\\n5. **Limpe o peito da vítima**: Limpe o peito da vítima com um pano limpo para remover qualquer sujeira ou líquido.\\n6. **Coloque os eletrodos**: Coloque os eletrodos do desfibrilador no peito da vítima, seguindo as instruções do dispositivo. A posição tradicional recomendada é um eletrodo na região apical e outro na região infraclavicular direita.\\n7. **Verifique se o desfibrilador está em modo automático**: Certifique-se de que o desfibrilador esteja em modo automático e que o dispositivo esteja preparado para desfibrilar.\\n8. **Desligue o desfibrilador**: Se o desfibrilador estiver em modo manual, desligue-o antes de prosseguir.\\n9. **Realize a desfibrilação**: O desfibrilador automatizado fará a desfibrilação automaticamente se o ritmo da vítima for considerado \"chocável\". Se estiver em modo manual, pressione o botão para realizar a desfibrilação.\\n10. **Recomece as compressões torácicas**: Depois de realizar a desfibrilação, recomece as compressões torácicas imediatamente.\\n11. **Verifique o ritmo da vítima**: Depois de 2 minutos de compressões torácicas, verifique o ritmo da vítima para determinar se a desfibrilação foi bem-sucedida.\\n\\nLembre-se de que o uso de um desfibrilador deve ser feito por alguém treinado e que a vítima deve ser encaminhada para um hospital o mais rápido possível após a desfibrilação.', additional_kwargs={}, response_metadata={})]"
            ]
          },
          "metadata": {},
          "execution_count": 29
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "second_question['context']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "mImR0DI5aHkJ",
        "outputId": "84975922-a07d-42d4-ed4e-ff2a3fe07bea"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 21}, page_content='o retorno completo do tórax, a frequência deve ser de 100/120 por minuto e deve -\\nse  minimizar interrupções nas compressões. \\n• Deve-se realizar a abertura das vias aéreas e a ventilação. \\n• A ventilação ideal pode ser realizada boca a boca ou com di spositivos de proteção, \\nmantendo a relação compressão/ventilação de 30:2. \\n• A desfibrilação deve ser realizada assim que possível  na presença de ritmos de \\nparada “chocáveis” (Taquicardia Ventricular s/ pulso e Fibrilação Ventricular).'),\n",
              " Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 12}, page_content='12 Cardiologia na Emergência: Guia para o Pronto-Socorro \\nCAPÍTULO I | RESSUSCITAÇÃO CARDIOPULMONAR (RCP) \\n(Desfibrilation). A sequência de realização das manobras mais preconizadas é C -A-B. A \\nmanobra correspondente a letra  D (Desfibrilation), que corresponde à desfibrilação, deve ser \\nrealizada, quando bem indicada, assim que possível⁵,⁸. \\n2.1. C (CIRCULATION – CIRCULAÇÃO) \\nApós a identificação da PCR, é imprescindível o início imediato das compressões \\ntorácicas. Alguns pilares importantes desta manobra são: \\n• A vítima deve estar sobre superfície rígida \\n• Deve ser realizada sobre o esterno, aplicando força sobre o tórax, com braços \\nestendidos. \\n• A compressão deve gerar uma profundidade no tórax de 5-6 cm \\n• Permitir o retorno completo do tórax \\n• A frequência deve ser de 100/120 por minuto \\n• Minimizar as interrupções nas compressões (“no hands-off”) \\n• Trocar rapidamente o reanimador a cada 2 minutos'),\n",
              " Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 13}, page_content='forma automática, indicando ou não a desfibrilação, contribuindo para aumento das chances de \\nsobrevivência da vítima. A posição tradicional recomendada dos eletrodos é um na região apical \\ne outro na região infraclavicular direita. A carga recomendada depende do cardiodesfibrilador, \\nsendo indicado 360J no monofásico. Já no bifásico, a preferência é pela carga preconizada pelo \\nfabricante do aparelho, geralmente entre 120 -200 J, mas se dúvida, utilize 200J. Logo após a \\nrealização do choque, é recomendado recomeçar novo ciclo de RCP, para posteriormente ser \\nchecado o ritmo⁵,⁸. \\nBOX 3. APÓS A CHEGADA DA EQUIPE MÉDICA, QUE MEDIDAS DE SUPORTE MAIS \\nAVANÇADAS PODEM SER TOMADAS? \\nCom a chegada do Serviço de Atendimento Móvel de Urgência (SAMU), foram \\nrealizadas intubação orotraqueal, medicações e cuidados necessários condizentes com o \\nsuporte de vida avançado (SAV). \\nA vítima foi encaminhada para um hospital secundário, dando entrada inconsciente,'),\n",
              " Document(metadata={'source': 'CardiologianaEmergencia.pdf', 'page': 11}, page_content='retomadas, e o DEA indicou 3 choques ao longo de 10 minutos, todos seguidos de CTC. \\nApós o quarto choque, a vítima voltou a respirar ainda que inconsciente, não apresentando \\nmais indicação de desfibrilação devido à retomada do ritmo sinusal. \\n2. SUPORTE BÁSICO DE VIDA (SBV) \\nO Suporte Básico de Vida (SBV) é o protocolo de atendimento inicial às vítimas de parada \\ncardiorrespiratória (PCR), que pode ser iniciado no ambiente extra -hospitalar, no qual se \\nestabelece o reconhecimento e a realização de manobras. O grande objetivo do SBV é manter o \\npaciente viável e com o Sistema Nervoso Central (SNC) o mais intacto possível. Com a chegada \\nda equipe médica equipada e treinada, terá início o Suporte Avançado de Vida (SAV)⁵,⁸. \\nO atendimento inicial é feito pela pessoa mais próxima e inicia com uma vítima suspeita \\nde PCR. De início, após identificação de vítima suspeita de PCR, é preciso verificar se o local do')]"
            ]
          },
          "metadata": {},
          "execution_count": 30
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "second_question['input']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "HTaCv5ZdaPTZ",
        "outputId": "2bdec89c-5560-42d6-9fe6-eb6883a6bba5"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'O que fazer depois?'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 31
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Desafios Práticos\n",
        "\n",
        "Os desafios a seguir exploram as aplicações práticas da técnica Retrieval Augmented Generation (RAG) na construção de sistemas inteligentes de perguntas e respostas e assistentes virtuais. Cada desafio apresenta um problema específico e um conjunto de instruções para guiar a implementação de uma solução baseada em RAG. As soluções serão avaliadas com base em métricas relevantes para cada contexto, como acurácia, relevância, personalização e eficiência."
      ],
      "metadata": {
        "id": "GJRHouV07wuH"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Desafio 1:\n",
        "\n",
        "\n",
        "*   **Objetivo:** criar um sistema de perguntas e respostas usando RAG.\n",
        "*   **Instruções:** desenvolver um modelo que integre recuperação de informações e geração de respostas com base em um conjunto de documentos específicos.\n",
        "*   **Avaliação:** medir a acurácia e a relevância das respostas geradas.\n",
        "\n",
        "\n",
        "\n",
        "Desafio 2:\n",
        "*   **Objetivo:** criar um sistema de perguntas e respostas usando RAG.\n",
        "*   **Instruções:** utilizar RAG para personalizar recomendações baseadas no histórico de interações do usuário.\n",
        "*   **Avaliação:** analisar a personalização e a satisfação do usuário com as recomendações.\n",
        "\n",
        "    \n",
        "Desafio 3:\n",
        "*   **Objetivo:** implementar um assistente virtual para suporte ao cliente que utilize RAG para fornecer respostas precisas.\n",
        "*   **Instruções:** integrar um banco de dados de FAQs com um modelo de RAG para responder a questões técnicas complexas.\n",
        "*   **Avaliação:**  avaliar a eficiência e precisão das respostas em situações de teste.\n",
        "\n",
        "   "
      ],
      "metadata": {
        "id": "kwNUZj6trxQL"
      }
    }
  ]
}